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Abstract 
In spite of recent progress in the field of adipose tissue engineering (ATE), the optimal 
adipose tissue scaffold still remains illusive and the tailoring of the structure and properties of 
tissue scaffolds according to adipose tissue were less explored or even neglected. Thus, 
synthetic poly(glycerol sebacate) (PGS)-based scaffolds and hydrogels which mimic  
the properties of adipose tissue were developed in this PhD project for potential  
application in ATE. 
Large and porous three-dimensional PGS/poly(L-lactic acid) (PLLA) blend scaffolds with 
various weight ratios were successfully fabricated via a freeze-drying and a subsequent curing 
process, illustrating that a minor amount of PLLA can act as a structure-supporting polymer. 
The presence of PLLA prevented the low-viscosity pre-polymer of PGS from enclosing 
interconnected open-cell structure during the curing stage, thereby avoiding structural 
collapse of the scaffold. This novel versatile approach will simplify the fabrication of large 
and porous PGS-based scaffolds for soft tissue engineering. 
The above PGS/PLLA blend scaffolds were optimised to achieve similar bulk mechanical 
properties to those of native low and high stress adapted adipose tissue. The scaffolds were 
fabricated by using two different organic solvents and presented suitable porous structures for 
cell penetration and growth for prospective applications in ATE. 
The development of poly(glycerol sebacate urethane) (PGSU) scaffolds via the freeze-
drying process allowed to enhance the mechanical properties, the degradation behaviour and 
the fabrication simplicity, in comparison to the prior fabricated PGS/PLLA blend scaffolds. 
The PGSU scaffolds were successfully fabricated with three different molar ratios of 
hexamethylene diisocyanate, without the necessity of an additional curing stage and a minor 
structure-supporting biopolymer. The scaffolds were stretchable, featured long-term stability 
 vi 
and tuneable degradation kinetics, demonstrating great potential for applications in ATE and 
in other fields of soft tissue engineering. 
Despite the highly interesting properties, the previously applied PGS-based materials 
presented limited water absorption and diffusion capabilities. Therefore, novel biodegradable 
PGS-based polyurethane hydrogels were successfully synthesised via the pre-polymer of PGS 
and isocyanate-terminated poly(ethylene glycol)s with varying molecular weights. The 
hydrogels featured high flexibility and strechability, enhanced hydrophilicity and good 
biodegradability and biocompatibility, as well as thermoresponsivity. The hydrogels were 
evaluated for potential applications in ATE and other fields of soft tissue engineering. 
Additionally, its implementation for drug delivery, thermal actuation and ultralow power 
generation applications has been examined. 
Overall, PGS-based scaffolds and hydrogels present great potential in ATE and will further 
advance this field of research. 
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Chapter 1. Introduction 
Tissue engineering is an extensively evolving field of research which combines the 
fundamental principles of biomaterials and biochemical engineering with cell biology to 
develop complex artificial tissues and organs, addressing the current clinical limitations in 
using either autologous or allogeneic grafts in traditional implantation approaches [1,2]. 
Numerous tissue engineering strategies have been developed during the last decades with 
promising results in a wide variety of tissue engineering applications, with significant market 
potential in the healthcare sector [3,4]. 
Adipose tissue engineering (ATE) aims to restore soft tissue defects, and studies have 
shown that the regeneration of adipose tissue is possible via engineered natural or synthetic 
tissue substitutes in vitro and in vivo, offering potential alternatives to current clinical 
treatment options [5,6]. With respect to synthetic engineered substitutes, common 
biodegradable and biocompatible synthetic polymers with inappropriate physical properties 
were primarily used with limited attempts to adopt the structure and properties of adipose 
tissue [5–9]. Unfortunately, most of the biodegradable and biocompatible synthetic polymers 
available today do not provide satisfactory performance in soft tissue applications, due to their 
high stiffness, plastic deformation and mechanical failure when exposed to cyclic loads, thus, 
restraining their clinical use [10,11]. Research studies demonstrated that mechanically 
appropriate scaffolds are beneficial in terms of mechanical signal transmission and 
stimulation which can be beneficial for cell differentiation and proliferation [12,13].  
Therefore, the optimal adipose tissue substitute remains illusive and the research for new 
biodegradable polymer scaffolds is needed. 
Synthetic biodegradable and biocompatible elastomers are a relatively new class of 
polymers and have recently gained much attention in the field of soft tissue engineering 
[14,15]. Synthetic bioelastomers feature attractive elastomeric properties and can withstand 
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highly dynamic mechanical environments in vitro and in vivo [14,15]. Thus, the developments 
of functionally compliant and mechanically flexible scaffolds from synthetic bioelastomers 
are highly interesting for soft tissue engineering applications where non-elastomeric synthetic 
biodegradable polymers are currently mainly used [14,15]. 
Among the new class of emerging synthetic biodegradable and biocompatible elastomers, 
poly(glycerol sebacate) (PGS) has gained most attention in recent years [16,17]. PGS showed 
great potential for a variety of biomedical applications and featured tailorable mechanical 
properties to match specific tissue requirements [16,17]. It demonstrated good in vitro and  
in vivo biocompatibility and is characterised with relatively linear degradation kinetics, low 
swelling properties and good retention of mechanical strength relative to the mass loss 
[16,17]. PGS is synthesised via a polycondensation reaction of glycerol and sebacic acid, 
forming a meltable and soluble pre-polymer which is subsequently cured to create a 
covalently crosslinked network [16,17]. However, in contrast to other synthetic biopolymers, 
PGS reveals a set of limitations and various challenges in manufacturing large three-
dimensional (3D) scaffolds, overall constraining the full potential and adoption of PGS in a 
broader field of soft tissue engineering applications. 
The overall aim of this research is to design and develop biomimetic tissue scaffolds based 
on PGS with similar bulk mechanical properties to those of adipose tissue and with 
appropriate porous structures suitable for cell penetration and growth for potential application 
in ATE. There are four objectives associated with this research, which are outlined below: 
 To develop a novel fabrication strategy to create large and porous 3D PGS-based 
scaffolds, by applying the freeze-drying technique, with enhancements in terms of 
fabrication simplicity, flexibility and efficiency, in comparison to previous  
fabrication methods. 
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 To engineer large PGS-based scaffolds for ATE with similar bulk mechanical 
properties to those of adipose tissue, and investigate the porous structure, the 
mechanical properties, the degradation behaviour and the biocompatibility of  
the biomimetic scaffolds. 
 To create large PGS copolymer scaffolds for ATE with similar bulk mechanical 
properties to those of adipose tissue, with enhancements in terms of soft and flexible 
mechanical properties, tuneable degradation behaviour as well as  
fabrication simplicity. 
 To develop novel PGS copolymer hydrogels for ATE with enhanced hydrophilic 
properties, and investigate the mechanical properties, the degradation behaviour and 
the biocompatibility. 
The novel fabrication and synthesis approach of elastomeric PGS-based scaffolds and 
hydrogels are expected to help advancing ATE and other fields of soft tissue engineering.  
 4 
Chapter 2. Literature review 
2.1 Tissue engineering 
Tissue engineering is an interdisciplinary field which unites the principles of engineering and 
life sciences [18]. The main objective of tissue engineering is the regeneration of damaged 
tissues or organs through the use of artificial substitutes in structure and function, thus 
eliminating the need for patients to obtain tissue or organ transplants, either autologous or 
from designated donors. The transplantation of tissue and organ is besieged with medical and 
ethical concerns [19–22], such as the rising ageing population and the growing shortage in 
donor organ availability [23,24]. Thus, new state-of-the-art technologies and tissue 
engineering strategies are urgently needed to eliminate these concerns [18,25]. 
Tissue engineering strategies are derived from three basic components, which involves the 
combination of cells, signals and scaffold, otherwise known as the tissue engineering triad 
[26]. The cells must express stable genotype and appropriate phenotype in order to regenerate 
the tissue and its specific functions, which can encompass autologous cells from the host 
tissue or various stem cell sources [26,27]. The signalling system should direct the growth and 
differentiation of cells via chemical or physical stimuli, involving growth factors and 
cytokines, or bioreactors [28], while the scaffold acts as a framework for cell migration and 
tissue growth [29]. The scaffold matrix should degrade gradually upon implantation and be 
replaced by the cell secreted extracellular matrix (ECM). In fact, each of these basic tissue 
engineering components can be used individually or in combination to restore or regenerate  
functional tissues [30]. 
Two fundamental fabrication strategies were developed for engineering fully functional 
tissues and organs, the so-called bottom-up and top-down approaches [31,32]. Each of the 
approaches has its own strength and weakness and is suitable for different tissue engineering 
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applications [31]. The bottom-up approach uses different fabrication techniques to create 
modular micro-tissues, which can be assembled into larger scales of tissues with specific and 
complex structural features [31]. It aims to create more biomimetic engineered tissues by 
mimicking the physiological microstructural functions of native tissue [31]. The modular 
micro-tissues can be fabricated via cell aggregation, cell sheeting, cell-laden microfabrication 
and direct three-dimensional cell printing [33–36]. The engineered micro-tissues can be 
subsequently assembled into larger tissues with specific architectural features via random 
packing, stacking of layers or directed assembly [35,37,38]. Hence, the use of the different 
fabrication and assemble techniques on a microscale, allows one to guide tissue growth and 
morphogenesis on a cellular level. 
The top-down approach is the most commonly used strategy for tissue engineering [32], in 
which cells are seeded on scaffold constructs, resulting in the formation of new tissue. The 
cells adhere, proliferate and regenerate new ECM within the scaffold [30], frequently assisted 
via perfusion, growth factors and/or mechanical stimulation. In this approach, a highly porous 
scaffold structure is needed to accommodate the seeded cells to support their growth and 
tissue regeneration in 3D. An ideal scaffold must fulfil many requirements to be considered 
for tissue engineering applications [2,39]. The scaffold material must be biocompatible and 
should feature bioactivity to promote cell adhesion, differentiation and proliferation [2,39]. 
The biodegradability and the mechanical properties of the scaffold are two further important 
characteristics and often depend on the application [2,39]. Ideally, the scaffold should be 
made from a material with a controllable biodegradation profile which closely matches the 
regeneration profile of the desired native tissue, while the biodegradation products should not 
induce any adverse response [40]. The mechanical properties of the scaffold should also 
match the anatomical site of implantation and possess sufficient mechanical integrity to 
support tissue growth, particularly during the early stages [2,41]. In addition, the scaffold 
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should be easily fabricated into a variety of shapes and sizes, and possess highly inter-
connected 3D porous structures with appropriate pore sizes, porosities and large surface areas 
[2,39]. The void space within the scaffold is not only essential for cell migration and tissue 
growth, but also for the diffusion of nutrients and waste products [2,39,41]. 
2.2 Adipose tissue engineering 
2.2.1 Introduction to adipose tissue engineering 
ATE aims to regenerate soft tissue defects caused by complex traumas, oncologic resections 
and congenital abnormalities, as well as confronting the current clinical limitation of 
autologous adipose tissue transplantation [5,6]. Soft tissue defects can lead to cosmetic 
abnormalities, functional impairments and affect the patient’s emotional and psychological 
well-being [6]. In 2014, approximately 5.8 million reconstructive procedures were performed 
in the United States of America, with 4.4 million cases related with tumour removal [42]. 
Current conventional soft tissue reconstruction strategies primarily involve autologous 
adipose tissue transplantation, including autologous composite tissue flaps which contain two 
or more tissue elements, or commercially available synthetic implants or fillers [5,43]. The 
transfer of large autologous tissues remains the gold standard for soft tissue reconstruction, 
however, this technique requires complex surgical procedures with unpredictable clinical 
outcome, due to the absorption and subsequent volume loss of the transplanted adipose tissues 
with 40-60% graft volume reduction [6]. In particular the lack of sufficient revascularisation 
limits the long-term tissue viability and is one of the main reasons for tissue resorption 
[6,44,45]. Studies showed that the transplantation of small volumes of autologous adipose 
tissue can succeed through diffusion, however, the transplantation of small tissue volumes is 
clinically irrelevant for most soft tissue defects [6,46,47]. The application of synthetic 
implants and fillers are associated with immune response and rejection, along with migration 
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and resorption issues, and consequent failure in host tissue integration [7,43]. In addition, 
because of the large volumes of specific adipose tissue depots in humans, current clinical 
requirements seek engineered constructs of considerable size in the order of several cubic 
centimetres which is still unfulfilled in ATE [8]. Despite recent successful achievements and 
progress in the field of adipose tissue reconstruction [48,49], new techniques and materials 
are needed. 
ATE aims to address these challenges and shows the potential to facilitate large volume 
soft tissue augmentation, enabling the development of synthetic tissue constructs which can 
imitate adipose tissue, both structurally and functionally [5]. Thus, the development of new 
ATE strategies is essential for the soft tissue restoration [50]. 
2.2.2 Physiology and cellular components of adipose tissue 
Adipose tissue, commonly known as fat, is distributed throughout the human body and forms 
a specialised connective soft tissue [51]. Adipose tissue can be differentiated between two 
major types in humans [51]: brown adipose tissue (BAT) and white adipose tissue (WAT). 
The basic functions of both adipose tissue types are the insulation and cushion of the body, as 
well as the main storage sites for energy in form of triglycerides [51]. BAT, which provides a 
high vascularity, is mainly found in infants and responsible for the heat generation in the early 
stage at birth and decreases during the body ageing, while WAT content gradually increases 
[52,53]. WAT, shown in Figure 2.1, is the most prominent form of the adipose tissue, which 
not only serves as the main energy reservoir, but is also associated with metabolic functions 
and is involved in various pathological syndromes [54,55]. Even though WAT is not as highly 
vascularised as BAT, it features a sufficiently vascularised network, in which all adipocytes 
are in contact with at least one capillary, supporting active metabolism and allowing a 
continuous growth of the tissue [56,57]. Beside the extensive system of blood vessels, it also 
contains a network of lymph nodes and nerves, which are supported by the ECM structure. 
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Figure 2.1: Light micrograph of human WAT, stained with haematoxylin and eosin. Adapted 
from Cinti et al. [58] with permission from Elsevier, copyright 2005. 
 
WAT can be categorised by depot and location and can be found in areas all over the body: 
subcutaneous (cranial, facial, abdominal, gluteal and extremity), intra-abdominal (omental, 
retroperitoneal, visceral) and other sites (retro-orbital, periarticular regions, bone marrow, 
intramuscular, pericardial), within which the subcutaneous and intra-abdominal depots form 
the main compartments for WAT storage [59]. In an adult organism, WAT undergoes a 
continuous process of remodelling and is the only tissue that can significantly change its mass 
[60]. The normal weight percentage of WAT mass in adult humans, in respect to the total 
body weight, are between the values of 9-18% in males and 14-28% in females, while athletes 
reach low values of 2-3% whereas extremely obese individuals have high values  
of 60-70% [61]. 
The predominant cellular components of adipose tissue are adipocytes, also known as 
lipocytes or fat cells, which are composed of lipidic fluid (60-85 wt%), water (5-30 wt%) and 
protein (2-3 wt%) [51]. The lipidic fluid consists of 90-99% triglycerides, free fatty acids, 
diglycerides, cholesterol phospholipids, as well as cholesterol ester and monoglycerides [51]. 
Adipocytes contain a large and centrally located lipid droplet, surrounded by cytoplasm and a 
peripheral located nucleus, while the cells themselves are characterised by spherical or 
polyhedral shapes with diameters in the rage of 80-180 μm (depending on the degree of 
obesity) [62,63]. The size and number of adipocytes can influence the mass and volume of 
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adipose tissue [51]. Fully differentiated adipocytes do not proliferate but can increase or 
decrease in size, primarily through the accumulation of lipid fluid within the cells, which 
depends on the energy intake and expenditure [64]. The development of new adipocytes 
involves the proliferation of preadipocytes, which can differentiate into mature adipocytes for 
adipose tissue renewal or expansion [50]. 
 
Figure 2.2: (A) Schematic of a lobule (fat cell cluster) of adipose tissue. (B) Scanning 
electron microscopic (SEM) images of the reinforced basement membrane of porcine adipose 
tissue. Adapted and modified from Comley et al. [65] with permission from Elsevier, 
copyright 2010. 
 
As seen in Figure 2.2 (A, B), adipocytes are organised in lobules (fat cell clusters) and 
enclosed within ECM structures, the so-called reinforced basement membrane and 
interlobular septa, predominately composed of collagen types I, III, IV, V and VI [66]. Both 
inter-penetrating structures form a complex 3D network in which the reinforced basement 
membrane creates a 3D closed-cell structure, where the cavities are filled by adipocytes, while 
the interlobular septa interact as a reinforcement base by establishing a 3D open-cell structure 
throughout the basement membrane [62]. Studies indicated that the reinforced basement 
membrane has a thickness of around ~1 µm, while the interlobular septa consists of long 
fibrous bundles of several millimetres in length and diameters of up to 30 µm [65,67]. In 
addition to adipocytes and preadipocytes, other cell types such as fibroblasts, endothelial 
cells, various immune cells and stem cells are present in adipose tissue. However, the cellular 
composition of adipose tissue depends on its type, depot, and anatomical location [68,69]. 
 10 
2.2.3 Mechanical properties of adipose tissue 
Adipose tissue is a viscoelastic soft tissue which is physiologically exposed to large 
deformations that are associated with body weight loads and weight-bearing [12,70,71]. From 
the mechanical point of view, adipose tissue can be considered as a closed-cell foam with 
cavities of fluid-filled adipocytes [72]. As discussed in Section 2.2.2, the adipocytes are 
enclosed within a 3D collagen network that is based on the reinforced basement membrane 
and the fibrous interlobular septa, which form an inter-penetrating closed- and open-cell foam 
[62,65], respectively. Although majority of the adipose tissue volume consists of the 
adipocytes lipid content [64], research studies demonstrated that the lipid droplets can be 
idealised as an incompressible inviscid fluid and yields a negligible contribution to the 
modulus of adipose tissue [62,65]. With this respect, porcine lipid exhibited a viscosity in the 
range of 37-61 mPa s, depending on the test temperature [65]. The mechanical properties of 
adipose tissue are therefore mainly dictated by the reinforced basement membrane, while the 
low volume fraction of the interlobular septa provides a less dominant contribution [62,65]. 
However, recent studies showed that the alignment of the fibrous interlobular septa causes 
mechanical anisotropy in adipose tissue [73]. 
The mechanical properties of adipose tissue were determined via tension tests [72,74], 
compression tests [62,72,75,76], indentation tests [77,78] and via elastography [79,80]. 
Adipose tissue showed in general a nonlinear dependency upon strain rate [65,72]. Adipose 
tissue exhibits under tension and compression a nonlinear stress versus strain response at 
large strain levels, while at low strain levels the response is linear [65,67,72]. At strains 
greater than 25-30%, adipose tissue 'locks up' and the stress level increases rapidly [65,67,81]. 
Also, the mechanical investigation under tension indicated higher risks of adipose tissue 
tearing at strains greater than 30%, although large strains do occur in vivo [12,70,71,73]. In 
normal human physiology, e.g. during normal sitting or lying, adipose tissue is exposed to 
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large physiological deformations [12,70,71,82]. For instance, a sitting posture induces peak 
tensile, compressive and shear strains of ~30%, ~45% and ~40% on the anatomical site 
related adipose tissues, while a lying posture induces approximately half these loads on the 
same anatomical locations [12,70,71,82]. 
Research studies indicated that the mechanical properties of adipose tissue depend on the 
anatomical site and function [76], similar to the structure-function relationships in other 
human tissues [83]. For instance, Alkhouli et al. [73] compared the mechanical properties of 
human subcutaneous and omental adipose tissues, which have different physiological 
functions, demonstrating that subcutaneous adipose tissue features greater expansion and 
recovery capabilities from mechanical deformation than omental adipose tissue. Other studies 
concerning the analysis of adipose tissue from human abdomen [76,84], breast [76–78,85] 
and heel pads [76,80,86] demonstrated similar structure-function relationships. Studies 
determined that low stress adapted adipose tissue from abdomen and breast features a Young's 
modulus in the range of 0.0003-0.003 MPa [76,84] and 0.003-0.024 MPa [76–78,85], while 
high stress adapted adipose tissue samples from the heel pads obtained results in the range of 
0.024-0.18 MPa [76,80,86]. Hence, adipose tissue from the heel pad is exposed to intense 
mechanical loads, while the adipose tissue from abdomen and breast do not ordinarily  
bear high loads [76]. 
Rheological shear experiments on adipose tissue revealed that the linear regime is only 
valid for very small strains up to 0.1%, in which the storage and loss modulus showed a 
frequency and temperature dependent behaviour [67,87]. In addition, animal subcutaneous 
and orbital adipose tissue were characterised with an elastic and viscous shear moduli in the 
range of 0.0003-0.0009 MPa and 0.0001-0.0005 MPa [81,88], while adipose tissue from 
animal kidneys featured greater elastic and viscous shear moduli of 0.003-0.005 MPa and 
0.001-0.003 MPa [88], respectively. Dynamic tests showed that adipose tissue becomes less 
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firm and diverge with increasing forces, strains and frequencies, as well as poor form 
recoverability after induced deformations [84]. 
2.2.4 Cell sources for adipose tissue engineering 
Cell sources for ATE must satisfy several critical characteristics and should ideally be 
autologous or non-immunogenic, be readily available and obtainable via minimally invasive 
procedures [8]. Most ATE strategies involved the utilisation of preadipocyte cell lines or stem 
cells, either embryonic or adult [5,7,8,50]. The transplantation of mature adipocytes is limited, 
due to their fragile nature and susceptibility to ischemic cell death, resulting in poor volume 
retention abilities [7,8,89]. Fully differentiated adipocytes do not proliferate, restraining their 
growth and regeneration potential in the site of tissue damage [7,50]. Thus, the transplantation 
of large adipose tissue volumes have been demonstrated to be inadequate in terms of tissue 
regeneration and volume stability, due to the insufficient angiogenesis [90]. 
Preadipocyte cell lines from autologous, allogeneic or xenogeneic origin were utilised in 
ATE applications, analysing their potential in various two-dimensional (2D) and 3D culture 
environments for adipogenic differentiation and formation of adipose tissue [7,8]. 
Preadipocytes can be expanded in culture, are mechanically stable and are acquirable from 
biopsies or liposuction aspirates [50,91,92]. However, experimental studies in ATE primarily 
use 3T3-L1 cells as preadipocyte surrogates, which are not considered to be suitable for 
clinical applications because of their aneuploid status and xenogeneic origin [7,8]. 
The application of embryonic or adult stem cell sources for ATE has been dominated in the 
recent years and many studies have demonstrated that these cells possess the capability of 
adipogenic differentiation, and presented the formation of adipose tissue both in vitro and  
in vivo [5,7,8,50]. Stem cells are unspecialised cells which are capable of dividing and 
renewing themselves for long periods, and can differentiate into a wide variety of other 
specialised cell types [8,50]. Embryonic stem cells appear to be an appropriate cell source for 
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soft tissue reconstructions, however, only limited quantities of ATE related studies have been 
performed with these types of cells, because of ethical concerns and legal constraints [5,8,50]. 
With this respect, most cell-based approaches in ATE used adult stem cells, derived from 
bone marrow or adipose tissue [5,7,8,50]. Both bone marrow-derived stem cells (BDSCs) and 
adipose-derived stem cells (ADSCs) have been successfully employed in ATE and yielded 
similar good outcomes in the context of adipose tissue formation, when cultured with the 
appropriate lineage specific stimuli [5,50]. 
BDSCs are multipotent cells, capable of differentiating into lineages of multiple cell types 
and are obtainable via bone marrow aspiration or biopsy procedures [8]. However, extensive 
in vitro culture expansion of BDSCs are necessary, due to the relatively low yield of stem 
cells derived from bone marrow [93,94], while the differentiation capacity of BDCSs tends to 
decline with increasing time and passage in culture [95]. In addition, the  
harvesting procedures are relatively inconvenient and painful for the autologous  
or allogeneic donors [93,94]. 
ADSCs are a strong alternative cell source for ATE and easily obtainable via liposuction or 
abdominoplasty from the stromal vascular fraction (SVF) of adipose tissue [50,69]. ADCSs 
are also multipotent cells, available in abundance and expendable quantities, and are easier to 
harvest than BDSCs [96,97]. In addition, when the differentiation capacities of both stem cell 
types are directly compared, ADSCs presented a more efficient differentiation towards 
adipocytes, whereas BDSCs differentiated better into osteocytes and chondrocytes [98]. 
However, the yield, differentiation and growth characteristics of ADSCs depend on various 
factors, such as sex, age and health status of the donor, in addition to the used anatomic site 
and isolation method [97,99]. Nevertheless, ADSCs demonstrated to be a highly promising 
cell source for ATE and future clinical research studies and therapies. 
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2.2.5 Current adipose tissue engineering strategies 
Several ATE strategies have been investigated to engineer adipose tissue [50], as listed in 
Table 2.1. The traditional cell-based scaffold guided tissue regeneration method is the most 
common strategy [8,50], which is based on porous implantable substitutes from various 
natural and synthetic materials [5,9,50]. Further ATE strategies include the utilisation of cell-
seeded microspheres or cell-encapsulated hydrogels [100–108], the acellular approach  
of de novo adipogenesis [109–119], as well as the fragmented omentum based-tissue  
regeneration method [110]. 
Table 2.1: Current ATE strategies. Adapted and updated from Gomillion et al. [50] with 
permission from Elsevier, copyright 2006. 
ATE strategy Advantages Limitations References 
Scaffold guided tissue 
regeneration 
Shape definition; Shape 
maintenance 
Surgical procedures necessary; 
Volume reduction of implants over 
time if biodegradable materials 
are used 
[5,9,50] 
Injectable cell-seeded 
microspheres or cell-
encapsulated hydrogels 
Avoidance of surgical 
procedures; Filling of 
irregularly shaped defect 
sites 
Control over shape and dimension  
of the newly developed adipose tissue 
is limited; Volume reduction of 
implants over time if biodegradable 
materials are used 
[100–108] 
De novo adipogenesis Avoidance of cell 
harvesting; Avoidance of 
in vitro culture processes; 
Immunological 
compatibility 
Surgical procedures necessary if  
non-injectable materials are used; 
Volume reduction of implants over 
time if biodegradable materials  
are used 
[109–119] 
Fragmented omentum 
based-tissue regeneration 
Native ECM; Highly 
vascularised 
Surgical procedures necessary; 
Tissue availability; Graft volume 
reduction 
[110] 
 
Scaffold guided tissue regeneration 
The scaffold guided tissue redevelopment strategy utilises 3D porous scaffolds to mimic the 
target tissue environment and to provide a support structure for cell ingrowth and proliferation 
[5,50]. The in vivo implantation of appropriate cell-seeded scaffolds into the patient defect site 
would provide the creation of new tissue, while the scaffold material degrades and gets 
absorbed over time. This process is generally applied for the cell-based regeneration approach 
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in ATE, regardless of the scaffold material [50]. In this context, engineered scaffolds for 
adipose tissue substitutes should meet critical criteria such as host compatibility (minimal to 
no immune response of host and appropriate degradation characteristics), bioactivity (cell 
adhesion and proliferation, cell-cell contact and cell migration along with the incorporation of 
an efficient vascular supply), sustainability (long-term viability) as well as a high porosity 
with suitable pore interconnectivity and matching the mechanical properties of adipose tissue 
[5,50]. Ideal biodegradable polymeric materials for ATE should feature degradation times of 
minimum 180 days to support the complete adipose tissue development in vivo [120,121]. 
Injectable cell-seeded microspheres or cell-encapsulated hydrogels 
The use of injectable cell-seeded microspheres or cell-encapsulated hydrogels enables the 
direct treatment of the patient defect site via syringe injections [100–108,122]. Anchorage-
dependent cells, like preadipocytes, adipocytes and stem cells [50,123], need an attachable 
matrix for cell differentiation and proliferation, which the injectable carrier systems allow. 
Various injectable cell carriers based on synthetic and natural biocompatible and 
biodegradable materials were developed, which overall presented attractive properties in 
terms of low infection risk, minimal scarring and reduced treatment costs, due to the 
avoidance of complex surgeries [8,122]. A further advantage of injectable cell carriers is the 
possibility to fill irregularly shaped defect sites [8,122]. However, the control over shape and 
dimension of the newly developed adipose tissue is limited [8,122]. The volume reduction of 
implanted cell carriers is unavoidable due to the material resorption over time, and subsequent 
injections to the defect site will be required in order to restore the original volume [50,122]. 
De novo adipogenesis 
The de novo adipogenesis tissue strategy is based on the in vivo implantation of acellular 
tissue engineered replacements, which contain growth factors and stimulate the migration of 
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preadipocyte cells to the implant site [109–119]. The cells subsequently differentiate and 
proliferate into adipocytes to form connected adipose tissue [50]. Different growth factors 
were used and tested, amongst which particular isoforms of fibroblast growth factors (FGF) 
were involved. These factors demonstrated good adipogenesis and angiogenesis stimulation 
and the acceleration of cell differentiation [109–116]. Techniques such as the injection of 
hydrogels or microsphere systems, as well as the implantation of scaffold constructs within 
the defect site were used for the de novo adipogenesis strategy. The advantage of these 
techniques is the avoidance of complications associated with cell harvesting and 
immunological compatibility, as well as the necessity of cost- and time-intensive in vitro 
culture processes [124]. 
Fragmented omentum based-tissue regeneration 
Another ATE strategy for adipose tissue regeneration is the utilisation of fragmented 
omentum tissue from the donor site of the patient [110]. The omentum is a highly 
vascularised membrane and includes a great amount of adipose tissue. It covers and supports 
various organs in the abdomen, while a distinction is made between the lesser and greater 
omentum, which are located above the stomach and below the small intestine, respectively 
[110]. Masuda et al. [110] demonstrated that the in vivo implantation of fragmented omentum 
tissue with preadipocytes has the capability to form adipose tissue. 
2.2.6 Polymers for adipose tissue engineering 
2.2.6.1 Natural polymers 
Natural polymers are derived from the native ECM or created by biological systems [125]. 
Various natural polymers have been used for ATE, demonstrating good biodegradability and 
high biocompatibility in conjunction with good adipogenesis support [5,7,8]. The most 
common natural polymers utilised for ATE applications are collagen [106,116,126–137], 
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hyaluronan [43,102,138–145] and matrigel [109,111–113,117,119,130,146–152], which will 
be further discussed. Other natural polymers which demonstrate potential for adipose tissue 
replacements include alginate [153–156], fibrin [157–161], gelatin 
[109,112,116,129,162,163] and silk [127,164–166], as well as adipose-derived ECM 
[146,167,168] and decellurised human placenta [43,66,138,139]. These natural polymers have 
been utilised in many forms, including scaffolds, fibres, hydrogels and  
microspheres [5–9,122]. Although varying degrees of success have been reported by using 
natural polymers in ATE, this thesis will primarily focus on the application of synthetic 
polymers. Reviews of natural polymers utilised in ATE have been previously reported  
[5–9,122] and Table 2.2 presents a summary. 
Table 2.2: Natural materials used in ATE. Adapted and updated from Choi et al. [5] with 
permission from Mary Ann Liebert, copyright 2010. 
Natural materials Advantages Limitations References 
Collagen Component of native ECM Fast degradation rates; Toxic 
crosslinking reagents 
[106,107,116,126–137] 
Hyaluronan Favourable mechanical 
properties 
Minimal adipose tissue 
formation 
[43,102,138–145]  
Matrigel Favourable mechanical 
properties; Supports 
adipogenesis 
Tumour-derived xenogeneic 
origin 
[109,111–113,117,119, 
130,146–152] 
Alginate Favourable mechanical 
properties 
Minimal adipose tissue 
formation; Fast degradation 
rates;  
[108,153–156] 
Fibrin Favourable mechanical 
properties; Supports 
adipogenesis 
Fast degradation rates [157–161]  
Gelatin Supports adipogenesis Fast degradation rates; Toxic 
crosslinking reagents 
[109,112,116,129,162,
163]  
Silk Favourable mechanical 
properties; Supports 
adipogenesis; Slow 
degradation rates 
Processability [127,164–166]  
Adipose-derived 
ECM 
Native ECM Material availability; Isolation 
and preparation procedure 
[146,167,168] 
Decellurised 
human placenta 
Native ECM Material availability; Isolation 
and preparation procedure 
[43,66,138,139]  
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Collagen 
 
Figure 2.3: Collagen implants in ATE. (A1) Preadipocyte-seeded collagen gel specimen 
containing short collagen fibres. (A2) Oil Red O stained preadipocyte-seeded collagen gels 
after 21 days in vitro culture, implying the development of lipids (scale bar: (A1) 10 mm; 
(A2) 5 mm). Adapted from Gentleman et al. [132] with permission from Mary Ann Liebert, 
copyright 2006. (B) Porous collagenous microspheres with diameters ranging from of  
100-380 µm, adapted from Rubin et al. [106] with permission from Wolters Kluwer Health,  
copyright 2007. 
 
Collagen is a widely used natural polymer in tissue engineering applications, owing to its 
similarity in composition to the ECM, and to its low immunogenicity and cytotoxicity  
[169–171]. In ATE, crosslinked and non-crosslinked collagen substitutes were used 
[116,132,134], as seen in Figure 2.3 (A1-2, B), which demonstrated adipogenesis support and 
the development of new adipose tissue in vivo [116,129]. Non-crosslinked collagen features in 
general faster degradation rates in vivo [127], while crosslinked collagen exhibits slower 
degradation rates in vivo [131,137], along with enhanced mechanical properties [116,134]. 
Slower degradation rates and enhanced in vivo stability are desired in ATE, however, 
substitutes with rigid mechanical properties may result in a comfort deficit for the patient [6]. 
In addition, mainly chemical crosslinking methods were used, involving  
toxic reagents [116,134]. 
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Hyaluronan 
Hyaluronan, also known as hyaluronic acid, is a ubiquitous component in the ECM and plays 
an important role in terms of cell motility, differentiation and adhesion, as well as in other 
processes, e.g. wound healing processes and cancer metastasis [172–174]. Hyaluronan is in it 
natural state highly soluble, poses fast degradation rates and features overall low mechanical 
properties with compressive Young’s modulus, 𝐸𝑐, values of below 0.0001 MPa [175,176], 
owing to its high viscosity [172–174]. The utilisation of different crosslinking or esterification 
methods results in an insoluble polymer, characterised with degradation rates of 56 days  
in vivo [139]. In ATE, various hyaluronan based substitutes were implanted in vivo, as seen in 
Figure 2.4 (A, B, C), in which neovascularised structures were observed but relatively weak 
adipogenic differentiation [144,177]. 
 
Figure 2.4: Hyaluronic acid-based implants in ATE. (A) Hyaluronic acid-based scaffolds 
were seeded with preadipocyte and (B, C) implanted in vivo (human model) in the 
subumbilical area in a subcutaneous pocket, adapted from Stillaert et al. [144] with 
permission from Elsevier, copyright 2008. 
 
Matrigel 
Matrigel is an ECM-derived biomaterial, based from the Engelbreth-Holm-Swarm mouse 
sarcoma and contains a range of proteins, including collagen IV, laminin and various growth 
factors which can promote differentiation and proliferation of various cell lines [178]. Thus, 
matrigel mimics the complex extracellular environment of many soft tissues and has been 
extensively used to study cellular responses within 3D environments [130,146]. Matrigel 
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exhibits high malleability and is characterised with a low 𝐸𝑐 in the range of 0.0001-0.0007 
MPa [179–182], along with degradation rates of over 42 days in vivo [116,147,183]. 
However, matrigel has only limited potential for clinical applications, due to its  
tumour-derived xenogeneic origin and its likely immunogenicity [116]. In ATE, matrigel has 
shown to support adipogenesis from various cell sources and the extensive formation of 
adipose tissue [7,177], in particular with additional growth factors [109,112,117]. 
In general, natural polymers have many advantages especially in terms of biocompatibility 
and adipogenesis support, as well as favourable mechanical properties. However, many 
natural polymers are limited in supply, reproducibility and application capabilities, due to 
their fast degradation rates in vivo. Further concerns involve the possibility of immunogenic 
reactions and infection in vivo when animal-derived natural polymers are used. 
2.2.6.2 Synthetic polymers 
Synthetic biocompatible and biodegradable polymers provide a significant advancement in 
respect to the ability to design tissue scaffolds with predictable and reproducible mechanical, 
chemical and biodegradation properties [184]. In ATE, considerable work has been performed 
using polymers such as poly(lactic acid) (PLA) [127,185,186], poly(glycolic acid) (PGA) 
[121,137,158,162,187] and the copolymer poly(lactic-co-glycolic acid) (PLGA) 
[91,104,105,118,119,188–194], which are among the most commonly used synthetic 
polymers in tissue engineering [2,10,39]. Further, synthetic biodegradable materials which 
showed potential for adipose tissue replacements include hydrogels and polymers formed 
from varying compositions of poly(ε-caprolactone) (PCL) [120,195], poly(ethylene glycol) 
(PEG) [84,196–202], poly(ethylene glycol)terephthalate/poly(butylene terephthalate) 
(PEGT/PBT) [197] and biodegradable polyurethane (PU) [195,203]. Non-degradable 
synthetic materials such as polycarbonate (PC) [118,119], poly(ethylene terephthalate) (PET) 
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[204], polypropylene (PP) [128,162], fluoropolymers [205,206] and silicones [117,119] were 
also investigated for ATE, as listed in Table 2.3. 
Table 2.3: Synthetic materials used in ATE. Adapted and updated from Choi et al. [5] with 
permission from Mary Ann Liebert, copyright 2010. 
Synthetic materials Advantages Limitations References 
Poly(lactic acid) Biodegradable; 
Supports adipogenesis; 
Tailorable 
Hydrophobic; Stiff / 
inflexible 
[127,185,186] 
Poly(glycolic acid) Biodegradable; 
Supports adipogenesis; 
Tailorable 
Fast degradation rates; 
Hydrophobic; Stiff / 
inflexible 
[121,137,158,162,187] 
Poly(lactic-co-glycolic 
acid) 
Biodegradable; 
Tailorable 
Hydrophobic; Stiff / 
inflexible 
[91,104,105,118,119,1
88–194] 
Poly(ε-caprolactone) Biodegradable; 
Tailorable 
Hydrophobic; Inflexible [120,195] 
Poly(ethylene glycol)a Hydrophilic; Supports 
adipogenesis; 
Soft/flexible; Tailorable 
Non-biodegradable [84,196–202] 
Poly(ethylene glycol) 
Terephthalate/poly(butylene 
terephthalate) 
Biodegradable; 
Hydrophilic; 
Soft/flexible; 
Tailorable; Supports 
adipose tissue formation 
Slow degradation rate; 
Incomplete degradation 
in vivo 
[197] 
Biodegradable 
polyurethane 
Biodegradable; 
Flexible; Tailorable 
Hydrophobic [195,203] 
Polycarbonate Shape maintenance Non-biodegradable; 
Hydrophobic; Stiff / 
inflexible 
[118,119] 
Poly(ethylene terephthalate) Shape maintenance; 
Supports adipose tissue 
formation 
Non-biodegradable; 
Hydrophobic; Stiff / 
inflexible 
[204] 
Polypropylene Shape maintenance Non-biodegradable; 
Hydrophobic; 
Stiff/inflexible 
[128,162] 
Fluoropolymers Shape maintenance Non-biodegradable; 
Hydrophobic; Stiff / 
inflexible 
[205,206] 
Silicones Shape maintenance Non-biodegradable; 
Hydrophobic 
[117,119] 
a Acrylated PEG-based hydrogels were mainly utilised in ATE. 
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Poly(lactic acid) 
PLA is an aliphatic polyester derived from lactic acid monomers and has been used for a wide 
variety of tissue engineering applications, due to its good biocompatibility and 
biodegradability [207,208]. It possesses adjustable physicochemical properties, is highly 
hydrophobic, and is characterised with long degradation times via bulk erosion [207,208]. 
PLA is a stiff polymer and features a tensile Young’s modulus, 𝐸𝑠, ultimate tensile strength, 
𝜎𝑠𝑚𝑎𝑥, and strain at break, 𝜀𝑠𝑏, in the range of 1.57-4.18 GPa, 34.5-67.2 MPa and 2.43-8.57% 
[209], respectively. Furthermore, PLA has stereoisomers [210], such as poly(L-lactic acid) 
(PLLA) and poly(D-Lactic acid) (PDLA). 
With respect to ATE, Mauney et al. [127] investigated the in vitro and in vivo (athymic 
nude mouse model) response of human BDSCs and ADSCs on woven PLA meshes for up to 
28 days. Cell differentiation into adipocytes was assessed in both in vitro and in vivo, while 
the woven PLA meshes degraded completely in vivo within the test period. However, silk or 
collagen scaffolds presented quantitatively higher cell differentiation performances under the 
same cell culture conditions. In addition, Chaubey et al. [186] examined the response of 
mouse BDSCs on patterned and plain PLLA film surfaces for up to 36 days in vitro, 
demonstrating that the cells fully differentiated into adipocytes, with greater lipid 
accumulation on the plain PLLA film surfaces. 
Poly(glycolic acid) 
PGA is an aliphatic polyester derived from glycolic acid monomers, features good 
biocompatible and biodegradable properties and has been studied for numerous tissue 
engineering applications [207,208]. It is a highly crystalline polymer and more hydrophilic 
than PLA, thus it is more easily degradable via bulk erosion. PGA has alterable 
physicochemical properties and features a 𝐸𝑠, 𝜎𝑠𝑚𝑎𝑥 and 𝜀𝑠𝑏 in the ranges of 6.08-7.18 GPa, 
60.8-71.8 MPa and 4.61-18.9% [209], respectively. 
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Figure 2.5: PGA scaffolds for ATE. (A) Dome-shaped PGA fibre-based matrix reinforced 
with PLLA. (B) SEM micrographs of the cross-section of the PGA fibre-based matrix (scale 
bar: 200 µm). (C) Implanted PGA-based scaffold into the subcutaneous pocket of athymic 
nude mouse. The arrow indicates the implantation sites. (D) Implant after 42 days in vivo 
implantation. Adapted from Cho et al. [158] with permission from Elsevier, copyright 2005. 
 
With regard to ATE, Fischbach et al. [187] and Weiser et al. [121] analysed the in vitro 
and in vivo (athymic nude mouse model) response of murine 3T3-L1 preadipocytes on  
non-woven PGA meshes for up to 35 or 168 days. The non-woven PGA meshes were 
characterised with fibre diameters and porosities of 12-14 µm and 96%, respectively, and 
degraded in vivo within 84 days. The studies illustrated that the in vitro cell differentiation 
prior to in vivo implantation facilitated favourable formations of vascularised fat pads. As 
presented in Figure 2.5 (A, B, C, D), Cho et al. [158] developed hollow dome-shaped PGA 
fibre-based matrices reinforced with PLLA as mechanical support structures, which were 
tested for up to 42 days in vivo (athymic nude mouse model). The support structures exhibited 
a compression modulus of ~11.9 MPa, after 42 days in vitro incubation. In addition, the 
support structures withstood the in vivo compressive loads and did not biodegrade in vivo 
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within the test period. Human preadipocytes with fibrin gel containing FGF were injected into 
the hollow support structures and had the capacity to differentiate into adipocytes. 
Poly(lactic-co-glycolic acid) 
PLGA is an aliphatic copolymer, composed of lactic and glycolic acid, which has been 
extensively researched for various tissue engineering applications, owing to its 
biocompatibility and biodegradability [208]. PLGA combines the attractive properties of both, 
PLA and PGA, which thus possesses changeable physicochemical properties, while  
featuring a 𝐸𝑠, 𝜎𝑠𝑚𝑎𝑥 and 𝜀𝑠𝑏 in the ranges of 1.25-2.86 GPa, 41.7-55.6 MPa and  
2.3-9.5% [209], respectively. 
 
Figure 2.6: PLGA scaffolds and microspheres in ATE. (A) SEM micrograph of the 
microstructure of PLGA scaffolds, characterised with pore sizes of 135-633 µm and porosity 
of 90% (scale bar: 600 µm), adapted from Patrick et al. [91] with permission from Mary Ann 
Liebert, copyright 2008. SEM micrographs of (B) non-porous and (C) porous PLGA 
microspheres, adapted from Chung et al. [193] with permission from Mary Ann Liebert, 
copyright 2009. 
 
In respect to ATE, PLGA was used in the form of porous scaffolds and microspheres 
[91,104,105,118,119,188–194]. Patrick et al. [91,190] investigated the response of rat 
preadipocyte on PLGA scaffolds for up to 365 days in vivo (Sprague-Dawley or  
Lewis rat model). As seen in Figure 2.6 (A), the PLGA scaffolds were fabricated via the 
solvent casting/particulate leaching technique and characterised with pore sizes and porosities 
in the range of 135-633 µm and ~90%, respectively, and biodegraded in vivo completely after  
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152 days. Cell-seeded PLGA scaffolds presented the formation of new adipose tissue after  
14 days of transplantation, it peaked at ~62 days and decreased dramatically thereafter. In 
addition, the formation of de novo adipose was also observed within in vivo implanted 
acellular PLGA scaffolds, but it featured less favourable outcomes. In a different study, 
Neubauer et al. [189] analysed the response of rat BDSCs in the presence and absence of FGF 
within PLGA scaffolds for up to 28 days in vitro. The PLGA scaffolds were fabricated via a 
porogen leaching technique and characterise with pore sizes of 100-300 µm. Cell 
differentiation and the accumulation of lipid droplets were significantly enhanced in the 
presence of FGF. Also, Morgan at el. [191] analysed the response of human BDSCs on 
hollow PLGA fibre and PLGA fibre-alginate/chitosan scaffolds with for up to 56 days in vivo 
(MF-1 nu/nu immunodeficient mice model). The scaffolds showed signs of disintegration 
after 56 days implantation, but demonstrated the ability of cell differentiation and adipose 
tissue formation. In different studies, Dolderer et al. [118] and Cronin et al. [119] used 
acellular PLGA scaffolds as filler materials in hollow chamber implants, demonstrating the 
formation of de novo adipose tissue in vivo within 42 days implantation (Sprague-Dawley rat 
or wild-type mice model). 
Choi et al. [104] analysed the response of attached rabbit BDSCs on injectable PLGA 
microspheres for up to 14 days in vivo (athymic nude mouse model). The PLGA microspheres 
were fabricated via an emulsification technique and were characterised with sizes in the range 
of 100-250 µm. Adipogenically induced cells differentiated fully into adipocytes and 
generated adipose tissue. In addition, Choi et al. [105] examined the response of 
subcutaneously injected ADSCs, PLGA microspheres and ADSC attached PLGA 
microspheres for up to 56 days in vivo (athymic nude mouse model), respectively. Newly 
formed adipose tissue was only observed at the site of injection with cell-free PLGA 
microspheres and ADSC attached PLGA microspheres, while the latter performed the best. 
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Choi et al. [192] also investigated the effects of the diameter of PLGA microspheres on the 
adipogenic differentiation of attached rabbit BDSCs for up to 28 days in vivo (athymic nude 
mouse model), concluding that the optimal microsphere size for adipogenesis was  
100-150 µm. In a further study, Kang et al. [188] developed porous PLGA microspheres for 
ATE, which were characterised with diameters and pore sizes of ~372 µm and ~36 µm, 
respectively. The in vivo analysis of the porous PLGA microspheres permitted cell adhesion, 
proliferation and differentiation of human ADSCs. Chung at el. [193] investigated the 
response of murine 3T3-L1 preadipocytes on injectable nonporous and porous PLGA 
microspheres for up to 28 days in vivo (athymic nude mouse model). As seen in  
Figure 2.6 (B, C), both microsphere types featured sizes of ~50 µm, while the porous 
microspheres were characterised with sizes and porosities of ~5 µm and ~90%, respectively. 
In vivo results demonstrated that the porous PLGA microspheres provided the most 
favourable cell environment and showed the formation of adipose tissue. 
Poly(ε-caprolactone) 
 
Figure 2.7: PCL scaffolds in ATE. (A) PCL scaffold with stacked-fibre architecture were 
fabricated via the fused deposition modeling method, characterised with a porosity of 58%. 
(B) PCL scaffold after 28 days in vivo (nude mouse model) implantation in the femoral region 
(scale bar: (A, B) 1 mm). Adapted from Wiggenhauser et al. [120] with permission from 
Springer, copyright 2011. 
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PCL is a biodegradable and biocompatible aliphatic polyester and has been studied 
extensively for tissue engineering applications [207,208]. PCL features intrinsic hydrophobic 
properties and can degrade over a period of 2-4 years, depending on its molecular weight and 
degree of crystallinity [211]. In addition, PCL possesses 𝐸𝑠, 𝜎𝑠𝑚𝑎𝑥 and 𝜀𝑠𝑏 values in the range 
of 250-430 MPa, 14-57 MPa and 50-900% [212,213], respectively. 
In the context of ATE, Kang et al. [195] analysed the in vitro response of murine 
embryonic stem cells on 3D nanofibrous PCL scaffolds. The 3D nanofibrous PCL scaffolds 
were fabricated via electrospinning and characterised with a scaffold thickness, fibre 
diameter, pore size and porosity of ~200 µm, ~0.69 µm, ~30 µm and ~88%, respectively, and 
presented no changes in structural integrity within 21 days in vitro culture. The murine 
embryonic stem cells migrated to a scaffold depth of ~40 µm and differentiated into mature 
adipocytes within 14 days. Also, the expression of adipocyte related genes were more 
prominent in the 3D culture environment, compared to conventional 2D culture conditions, 
while the use of adipogenic differentiation medium enhanced the adipocyte differentiation in 
general. Wiggenhauser et al. [120] investigated the response of human ADSCs on PCL 
scaffolds for up to 28 days in vitro and in vivo (athymic nude mouse model), as illustrated in 
Figure 2.7. The PCL scaffold with stacked-fibre architecture were fabricated via a fused 
deposition modelling technique and featured an 𝐸𝑐, porosity and pore size of 17.5 MPa, 58% 
and 0.42 mm, respectively. In vivo, the ADSCs differentiated into adipocytes and the 
formation of adipose tissue was observed throughout the scaffold. 
Poly(ethylene glycol) 
PEG is a hydrophilic, biocompatible and non-biodegradable polymer, which has been 
extensively used for synthesising crosslinked hydrogels for numerous tissue engineering 
applications [214]. Crosslinked PEG-based hydrogels are swellable in aqueous environments 
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and feature viscoelastic properties similar to soft tissues, while the physicochemical properties 
are highly versatile and flexible, depending on the selected polymerisation conditions [214]. 
 
Figure 2.8: Poly(ethylene glycol) diacrylated (PEGDA) hydrogels for ATE. (A) Pristine 
PEGDA hydrogel (scale bar: 5 mm), adapted from Patel et al. [201] with permission from 
Mary Ann Liebert, copyright 2005. (B) PEGDA engineered construct with encapsulated 
human BDSCs, adapted from Alhadlaq et al. [196] with permission from Mary Ann Liebert, 
copyright 2005. 
 
With respect to ATE, significant work has been performed on cell-encapsulated 
photopolymerisable PEGDA hydrogels [84,196,199–202], as seen in Figure 2.8 (A, B). The 
PEGDA hydrogels featured a high water content, slow degradation rates and high volume 
retention after in vitro and in vivo evaluations, along with no cytotoxic induced effects [215]. 
Patel et al. [84] investigated the rheological properties of PEGDA hydrogels, indicating 
superior properties compared to human adipose tissue, because the tested PEGDA hydrogels 
were able to recover up to 78% of their original height after 15% deformation, while adipose 
tissue failed under the same test conditions. Stacey et al. [202] analysed the in vitro response 
of encapsulated human preadipocytes within PEGDA hydrogels, which were characterised 
with an 𝐸𝑠 in the range of 0.002-0.04 MPa, under 2D and 3D culture conditions for up to 16 
days. Preadipocytes which were treated with adipogenic differentiation medium presented 
enhanced adipogenic differentiation under 3D culture conditions, as well as under coculture 
conditions with adipocytes [202]. Similar results were found via the encapsulation of 
embryonic [200] and adult stem cells [196] [199], demonstrating that these cells are capable 
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of differentiating within the PEGDA hydrogels toward an adipogenic lineage. Furthermore, 
Patel et al. [201] demonstrated that the cell viability, adhesion and proliferation performance 
of PEGDA hydrogels can be enhanced through the incorporation of specific peptide 
sequences. In a different study, Brandl et al. [198] evaluated the in vitro response of 
encapsulated murine 3T3-L1 preadipocytes in modified biodegradable and non-biodegradable 
branched PEG-amines for up to 42 days. The biodegradable branched PEG-amines were 
modified with enzyme-sensitive peptides and crosslinked with branched PEG-succinimidyl 
propionates (under the omission of free-radical initiators), while alanine-modified  
PEG-amines were used as non-biodegradable hydrogels. The biodegradable branched  
PEG-amines degraded completely under enzyme-containing conditions within 10-19 days in 
vitro.  Fully differentiated adipocytes and the formation of adipose tissue were evident in all 
hydrogels, while the non-biodegradable branched PEG-amines presented less favourable 
tissue formation and higher degrees of isolated adipocytes. 
Poly(ethylene glycol) terephthalate/poly(butylene terephthalate) block copolymer 
 
Figure 2.9: PEGT/PBT scaffolds in ATE. SEM micrographs of compression moulded and 
salt leached (salt grains of sizes in rang of 500-600 µm) PEGT/PBT scaffolds, adapted from 
Lamme et al. [197] with permission from SAGE Publications, copyright 2008. 
 
PEGT/PBT is a block copolymer composed of altering hydrophilic PEGT and hydrophobic 
PBT soft/hard segments [216–218]. PEGT/PBT implants presented suitable biocompatibility 
and biodegradability in various biomedical applications, with no initiation of adverse  
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effects on the surrounding tissue [216–218]. The swelling, degradability and mechanical 
properties of PEGT/PBT block copolymers are tailorable and depend on the  
copolymer composition [197]. 
In ATE, Lamme et al. [197] investigated the implantation of porous degradable 
PEGT/PBT copolymer implants with different compositions for up to 360 days in vivo 
(Göttinger mini-pig model), as illustrated in Figure 2.9. Implants with various polymer ratios 
were fabricated via the compression moulding/leaching technique and possessed porosities 
and pore sizes of 76-82% and 500-600 µm, respectively. Histological observation showed 
unevenly distributed cell clusters on the implant surfaces. Hydrophobic PEGT/PBT 
copolymer implants with a higher ratio of PEGT displayed overall lower degrees of foreign 
body reaction, generated greater quantities of connective tissue and presented slower 
degradation related changes in molecular weight, compared to hydrophilic PEGT/PBT 
copolymer implants with a higher ratio of PBT. 
Polyurethane 
 
Figure 2.10: PU scaffolds in ATE. (A) PU scaffold characterised with a porosity of 93%. (B) 
PU scaffold after 28 days in vivo (nude mouse model) implantation in the femoral region, 
encapsulated by abundant fibrous tissue (white arrows) (scale bar: (A, B) 1 mm). Adapted 
from Wiggenhauser et al. [120] with permission from Springer, copyright 2011. 
 
PUs are among the most versatile polymeric materials and have been used in numerous 
medical applications [219,220]. They are synthesised commonly from a wide variety of di- or 
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polyisocyanate and polyols, offering the flexibility of tailoring their physicochemical 
properties to match specific requirements [219,220]. PUs can be designed to have a broad 
range of mechanical properties, good biocompatible and biodegradable characteristics, as well 
as hydrophilic properties, which makes them a promising alternative to the classical synthetic 
biopolymers and their copolymers [219,220]. 
Wiggenhauser et al. [120] analysed the response of human ADSCs on biodegradable  
PCL-based PU scaffolds for up to 28 days in vitro and in vivo (athymic nude mouse model), 
as illustrated in Figure 2.10. PU scaffolds were fabricated via mould casting and methylal as a 
forming agent and featured an 𝐸𝑐, porosity and pore size of 0.0135 MPa, 93% and 0.56 mm, 
respectively. Adipose tissue formation was observed in vivo throughout the PCL-based PU 
scaffold. Gugerell et al. [203] investigated the response of human ADSCs on electrospun and 
biodegradable poly(ε-caprolactone-co-urethane-co-urea) and poly[(L-lactide-co-ε-
caprolactone)-co-(L-lysine ethyl ester diisocyanate)-block-oligo(ethylene glycol)-urethane] 
non-woven meshes for up to 21 days in vitro. The electrospun PU meshes were composed of 
fibres with a diameter of 0.5-1.3 µm, high porosities and good and mechanical flexibilities.  
In vitro results demonstrated that the seeded ADSCs were able to adhere, proliferate and 
differentiate into the adipogenic lineage on both PU meshes. 
Polycarbonate 
PC is a hydrophobic thermoplastic polymer, biologically inert and features an 𝐸𝑠, 𝜎𝑠𝑚𝑎𝑥 and 
𝜀𝑠𝑏 in the range of 2.1-2.4 GPa, 60-121 MPa and 65-150% [221–223], and mainly used for 
medical devices and engineering applications [224]. 
In ATE, Dolderer et al. [118] and Cronin et al. [119] investigated the use of hollow  
dome-shaped PC housings as a support structure for the de novo adipose tissue formation for 
up to 42 days in vivo (Sprague-Dawley rat or wild-type mice model), as illustrated in  
Figure 2.11 (A, B, C). The PC chambers were accompanied with vascularised pedicled fat 
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pads (containing veins and arteries for vascular supply) and filled with matrigel or PLGA 
scaffolds, which were capable of inducing cell migration and angiogenesis. 
 
Figure 2.11: PC constructs in ATE. (A) Dome-shaped PC housing with included pedicled fat 
flap. (B) Harvest tissue out of the PC housing chamber after 42 days. (C) Cross section of the 
harvest tissue, showing fat tissue surrounded by a capsule (scale bars: (A, B, C) 5 mm). 
Adapted from Dolderer et al. [118] with permission from Mary Ann Liebert, copyright 2007. 
 
Poly(ethylene terephthalate) 
PET is a non-biodegradable polyester which features good biocompatibility properties and 
was used for a variety of biomedical long-term implants, such as for abdominal hernia, 
rhinoplasty and ligament reconstruction applications, particularly in the form of surgical 
meshes [225,226]. PET has hydrophobic properties and is characterised with 𝐸𝑠, 𝜎𝑠𝑚𝑎𝑥 and 
𝜀𝑠𝑏 values in the range of 2.7-4.1 GPa, 50-70 MPa and 30-300 % [223], respectively. 
In regard to ATE, Kang et al. [204] investigated the in vitro response of seeded murine 
3T3-L1 preadipocytes on non-biodegradable 3D fibrous PET meshes. The non-woven PET 
meshes were characterised with fibre diameters of ~20 µm and a porosity of ~87%, while the 
surface of the fibres were chemically treated to enhance the hydrophilicity and 
biocompatibility. The preadipocytes differentiated into mature adipocytes within 14 days after 
induction of adipogenic differentiation medium. Fully differentiated adipocytes secreted 
higher degrees of leptin on the 3D fibrous PET meshes, compared to conventional  
2D culture conditions. 
 33 
Polypropylene 
 
Figure 2.12: PP meshes in ATE. (A1) PP mesh framework with gelatin sponges and PGA 
meshes in the core. (A2) Engineered adipose tissue implant after 180 days in vivo (nude 
mouse model) implantation. Adapted from Lin et al. [162] with permission from Mary Ann 
Liebert, copyright 2008. (B1) PP mesh framework with a collagen sponge core.  
(B2) Histological section of the implantation site (scale bar: 200 µm). Adapted from Hiraoka 
et al. [128] with permission from Mary Ann Liebert, copyright 2006. 
 
PP is a non-degradable, hydrophobic thermoplastic and used in a variety of medical 
applications, due to its cost-effectiveness and inertness in terms of biological and chemical 
interactions [224], and characterised with an 𝐸𝑠, 𝜎𝑠𝑚𝑎𝑥 and 𝜀𝑠𝑏 in the range of 1.1-1.5 GPa,  
30-40 MPa and 100-600% [223], respectively. PP in the form of woven surgical meshes are 
widely used to repair hernias and other abdominal defects [162,227], owing to their good 
dimensional stability and the relatively simple suturation onto the defect site. 
With the respect of ATE, Lin et al. [162] developed implantable scaffold constructs based 
on a PP mesh framework, while gelatin sponges and PGA meshes constructed the core 
material, as illustrated in Figure 2.12 (A1-2). Human ADSCs were seeded into the scaffold 
core and implanted for up to 270 days in vivo (athymic nude mouse model). The scaffolds 
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harvested at day 180 presented large numbers of fully differentiated adipocytes and newly 
formed adipose tissue. The gelatin sponges and PGA meshes resorbed completely, while the 
PP meshes maintained the scaffold framework. No inflammatory reaction was observed, 
however, at day 270 the implanted scaffolds were lost due to skin erosion. As seen in Figure 
2.12 (B1-2), Hiraoka et al. [128] also developed implantable scaffold constructs based on a 
PP mesh framework and a collagen sponge core, along with gelatin microspheres containing 
different amounts of growth factors. The scaffold constructs were implanted with or without 
preadipocytes for up to 42 days in vivo (rat model). The cell-seeded scaffold constructs 
presented fully differentiated adipocytes, while the cell-free scaffold constructs indicated the 
de novo formation of adipose tissue. 
Fluoropolymers 
 
Figure 2.13: PTFE meshes in ATE. SEM micrographs of fibronectin-coated PTFE meshes 
with seeded human preadipocyte, at (A) low and (B) high magnification. Adapted from Kral 
et al. [206] with permission from Wolters Kluwer Health, copyright 1999. 
 
Poly(tetrafluoroethylene) (PTFE) is highly hydrophobic, biologically and chemically inert 
polymer, and has been used in form of surgical meshes in numerous biomedical applications 
[228,229]. PTFE is characterised with an 𝐸𝑠, 𝜎𝑠𝑚𝑎𝑥 and 𝜀𝑠𝑏 in the range of 400-550 MPA,  
14-35 MPa and 200-400% [223]. 
With respect to ATE, Kral et al. [206] analysed the in vitro response of human 
preadipocytes on non-biodegradable PTFE meshes, as shown in Figure 2.13 (A, B), which 
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featured pore sizes of 52 µm and fibre coatings of collagen, albumin or fibronectin. Uncoated 
PTFE meshes demonstrated poor cell attachment characteristics, while the fibronectin-coated 
PTFE meshes obtained the highest cell seeding efficiency. Over a period of 3 days the human 
preadipocytes proliferated and differentiated into adipocytes on the fibronectin-coated PTFE 
meshes. In a different study, Calvijo-Alvarez et al. [205] investigated the in vitro and in vivo 
(athymic nude mouse model) response of human ADSCs on porous scaffolds with pore sizes 
of 10-55 µm and 100-180 µm, based on commercially available none-degradable 
fluoropolymers. Fibronectin-coated fluoropolymers scaffolds presented most favourable cell 
attachment and proliferation characteristics, both in vitro and in vivo over a period of up to  
30 days, respectively. 
Silicones 
 
Figure 2.14: Silicone constructs in ATE. Schematic of (A1) dome-shaped silicone housing 
and (B1) flat silicone sheets with included vascular pedicle. Fat growth in (A2) the  
dome-shaped silicone housing and in (B2) the flat silicone sheets. Adapted from  
Walton et al. [117] with permission from John Wiley and Sons, copyright 2004. 
 
 36 
Silicones exhibit a wide variety of physicochemical properties and are considered as  
non-degradable elastomers, characterised with biological and chemical inertness [230,231]. 
However, research studies showed that silicone implants can be associated to capsular fibrosis 
formation, carcinogenesis and autoimmune diseases [232]. 
As shown in Figure 2.14 (A1-2, B1-2), Walton et al. [117] developed implantable hollow 
non-degradable silicone dome and sheet constructs, which were filled with matrigel and FGF. 
The support constructs were connected to their own pedicled blood supply and lead to the 
formation of de novo adipose tissue via the in vivo (rat model) migration of preadipocytes. 
The silicone constructs protected the developing tissue against mechanical loads and allowed 
to control the shape and dimension of the adipose tissue ingrowth within 140 days. Fully 
differentiated adipocytes, as well as the de novo formation of adipose tissue were confirmed. 
In a different study, Cronin et al. [119] used silicone tubes and chambers as a support 
structure for the de novo adipose tissue formation. 
Overall, the applied synthetic biodegradable and non-biodegradable polymers in ATE 
demonstrated the ability to support cell differentiation, cell proliferation and the formation of 
new adipose tissue in vitro and in vivo. In some cases combined approaches of natural and 
synthetic polymers were performed, in particular to improve the performance of the synthetic 
polymer implants in terms of cell attachment and biocompatibility [128,162,206]. However, 
this raises concerns with respect to immunogenic reactions and infection in vivo when  
animal-derived natural polymers are used, as stated in Section 2.2.6.1. Also, the development 
of synthetic polymer scaffolds with similar mechanical properties to those of native human 
adipose tissue was less explored, with the exception of research studies based on PEGDA 
hydrogels and PU scaffolds [84,120,196,198–202]. Therefore, most synthetic biodegradable 
and non-biodegradable polymers used in ATE were characterised with unsuitable mechanical 
properties compared to native human adipose tissue [76–78,80,84–86]. The engineered 
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implants based on these types of synthetic polymers are more prone to plastic deformations 
under external loads, feature stiffer bulk properties and lack of ﬂexibility and strechability, 
which consequently will decrease the comfort of the patient after implantation [6]. Implants 
which featured a hollow chamber for tissue grow and served as a mechanical support structure 
demonstrated to be useful for the development of volume-stable adipose  
tissue [117–119,158]. However, it is questionable if this technique is clinically applicable, in 
particular if synthetic non-biodegradable polymers are used, due to the necessity of an 
additional surgery for implant removal [8]. 
2.3 Poly(glycerol sebacate) 
2.3.1 Introduction to poly(glycerol sebacate) 
 
Scheme 2.1: Reaction scheme and chemical structure of PGS. 
 
 
Scheme 2.2: Crosslinking scheme between PGS chains with a low degree of crosslinking, 
adapted from Li et al. [14] with permission from The Royal Society of Chemistry,  
copyright 2012. 
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PGS is a recently developed biocompatible and biodegradable elastomer whose mechanical 
properties can be tailored to match specific soft tissue requirements [16,17]. In respect to its 
soft tissue applications, PGS has been successfully approached in the fields of nerve [233], 
cardiac [234–237], retinal [238,239], vascular [240,241], cartilage [242] and bone [243] tissue 
engineering. Due to its positive attributes, PGS has been further explored in various 
biomedical applications, such as drug delivery devices [244], tissue adhesives and sealants 
[245–247], as well as coating materials [248–250], highlighting its versatility in many  
different applications. 
PGS is a polycondensed polyester, derived from glycerol and sebacic acid monomers, in 
which both tri- and two-functional monomers form a 3D network of randomly crosslinked 
coils during the polymer synthesis [16]. The conventional PGS synthesis is proceeded in two 
steps with an equimolar mixture of glycerol and sebacic acid, in which first a highly viscous 
pre-polymer is synthesised, while in the second step the pre-polymer is further polymerised to 
a covalently crosslinked polymer, as illustrated in Schemes 2.1 and 2.2. This method 
represents the current gold standard in PGS synthesis which allows one to prepare the PGS 
pre-polymer (pre-PGS) first into various shapes by melting it at high temperatures or by 
dissolving it in organic solvents, before the crosslinking process is performed [16,17]. Both 
polycondensation steps are executed under harsh process conditions (noble gas or vacuum 
environment, temperature range of 110-165 °C) [237,251,252] and long reaction times (time 
range of 24-114 hours) [237,251,252]. The crosslinking of PGS in vivo, as well as the 
incorporation of temperature sensitive molecules with the conventional PGS synthesis method 
is therefore not possible [253]. Aydin et al. [254] presented recently the option to accelerate 
the synthesis reaction of PGS via a microwave-assisted pre-polymerisation, significantly 
reducing the reaction times. The properties of PGS can be modified simply by either changing 
the parameters of the molar ratio between glycerol and sebacic acid [242] or by altering the 
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time and/or temperature [237,251,252] in one or both of the pre-polymer synthesis and 
crosslinking processes [251,252]. 
 
Figure 2.15: Stress-strain curves for PGS as a function of curing time (42-114 h), adapted 
from Pomerantseva et al. [251] with permission from John Wiley and Sons, copyright 2008. 
 
PGS exhibits a non-linear stress-strain behaviour under quasi-static tensile tests, which is 
typical for elastomers [16]. The mechanical properties of PGS depend on the crosslink density 
of the covalently crosslinked 3D network [16,251], while the hydrogen bonding interaction 
between the hydroxyl groups contribute to the elastomeric nature of PGS [16]. The virtue of 
PGS is the capability to tailor its mechanical properties, which overall depend on the 
processing conditions and alters the crosslinking density [16,251]. Previous studies 
demonstrated that an increase in the molar ratio of glycerol to sebacid acid lead to decreased 
stiffness [242], while longer times and/or higher temperatures increased the Young’s modulus 
and vice versa [237,251,252], as seen in Figure 2.15. With this respect, the mechanical 
properties of PGS were characterised with an 𝐸𝑠, 𝜎𝑠𝑚𝑎𝑥 and 𝜀𝑠𝑏 in the range of 0.05-2.12 
MPa, 0.23-0.79 MPa and 69-448%, respectively [16,237,251,255–257]. Furthermore, PGS 
presented stable mechanical properties under cyclic load [256], demonstrating high flexibility 
and good recovery characteristics in mechanically dynamic environments. As typical for an 
elastomer, PGS is characterised by a low glass transition temperature between -30 °C and 
-40 °C, thus, it remains flexible over a wide temperature range [252]. The ability to undergo 
large reversible deformations compared to conventional polyester-based polymers, such as 
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PLA, PGA, PCL and their copolymers, which undergo plastic deformation and failure when 
exposed to long-term cyclic loads [10,11,258], makes PGS particularly interesting for soft 
tissue engineering applications [16,17]. 
PGS undergoes relatively linear degradation kinetics under various in vitro [251,259] and 
in vivo [251,260] conditions, indicating that the degradation mechanism is based on surface 
erosion and prone to the hydrolytic cleavage of ester groups [251]. The surface degradation 
mechanism of PGS leads to a preservation of geometry, low swelling properties and retention 
of mechanical strength relative to the mass loss [237,238,260]. Compared to in vitro 
degradation conditions, PGS presents enhanced in vivo degradation kinetics [16], 
demonstrating accelerated degradation rates under enzymatic environments. With this respect, 
PGS exhibited complete in vivo degradation within 60 days, while under the same time period 
PGS was characterised with an in vitro degradation of only 18% weight loss [16]. In addition, 
the degradation kinetics of PGS are tuneable and dependant on the crosslinking density, in 
which a higher crosslinking density decreases the water diffusion in the chain network and 
decelerates the degradation kinetics [259,261]. 
PGS demonstrated good in vitro and in vivo biocompatibility with no cytotoxic effects, 
enhanced hemocompatibility and minimal inflammatory responses to implants in various soft 
tissue engineering applications [16,233,237,239,251,259,260,262,263]. The biocompatibility 
of PGS originates from both monomers, glycerol and sebacic acid. Glycerol is one of the 
basic components in lipids, while sebacic acid is a natural metabolic intermediate of various 
fatty acids [16]. Both monomers are nontoxic, endogenous to the human metabolism and have 
been approved in medical applications by the United States Food and Drug Administration 
(FDA) [16]. The omission of a catalyst or other additives during the pristine PGS synthesis 
avoids further possible toxic effects and chemical by-products of degradation in biomedical 
applications [17]. However, research studies showed that localised acidic environments, 
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caused by non-crosslinked pre-PGS or by acidic degradation products of PGS, can result in 
cytotoxic effects if not removed [256,259]. Compared to conventional polyester-based 
polymers, PGS exhibited overall similar or superior in vitro or in vivo biocompatibility 
characteristics [16]. Wang et al. [16] investigated the in vitro cell response of mouse 
embryonic fibroblast cells on PGS and PLGA reference surfaces, observing a higher cell 
adhesion and cell growth rate on the PGS specimens, as well as the development of normal 
cell morphologies with no cluster formation. Further in vitro biocompatibility studies 
involving arterial smooth muscle cells [264] and Schwann cells [233] presented similar 
results, in which PGS performed with favourable cell metabolic activity, attachment, 
proliferation and apoptosis in comparison to PLGA. The minimal inflammatory responses of 
PGS during in vivo tests in rats were similar to or lower than PLGA and presented in addition 
reduced fibrous capsule formation [16]. Also, the surface erosion mechanism of PGS and its 
gradual resorption affected tissue responses positively, while the bulk degradation mechanism 
of PLGA resulted in spiked inflammatory responses, due to the late rapid mass loss [233]. 
Overall, the in vitro and in vivo performance of PGS is adaptable and dependent on various 
factors, such as the porosity and permeability [238,265], surface energy and  
hydrophilicity [266], contact guidance and surface morphology [267], as well as on the  
degradation products [256,259]. 
2.3.2 Scaffold manufacturing strategies for PGS 
Various fabrication methods have been developed to fabricate biocompatible and 
biodegradable polymeric materials into porous three-dimensional scaffolds [2,39]. In contrast 
to other biomaterials including natural and synthetic polymers, PGS reveals a set of 
limitations and various challenges in manufacturing large 3D scaffolds [17]. This is due to the 
harsh curing conditions of PGS, including high curing temperatures, long curing times and a 
vacuum environment as previously described [237,251,252]. In addition, the viscosity of  
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pre-PGS decreases significantly at high temperatures and liquefies, unable to maintain any 3D 
structure by itself [268]. As listed in Table 2.4, several processing methods have been utilised 
or developed to engineer porous and pristine PGS scaffolds, such as 
micromoulding/lamination [238,239,265,267,269–271], laser micro-ablation (LM)/lamination 
[234,255,272,273], solid freeform (SFF) fabrication method [242], blend [266,268,274–281] 
and coaxial core/shell [268,278,282–286] electrospinning, as well as the combined salt- 
leaching and salt-fusion method [235,236,287–289]. Despite specific advantages of using 
these technologies, the efficient fabrication of large 3D scaffolds based on PGS is  
still infeasible. 
Table 2.4: Scaffold manufacturing strategies for pristine PGS 
Manufacturing strategy Advantages Limitations References 
Micromoulding/ 
lamination 
Freedom to design 
complex 2D 
geometries; High 
resolution 
Sophisticated fabrication method; 
Multi-layered scaffold design; 
Relatively fragile scaffolds; Low-
throughput; Expensive 
[238,239,265,267,269
–271] 
Laser micro-ablation/ 
lamination 
Freedom to design 
complex 2D 
geometries; High 
resolution 
Sophisticated fabrication method; 
Multi-layered scaffold design; 
Relatively fragile scaffolds; Low-
throughput; Expensive 
[234,255,272,273] 
Solid freeform 
fabrication 
Freedom to design 
complex 3D 
geometries; No use of 
organic solvents 
Sophisticated fabrication method; 
Usage of sacrificing mould 
technique; Low resolution; Low-
throughput; Expensive 
[242] 
Electrospinning with 
polymer blend 
Facile fabrication 
method; High 
porosity; Low cost 
Low pore size; High fibre pack 
density; Low porosity; Limited 
thickness; Low-throughput 
[266,268,274–281] 
Coaxial electrospinning High porosity; Low 
cost 
Sophisticated fabrication method; 
Low pore size; High fibre pack 
density; Low porosity; Limited 
thickness; Low-throughput 
[268,278,282–286] 
Salt-leaching and salt-
fusion 
Facile fabrication 
method; High 
porosity; Low cost 
Pore shape and interpore opening; 
Dense surface skin layers; 
Residual salt particles; Leaching 
process necessary 
[235,236,287–289] 
 
 
 
 43 
Micromoulding / lamination 
 
Figure 2.16: PGS scaffold fabricated via the micromoulding fabrication technique and 
physically bonded through heat. (A) Bright-field optical micrograph of a stacked two-layered 
PGS scaffold. (B) SEM micrograph of a stacked three-layered PGS scaffold (scale bar: (A, B) 
200 µm). Adapted from Bettinger et al. [265] with permission from John Wiley and Sons, 
copyright 2005. 
 
The microelectromechanical systems [269] and the replica moulding [238,239,265,267] 
techniques were used to manufacture photolithography patterned moulds for PGS crosslinking 
of individual sheets, whereas multi-layered PGS sheets were engineered via lamination and 
additional physically bonding steps [265,269]. Machining-based moulding methods were also 
utilised to fabricate simple patterned moulds [270,271]. Crosslinked PGS sheets with a 
thickness of 45-1000 µm were fabricated on pre-treated silicone, replica-moulded 
poly(dimethylsiloxane) and machined ceramic micromoulds, characterised with feature 
resolutions down to 30 µm [238,239,265,269–271]. Prior to the PGS curing process, the 
micromoulds were plasma oxidised to create hydrophilic surfaces and spin-coated with 
sucrose, enabling a damage-free delamination of the crosslinked PGS sheets after incubating 
in distilled water for 1-16 days [238,239,265,269–271]. As seen in Figure 2.16 (A, B),  
multi-layered PGS sheets were fabricated via sheet stacking and heat treatments lead to the 
formation of new ester linkages between the sheets (chemically crosslinked), owing to the 
free hydroxyl and acid groups [265,269]. The pores and struts of each layer were off-set, 
allowing to create porous 3D scaffold with interconnected pores. Still, only two- or  
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three-layered PGS scaffolds were constructed and analysed via micromoulding techniques 
[265,269]. The thickness of each layer has to be considered in order to permit mass transport 
of oxygen through the material [265]. With respect to achievable bond strength between the 
bonded PGS sheets, only qualitative data were provided, whereas quantitative data are still 
missing which are crucial for dynamic applications. Also, the heat treatment for the layer 
bonding enhanced the stiffness of PGS, thus increasing the difficulty to target specific  
mechanical properties [265,269]. 
Laser micro-ablation / lamination 
 
Figure 2.17: PGS scaffold fabricated via the laser micro-ablation technique and physically 
bonded through heat. (A) SEM micrograph of an accordion-like honeycomb PGS scaffold 
layer. (B) SEM micrograph of a stacked two-layered PGS scaffold (scale bar: (A, B) 100 µm). 
Adapted from Englemayr et al. [255] with permission from Nature Publishing Group, 
copyright 2008. 
 
The LM technique enabled the ablation of highly accurate micropatterns on individual PGS 
sheets, whereas the construction of laminated multi-layered PGS sheets were accomplished 
via additional physical bonding steps [234,255,272], as seen in Figure 2.17 (A, B). 
Crosslinked PGS sheets with a thickness of 250-500 µm were fabricated on sucrose  
spin-coated moulds and microstructure geometries shaped via excimer or solid-state  
Nd-YAG lasers [234,255]. Feature resolutions of down to 50 µm were realisable and 
characterised with a slight top-to-bottom taper, which is typically for laser drilling [255,273]. 
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Completed PGS sheets were damage-free delaminated after incubating in distilled water for 
one day [234,255]. Multi-layered PGS sheets were fabricated via sheet stacking and 
physically bonded through heat or oxygen-plasma treatments under compression, resulting in 
a close bonding interface between the layers [234,255]. The pores and struts of each layer 
were off-set, allowing to create 3D scaffold constructs. However, the LM technique exhibits 
overall similar difficulties as the micromoulding techniques discussed earlier. In addition, the 
thickness of some PGS sheets were limited to permit mass transport of oxygen through the 
material [265,290,291], resulting in only delicate 2D sheets or small-sized 3D layered 
scaffolds [234,255]. 
Solid freeform fabrication 
 
Figure 2.18: PGS scaffold fabricated via the solid free-form technique. (A) Side view picture 
of the PGS scaffold specimen. (B) X-ray micro-computed tomography picture of the scaffolds 
microstructure (scale bar: (A, B) 1 mm). Adapted from Kemppainen et al. [242] with 
permission from John Wiley and Sons, copyright 2010. 
 
An alternative technique for the fabrication of PGS scaffolds is the utilisation of sacrificial 3D 
hydroxyapatite moulds, which can sustain the harsh curing conditions of PGS [242]. Curable 
hydroxyapatite slurry was poured into positive wax moulds, which were created via the SFF 
fabrication method. The inverse 3D hydroxyapatite moulds were then embedded into melted 
pre-PGS, followed by curing pre-PGS and dissolving the hydroxyapatite with a rapid 
decalcifying agent, resulting in 3D PGS scaffolds. The fabricated PGS scaffolds were 
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characterised by a large average pore size of ~1 mm and a low porosity of 48%, 
demonstrating the poor porosity due to a low 3D printing resolution [242], as seen in  
Figure 2.18 (A, B). The SFF fabrication approach presented overall a low-throughput of 3D 
PGS scaffolds, however, no organic solvents were used during the fabrication process. 
Electrospinning 
 
Figure 2.19: PGS-based nanofibrous scaffolds fabricated via blend electrospinning. (A) SEM 
micrograph of electrospun pre-PGS/PCL fibres (scale bar: 100 µm), adapted from Sant et al. 
[274] with permission from Elsevier, copyright 2013. (B) SEM micrograph of electrospun and 
thermally crosslinked PGS/PVA fibres (scale bar: 10 µm; scale bar inset: 5 µm), adapted from 
Jeffries et al. [277] with permission from Elsevier, copyright 2015. 
 
The formation of pristine PGS nanofibres is challenging, however, non-woven meshes of 
randomly deposited PGS-based nanofibres were fabricated using polymer blends 
[266,268,274–281] or via coaxial core/shell [268,278,282–286] electrospinning, as shown in 
Figure 2.19 (A, B) and 2.20 (A, B). The blend electrospinning process was performed using 
blended solutions of pre-PGS and natural or synthetic biopolymers as carrier materials, such 
as gelatin [276], poly(vinyl alcohol) (PVA) [277], PCL [266,274,275,281], PLLA [268,278], 
poly(butylene succinate-butylene dilinoleate) (PBS-DLA) [280], poly(L-lactide-co-D,L-
lacitide) (PLDLLA) and poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV) [279]. The 
addition of a carrier material into the pre-PGS solution is required to increase the viscosity to 
suitable values for the electrospinning process [268]. Pre-PGS itself cannot be electrospun to 
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form stable nanofibres, because of its low molecular weight and consequently low solution 
viscosity [268,275]. The thermal curing process of pristine formed pre-PGS nanofibers is also 
not feasible [268], due to the low melting point (5-8 °C) [248,292] of pre-PGS and the high 
curing temperatures (110-165 °C) [237,251,252] which are required for crosslinking. With 
this respect, no crosslinking processes were conducted on fibrous pre-PGS/PCL 
[266,274,275,281], pre-PGS/PBS-DLA [280] and pre-PGS/PLDLLA/PHBV blends [279]. 
Pre-PGS was thermally crosslinked in fibrous pre-PGS/PVA [277] and pre-PGS/PLLA 
[268,278] blends, while the fibrous pre-PGS/gelatin blends [276] were crosslinked via the 
immersion in an ethanol solution containing N,N-(3-dimethylaminopropyl)-N′-ethyl-
carbodiimide hydrochloride and N-hydroxysuccinimide as crosslinking agents. The 
electrospinning process enabled the production of fibrous PGS-based blends with average 
fibre diameters in the range of 0.3-8.3 µm [266,275,277], with randomly dispersed or aligned 
fibre formations, large specific surface areas and small pore sizes. 
 
Figure 2.20: PGS-based nanofibrous scaffolds fabricated via coaxial electrospinning. SEM 
micrograph of electrospun and crosslinked PGS/PLLA core/shell fibres: (A) Top view, (B) 
cross section (scale bar: (A, B) 10 µm). Adapted from Xu et al. [278] with permission from 
Elsevier under the Creative Commons Attribution License 2013. 
 
The coaxial core/shell electrospinning process was used to produce core/shell nanofibres, 
containing pre-PGS or PGS as a core and natural or synthetic biopolymers as a protective or 
removable shell, using materials such as gelatin [283], collagen [284], fibrinogen [285], PVA 
[286] or PLLA [268,278,282]. The use of a natural biopolymer as the shell material allowed 
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to create core/shell nanofibres, where the PGS core was accountable for the mechanical 
properties, whereas the shell material provided additional functional properties, such as 
improved cell attachment and proliferation capability [283–285]. The shell materials based on 
natural biopolymers were crossslinked via glutaraldehyde vapour, to enhance their 
performance under physiological conditions [283,284]. The thermal crosslinking of the pre-
PGS core was restricted within natural biopolymers, due to the polymers limited thermal 
long-term stability. In contrast, the application of a synthetic biopolymer as the shell material 
allowed subsequent thermal crosslinking treatments on the fibrous pre-PGS-based core/shell 
formations [268,278,282,286]. PVA and PLLA maintained the tube shape during the harsh 
curing condition of pre-PGS, and were removable via an organic solvent or aqueous washing 
treatments, after the PGS core was crosslinked [268,282,286]. In general, the coaxial 
core/shell electrospinning process produced PGS-based core/shell meshes with average fibre 
diameters in the range of 0.4-10.0 µm, which were characterised by random fibre formations 
and non-uniform pore structures [268,278,282,283]. Compared to the electrospinning process 
with a polymer blend, the coaxial core/shell electrospinning process presented overall a more 
complex fabrication set-up and poor adjustability of the scaffold properties, due to the limited 
ratio control between the two electrospun polymers [277]. Both the polymer blend and coaxial 
core/shell electrospinning processes, can fabricate fibrous meshes with large specific surface 
areas, however, these are mainly characterised by small pore sizes and low porosities within 
the electrospun scaffolds [266,268,277,282]. A tight fibre density is a common problem in 
electrospun scaffolds and known to limit cell infiltration [277,293,294]. Further drawbacks 
are the low rates of generating large masses of fibres as well as the incidence of charge  
build-up at the collector, preventing the production of thick scaffolds [295–297]. Also, the 
removal of the carrier or shell polymer from the nanofibrous PGS-based scaffolds was only 
possible to a limited extent [277]. 
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The application of photocrosslinkable PGS is an alternative approach to electrospinning 
PGS, which avoids additional curing steps [298,299]. 
Salt-leaching and salt-fusion 
 
Figure 2.21: PGS scaffold fabricated via the salt-leaching and salt-fusion technique. (A) SEM 
micrograph of the cross section of crosslinked PGS scaffold (scale bar: 100 µm), adapted 
from Gao et al. [288] with permission from Mary Ann Liebert, copyright 2006. (B) SEM 
micrograph of the cross section of crosslinked PGS scaffold (scale bar: 200 µm), adapted 
from Radisic et al. [236] with permission from John Wiley and Sons, copyright 2007. 
 
A less complex scaffold processing technology is the combined salt-leaching and salt-fusion 
technique, as seen in Figure 2.21 (A, B), which was successfully applied to create 
interconnected porous PGS circular scaffolds as well as tubular scaffolds with an average 
pore size in the range of 20-300 µm and a porosity of 75-95% [235,236,287–289]. While the 
porosity and pore size are adjustable, other important parameters such as pore shape and 
interpore opening are only poorly modifiable [300]. Other drawbacks of this technique 
include the possibility of dense surface skin layers and the remaining residual salt particles. 
Furthermore, only relatively thin scaffolds (thickness in the range of 1-5 mm)  
[235,236,287–289] were prepared, and some of these scaffolds were further modified with the 
laser microablation method to integrate an array of parallel channels (accurate diameter 
dimension of 250 µm) to improve the scaffold perfusion [235,287]. 
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The creation of PGS scaffolds involved the utilisation of various sophisticated technologies 
[17], primarily characterised by a low-throughput of small-sized scaffolds with unsuitable 
porous structures or porosities, constraining the full potential and adoption of PGS in a 
broader field of soft tissue engineering applications. 
2.3.3 Modification of PGS 
Various PGS-based copolymeric systems [246,247,253,292,298,299,301–312], blends 
[266,268,274–279] and composites [243,256,257,259,313–317] were developed to improve 
the applications of PGS, by incorporating different functionalities and tailoring its 
physicochemical properties for specific tissue engineering applications. With this respect, 
most research studies aimed to either improve the processability of PGS, or modify the 
mechanical properties, biocompatibility, bioactivity, degradation behaviour or its  
hydration properties. 
Functionalisation of PGS 
The functionalisation or copolymerisation of PGS or pre-PGS with other chemical entities can 
yield physicochemical property enhancements, increase its range of applicability and enhance 
its processing capabilities. With this respect, photopolymerisation is an alternative processing 
approach to from a crosslinked elastomeric network from PGS, overcoming the limitation of 
the thermal curing process [246,247,253,298,299,301–303]. Nijst et al. [253] demonstrate the 
synthesis of photocrosslinkable poly(glycerol sebacate) acrylate (PGS-Acr), by reacting  
pre-PGS with acrylic chloride under mild conditions and short UV exposure times. The 
physicochemical properties of the PGS-Acr elastomers were adjustable, by varying the degree 
of acrylation during the PGS-Acr synthesis. The PGS-Acr elastomers were characterised with 
𝐸𝑠, 𝜎𝑠𝑚𝑎𝑥 and 𝜀𝑠𝑏 values in the range of 0.05-1.38 MPa, 0.05-0.50 MPa and 42-189% [253], 
respectively, which increased linearly with the degree of acylation. The elastomers exhibited 
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in vitro degradation rates of 10% in 49 days under enzyme-free conditions and enhanced 
weight losses under enzyme-containing conditions [253], while PGS-Acr exhibited in vivo 
degradation rates of 3-12% in 7 days [246]. PGS-Acr presented good biocompatibility but 
indicated the tendency of enhanced inflammatory response in vivo with an increased degree of 
acrylation [298]. Bodakhe et al. [318] synthesised photocrosslinkable poly(glycerol sebacate) 
fumarate (PGS-Fur), by reacting pre-PGS with different ratios of fumaryl chloride under mild 
conditions and short UV exposure times. The physical and mechanical properties of the  
PGS-Fur depended on the degree of fumarylation and were characterised with 𝐸𝑠 and 𝜀𝑠𝑏 
values in the range of 0.5-1.0 MPa and 37-80%, respectively. The elastomers presented good 
in vitro and in vivo biocompatibility and exhibited in vitro degradation rates of up to 8% in  
45 days under enzyme-free conditions, while PGS-Fur exhibited enhanced in vivo degradation 
rates of up to 60% in 45 days. Zhu et al. [303] prepared photocrosslinkable poly(glycerol 
sebacate) cinnamate (PGS-Cin) elastomers, by functionalising pre-PGS with pendant 
cinnamate groups under mild condition and without photoinitiators. The PGS-Cin elastomers 
required long UV exposure times and featured relatively high sol contents between 31-49% 
after the photocrosslinking process. Depending on the cinnamate moieties, PGS-Cin 
elastomers exhibited 𝐸𝑠, 𝜎𝑠𝑚𝑎𝑥 and 𝜀𝑠𝑏 values of 0.05-0.15 MPa, ~0.03-0.07 MPa and  
80-140%, respectively. The elastomers were characterised with weight losses in the range of 
between ~20-50% after 90 days in enzyme-free in vitro degradation tests, and possessed good 
biocompatibility properties. 
The incorporation of alpha hydroxy acid monomers or low molecular polyester into PGS is 
a different and simple method to alter its physicochemical properties. Liu et al. [309] 
synthesised poly(glycerol sebacate citric acid) (PGSCA) elastomers by using various molar 
ratios of citric acid and curing times to crosslink with pre-PGS. The addition of citric acid 
increased the crosslinking density, the mechanical properties and the hydrophilicity of the 
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elastomer. The PGSCA elastomers were characterised with 𝐸𝑠, 𝜎𝑠𝑚𝑎𝑥 and 𝜀𝑠𝑏 values of  
0.6-6.9 MPa, 0.6-2.7 MPa and 33-170%, respectively, and presented in vitro degradation rates 
of ~9-32% in 28 days under enzyme-free conditions [307–309]. However, pure PGSCA 
elastomers presented a certain cytotoxicity, due to the high degree of acidic degradation 
products [307,309], which was counteracted through the incorporation of composite materials 
[307,309]. Sun et al. [306] analysed the degradation behaviour of poly(glycerol sebacate 
lactic acid) (PGSLA) elastomers, which were synthesised with different ratios of lactic acid. 
In vitro degradation tests indicated characteristics of surface and bulk erosion [305,306], 
while the PGSLA elastomers exhibited in vitro degradation rates of ~20-40% in 80 days 
under enzyme-free conditions [305]. The PGSLA elastomers featured 𝐸𝑠 values of  
2.94-21 MPa and presented suitable biocompatibility [305,306]. Similarly, Cheng et al. [311] 
synthesised a series of poly(glycerol-sebacate)-co-poly(L-lactic acid) (PGS-co-PLLA) 
branched copolymers via the ring opening copolymerisation of low molecular weight  
L-lactide with pre-PGS. PGS-co-PLLA presented overall improved hydrophilicity and 
favourable inflammatory responses in vivo, compared to low molecular weight PLLA and 
PGS/PLLA blends. Sun et al. [304] investigated the biodegradability and mechanical 
properties of poly(glycerol sebacate glycolic acid) (PGSGA) elastomers, which were 
produced with various molar ratios of glycolic acid, while the synthesis reaction was 
conducted with all constituent monomers simultaneously. The PGSGA elastomers were 
characterised with 𝐸𝑠 values of ~2.5-12.5 MPa, which dropped with higher degrees of 
glycolic acid. The elastomers were characterised with in vitro degradation rates of ~30-75% 
in 65 days under enzyme-free conditions, while the PGSGA elastomers degraded in vivo 
completely after 60 days. Aydin et al. [319] reported the synthesis of poly(glycerol sebacate)-
co-poly(ε-caprolactone) (PGS-co-PCL) via a two-stage, catalyst-assisted terpolymerisation 
reaction. PGS-co-PCL elastomers were flexible and presented good biocompatibility, but 
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characterised with poor cell-adhesion properties in vitro. The usage of a supercritical carbon 
dioxide fluid-assisted foaming method failed to create stable and porous structures with the 
elastomer, however, PGS-co-PCL presented self-healing behaviours through the relaxation of 
the random chain network and the formation of new hydrogen bonds. 
The incorporation of hydrophilic polyols into the PGS is another route to alter its 
physicochemical properties, enhancing its hydration characteristics but with limited water 
uptake capacity. Patel et al. [310] developed poly(glycerol sebacate)-co-poly(ethylene glycol) 
(PGS-co-PEG) copolymers with different molar ratios of glycerol to PEG. The elastomers 
were synthesised via the polycondensation of sebacic acid and PEG, followed by the addition 
of glycerol. The incorporation of PEG increased the hydrophilic characteristics of the  
PGS-co-PEG elastomers and affected their physicochemical properties, such as its mechanical 
properties, along with their swelling and degradation behaviour. Hydrated PGS-co-PEG 
elastomers were characterised with 𝐸𝑠, 𝜎𝑠𝑚𝑎𝑥 and 𝜀𝑠𝑏 values of 0.01-1.5 MPa, 0.01-0.3 MPa 
and ~25-190%, and featured in vitro degradation rates of between 15-81% after 21 days under 
enzyme-free conditions. The PGS-co-PEG elastomers presented good cyclic mechanical 
properties and good biocompatibility properties. Wu et al. [302] developed 
photocrosslinkable hydrogels based on methacrylated poly(glycerol sebacate)-co-
poly(ethylene glycol) (PGS-co-PEG-MAc) copolymers. The sebacic acid and PEG were 
polycondensed to a pre-polymer, followed by the addition of glycerol to synthesise the 
copolymer, and then methacrylated. The physicochemical properties of the  
PGS-co-PEG-MAc hydrogels were controllable by altering the degree of methacrylation. The 
hydrogels were characterised with in vitro degradation rates of between 13%-87% after  
25 days under enzyme-free conditions, along with good biocompatibility properties. Recently, 
Ye et al. [292] developed supramolecular hydrogels via PGS-based copolymers through the 
atom transfer radical polymerisation method. Briefly, brominated PGS macroinitiators were 
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copolymerised with poly(ethylene glycol) methyl ether methacrylate and threaded with  
α-cyclodextrin, creating the supramolecular hydrogel system. The hydrogel system featured 
injectable properties, as well as a tuneable and a low upper critical solution temperature of 
less than 90 ºC, in addition to rapid gelation and rapid self-healing properties. 
The use of isocyanate-based crosslinkers to create PGS-based urethane is a different 
approach to overcome the long and harsh process conditions of pristine PGS. Pereira et al. 
[312] developed highly tuneable PGS-based urethane with hexamethylene diisocyanate 
(HDI), which will be more specifically discussed in Chapter 5. Li et al. [320] synthesised 
PGS-based urethane with low molar ratios of 4,4’-diphenylmethylene diisocyanate (MDI), via 
the additional use of a thermal crosslinking step. The PGS-based urethane exhibited 𝐸𝑠, 𝜎𝑠𝑚𝑎𝑥 
and 𝜀𝑠𝑏 values in the ranges of 0.3-1.6 MPa, 0.9-1.7 MPa and 240-270%, respectively. The 
elastomers were characterised with in vitro degradation rates of between ~15%-23% after  
21 days under enzyme-free conditions. However, the application of MDI as a crosslinking 
agent is limited due to its high cytotoxicity [320,321]. 
PGS-based blends 
The blending of PGS with different biopolymers is a versatile method of combining two or 
more polymers with different physical properties in a single system [322]. However, the 
development of PGS-based blends was mainly applied in association with the electrospinning 
process, as discussed in Section 2.3.3. PGS-based blends were fabricated with natural and 
synthetic biopolymers, such as gelatin [276], PCL [266,275], PVA [277], PLLA [278],  
PBS-DLA [281,323], poly(3-hydroxbutyrate) (P3HB) [324], PHBV [279] and PLDLLA 
[279], as well as polyaniline (PANI) [325]. 
Kharaziha et al. [276] engineered fibrous pre-PGS/gelatin blend scaffolds containing  
33 wt% and 66 wt% of pre-PGS. The pre-PGS/gelatin blends were crosslinked  
via the crosslinking agents N-(3-dimethylaminopropyl)-N’-ethylcarbodiimide and  
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N-hydroxysuccinimide, which lead to the formation of amide bonds between the carboxyl and 
amine groups of both polymers [276]. The fibrous pre-PGS/gelatin blend scaffolds with  
66 wt% of pre-PGS presented lower stiffness and strength, but enhanced elongation at break 
compared to pristine gelatin scaffolds, which was attributed to the plasticising effects  
of pre-PGS [276]. 
Sant et al. [266] developed electrospun pre-PGS/PCL blend scaffolds which contained  
66 wt%, 75 wt% and 83 wt% of pre-PGS. Compared to the pristine electrospun PCL scaffold, 
the pre-PGS/PCL scaffolds exhibited superior hydrophilicity and biocompatibility, due to the 
high degree of non-bonded hydroxyl groups on the pre-PGS backbone chain [266]. The pre-
PGS/PCL scaffolds with 66 wt% and 75 wt% of pre-PGS exhibited decreased stiffness and 
elongation compared to PCL, while higher pre-PGS concentrations enhanced the stiffness and 
strength of the fibrous scaffolds, owing to the increase in electrospun fibre diameter [266]. 
Jeffris et al. [277] manufactured fibrous PGS/PVA blend scaffolds containing 55 wt% of 
PGS. PVA was used solely as a soluble carrier material and was removed by washing in 
water, after the PGS was thermally crosslinked. However, the fibrous PGS scaffolds were still 
comprised of residual PVA, after performed washing procedures [277]. The residual PVA in 
the fibrous PGS scaffolds were attributed to material encapsulation, or PVA was thermally 
crosslinked with PGS, due to the condensation reaction between the carboxyl groups of PGS 
and the hydroxyl groups of PVA [277]. 
Kenar et al. [279] fabricated fibrous pre-PGS/PLDLLA/PHBV blend scaffold with  
2 wt% of pre-PGS, as well as macroporous pre-PGS/PLDLLA scaffold with 4 wt% of  
pre-PGS, without any crosslinking process applied. 
Tallawi et al. [281,323] investigated fibrous pre-PGS/PBS-DLA blend scaffolds and films 
with 30 wt%, 40 wt%, 50 wt%, 60 wt% and 70 wt% of pre-PGS. The mechanical properties, 
the hydrophobicity increased with higher weight ratios of PBS-DLA in the blend, while the 
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degradation rate decreased. In addition, the pre-PGS/PBS-DLA blends presented also good 
biocompatibility in vitro, however, the blends with a higher ratio of pre-PGS presented a 
lower cell viability, due to the higher acidity. 
Xu et al. [278] prepared PGS/PLLA blend films containing 80 wt%, 90 wt% and 95 wt% 
of PGS. The films were created via solution casting and were thermally crosslinked. All 
PGS/PLLA film blends presented similar mechanical properties to pristine PGS, but they 
featured enhanced elongation at break. 
Roether et al. [324] developed PGS/P3HB blend films with 87.5 wt% and 90 wt% of PGS 
via solvent casting and thermal crosslinking. The addition of P3HB improved the mechanical 
properties and the hydrophilicity of the blends, but increased the in vitro degradation rates. 
The incorporation of titanium dioxide nanoparticles of 1 vol% and 2 vol% was also 
investigated, affecting the morphology, hydrophilicity, mechanical and chemical properties of 
the PGS/P3HB blends. 
Qazi et al. [325] developed electrically conductive PGS/PANI blends with 10-30 vol% of 
PANI content, created via solution casting and thermal crosslinking. The electrical 
conductivity and the mechanical properties of the blends improved with increasing PANI 
content. The PGS/PANI blends featured mechanical properties with 𝐸𝑠, 𝜎𝑠𝑚𝑎𝑥 and 𝜀𝑠𝑏 values 
in the ranges of 2.4-6.3 MPa, 1.9-9.2 MPa and 20-31%, respectively. The conductivity of the 
PGS/PANI blends was preserved for at least 100 h and presented in vitro degradation rates of 
up to 7.72% in enzyme-free PBS solution. The PGS/PANI blends presented good 
biocompatibility and possessed an attractive pH buffering effect compared to pure PGS. 
PGS-based composites 
The creation of PGS-based composites is a simple and effective method to improve the 
physicochemical properties of PGS. Nano- or micro-sized inorganic or organic fillers, such as 
Bioglass® [256,259,313], nanohydroxyapatite [314], silica glass [243,317], cellulose [315], 
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titanium dioxide [324], halloysite nanotubes [257], and carbon nanotubes [316] have been 
added into the matrix of PGS to incorporate different functionalities and to tailor its properties 
for specific tissue engineering applications. For instance, the incorporation of cellulose into 
PGS presented enhanced tensile strength and modulus, due to the strong bonding between the 
hydroxyl groups of PGS and cellulose as well as the high strength and modulus of cellulose, 
along with tuneable biodegradation and hydrophilicity characteristics [315]. Also, Wu et al. 
[326] developed poly(glycerol sebacate urethane)-cellulose nanocomposites which 
demonstrated water-active shape-memory effects and mechanically adaptive functions, due to 
the reversible formation and disruption of a cellulose percolation network in the polymer 
matrix. The addition of Bioglass® into PGS resulted in reinforced mechanical properties, 
along with improved biocompatibility, attributed to the decrease of acidic degradation 
products of PGS [256,259,313]. Gaharwar et al. [316] developed covalent crosslinked 
PGS/carbon nanotubes composites which significantly increased in mechanical stiffness with 
no compromised effects on its elastomeric properties. Overall, the development of PGS-based 
composites presented to be an effective and cost-efficient strategy to enhance the 
physicochemical properties of PGS, while maintaining the desired compliance of biomaterials 
required for soft tissue engineering. 
2.4 Principle of freeze-drying 
Freeze-drying, also known as lyophilisation, is a common method for producing porous 
scaffolds from natural and synthetic polymers [327–330]. It is a special drying process in 
which the solvent of an appropriate polymer/solvent solution crystallises at a temperature 
below its freezing point and then directly sublimes from solid phase into vapour phase by 
reducing the surrounding pressure. Thus, the crystallised solvent acts as a template for the 
pores and the polymer remains in its dry state after solvent sublimation, yielding  
a porous structure. 
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Figure 2.22: Diagram of a typical three stage program during a freeze-drying process, 
adapted from Labconco Corporation [331]. 
 
The freeze-drying process consists of three stages [332,333], as seen in Figure 2.22. In the 
first stage, the so-called pre-freeze stage, the polymer/solvent solution crystallises to create a 
solid matrix while holding the temperature constant for equilibration. The second stage, the so 
called primary-drying stage, involves the sublimation of the crystallised solvent by reducing 
the pressure of the environment by a vacuum, which also takes place at low temperatures. The 
difference between the vapour pressure of the crystallised solvent and the environment 
pressure provides the driving force for sublimation. The primary-drying stage is completed 
when all crystallised solvent sublimates. At this stage, it is still possible that some bound 
solvent is remaining in the product which can be removed by desorption at higher 
temperatures. Therefore, in the last stage, the so-called secondary-drying stage, the 
environment temperature is raised to ambient or higher temperatures and held until the 
polymer material is equilibrated at the desired temperature. 
The porous structure and properties of the scaffolds such as pore size, porosity, interpore 
connectivity, pore shape, pore wall morphology and mechanical properties can be modified 
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via the alteration of the process conditions, or by adjusting the polymer/solvent solution 
[329,330,334]. For instance, the differences in the pore size and inner scaffold structure 
reflect the differences in heat transfer rates during the solvent crystallisation process at low 
temperatures. Higher freezing rates produce a large number of small sized solvent crystals and 
therefore the formation of many nuclei of solvent crystals, resulting in a structure of  
smaller-sized pores. In contrast, lower freezing rates lead to larger porous structure due to the 
fact that larger solvent crystals occur [335]. In addition, studies have shown that it is possible 
to influence the growing direction of solvent crystals by controlling the heat  
transfer direction [329,330]. 
2.5 Summary of the literature review 
Various ATE strategies, cell sources, materials and types of cell carriers have been 
investigated to engineer adipose tissue in vitro and in vivo. Despite promising approaches, the 
optimal adipose tissue scaffolds from either natural or synthetic materials remain illusive and 
engineered scaffolds that mimic structure and properties of adipose tissue are not yet readily 
available. The utilisation of synthetic materials combined with adult stem cells presented 
potential to generate adipose tissue, however, the current synthetic scaffolds do not provide 
satisfactory performance in ATE, due to their high stiffness, plastic deformation and failure 
when exposed to dynamic loads. With this respect, adipose tissue is exposed to large 
deformations and engineered scaffolds for ATE need to be flexible and withstand 
physiologically induced deformations, hence, the mechanical properties of engineered 
scaffolds cannot be ignored when regenerative therapies are being developed, indicating a 
strong need for developing tissue scaffolds from other synthetic biomaterials [82]. 
PGS demonstrated to be a highly versatile synthetic biodegradable and biocompatible 
elastomer, which was specifically designed to imitate the mechanical behaviour of soft 
tissues. PGS features several benefits compared to common synthetic biopolymers, such as 
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tailorable physicochemical properties and superior performance in dynamic mechanical 
environments, overall demonstrating high potential in ATE. Recent developments in terms of 
PGS-based copolymers, blends or composites presented further performance improvements 
with respect to the bioelastomers processability, biocompatibility, bioactivity, degradation 
behaviour, mechanical properties or hydration properties, overall indicating high modifiability 
for specific requirements. However, PGS reveals various processing limitations and 
challenges, due to its harsh curing conditions including long periods of curing time, high 
curing temperatures and a mandatory vacuum environment. In addition, pre-PGS melts at its 
curing temperature and is unable to maintain its structure, making it challenging to fabricate 
3D structures. With this respect, current fabrication strategies for manufacturing large-volume 
3D PGS-based scaffolds are limited, which constrains the full potential and adoption of PGS 
in a broader field of biomedical applications. Thus, the development of novel fabrication 
technologies or strategies is essential for the design of PGS-based scaffolds with biomimetic 
structures and properties for prospective tissue engineering applications.  
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Chapter 3. Large three-dimensional poly(glycerol 
sebacate)-based scaffolds - A freeze-drying preparation 
approach 
3.1 Introduction 
As discussed in Chapter 2, various sophisticated technologies such as 
micromoulding/lamination [238,239,265,267,269–271], laser micro-ablation/lamination 
[234,255,272,273], solid freeform fabrication method [242], blend [266,268,274–281] and 
coaxial core/shell [268,278,282–286] electrospinning, as well as the combined salt-leaching 
and salt-fusion method [235,236,287–289] were utilised to create PGS scaffolds. Despite their 
specific advantages, these technologies led to a primarily low throughput of small-sized 
scaffolds with unsuitable porous structures or porosities, constraining the full potential and 
adoption of PGS in a broader field of soft tissue engineering applications. The focus of this 
chapter is, therefore, the development of a novel fabrication strategy which will enable an 
efficient preparation of large 3D porous PGS-based scaffolds.  
The novel fabrication strategy will employ a minor structure-supporting biopolymer and 
create large 3D porous PGS-based scaffolds containing the additional biopolymer via a 
freeze-drying and a subsequent curing process. Biocompatible and biodegradable PLLA was 
chosen as the structure-supporting polymer because of its high melting point, which will 
prevent the low-viscosity pre-PGS from enclosing the porous structures during the curing 
stage and therefore avoiding structural collapse and maintaining 3D structures. 
This will allow one to overcome several constraints of pure PGS in terms of the scaffold 
design and fabrication possibilities. The variation of the PGS/PLLA blends in respect to the 
composition and concentration will enable the creation of scaffolds with the desired physical 
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properties, such as high porosities and interconnected open-cell structures, as well as softer 
and more ductile scaffolds resulting from the higher PGS ratios. 
The PGS/PLLA blend scaffold samples were created using different ratios of PGS and 
PLLA material along with the solvent 1,4-dioxane, via the combined processes of  
freeze-drying and curing. The microstructure characteristics of the fabricated scaffolds were 
analysed by SEM after each processing step, as well as analysing the effects of varying the 
ratios of the material compositions and concentrations on the scaffold morphology. The 
mechanical properties were examined by quasi-static tensile tests, and the in vitro degradation 
kinetics of the scaffolds assessed in enzyme-free and enzyme-containing PBS solution. The 
structure and properties of the pre-PGS, the crosslinked PGS film and pristine PLLA scaffold 
were also investigated. 
3.2 Experimental section 
3.2.1 Materials 
Sebacic acid, glycerol, tetrahydrofuran (THF), 1,4-dioxane, phosphate buffered saline (PBS) 
tablets, ethanol and lipase enzyme from porcine pancreas (54 U mg-1), were purchased from 
Sigma-Aldrich. PLLA (NatureWorks 4043D; Number average molecular weight,  
?̅?𝑛 = 130,000 g mol
-1) was from Cargill Dow LLC. 
3.2.2 Preparation of pre-PGS 
Pre-PGS was synthesised by using an established method in the literature [16,288]. Briefly, a 
three-neck flask, loaded with a 1:1 molar mixture of sebacic acid and glycerol, was attached 
to a Dean-Stark trap with a condenser and a nitrogen bubbler. The mixture was reacted at  
120 °C for 72 h under a low-flow nitrogen environment and at constant stirring. The resulting 
highly viscous pre-PGS was cooled and stored in a closed glass container at room temperature 
until further use. 
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3.2.3 Preparation of PGS films 
Pre-PGS was dissolved in THF and cast into a non-sticky Teflon-coated metal mould 
(purchased from a local store). The cast pre-PGS samples were dried under room temperature 
for 24 h and then cured under vacuum at 150 °C for 24 h. Cured PGS films were stored at 
room temperature before further examinations were carried out. 
3.2.4 Preparation of PLLA and PGS/PLLA blend scaffolds 
 
Scheme 3.1: Fabrication steps to obtain cured PGS/PLLA blend scaffolds. The first 
processing stage is comprised by (A) the solution preparation (dissolution of pre-PGS and 
PLLA in 1,4-dioxane) and (B) the lyophilisation process (crystallisation of the solvent below 
its triple point and subsequent sublimation due to low pressure), which produce (C) porous 
pre-PGS/PLLA scaffolds. The second processing stage involves (D) the curing of the porous 
pre-PGS/PLLA scaffolds in a vacuum oven at high temperature (crosslinking of pre-PGS), 
resulting in (E) porous cured PGS/PLLA blend scaffolds. 
 
Cured PGS/PLLA blend scaffolds were prepared in a two-step process, as illustrated in 
Scheme 3.1. The first step includes the solution preparation, in which various pre-PGS/PLLA 
weight ratios (in g g-1 = 0:2, 1:2, 2:2, 2:3, 2:1, 2.5:1, 3:1, 3.5:1 and 4:1) were dissolved in  
40 mL 1,4-dioxane (freezing point: 10-12 °C). All solutions were prepared separately in 
closed glass containers and stirred for 48 h at 50 °C. The solutions were then cast into a  
non-sticky Teflon-coated metal baking tray (six cylindrical cavities with a diameter of 60 mm 
purchased from a local store) and placed in a Labconco FreeZone Triad freeze-dryer for 
lyophilisation. All solutions were cooled to -40 °C and kept at the temperature for  
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5 h, allowing the solutions to freeze completely. The frozen solutions were then heated to  
10 °C (heating rate of 1 °C min-1) for primary-drying under vacuum for 10 h. In the 
secondary-drying stage, the temperature was raised to 40 °C (heating rate of 5 °C min-1), held 
for 10 h, and then lowered to 20 °C (cooling rate of 1 °C min-1) and held for further 10 h to 
maximize the removal of the solvent. All the as-fabricated pre-PGS/PLLA scaffolds were cut 
into halves; one half was directly used for analysis, while the other half was utilised for the 
second processing stage. The second processing stage involved the curing process of all  
pre-PGS/PLLA scaffolds in a vacuum oven for 24 h at 150 °C, in order to crosslink the  
pre-PGS. For the purpose of comparison, one type of pristine PLLA scaffolds was created, 
under the same fabrication scheme as described above. All fabricated scaffolds were stored at 
room temperature until further use. 
3.2.5 Characterisation and testing of pre-PGS and PGS films 
Fourier transform infrared spectroscopy (FTIR) was executed by using a Perkin Elmer 
Spectrum One NTS analyser under attenuated total reflection (ATR) mode (ATR crystal: 
diamond). Pre-PGS and cured PGS were analysed in the mid-infrared region of  
4000-550 cm-1 and recorded with a resolution of 1 cm-1. 
The density, 𝜌𝑃𝐺𝑆, of cured PGS film (n = 5) was determined by weight and volume 
measurements. A Mettler Toledo AB204-S balance was used for weight measurements, while 
the film volumes were determined by calliper measurements. Samples were dried in a vacuum 
oven for 24 h at 37 °C, prior to measurements. 
Quasi-static tensile tests of cured PGS film were performed on a Zwick Z005 testing 
machine. Punched-out ‘‘dog bone’’ shaped specimens (n = 5; width: 2.6 mm, gauge length: 
20 mm, thickness: 1.74 ± 0.17 mm) were tested at a strain rate of 50 mm min-1 using a 100 N 
load cell till fracture (ASTM D412). All tests were performed at room temperature. 
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The crosslink density, 𝑛𝑚𝑒𝑐ℎ, of the cured PGS film was evaluated by mechanical 
measurements and calculated based on the theory of rubber elasticity, which is related to the 
ideal gas law and given by Equation 3.1 [16,336], 
 
𝑛𝑚𝑒𝑐ℎ =
𝐸𝑠
3𝑅𝑇
 (3.1) 
where 𝐸𝑠 is the Young's modulus of the solid film, 𝑅 the universal gas constant, and 𝑇 the 
absolute temperature during the tensile tests. With this respect, the crosslink density is 
expressed in moles of elastically effective network chains per unit volume, and  
depends on the average molecular weight of the polymer chain segments between two 
adjacent crosslinks [16,336]. 
Residual monomer analysis was performed by examining the weight difference of cured 
PGS samples before and after 24 h ethanol extraction, identifying the leaching quantity of 
unreacted monomers and oligomers. 
3.2.6 Characterisation and testing of PLLA and PGS/PLLA blend scaffolds 
The microstructures of all scaffolds were examined by SEM on a Tescan Mira XMU and a 
FEI Inspect F50. The samples were placed on an aluminium stub and coated with gold 
(approx. 35 nm thickness) by using a High Resolution Polatron Sputter Coater before SEM 
observations at 5 kV (pristine PLLA, pre-PGS/PLLA and cured PGS/PLLA scaffolds) or  
10 kV (PGS films) were executed. Scanning electron micrographs were taken from the 
scaffold cross-sections and the average pore sizes of all scaffolds were evaluated by using 
ImageJ software (n = 600). Only fully defined pores were considered for the  
geometrical measurements. 
The scaffold densities (n = 5), 𝜌𝑓, were determined by weight and volume measurements. 
A Mettler Toledo AB204-S balance was used for weight measurements, while the scaffold 
volumes were determined by calliper measurements. Samples were dried in a vacuum oven 
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for 24 h at 37 °C, prior to measurements. The theoretical densities of the solid matrix, 
𝜌𝑓−𝑚𝑎𝑡𝑟𝑖𝑥, used in the formation of the PGS/PLLA scaffolds with different weight ratios were 
calculated according to Equation 3.2, 
 
𝜌𝑓−𝑚𝑎𝑡𝑟𝑖𝑥 =
(𝑤𝑃𝐺𝑆 + 𝑤𝑃𝐿𝐿𝐴)
(𝑤𝑃𝐺𝑆 𝜌𝑃𝐺𝑆⁄ + 𝑤𝑃𝐿𝐿𝐴 𝜌𝑃𝐿𝐿𝐴⁄ )
 (3.2) 
where 𝑤𝑃𝐺𝑆 and 𝑤𝑃𝐿𝐿𝐴 are the weight fractions of PGS and PLLA in the scaffold material 
(note that 𝑤𝑃𝐺𝑆 + 𝑤𝑃𝐿𝐿𝐴 = 1), while 𝜌𝑃𝐿𝐿𝐴 is the density of pristine PLLA (1.22 Mg m
-3) 
(note that 𝜌𝑃𝐺𝑆 was determined in Section 3.3.1) [337]. The volume ratio of PGS, 𝜑𝑃𝐺𝑆, was 
calculated by Equation 3.3, and the volume ratio of PLLA, 𝜑𝑃𝐿𝐿𝐴, is equal to 1 − 𝜑𝑃𝐺𝑆, 
 
𝜑𝑃𝐺𝑆 =
(𝑤𝑃𝐺𝑆 𝜌𝑃𝐺𝑆⁄ )
(𝑤𝑃𝐺𝑆 𝜌𝑃𝐺𝑆⁄ + 𝑤𝑃𝐿𝐿𝐴 𝜌𝑃𝐿𝐿𝐴⁄ )
 (3.3) 
The relative density, 𝜌𝑟, and the porosity, 𝑃𝑓, of all scaffolds were calculated by Equation 3.4 
and 3.5, 
 𝜌𝑟 =
𝜌𝑓
𝜌𝑓−𝑚𝑎𝑡𝑟𝑖𝑥
 (3.4) 
 𝑃𝑓 = (1 − 𝜌𝑟) × 100% (3.5) 
respectively. 
Quasi-static tensile tests were performed on a Hounsfield H100KS testing machine. As 
Scheme 3.2 illustrates, scaffold tensile test samples (n = 5; width: 5.92 ± 0.11 mm (y-axis), 
gauge length: 15 mm (x-axis), thickness: 3.23 ± 0.11 mm (z-axis)) were cut from the centre 
cross section of each scaffold and tested in the longitudinal direction. Each end of a tensile 
test strip was glued with adhesive to home-built sample end holders, allowing the fixation 
onto the tensile grip without damaging the scaffold sample. A 10 N load cell was used and a 
strain rate of 5 mm min-1 was executed till fracture. 
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Scheme 3.2: (A) Scaffold tensile test samples were cut out from the centre cross-section of 
each individual scaffold type. (B) Each tensile test sample was tested in the longitudinal 
direction and glued with epoxy resin onto home-built sample end holders, allowing a damage-
free fixture onto tensile test grips. 
 
3.2.7 In vitro degradation tests 
In vitro degradation studies were performed on cured PGS film (n = 3; diameter: 3.5 mm, 
thickness: 1.57 ± 0.18 mm mm), as well as on PLLA scaffold and PGS/PLLA (weight ratios 
2.5:1 and 3:1) scaffolds (n = 3; width: 3.83 ± 0.41 mm, length: 5.41 ± 0.81 mm, thickness: 
2.91 ± 0.22 mm). All samples were first subjected to a sterilisation procedure, before 
degradation studies were performed. Briefly, all specimens were saturated in a 70% v/v 
ethanol-water solution and shaked in a Stuart SI500 shaking incubator (15 min, 100 rpm) to 
extract the unreacted pre-polymer and monomers, and were then washed with copious 
amounts of distilled water. This cleaning procedure was performed three times in series, while 
at the end all specimens were dried in a vacuum oven at 37 °C until constant weight was 
obtained. For the enzymatic degradation tests, specimens were saturated in a PBS solution  
(30 mL, pH = 7.4) containing 110 U L-1 lipase enzyme, noting that serum lipase in healthy 
adults is in the range of 30-190 U L-1 [338]. Specimens were placed in a Stuart SI500 shaker 
incubator at 37 °C and 100 rpm. The enzyme containing solutions were changed every day to 
guarantee enzymatic activity. The pH value of the degradation medium was monitored after 
each solution change. After 1, 3, 7, 11, 15, 19, 23, 27 and 31 days of incubation, the 
specimens were removed from the vials, washed with distilled water and dried in an vacuum 
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oven at 37 °C, until constant weight was obtained. The percentage of weight loss, 𝑊𝑙𝑜𝑠𝑠, was 
calculated by Equation 3.6, 
 𝑊𝑙𝑜𝑠𝑠 =
𝑊0 − 𝑊𝑑𝑎𝑦
𝑊0
× 100% (3.6) 
where 𝑊0 and 𝑊𝑑𝑎𝑦 are the initial weight before incubation and the weight measured on the 
day of the incubation. Control studies were performed on all sample types in enzyme-free 
PBS solutions, under the same test conditions. SEM analysis was performed after 31 days of 
in vitro degradation on a Camscan S2 at 5 kV on gold coated cured PGS film, as well as 
PLLA and PGS/PLLA scaffold specimens. 
3.2.8 Statistical analysis 
All measurements were reported as mean ± standard deviation (SD) with a confidence level of 
95%. Differences were statistically tested against a null hypothesis of no difference between 
samples using a two-sample t-test (two-tailed) with equal variance not assumed  
(significance = 𝑝 < 0.05). 
3.3 Results and discussion 
3.3.1 Characterisation of pre-PGS and cured PGS film 
Pre-PGS and cured PGS film samples were successfully fabricated. Pre-PGS was 
characterised by a white/yellowish colour, high viscosity and extreme adhesive properties. 
Cured PGS films were transparent and characterised by a light yellow colour, high elasticity 
and low adhesive qualities. 
FTIR spectra of pre-PGS and cured PGS, which was treated at 150 °C for 24 h, are 
illustrated in Figure 3.1 (A, B). With respect to the spectrum of pre-PGS, the broad peak at  
3442 cm-1 is attributed to hydrogen bonded hydroxyl groups (O-H) [339], while the intense 
peaks at 2926 cm-1 and 2852 cm-1 are associated to the stretching vibration of alkane groups 
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[252,339]. The sharp absorption peaks at 1732 cm-1 and 1166 cm-1 are attributed to the 
formation of ester bonds C=O and C-O, respectively [252,339]. Peaks at around 1400 cm-1 are 
related to carboxylic acid O-H bend, and the distinct peaks in the range of 1300-1200 cm-1 as 
well as at 1097 cm-1 and 1048 cm-1 belong to the stretch vibration bands of C-O [17]. 
  
Figure 3.1: (A) Vertically shifted and (B) overlapped FTIR spectra of pre-PGS and  
cured PGS (24 h at 150 °C). 
 
FTIR spectrum of the cured PGS sample is characterised by the same distinct bands as the 
pre-PGS. Due to the curing process, the broad absorption peaks of hydroxyl groups at around 
3456 cm-1 decreased, while the absorption peaks of the ester bonds at around 1733 cm-1 and 
1161 cm-1 increased. In addition, the distinct peaks at around 1400-1200 cm-1 became weaker 
or disappeared, the band at 1100 cm-1 increased and the peak at 1050 cm-1 decreased. The 
obtained results are in accordance with previous studies, overall indicating an increase in the 
degree of crosslinking [244,252,256,339]. 
Representative tensile stress-strain curve of cured PGS film (24 h at 150 °C) is illustrated 
in Figure 3.2, which featured a tensile Young’s modulus, 𝐸𝑠, ultimate tensile strength, 𝜎𝑠𝑚𝑎𝑥, 
strain at break, 𝜀𝑠𝑏, and energy at break, 𝑈𝑠𝑏, of 0.89 ± 0.17 MPa, 0.38 ± 0.03 MPa, 49.56 ± 
 70 
5.60% and 0.11 ± 0.01 MJ m-3, respectively. The mechanical properties of PLLA were 
determined in a previous research study, with a 𝐸𝑠, 𝜎𝑠𝑚𝑎𝑥, 𝜀𝑠𝑏 and 𝑈𝑠𝑏 of 1.56 ± 0.03 GPa, 
41.4 ± 1.6 MPa, 3.2 ± 0.3% and 0.79 ± 0.42 MJ m-3, respectively [337]. The results 
demonstrate an immense discrepancy between the mechanical properties of PGS and PLLA, 
in which PGS features softness and flexibility suggesting it is more appropriate for  
soft tissue engineering applications [16]. The density of the cured PGS was measured as  
1.13 ± 0.01 Mg m-3, which again is in agreement with previous research studies [237,251]. 
 
Figure 3.2: Representative tensile stress-strain curve of cured PGS film (24 h at 150 °C). 
 
The 𝑛𝑚𝑒𝑐ℎ of the cured PGS sample was calculated by using Equation 3.1 as 120.39 ± 
22.49 mol m-3, while the residual analysis presented a weight change of 6.25 ± 0.28% after  
24 h ethanol extraction. The surface of the cured PGS samples was analysed after the ethanol 
extraction, indicating that strong swelling might promote surface microcracking (Figure 3.S1, 
Appendix A). All results demonstrate that the curing process of pre-PGS resulted in a highly 
crosslinked polymer. 
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3.3.2 Microstructures of PLLA and PGS/PLLA blend scaffolds 
The pristine freeze-dried PLLA scaffold was characterised by a homogenous scaffold 
structure and white colour (Figure 3.S2, Appendix A). It presented a ladder-type and oval 
shaped open-cell microstructure, as seen in Figure 3.3 (A), which is commonly found for the 
freeze-drying process [340]. PLLA scaffolds were subjected to the same curing process as for 
PGS (24 h at 150 °C), and the results showed no major modification with respect to pore size 
and open-cell microstructure, as presented in Figure 3.4 (A). The mean pore size decreased 
after the curing stage by 13.7% to 70.1 μm, as listed in Table 3.1. The results demonstrate that 
PLLA can withstand the harsh curing condition of PGS due to its high melting temperature, 
and is a promising material for realizing the freeze-drying fabrication strategy for cured  
PGS/PLLA scaffolds. 
Table 3.1: Pore sizes of PLLA and PGS/PLLA blend scaffolds, before and after the  
curing process 
Solution 
conc.a 
/ g mL-1 
PGS : PLLA 
weight ratio  
/ g g-1 
PGS : PLLA 
volume ratio, 
𝜑𝑃𝐺𝑆: 𝜑𝑃𝐿𝐿𝐴 
Pore size, 
non-cured  
/ µm 
Pore size,  
cured 
/ µm 
Pore size difference 
before & after curing 
/ % 
0.050 0 : 2 0 : 100 81.2 ± 3.2 70.1 ± 2.4 -13.7 
0.075 1 : 2 35 : 65 78.5 ± 4.2 59.9 ± 2.3 -23.7 
0.100 2 : 2 52 : 48 82.8 ± 4.5 55.2 ± 4.2 -33.4 
0.125 2 : 3 42 : 58 54.8 ± 1.9 40.0 ± 0.8 -26.9 
0.075 2 : 1 68 : 32 85.9 ± 3.7 83.5 ± 4.2 -2.7 
0.088 2.5 : 1 73 : 27 104.1 ± 6.4 92.6 ± 2.8 -11.1 
0.100 3 : 1 76 : 24 93.7 ± 6.8 89.8 ± 3.5 -4.2 
0.113 3.5 : 1 79 : 21 88.2 ± 5.9 82.2 ± 3.1 -6.8 
0.125 4 : 1 81 : 19 81.7 ± 5.9 73.5 ± 3.4 -10.0 
a Concentration. 
 
Pre-PGS/PLLA blend scaffolds with different weight ratios were produced via the  
freeze-drying process, characterised by a homogenous scaffold structure and a 
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white/yellowish colour, as demonstrated in Figure 3.5 (A1-2). Each of the scaffolds was 
approximately 6 cm in diameter and over 1 cm in thickness. The surface of the  
pre-PGS/PLLA samples exhibited minor adhesive properties, due to the presence of pre-PGS. 
All freeze-dried pre-PGS/PLLA scaffolds were characterised by highly interconnected  
open-cell microstructure, as seen in Figure 3.3 (B-I) The structure analysis showed in general, 
that both polymers were well distributed throughout the scaffold matrix, indicating that both 
components can coexist in a hybrid system. All samples were analysed from three 
perspectives, evaluating how the material composition and solution concentration affect the 
pore size and microstructure of the pre-PGS/PLLA scaffolds. The scaffolds (listed in Table 
3.1) were classified into groups which featured (I) a fixed PLLA and a varied PGS 
concentration in the initial freeze-drying solution (pre-PGS/PLLA scaffolds with weight ratios 
of 1:2 and 2:2, as well as 2:1, 2.5:1, 3:1, 3.5:1 and 4:1), (II) a fixed PGS and a varied PLLA 
concentration (pre-PGS/PLLA scaffolds with weight ratios of 2:1, 2:2 and 2:3) and (III)  
pre-PGS/PLLA scaffolds with a fixed total material concentration (pre-PGS/PLLA scaffolds 
with weight ratios of 1:2 vs. 2:1, 2:2 vs. 3:1 and 2:3 vs. 4:1). 
The examination of pre-PGS/PLLA scaffolds which featured a fixed PLLA and a varied 
PGS concentration (Figure 3.3 (B, C, E-I)) showed that a higher weight ratio of pre-PGS had 
the tendency to form non-uniform and irregularly shaped cell structures (Figure 3.3 (E-I)), 
due to the presence of a higher amount of viscous and malleable pre-PGS under the 
secondary-drying stage (holding the samples at 40 °C for 10 h). In addition, at lower pre-PGS 
ratios (1:2 vs. 2:2, 2:1 vs. 2.5:1) the average pore size increased with increasing pre-PGS 
content. For instance, pre-PGS/PLLA scaffold with a weight ratio of 1:2 gave a lower pore 
size than that with a weight ratio of 2:2, and the scaffold with a weight ratio of 2:1 had a 
smaller pore size than that with a ratio of 2.5:1. In contrast, at higher pre-PGS ratios (3:1, 
3.5:1 and 4:1) the average pore size decreased with increasing pre-PGS ratio, presumably due 
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the higher material concentration and the high content of viscous pre-PGS under the 
secondary-drying stage. The pre-PGS/PLLA scaffold with a weight ratio of 2.5:1 exhibited 
the highest average pore size of 92.6 μm, which also represents a peak point within the 
characterised pre-PGS/PLLA scaffolds with weight ratios of 2:1, 2.5:1, 3:1, 3.5:1 and 4:1. 
 
Figure 3.3: SEM micrographs of (A) pristine PLLA, and pre-PGS/PLLA blend scaffolds with 
weight ratios of (B) 1:2, (C) 2:2, (D) 2:3, (E) 2:1, (F) 2.5:1, (G) 3:1, (H) 3.5:1 and (I) 4:1, 
presenting the highly interconnected pore structure after the freeze-drying stage. 
 
By analysing pre-PGS/PLLA scaffolds with a fixed PGS and a varied PLLA concentration, 
results demonstrated that an increase of the PLLA weight ratio reduced the pore size in the 
scaffolds (Table 3.1). For instance, pre-PGS/PLLA scaffold with a weight ratio of 2:1 
featured an average pore size of 85.9 μm, which decreased to 40.0 μm for the pre-PGS/PLLA 
scaffold with a weight ratio of 2:3. This change in pore size is attributable to the higher 
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material concentration. The material concentration influences the pore size, in which an 
increased material amount gives rise to a higher polymer volume in the solution and therefore 
smaller pore dimensions. The evaluation of the cell structures illustrated that a higher weight 
ratio of solid PLLA tended to form uniform circular and regular cell structure, characterised 
with rougher and thicker cell-walls, while a higher weight ratio of pre-PGS caused thinner 
and smoother cell-wall structures, as seen in Figure 3.6. 
 
Figure 3.4: SEM micrographs of (A) pristine PLLA and PGS/PLLA blend scaffolds with 
weight ratios of (B) 1:2, (C) 2:2, (D) 2:3, (E) 2:1, (F) 2.5:1, (G) 3:1, (G) 3.5:1 and (I) 4:1, 
demonstrating the final microstructure after the curing stage. 
 
The comparison of pre-PGS/PLLA scaffolds with a fixed total material content indicated 
that the weight ratio of pre-PGS to PLLA influenced the pore size and structure even when 
the material concentration was fixed. Results indicated clearly, that the pre-PGS/PLLA 
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scaffolds with a higher pre-PGS weight ratio accomplished larger pore sizes than their 
corresponding scaffolds with a higher PLLA weight ratio. For example, the pre-PGS/PLLA 
scaffold with a weight ratio of 4:1 achieved 83% bigger average pore size than the  
pre-PGS/PLLA scaffold with a weight ratio of 2:3, and the pre-PGS/PLLA scaffold with a 
weight ratio of 2:1 achieved 39% bigger pore size than the pre-PGS/PLLA scaffold with a 
weight ratio of 1:2. It is interesting to note, that pre-PGS is characterised by a lower density 
(namely a higher volume per equal weight) compared to PLLA, being 1.13 Mg m-3 vs.  
1.22 Mg m-3. Thus, freeze-dried pre-PGS/PLLA scaffolds with a higher pre-PGS weight ratio 
should have obtained smaller pore sizes owing to the higher polymer volume content in the 
solution. The discrepancy from this assumption to the actual results can be explained by two 
main effects from the pre-freezing and the secondary-drying stages. First, both polymers 
featured significantly different molecular weights and glass transition temperatures, 𝑇𝑔. PLLA 
was characterised by a higher number average molecular weight (?̅?𝑛= 130,000 g mol
-1) and a 
𝑇𝑔 of 54.2 °C [337], while non-crosslinked pre-PGS features generally a lower number 
average molecular weight value (below ?̅?𝑛 = 30,000 g mol
-1) [253,257,308] and a 𝑇𝑔 in the 
range of -40 °C to -30 °C [252]. Briefly, during the pre-freezing stage of the lyophilisation 
process (from room temperature to -40 °C), the polymer solution became gradually frozen, 
and crystals of the 1,4-dioxane solvent developed, with increasing freezing time. Owing to the 
high 𝑇𝑔 value of PLLA, the polymer chains of PLLA were immobilised and harder to be 
pushed around by the growing 1,4-dioxane crystals. In contrast, pre-PGS polymer chains were 
more flexible and easier to shift in the polymer-rich phase, thus, facilitating the growth of the 
solvent crystals and leading to a big pore size. Second, during the secondary-drying stage  
(in particular when holding the samples at 40 °C for 10 h), pre-PGS became viscous, which 
could move and affect the cell structure and pore size. As expected, scaffolds which were 
produced with lower material concentrations (pre-PGS/PLLA scaffolds with a weight ratio of 
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1:2 and 2:1), achieved greater pore sizes than scaffolds with higher material concentrations 
(pre-PGS/PLLA scaffolds with a weight ratio of 2:3 and 4:1), again indicating that the 
material concentration influences the pore size. 
 
Figure 3.5: Top and side views of pre-PGS/PLLA blend scaffold samples with a weight ratio 
of 2:1, (A1-2) before and (B1-2) after curing. 
 
Freeze-dried pre-PGS/PLLA blend scaffolds were successfully cured at 150 °C for 24 h, in 
which most scaffolds showed no external physical change, as presented in Figure 3.5 (B1-2). 
As seen in Figure 3.4 (B-I), all cured PGS/PLLA scaffolds were characterised by a highly 
interconnected open-cell structure, demonstrating that PLLA can act as a base support 
structure, preventing the melted low-viscosity pre-PGS from enclosing the existing open-cell 
structure, as well as from complete structural scaffold collapse during the curing stage. While 
the cell microstructure of all scaffolds was not affected by the curing process, the analysis 
indicated the tendency of a modest drop in the pore size, as presented in Table 3.1. The 
change in pore size was due to the pre-PGS, which melted and gained flowability during the 
curing process. Nevertheless, cured PGS/PLLA scaffolds which featured a higher weight ratio 
of PGS (PGS/PLLA scaffolds with weight ratios of 2:1, 2.5:1, 3:1, 3.5:1 and 4:1) showed only 
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a minimal pore size drop in the range of 2.7-11.1%, demonstrating good scaffold structure 
stability. Bigger changes were found in the cell-wall properties of the PGS/PLLA scaffolds, in 
which the cell-wall surfaces exhibited rougher features after curing, as illustrated in  
Figure 3.7. The increases in surface roughness can be beneficial for cell differentiation, 
influencing the cell adhesion and viability as various research studies presented [341,342]. 
 
Figure 3.6: SEM micrographs of non-cured pre-PGS/PLLA blend scaffolds with weight 
ratios of (A) 2:3, (B) 2:2 and (C) 2:1, indicating a change of surface roughness due to 
different material compositions. 
 
 
Figure 3.7: SEM micrographs present the change of the cell wall surface roughness after the 
curing process. Pre-PGS/PLLA blend scaffold with a weight ratio of 2:1, (A) before and (B) 
after curing. 
 
In most instances, cured PGS/PLLA scaffolds with a high PGS ratio showed no indication 
of external physical change (Figure 3.S3-4, Appendix A), with the exception of the scaffolds 
with weight ratios of 3.5:1 and 4:1 (Figure 3.S5-6, Appendix A). The sample with a 
PGS/PLLA weight ratio of 3.5:1 presented a drop of structure height in the middle of the 
scaffold sample, while the scaffold with a weight ratio of 4:1 exhibited an overall reduction in 
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sample height. This suggests that a high amount of the pre-PGS, without sufficient PLLA 
supporting matrix, would melt and collapse during the curing process. However, the 
fabrication of PGS/PLLA samples with an increased PGS weight ratio of up to 3:1 was 
possible, demonstrating good microstructure characteristics and a minimum PLLA volume 
percentage in the scaffold of only 24%. 
The SEM investigation illustrates that the freeze-drying fabrication approach in the 
presence of a structure-supporting polymer is a promising strategy for creating large PGS 
based open-cell interconnected scaffolds for soft tissue engineering applications. Cured 
PGS/PLLA scaffolds with the weight ratios of 2.5:1 and 3:1 presented the highest average 
pore sizes among the measurement range, namely 89.8-92.6 μm. The material composition 
and freeze-drying parameters (e.g. the cooling rate, the freezing temperature, and the total 
freezing time) can be altered to increase the pore size, which will be beneficial for potential 
cell growth and cell penetration. For instance, by decreasing the concentration of the  
pre-PGS/polymer in the solution or by reducing the cooling rate, bigger pore sizes can be 
achieved. The open-cell structure of the scaffolds can be altered to unidirectional pores by 
controlling the heat transfer direction in order to fabricate biomimetic scaffolds with different 
porous structures for different applications, e.g. interconnected open-cell structures for 
adipose or lung tissue engineering [5,343] and aligned laminar pores for cardiac or nerve 
tissue engineering [258,344]. 
3.3.3 Physical and mechanical properties of PLLA and PGS/PLLA blend scaffolds 
The 𝜌𝑓−𝑚𝑎𝑡𝑟𝑖𝑥, the 𝜌𝑓 and the 𝜌𝑟 of the neat PLLA and all cured PGS/PLLA scaffolds are 
listed in Table 3.2. The results illustrate that the densities and porosities depend on the 
material concentration, and the weight ratio of PGS to PLLA, and are affected by the presence 
of viscous pre-PGS during the curing process. For instance, the pristine PLLA scaffold 
(weight ratio of 0:2) with the lowest material concentration featured the lowest scaffold 
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density with 0.085 Mg m-3 and the highest porosity of 93%. PGS/PLLA scaffolds with the 
highest material amounts (weight ratios of 2:3 and 4:1) featured the highest scaffold densities 
of 0.188 Mg m-3 and 0.218 Mg m-3, corresponding to the lowest porosities of 84% and 81%, 
respectively. Due to the same solvent volume applied for each scaffold sample, the results 
demonstrate that the use of a greater material amount increases the scaffold density and 
reduces the porosity. The ratio of PGS to PLLA also affected the final scaffold density and 
porosity, in which higher PGS ratios presented the tendency of lower scaffold densities and 
greater porosities. For example, the PGS/PLLA scaffold with a weight ratio of 2:1 featured a 
14% lower scaffold density and a 2% increased porosity compared to the PGS/PLLA scaffold 
with a weight ratio of 1:2. However, when the PGS ratio in the scaffold was too high, the 
scaffold structure collapsed or changed during the curing stage due to the high amount of 
viscous pre-PGS as previously discussed, causing high scaffold densities and low porosities, 
as explicitly shown by the results for the PGS/PLLA scaffold with a weight ratio of 4:1. 
Table 3.2: Densities and porosities of PLLA and cured PGS/PLLA scaffolds. 
PGS : PLLA weight 
ratioa / g g-1 
Solid densityb  
𝜌𝑓−𝑚𝑎𝑡𝑟𝑖𝑥 / Mg m
-3 
Scaffold densityc,  
𝜌𝑓 / Mg m
-3 
Relative density,     
𝜌𝑟 
Porosity,  
𝑃𝑓 / %  
0:2 1.220 0.085 ± 0.002 0.070 93 
1:2 1.188 0.152 ± 0.005 0.128 87 
2:2 1.173 0.175 ± 0.009 0.149 85 
2:3 1.182 0.188 ± 0.040 0.159 84 
2:1 1.158 0.131 ± 0.003 0.113 89 
2.5:1 1.154 0.138 ± 0.004 0.114 88 
3:1 1.151 0.178 ± 0.032 0.149 85 
3.5:1 1.149 0.171 ± 0.015 0.149 85 
4:1 1.147 0.218 ± 0.017 0.190 81 
a Solvent volume: 40 mL; b Calculated by Equation 3.2; c Scaffold density was determined by 
measuring the weight and volume of each scaffold type. 
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Table 3.3: Mechanical properties of PLLA and cured PGS/PLLA scaffolds 
PGS : PLLA weight 
ratioa / g g-1 
Young’s modulus,  
𝐸𝑡 / MPa 
Ultimate tensile strength, 
𝜎𝑡𝑚𝑎𝑥 / MPa 
Elongation at 𝜎𝑡𝑚𝑎𝑥,  
𝜀𝑡𝜎𝑚𝑎𝑥 / % 
0:2 2.20 ± 0.34 0.18 ± 0.06 9.34 ± 3.13 
1:2 3.62 ± 1.08 0.11 ± 0.04 3.98 ± 1.17 
2:2 6.31 ± 0.64 0.13 ± 0.03 2.95 ± 0.43 
2:3 8.56 ± 1.36 0.28 ± 0.07 4.70 ± 0.83 
2:1 1.05 ± 0.21 0.03 ± 0.01 5.48 ± 0.79 
2.5:1 1.01 ± 0.17 0.08 ± 0.01 15.66 ± 3.35 
3:1 0.36 ± 0.27 0.03 ± 0.01 12.88 ± 3.71 
3.5:1 0.83 ± 0.24 0.05 ± 0.01 8.73 ± 1.51 
4:1 2.66 ± 0.53 0.18 ± 0.04 13.35 ± 2.21 
a Solvent volume: 40 mL. 
 
   
Figure 3.8: Representative tensile strength-strain curves of PLLA and cured PGS/PLLA 
blend scaffolds with various weight ratios: (A) PGS/PLLA blend scaffolds with high stiffness, 
(B) PGS/PLLA blend scaffolds with low stiffness. The 𝐸𝑡 of the PLLA scaffold (weight ratio 
of 0:2) served as a baseline in both cases (see Table 3.3). 
 
Table 3.3 lists the values for the tensile Young’s modulus, 𝐸𝑡, the ultimate tensile  
strength, 𝜎𝑡𝑚𝑎𝑥, and the elongation at ultimate tensile strength, 𝜀𝑡𝜎𝑚𝑎𝑥, of all cured scaffolds. 
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Representative tensile stress-strain curves for these scaffolds are depicted in Figure 3.8. 
Results show that soft and elastomeric PGS/PLLA scaffolds for soft tissue engineering 
applications are producible. As previously arranged, all scaffolds were classified in three 
groups which featured (I) a fixed PLLA and a varied PGS concentration, (II) a fixed total 
PGS and a varied PLLA concentration and (III) PGS/PLLA scaffolds with a fixed  
material content. 
The analysis of cured PGS/PLLA scaffolds which featured a fixed PLLA and a varied PGS 
concentration demonstrated the general tendency that a higher ratio of PGS improved the 
ductility of the elastomeric scaffold (depending on the material concentration). For instance, 
cured PGS/PLLA scaffolds with weight ratios of 2:1, 2.5:1 and 3:1 showed improvements in 
realising soft and elastomeric scaffolds at higher ratios, in which the PGS/PLLA scaffold with 
a weight ratio of 2.5:1 achieved the highest 𝜀𝑡𝜎𝑚𝑎𝑥 value of 15.66%, while the PGS/PLLA 
scaffold with a weight ratio of 3:1 featured the lowest 𝐸𝑡 and 𝜎𝑡𝑚𝑎𝑥 results of 0.36 MPa and 
0.03 MPa, respectively, as well as a high 𝜀𝑡𝜎𝑚𝑎𝑥 of 12.88%. In contrast, a further increase of 
the PGS ratio to 3.5:1 or 4:1 led to an enhancement of the 𝐸𝑡 and 𝜎𝑡𝑚𝑎𝑥, which can be 
accounted for by the reduced pore size and porosities because of the collapse of the scaffolds 
as previously discussed. The pristine PLLA scaffold (weight ratio of 0:2) presented an 𝐸𝑡, 
𝜎𝑡𝑚𝑎𝑥 and 𝜀𝑡𝜎𝑚𝑎𝑥 of 2.20 MPa, 0.18 MPa and 9.34%, respectively, demonstrating statistically 
stiffer scaffolds in comparison to PGS/PLLA scaffolds with weight ratios of 2:1, 2.5:1 and 3:1 
and 3.5:1. Also, cured PGS/PLLA scaffolds with weight ratios of 1:2 and 2:2 presented 
statistically lower 𝜀𝑡𝜎𝑚𝑎𝑥 values, owing to their relatively high PLLA contents. 
By examining the cured PGS/PLLA scaffolds with a fixed PGS and a varied PLLA 
concentration, results illustrated that an increase of the PLLA weight ratio enhanced the 
tensile strength and modulus of the scaffold. Among all the scaffold types (ratios of 2:1, 2:2 
and 2:3), the cured PGS/PLLA scaffold with a weight ratio of 2:3 obtained the highest 𝐸𝑡 and 
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𝜎𝑡𝑚𝑎𝑥 results with statistical significance of 8.6 MPa and 0.3 MPa, respectively, whereas 
PGS/PLLA scaffolds with lower PLLA concentrations exhibited higher 𝜀𝑡𝜎𝑚𝑎𝑥 (<5.48%), and 
statistical significant lower 𝐸𝑡 and 𝜎𝑡𝑚𝑎𝑥 values. The results show that these scaffolds with 
relatively high PLLA ratios are unsuitable for creating soft and elastomeric soft  
tissue substitutes. 
The evaluation of the cured PGS/PLLA scaffolds with a fixed material content indicated 
again that a higher content of PGS offered a softer and more ductile scaffold. The PGS/PLLA 
scaffold with a weight ratio of 2:1 presented statistically significant lower 𝐸𝑡 and 𝜎𝑡𝑚𝑎𝑥 
values, in contrast to the PGS/PLLA scaffold with a weight ratio of 1:2. The PGS/PLLA 
scaffold with a weight ratio of 2:2 versus 3:1 and with a ratio of 2:3 versus 4:1 presented a 
significant difference in 𝐸𝑡, 𝜎𝑡𝑚𝑎𝑥 and 𝜀𝑡𝜎𝑚𝑎𝑥, respectively. 
 
Figure 3.9: Specific Young’s modulus and specific tensile strength for PLLA and cured 
PGS/PLLA blend scaffolds with different weight ratios. 
 
It should be noted that the mechanical properties of the polymer blend scaffolds are also 
dependent on the porosity of the scaffold and the total material concentration in the  
freeze-drying solution. As illustrated in Figure 3.9, the elimination of the contribution from 
 83 
the porosity or relative density, namely specific Young's modulus, 𝐸𝑡 𝜌𝑓⁄ , and specific tensile 
strength, 𝜎𝑡𝑚𝑎𝑥 𝜌𝑓⁄ , of the scaffolds, demonstrated similar trends to those presented in  
Table 3.3 with the exception of the pristine PLLA. By comparing PGS/PLLA scaffolds 
produced with different concentrations, e.g. 3 g / 40 mL (PGS/PLLA weight ratio of 1:2 and 
2:1), 4 g / 40 mL (PGS/PLLA weight ratio of 2:2 and 3:1) and 5 g / 40 mL (PGS/PLLA 
weight ratio of 2:3), there is no clear trend in the mechanical properties due to the variations 
in the ratio of PGS to PLLA which affects the mechanical properties significantly as 
previously discussed. Nevertheless, when the ratio of PGS to PLLA is relatively close, an 
increase in the material concentration generally resulted in a higher specific strength and 
higher specific stiffness. All these results suggest that suitable PGS/PLLA scaffolds for soft 
tissue engineering applications should be fabricated with low material concentrations and 
high ratios of PGS to PLLA. 
The mechanical results as well as the porous structures illustrate that the freeze-drying 
fabrication strategy of PGS/polymer blend scaffolds has the potential to achieve ductile and 
highly porous scaffolds for soft tissue engineering applications. In this work, cured 
PGS/PLLA scaffolds with weight ratios of 2.5:1 and 3:1 presented the most promising 
mechanical results, in which both scaffold types accomplished a 𝐸𝑡 of 0.36-1.01 MPa, a 𝜎𝑡𝑚𝑎𝑥 
of 0.03-0.08 MPa and a 𝜀𝑡𝜎𝑚𝑎𝑥 of 13-16%. Also, the porous structures of both scaffold types 
featured a pore size and porosity in the range of 89.8-92.6 μm and 85-88%, respectively. The 
PGS/PLLA scaffolds are softer and more flexible compared to the pristine PLLA scaffold. 
Thus, these two PGS/PLLA scaffolds were selected for subsequent biodegradation studies. 
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3.3.4 In vitro degradation 
 
Figure 3.10: Percentage of weight loss of PGS film, PLLA and PGS/PLLA scaffolds, 
incubated in enzyme-free or enzyme-containing PBS solutions in a shaker incubator for up to 
31 days at 37 °C. 
 
Figure 3.10 presents the in vitro degradation behaviour of cured PGS film, PLLA scaffold and 
PGS/PLLA scaffolds with weight ratios of 2.5:1 and 3:1 in enzyme-free PBS solution and in 
lipase enzyme-induced PBS solution for up to 31 days. The PGS film specimens underwent a 
weight loss of 9.6% in the enzyme-free PBS solution in 31 days, while in the  
enzyme-containing PBS solution it exhibited with statistical significance an enhanced weight 
loss, being 29.1% within the same period of time. Due to the high weight loss, the 
enzymatically degraded PGS specimens presented a visible loss of volume (Figure 3.S7, 
Appendix A). The SEM analysis of the non-enzymatically tested PGS specimens presented 
smooth surface finishes, whereas the enzymatically tested PGS specimens were characterised 
by various degrees of surface imperfection, such as rough features with pits and craters, as 
seen in Figure 3.11. These results are in accordance with previous studies and demonstrate 
that the lipase enzyme catalyses the hydrolysis of the ester bonds in the PGS polymer 
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[244,251,259,345], resulting in a faster degradation process. The PLLA scaffold specimens 
presented insignificant weight losses of below 0.5% in 31 days in the PBS solutions with and 
without the presence of lipase enzyme. PLLA is a semi-crystalline polymer and is in general 
known as a long-term biodegradable polymer. No changes of the specimen sizes and shapes 
were detected (Figure 3.S8, Appendix A), and correspondingly SEM investigation displayed 
no explicit morphological changes after both in vitro degradation tests, as seen in Figure 3.12. 
The results indicate that the degradation of the PLLA scaffold via hydrolysis or  
enzyme-catalysed hydrolysis is minimal during the test period, which is in agreement with 
previous degradation studies [346–348]. 
 
Figure 3.11: SEM micrographs of cured PGS film (24 h at 150 °C) after 31 days incubation 
at 37 ˚C in (A1-3) enzyme-free and (B1-3) in enzyme-containing PBS solution (note that 
visual differences are minor). 
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Figure 3.12: SEM micrographs of PLLA scaffolds after 31 days incubation at 37 ˚C in (A1-3) 
enzyme-free and (B1-3) in enzyme-containing PBS solution (note that visual differences  
are minor). 
 
In contrast, the degradation of both types of PGS/PLLA scaffolds was with statistical 
significance faster, and the results showed relatively linear weight losses during the test 
period. The PGS/PLLA scaffolds with weight ratios of 2.5:1 and 3:1 obtained in the  
enzyme-free PBS solution similar degradation rates of 9.4% and 9.0% respectively in 31 days, 
and showed only minor shape modifications of the specimens (Figure 3.S9-10, Appendix A). 
In the enzyme-containing PBS solution, the specimens showed with statistical significance 
enhanced degradation rates of 40.1% and 40.4%, respectively, with visible shape changes 
(Figure 3.S9-10, Appendix A). The SEM investigation of both PGS/PLLA specimens 
presented no major changes in respect to the original open-cell scaffold microstructure; 
however, the analysis of the cell-wall and strut surface morphology demonstrated explicit 
signs of surface degradation, characterised by rough features, craters and pits, as seen in 
Figure 3.13 and 3.14. It is postulated that the large surface areas of the PGS/PLLA scaffolds 
have contributed to the high degradation rates, and that PGS is the main polymer that has 
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degraded, due to the slow degradation rate of PLLA. With respect to the pH values of the 
degradation media, no changes were measured during the test periods. 
 
Figure 3.13: SEM micrographs of PGS/PLLA scaffolds with a weight ratio of 2.5:1 after  
31 days incubation at 37 ˚C in (A1-3) enzyme-free and (B1-3) in enzyme-containing  
PBS solution (note that visual differences are minor). 
 
 
Figure 3.14: SEM micrographs of PGS/PLLA scaffolds with a weight ratio of 3:1 after  
31 days incubation at 37 ˚C in (A1-3) enzyme-free and (B1-3) in enzyme-containing  
PBS solution (note that visual differences are minor). 
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Overall, the freeze-drying fabrication strategy, with the use of a structure-supporting 
biopolymer, presented in this work permits the creation of interesting PGS-based scaffolds for 
soft tissue engineering. It also gives plenty of opportunities to optimise the porous structures 
and mechanical properties of the resulting scaffolds according to the targeted soft tissue 
environment. For instance, pre-PGS/PLLA scaffolds could be cured at a lower temperature 
after the freeze-drying stage, resulting in a PGS with a lower crosslink density [237,242,252], 
thus creating cured PGS/PLLA scaffolds with lower Young’s modulus, strength and superior 
ductility. Furthermore, the pore size, porosity, pore shape and pore orientation can be tailored 
by adjusting the material concentration in the solution, material ratio, freezing rate, mould 
material and geometry, as well as heat transfer direction [349], which can also lead to the 
optimisation of the mechanical properties of the scaffolds. PLLA can be changed to another 
structural-supporting polymer that has a high melting point (above the curing temperature of 
pre-PGS) to modify the structure and properties of the scaffolds. Regarding the usage of 
organic solvents and the possible residual solvent within the scaffolds, numerous studies 
demonstrated that scaffolds could be repeatedly washed and immersed in distilled water, PBS 
or ethanol for a prolonged period of time, to remove the residual solvent, without indication 
of negative cell toxicity [350,351]. 
After the cured PGS/PLLA blend scaffolds had been fabricated, attempts were made to 
remove PLLA by leaching in order to create pure PGS scaffolds. Organic solvents such as 
1,4-dioxane and chloroform were used to dissolve the high molecular PLLA. Within the 
solvent, the PGS/PLLA scaffolds swelled and the integrity of the scaffold structure decreased 
tremendously. Shaking movements for improving the PLLA leaching process broke the 
swollen scaffolds apart. When the swollen scaffolds were removed from the solvent, they 
collapsed and/or felt apart, unable to maintain their porous scaffold structure. Further work by 
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using an alternative polymer and different material compositions is currently ongoing in order 
to create pure PGS scaffold by using the freeze-drying approach. 
Nevertheless, the biocompatible PGS/PLLA scaffolds reported herein are still promising 
materials for soft tissue applications. The addition of a second polymer, such as PLLA, can 
achieve large elastomeric scaffolds with high porosities, suitable cell sizes and interconnected 
porous structure. It could also be a viable option for applications where the degradation of 
PGS is considered to be too fast. The in vitro degradation results shown above demonstrate 
that PGS poses a significantly faster degradation rate compared to PLLA. Previous in vivo 
degradation studies showed similar results; PGS degraded completely in 60 days in vivo 
[16,237], while it took at least 4 years to degrade PLLA completely in vivo [352]. PLLA 
could improve the structure integrity of the PGS-based scaffolds during degradation and act 
as a mechanical support for a longer term. 
3.4 Conclusions 
Large 3D porous PGS/PLLA blend scaffolds with varying PGS/PLLA ratios were 
successfully fabricated via a freeze-drying and a subsequent curing process. Results 
demonstrated that the presence of a minor second polymer such as PLLA can act as a base 
support structure during the curing stage, preventing the low-viscosity pre-PGS from 
enclosing the existing open-cell structure as well as the scaffolds from structure collapse. The 
cured PGS/PLLA scaffolds were characterised by a highly interconnected open-cell 
structures, in which the material concentration and the combination of PGS and PLLA 
influenced the final pore size, cell structure, porosity as well as the mechanical properties of 
the scaffolds. The scaffolds which featured a higher PGS to PLLA ratio accomplished more 
favourable cell microstructures and better elastomeric properties. In respect to the mechanical 
properties of pristine cured PGS film, results presented a Young’s modulus, tensile strength 
and elongation at break of 0.89 MPa, 0.38 MPa and 49.6%, respectively, indicating a high 
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crosslink density and superior ductility compared to PLLA. Cured PGS/PLLA scaffolds with 
weight ratios of 2.5:1 and 3:1 presented the most promising results for soft tissue scaffolds. 
Both scaffold types featured a low PLLA volume ratio, high porosity and pore size in the 
ranges of 24-27%, 85-88% and 89.8-92.6 μm, as well as a Young’s modulus, ultimate tensile 
strength and an elongation at ultimate tensile strength in the range of 0.36-1.01 MPa,  
0.03-0.08 MPa and 12.88-15.66%, respectively. In vitro degradation tests demonstrated the 
same results for both types of PGS/PLLA scaffolds, with weight losses of 40% and 9% in  
31 days in PBS solutions with and without the presence of lipase enzyme, respectively, and 
both with good scaffold microstructure retention. 
The freeze-dried PGS-based scaffolds have great potential to be further developed for uses 
in soft tissue engineering. In comparison with other PGS scaffold fabrication strategies, this 
freeze-drying method is less complex, and able to produce large 3D interconnected porous 
scaffolds with high porosities and pore sizes at ease, whilst offering opportunities for further 
optimisations of the structure, mechanical and biological properties. In addition, the 
fabrication strategy can be extended to other combinations of synthetic curable bioelastomers 
and structure-supporting biopolymers, on the condition that (I) both biopolymers (the  
pre-polymer and the structure-supporting polymer) are soluble in the same solvent (or a 
mixed solvent) and (II) the structure-supporting biopolymer can sustain the harsh curing 
condition of the bioelastomer.  
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Chapter 4. Biomimetic poly(glycerol sebacate) /  
poly(L-lactic acid) blend scaffolds for adipose tissue 
engineering 
4.1 Introduction 
The scaffold fabrication strategy described in Chapter 3 presents great potential to achieve 
flexible and highly porous PGS-based scaffolds for various soft tissue engineering 
applications. The freeze-drying and subsequent curing process of PGS/PLLA blends allows 
one to overcome significant constraints of pure PGS in terms of scaffold production and 
design flexibility, therefore improving the overall efficiency of the fabricating large-sized 
PGS-based scaffolds. The simple modification of the material composition of  
the polymer blend and/or the processing parameters, is expected to create porous scaffold 
constructs with the desired mechanical and biological properties, ideal for soft  
tissue substitutes. 
The focus of this chapter is based on the fabrication of large 3D PGS/PLLA blend 
scaffolds with similar bulk mechanical properties to those of native adipose tissue  
(see Section 2.2.3), as well as suitable porous structures for cell penetration and growth for 
prospective application in ATE. As described in Section 2.2.6, most synthetic scaffold 
constructs are composed of conventional polyester-based polymers which were found to be 
rigid and therefore unable to mimic the micro and macroscopic mechanical properties of 
adipose tissue, as well as other surrounding soft tissues [5,353,354]. In normal human 
physiology, e.g. during normal sitting or lying, the adipose tissue is exposed to large 
deformations, thus, the scaffolds for ATE need to be flexible and withstand physiologically 
induced deformations [12,70]. As stated in Section 2.2.3, a sitting posture induces peak 
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tensile, compressive and shear strains of ~30%, ~45% and ~40% on the anatomical site 
related adipose tissues, while a lying posture induces approximately half these loads on the 
same anatomical locations [12,70,71,82]. Hence, the mechanical properties of the engineered 
scaffolds for ATE cannot be ignored when regenerative medicine-based treatments are being 
developed [12,70,71,82]. 
The PLLA and PGS/PLLA blend scaffold samples were created using either 1,4-dioxane 
or dimethyl carbonate (DMC) as the solvent via a modified freeze-drying and a subsequent 
curing process. DMC is a ‘‘green’’ solvent and is characterised with low volatility and  
non-toxicity, as well as biodegradability [351]. The microstructure characteristics of the 
fabricated PLLA and PGS/PLLA scaffolds were analysed by SEM, the mechanical properties 
were evaluated by quasi-static tensile and compressive tests, and the hydrophilicity was 
investigated by water absorption tests. In vitro degradation tests were executed in enzyme-
free and enzyme-containing PBS solution to assess the degradation kinetics of the scaffolds. 
In vitro cell tests with cultured ADSCs were performed to evaluate the performance of the 
scaffolds in terms of cell proliferation, cell penetration and extracellular matrix production. 
The structure and properties of the pre-PGS and crosslinked PGS film were also investigated. 
4.2 Experimental section 
4.2.1 Materials 
The materials for this chapter are those used in Chapters 3, with the following additions: 
DMC, toluene, trypsin-ethylenediaminetetraacetic acid (trypsin-EDTA), fungizone, 
glutamine, paraformaldehyde, peracetic acid, Sirius red stain (Direct Red 80), sodium 
hydroxide and methanol were acquired from Sigma-Aldrich. Fetal calf serum (FCS), 
penicillin-streptomycin, Harris haematoxylin and eosin were purchased from Gibco. 
Isopropanol, xylene, dibutyl phthalate xylene (DPX) mounting medium and Tissue-Tek® 
 93 
4583 optimal cutting temperature (OCT) compound were acquired from Fisher Scientific. 
Collagenase type A was obtained from Roche Diagnostics GmbH. Dulbecco’s modified 
Eagle’s medium (DMEM) was purchased from Advanced Protein Products. 
4.2.2 Preparation of pre-PGS 
Pre-PGS was synthesised as described in Chapter 3. 
4.2.3 Preparation of PGS films 
Cured PGS film was produced via a solvent-free process. Briefly, pristine pre-PGS was 
melted on a hotplate at 80 °C and equally distributed into a non-sticky Teflon-coated metal 
mould (purchased from a local store). The viscous pre-PGS film was further degassed in a 
vacuum oven at 80 °C, until a void-free film was accomplished. In the last step, the pre-PGS 
film sample was crosslinked under vacuum at 120 °C for 36 h, cooled down to room 
temperature and slowly peeled off from the mould surface. Cured PGS films were stored at 
room temperature before further examinations were carried out. 
4.2.4 Preparation of PLLA and PGS/PLLA blend scaffolds 
Table 4.1: Material compositions of the PLLA and pre-PGS/PLLA blended solutions  
for freeze-drying. 
Sample code Polymer(s) 
Weight ratio of pre-
PGS to PLLA / g g-1 
Solvent 
Solvent quantity 
/ mL 
PLLA-D PLLA 0:1.75 1,4-dioxane 40 
PGS/PLLA-D Pre-PGS/PLLA 1.25:0.5 1,4-dioxane 40 
PLLA-DMC PLLA 0:1.75 Dimethyl carbonate 40 
PGS/PLLA-DMC Pre-PGS/PLLA 1.25:0.5 Dimethyl carbonate 40 
 
PLLA and PGS/PLLA scaffolds were prepared in a modified two-step process, based on the 
previous method in Chapter 3. Briefly, the first step included the PLLA and pre-PGS/PLLA 
solution preparation with 1,4-dioxane (freezing point: 10-12 °C) or DMC (freezing point:  
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2-4 °C) for the freeze-drying procedure, as listed in Table 4.1. For the preparation of the 
PLLA solution, PLLA was dissolved for 24 h at 60 °C in 1,4-dioxane or at 80 °C in DMC, 
respectively, and then cooled down to room temperature under continuous stirring until 
further use. The pre-PGS/PLLA solutions were prepared by dissolving first PLLA under the 
same conditions as described previously, while pre-PGS was added to the cooled solutions 
and dissolved under stirring, three hours before the freeze-drying process. All the solutions 
were produced separately in closed glass containers. The solutions were then cast into a non-
sticky Teflon-coated metal baking tray (six cylindrical cavities with a diameter of 60 mm 
purchased from a local store) and placed in a Labconco FreeZone Triad freeze-dryer for 
lyophilisation. All solutions were cooled during the freezing stage to -30 °C and kept at the 
temperature for 5 h, allowing the solution to freeze completely (note that the holding 
temperature during the primary drying stage was modified as compared to Chapter 3, 
allowing to accelerate the scaffold fabrication process). During the primary drying stage the 
solutions were heated to -5 °C (heating rate of 1 °C min-1) and sublimated for 10 h under 
vacuum (note that the holding temperature during the secondary-drying stage was modified as 
compared to Chapter 3, allowing to create scaffolds by using either 1,4-dioxane or DMC as 
the solvent via equal fabrication parameters). In the secondary drying stage, the temperature 
was raised to 40 °C (heating rate of 5 °C min-1), held for 5 h, and then lowered to 20 °C 
(cooling rate of 1 °C min-1) and held for a further 5 h (note that the holding times during the 
secondary-drying stage were reduced as compared to Chapter 3, allowing to accelerate the 
scaffold fabrication process). The second step involved the curing process of the  
pre-PGS/PLLA scaffolds in a vacuum oven for 36 h at 120 °C, in order to crosslink the  
pre-PGS into PGS, while the PLLA scaffolds passed through the same curing process for 
comparison reasons (note that the time and temperature were modified during the curing 
process as compared to Chapter 3, allowing to create soft and elastomeric PGS/PLLA 
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scaffolds). All specimens were subjected to a cleaning procedure prior to tests (24 h ethanol 
saturation and drying in a vacuum oven at 37 °C until constant weight was obtained) to 
remove unreacted pre-polymer and monomers from the scaffolds. The nomenclature of all 
scaffold specimens is listed in Table 4.1, under the column “Sample code”. 
4.2.5 Characterisation and testing of pre-PGS and PGS films 
The number average molecular weight, ?̅?𝑛, the weight average molecular weight, ?̅?𝑤, and 
the polydispersity index (PDI) of the pre-PGS were analysed by gel permeation 
chromatography (GPC) using THF as eluent at a flow rate of 1.0 mL min-1 with 1 x PLGel 10 
lm Guard and 3 x PLGel 10 lm Mixed B as columns. A Gilson 307 pump and an Erma  
ERC-7512 refractive index detector were utilised for the GPC measurements, while 
polystyrene standard samples were used for calibration. FTIR characterisation on pre-PGS 
and cured PGS films were performed as described in Chapter 3. 
The density, 𝜌𝑃𝐺𝑆, of cured PGS film was measured by using a AccuPycII 1340 helium 
pycnometer. Samples were dried in a vacuum oven for 24 h at 37 °C, prior to density 
measurements. 
Quasi-static tensile tests of cured PGS film were performed on a Hounsfield H100KS 
testing machine. Punched-out ‘‘dog bone’’ shaped PGS film specimens (n = 7; width:  
2.6 mm, gauge length: 20 mm, thickness: 0.83 ± 0.09 mm) were tested at a strain rate of  
50 mm min-1 using a 10 N load cell till fracture (ASTM D412). All tests were performed at 
room temperature. 
The crosslink density, 𝑛𝑚𝑒𝑐ℎ, of the cured PGS film was assessed as described in  
Chapter 3, as well as via swelling measurements [257,259]. For the evaluation of the crosslink 
density, 𝑛𝑠𝑤𝑒𝑙𝑙, specimens (n = 5; diameter: 6 mm and thickness: 0.61 ± 0.13 mm) were 
swollen in THF until the samples reached the state of equilibrium. 𝑛𝑠𝑤𝑒𝑙𝑙 was  
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calculated by the Flory-Rehner expression for an ideal tri-functional affine network, given by 
Equation 4.1 [257,259], 
 𝑛𝑠𝑤𝑒𝑙𝑙 =
𝑙𝑛(1 − 𝜐∞) + 𝜐∞ + 𝜒 𝜐∞
2
𝑉𝑚 (
2
3 𝜐∞ − 𝜐∞
1
3 )
 (4.1) 
where 𝜐∞ is the volume fraction of polymer in the swollen weight at equilibrium, 𝑉𝑚 is the 
molar volume of THF solvent, 𝜒 is the Flory-Huggins parameter and determined as 0.52 for 
PGS [259]. 𝜐∞ and the weight swelling degree at equilibrium, 𝑄∞, were calculated by 
Equation 4.2 and 4.3 [257,259], 
 𝜐∞ = [1 + (𝑄∞) (
𝜌𝑇𝐻𝐹
𝜌𝑃𝐺𝑆
)]
−1
 (4.2) 
 𝑄∞ =
𝑊∞ − 𝑊𝑑𝑟𝑦
𝑊𝑑𝑟𝑦
× 100% (4.3) 
where 𝑊∞ and 𝑊𝑑𝑟𝑦 are the weights of the polymer at equilibrium and at dry state, while 
𝜌𝑇𝐻𝐹 is the density of THF (0.89 Mg m
-3). 
Residual monomer analysis was performed as described in Chapter 3. 
4.2.6 Characterisation and testing of PLLA and PGS/PLLA blend scaffolds 
The microstructures of all scaffolds were analysed by SEM on a Camscan S2 and FEI Inspect 
F50. Cubic samples cut from the centre of the scaffolds were placed on an aluminium stub 
and coated with gold for 3 min at 15 mA by using an Emscope SC500 Sputter Coater before 
SEM observations at 5 kV were executed. The average pore sizes (n = 350) of all scaffolds 
were evaluated by using ImageJ software. Only fully defined pores were considered for 
geometrical measurements. 
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The procedures for measuring the scaffold densities, 𝜌𝑓, the theoretical densities of the 
solid matrix, 𝜌𝑓−𝑚𝑎𝑡𝑟𝑖𝑥, the volume ratio of PGS, 𝜑𝑃𝐺𝑆, the volume ratio of PLLA, 𝜑𝑃𝐿𝐿𝐴, as 
well as the porosity, 𝑃𝑓, of all PLLA and PGS/PLLA scaffolds (n = 5) were obtained as 
described in Chapter 3. 
Quasi-static tensile and compression tests were performed on a Hounsfield H100KS testing 
machine. Scaffold tensile test samples (n = 8; width: 5.95 ± 0.17 mm (y-axis), gauge length: 
15 mm (x-axis), thickness: 3.52 ± 0.14 mm (z-axis)) were prepared as described in Chapter 3. 
Tensile tests (ASTM D412) were performed at a tensile strain rate of 50 mm min-1 till fracture 
by using a 10 N load cell. Cylindrical scaffold samples for quasi-static (n = 8; diameter:  
12 mm, thickness: 5.3 ± 0.9 mm (y-axis)) compression tests were punched-out from the centre 
cross section of the scaffolds. Compression tests (ASTM C365-05) were performed at a strain 
rate of 1 mm min-1 up to a strain of 75%, using a 10 N load cell for PGS/PLLA samples, and a 
1 kN load cell for PLLA samples. All tests were performed at room temperature. 
Hydrophilicity of all the scaffolds was analysed by dropping 0.04 mL of blue-dyed PBS 
solution on the cross-section surface of scaffold samples and observing the absorption 
behaviour for up to 1 h. 
4.2.7 In vitro degradation tests 
In vitro degradation tests in enzyme-free and enzyme-containing PBS solution were 
performed on PLLA and PGS/PLLA scaffolds (n = 3; width: 5.78 ± 0.22 mm, length: 6.48 ± 
0.21 mm and thickness: 3.72 ± 0.17 mm) for up to 31 days at 37 °C, as described in  
Chapter 3. SEM analysis was performed after 31 days in vitro degradation on a Camscan S2 
at 5 kV on gold coated PLLA and PGS/PLLA scaffold specimens. 
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4.2.8 In vitro cell culture experiments 
Human subcutaneous fat tissue from abdominoplasties (biopsies were used on an anonymous 
basis, under a Human Tissue Authority research tissue bank licence: 08/H1308/39) was 
selected as the ADSC source and processed as previously stated [355]. Mechanical and 
enzymatic (collagenase type A) digestion was followed by several washes, and the SVF was 
cultured in DMEM culture medium (supplemented with 10% FCS, 1% penicillin–
streptomycin, 1% glutamine and 0.25% fungizone). Cells were subcultured to passage 6 for 
their use in all experiments. 
For sample preparation, PLLA-D and PGS/PLLA-D scaffolds (n = 3; diameter: 16 mm, 
thickness: 5 mm) were placed in a 24-well plate (well with the same diameter as sample) and 
each specimen was sterilised in 2 mL of 1% peracetic acid in PBS for 24 h. Then, scaffolds 
were washed 3 times with PBS and dried overnight in an incubator under ultraviolet  
(UV)-light (37 °C, 5% CO2). After trypsinisation, cells were seeded with 1 mL of DMEM 
onto the scaffold surface (8.5 x 105 cells/sample) and allowed to attach for 2 h in a laminar 
flow culture hood. One millilitre of DMEM was then added to each sample, and subsequently 
the culture medium was changed 3 times per week for up to 21 days. Cell-free scaffolds were 
included as controls in DMEM medium. 
For histology, samples (after 21 days culture in DMEM) were embedded with OCT 
compound and frozen in liquid nitrogen. Scaffold cross-sections (10 µm thickness) were cut 
with a Leica CM300 cryostat and placed on frosted slides. The sample-carrying slides were 
then soaked in deionised water (2 min) to remove the OCT, stained with Harris haematoxylin 
(8 min), and afterwards washed with running tap water (5 min) and stained with eosin  
(3 min). After another wash with tap water (1 min), samples were dehydrated in 70% alcohol 
(1 min), followed with the immersion in 100% alcohol (1 min). Finally, the slides were 
cleaned twice in xylene (1 min each), and mounted with a coverslip by using a DPX mounting 
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medium. An MOTIC DMB optical microscope was used for taking images. Nonstained  
cross-sections, as well as the cell-seeding surfaces were analysed by SEM with a Camscan S2 
at 5 kV. Samples were fixed in 3.7% formaldehyde and were processed as described in  
the literature [355]. 
For the evaluation of the total collagen production by cells on the scaffolds (after 21 days 
culture in DMEM), Sirius red staining was assessed and processed as described in the 
literature [355]. Briefly, after the excess stain was washed off, samples were dried and 
weighed. Then, the stain was eluted and the absorbance was read at 490 nm in a Bio-TEK 
plate reader spectrophotometer. Data analysis involved calculating absorbance of stain per 
gram of dry construct. Control measurements were performed on cell-free scaffolds for 
comparison purpose, under the same test conditions. 
4.2.9 Statistics 
All measurements were reported as mean ± SD with a confidence level of 95%. Statistical 
analysis was performed as described in Chapter 3. 
4.3 Results and discussion 
4.3.1 Characterisation of pre-PGS and cured PGS films 
GPC analysis of the pre-PGS determined an ?̅?𝑛, ?̅?𝑤 and PDI of 1248 g mol
-1, 8192 g mol-1 
and 6.6, respectively. As seen in Figure 4.1 (A,B) , the FTIR spectrum of the pre-PGS 
presented a broad absorption peak of hydroxyl groups at 3443 cm-1 and sharp peaks at 2926 
cm-1 and 2853 cm-1, which belong to the stretch vibration of methyl and alkane groups 
[252,339]. The distinct peak at 1732 cm-1 is associated to the formation of ester bonds, while 
the bands around 1291-1048 cm-1 belong to the stretch vibration bands of carboxyl bonds 
[17,252,339]. The curing process of pre-PGS at 120 °C for 36 h resulted in a reduction of the 
broad absorption peak of hydroxyl groups at 3456 cm-1 and a red shift. The distinct peaks 
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attributed to the ester bonds at 1731-1097 cm-1 increased their intensity, while the  
band at 1049 cm-1 decreased, indicating an increase in the crosslink degree of  
cured PGS [252,259,339]. 
  
Figure 4.1: (A) Vertically shifted and (B) overlapped FTIR spectra of pre-PGS and  
cured PGS (36 h at 120 °C). 
 
 
Figure 4.2: Representative tensile stress-strain curve of cured PGS film (36 h at 120 °C). 
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The 𝑄∞ of the cured PGS film in THF was measured as 708.8 ± 70.8%, giving a 𝑛𝑠𝑤𝑒𝑙𝑙 as 
24.6 ± 7.4 mol m-3. The tensile Young’s modulus, 𝐸𝑠, was determined as 0.22 ± 0.02 MPa, 
leading to a 𝑛𝑚𝑒𝑐ℎ of 29.8 ± 2.3 mol m
-3. Both, values of the crosslink density are in 
accordance with earlier studies [251], and indicated a low crosslink density. Correspondingly, 
the residual analysis presented a high weight change of 24.8 ± 6.2% after 24 h ethanol 
extraction, confirming the existence of a relatively high amount of non-crosslinked monomers 
and pre-PGS oligomers [251]. In comparison, the cured PGS film (24 h at 150 °C) of Chapter 
3 has in average a four times higher 𝑛𝑚𝑒𝑐ℎ and a four times lower residual amount (see 
Section 3.3.1). The density of the cured PGS was measured as 1.1397 ± 0.0014 Mg m-3. 
Due to the low crosslink density, the cured PGS presented soft and highly flexible 
properties, as seen in the representative tensile stress-strain curve in Figure 4.2. PGS exhibited 
a ultimate tensile strength, 𝜎𝑠𝑚𝑎𝑥, strain at break, 𝜀𝑠𝑏, and energy at break, 𝑈𝑠𝑏, of 0.39 ± 0.04 
MPa, 302.57 ± 25.71% and 0.64 ± 0.10 MJ m-3, respectively, which are similar to previous 
published results for PGS with similar crosslink densities [251], but more ductile than the 
PGS at a higher crosslink density [356]. In comparison, the cured PGS film (24 h at 150 °C) 
of Chapter 3 exhibited in average a four times higher 𝐸𝑠 and a six times lower 𝜀𝑠𝑏 (see Section 
3.3.1), indicating that the curing parameter have a significant effect on the materials final 
physicochemical properties. 
4.3.2 Microstructure of PLLA and PGS/PLLA blend scaffolds 
PLLA and PGS/PLLA scaffolds were fabricated via the freeze-drying process and the 
subsequent curing process at 120 °C for 36 h. The final PLLA-D and PLLA-DMC scaffolds 
were characterised by a white colour, whereas PGS/PLLA-D and PGS/PLLA-DMC scaffolds 
showed a light yellowish colour, as seen in Figure 4.3 (A1, B1) and  
4.4 (A1, B1). Except for the PGS/PLLA-DMC scaffold, all the other samples were 
approximately 6 cm in diameter and over 1 cm in thickness. The PGS/PLLA-DMC scaffold 
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shrank and caused a smaller specimen diameter and height. All the scaffolds were 
characterised by a highly interconnected open-pore microstructure, as presented in  
Figure 4.3 (A2-3, B2-3) and 4.4 (A2-3, B2-3). SEM analysis implies that the microstructure 
characteristics of the scaffolds vary with the solvent and the polymer composition. 
Both PLLA and pre-PGS demonstrated good solubility in 1,4-dioxane, resulting in 
relatively uniform scaffold microstructure characteristics after the freeze-drying and curing 
process, similar to the findings in Chapter 3. The PLLA-D scaffold samples were 
characterised by a ladder-type and oval shaped open-pore microstructure, as seen in  
Figure 4.3 (A2-3), and featured an average pore size of 74.3 ± 4.3 µm. This type of 
microstructure is commonly found in freeze-dried PLLA scaffolds with 1,4-dioxane as the 
solvent [259]. In comparison, the PGS/PLLA-D scaffold presented randomly distributed and 
highly interconnected open-pore structures with a high average pore size of 141.2 ± 6.4 µm, 
as illustrated in Figure 4.3 (B2-3). 
Pre-PGS presented good solubility in DMC, while PLLA demonstrated a rather low 
solubility. As shown in Figure 4.4 (A2-3), the PLLA-DMC scaffold samples showed 
vertically large flaky-like aligned pores, with thin and highly porous walls. The scaffold was 
very weak and brittle, and so it was not further analysed. Due to the poor solubility of PLLA 
in DMC, it is assumed that the inhomogeneous polymer solution prevented the formation of a 
continuous structure-supporting foundation for the scaffold during freeze-drying [357]. In 
contrast, the microstructure of the PGS/PLLA-DMC scaffold was characterised by 
interconnected, elongated and orientated open-pores with thicker pore struts and an average 
pore size of 108.6 ± 5.4 µm, as seen in Figure 4.4 (B2-3). The thick pore struts indicate a 
relatively poor polymer dispersion, which could lead to the shrinking of the PGS/PLLA-DMC 
scaffold samples after the curing process. 
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Figure 4.3: Pictures and SEM micrographs of (A1-3) PLLA-D and (B1-3) PGS/PLLA-D 
scaffold samples after freeze-drying and curing, showing their microstructures. 
 
 
Figure 4.4: Pictures and SEM micrographs of (A1-3) PLLA-DMC and (B1-3) PGS/PLLA-
DMC scaffold samples after freeze-drying and curing, showing their microstructures. 
 
Compared to the PLLA-D scaffold, the PGS/PLLA-D and PGS/PLLA-DMC scaffold 
samples had larger pore sizes of 90% and 46%, respectively, as well as wider pore size 
distributions (Figure 4.S1, Appendix B). The increases in pore size can be attributed to the 
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non-crosslinked pre-PGS polymer and its low glass transition temperature, 𝑇𝑔, and low ?̅?𝑛, as 
previously discussed in Chapter 3 [356]. Briefly, the pre-PGS features a 𝑇𝑔 in the range of  
-40 °C to -30 °C [252] and a ?̅?𝑛 of 1248 g mol
-1, while the PLLA polymer is characterised 
with a 𝑇𝑔 of 54.2 °C and a ?̅?𝑛 of 130,000 g mol
-1 [337]. Thus, pre-PGS molecular chains 
were more flexible and easier to move during the pre-freeze and holding stages of the  
freeze-drying process, whereas the growth of the solvent crystals might have been restrained 
by the glassy PLLA polymer chains [356]. In addition, the PGS/PLLA-D and PGS/PLLA-
DMC scaffolds featured overall larger pore sizes then the PGS/PLLA scaffolds of Chapter 3, 
due to a lower total material content in the initial freeze-drying solution. 
4.3.3 Physical and mechanical properties of PLLA and PGS/PLLA scaffolds 
Table 4.2: Pore size, volume ratios, densities and porosities of PLLA and  
PGS/PLLA scaffolds. 
Sample code 
Pore size  
/ µm 
PGS:PLLA 
volume ratio, 
𝜑𝑃𝐺𝑆: 𝜑𝑃𝐿𝐿𝐴 
Solid density, 
𝜌𝑓−𝑚𝑎𝑡𝑟𝑖𝑥 / Mg m
-3 
Scaffold densitya, 
𝜌𝑓 / Mg m
-3 
Porosity, 
𝑃𝑓 / % 
PLLA-D 74.29 ± 4.28 0:100 1.22 0.088 ± 0.008 93 
PGS/PLLA-D 141.21 ± 6.40 73:27 1.16 0.091 ± 0.001 92 
PGS/PLLA-DMC 108.55 ± 5.37 73:27 1.16 0.106 ± 0.009 91 
a Scaffold density was determined by measuring the weight and volume of each scaffold type. 
 
Table 4.3: Tensile and compression properties of PLLA and PGS/PLLA scaffolds. 
Sample code 
Tensile  Compression 
Young’s 
modulus, 
𝐸𝑡 / MPa 
UTSa,  
𝜎𝑡𝑚𝑎𝑥 / 
MPa 
Elong.b at 
𝜎𝑡𝑚𝑎𝑥, 
𝜀𝑡𝜎𝑚𝑎𝑥 / 
% 
 
Young’s 
modulus, 
𝐸𝑐 / MPa 
Comp.c 
collapse 
stress, 
𝜎𝑐 /MPa 
Comp.c 
stress at 
50% strain, 
𝜎𝑐50% / 
MPa 
Comp.c 
collapse 
strain, 
𝜀𝑐 / % 
PLLA-D 
2.23 ± 
0.53 
0.12 ± 
0.027 
7.82 ± 
1.07 
 
4.67 ± 
1.02 
0.44 ± 
0.11 
1.23 ±  
0.05 
9.16 ± 
1.11 
PGS/PLLA-Dd 
0.030 ± 
0.005 
0.007 ± 
0.001 
26.17 ± 
3.15 
0.014 ± 
0.006 
N/A 
0.019 ± 
0.004 
N/A 
PGS/PLLA-DMCd 
0.031 ± 
0.008 
0.007 ± 
0.001 
23.55 ± 
2.40 
0.006 ± 
0.001 
N/A 
0.007 ± 
0.003 
N/A 
a Ultimate tensile strength; b Elongation; c Compressive; d PGS/PLLA-D and PGS/PLLA-
DMC scaffolds did not collapse during compression tests. 
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The pore sizes, the PGS:PLLA volume ratio, the 𝜌𝑓−𝑚𝑎𝑡𝑟𝑖𝑥, the 𝜌𝑓 and the 𝑃𝑓 of the PLLA 
and PGS/PLLA scaffolds are listed in Table 4.2. All scaffolds had a high porosity in the range 
of 91-93%. The results also showed that the use of 1,4-dioxane or DMC as a solvent slightly 
affected the density and porosity of the scaffold, due to the different polymer solubility 
characteristics and polymer compositions. 
 
Figure 4.5: Representative tensile stress-strain curves of the polymer scaffolds. PGS/PLLA-D 
and PGS/PLLA-DMC scaffolds are softer and more resilient than the PLLA-D scaffold with 
statistical significance (p < 0.05). The insets show the stress-strain curves at a smaller scale of 
Y-axis and highlight the results of both PGS/PLLA scaffolds. 
 
Figure 4.5 illustrates representative tensile stress-strain curves of the PLLA and 
PGS/PLLA scaffolds. The tensile Young’s modulus, 𝐸𝑡, the ultimate tensile strength, 𝜎𝑡𝑚𝑎𝑥, 
and the elongation at ultimate tensile strength, 𝜀𝑡𝜎𝑚𝑎𝑥, were obtained, as listed in Table 4.3. 
The tensile testing results demonstrated with statistical significance (p < 0.05) that the 
PGS/PLLA-D and PGS/PLLA-DMC scaffolds are softer and more flexible compared to the 
PLLA-D scaffold. The PLLA-D scaffold presented at the same material concentration a  
70 times higher 𝐸𝑡, a 16 times higher 𝜎𝑡𝑚𝑎𝑥 and an approximately twice lower 𝜀𝑡𝜎𝑚𝑎𝑥 than 
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both PGS-based scaffolds. Compared to the PGS/PLLA scaffolds with weight ratios of 2.5:1 
and 3:1 of Chapter 3, the PGS/PLLA-D and PGS/PLLA-DMC scaffolds have in average a 
~12-34 times lower 𝐸𝑡 and a ~two times higher 𝜀𝑡𝜎𝑚𝑎𝑥 (see Section 3.3.3), overall 
demonstrating favourable mechanical properties. 
 
Figure 4.6: Representative compressive stress-strain curves of the polymer scaffolds. 
PGS/PLLA scaffolds are significantly softer than the PLLA-D scaffold (p < 0.05) and also do 
not collapse during the tests. The insets show the stress-strain curves at a smaller scale of  
Y-axis and highlight the results of both PGS/PLLA scaffolds. 
 
Figure 4.6 shows representative compressive stress-strain curves of all the scaffolds. The 
compressive Young’s modulus, 𝐸𝑐, the compressive collapse stress, 𝜎𝑐, the compressive 
collapse stress at 50% strain, 𝜎𝑐50%, and compressive collapse strain, 𝜀𝑐, were obtained, as 
listed in Table 4.3 (Figure 4.S2, Appendix B). The results presented highly flexible 
PGS/PLLA-D and PGS/PLLA-DMC scaffolds, characterised with only a linear elastic and a 
densification regime, while the stiffer PLLA-D scaffold featured in addition a collapse plateau 
regime [358]. Both PGS-based scaffolds withstood high compression and presented full shape 
recovery after the release of load, while the PLLA-D scaffold was not capable to recover 
because of the collapse of the scaffold during testing, as seen in Figure 4.7. The PLLA-D 
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scaffold exhibited a 466 times greater 𝐸𝑐, presenting significantly higher stiffness compared 
to both PGS-based scaffolds (p < 0.05). The overall softness and flexibility characteristics of 
both PGS-based scaffolds can be attributed to the high volume ratio of the elastomeric PGS in 
the scaffold and its related low crosslink density. 
 
Figure 4.7: Compressive behaviour of all PLLA-D, PGS/PLLA-D and PGS/PLLA-DMC 
scaffolds after 75% strain compression. 
 
Figure 4.8 illustrates the wetting behaviour of all the scaffolds by dropping a blue-dyed 
PBS solution on the scaffold surface. The PGS/PLLA-D and PGS/PLLA-DMC scaffolds 
featured hydrophilic characteristics with an accelerated uptake of fluid (complete soaking  
< 30 s), whereas the PLLA-D scaffold presented hydrophobic characteristics which prevented 
fluid absorption within 1 h. The hydrophilic characteristics of both PGS-based scaffolds can 
be attributed to non-bonded hydroxyl groups on the PGS polymer backbone (due to the low 
crosslink density), while the hydrophobic properties of the PLLA scaffolds are ascribed to the 
pendant methyl group on the alpha carbon [359]. The wettability results are in accordance 
with previous studies [242,266], which demonstrated that the addition of non-crosslinked  
pre-PGS or PGS itself with a low crosslink density can improve the hydrophilicity of  
scaffold constructs. 
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Figure 4.8: Wettability of PLLA-D, PGS/PLLA-D and PGS/PLLA-DMC scaffold samples 
(drop size: 0.04 mL; blue-dyed PBS). PGS-based scaffolds presented hydrophilic properties 
with good wetting behaviour, while the PLLA-D scaffold showed  
hydrophobic characteristics. 
 
4.3.4 In vitro degradation 
 
Figure 4.9: Percentage of weight loss of PLLA-D, PGS/PLLA-D and PGS/PLLA-DMC 
scaffolds, incubated in enzyme-free or enzyme-containing PBS solutions in a shaker incubator 
for up to 31 days at 37 °C. 
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Figure 4.9 presents the in vitro degradation performance of PLLA-D, PGS/PLLA-D and 
PGS/PLLA-DMC scaffolds in enzyme-free and lipase enzyme-containing PBS solution for up 
to 31 days. The PLLA-D scaffold samples presented a stable horizontal trend with only minor 
weight losses of 1% and 5% in the enzyme-free and enzyme-included PBS solutions, 
respectively, similar to the findings in Chapter 3. PLLA-D scaffold samples demonstrated no 
morphological changes as seen in Figure 4.10 (A1-2) and 4.11 (A1-2). PLLA is in general 
characterised by bulk degradation and known as a long-term biodegradable polymer due to its 
hydrophobic characteristics, in which the hydrolysis or enzyme-catalysed hydrolysis is 
minimal [346,347,356]. The degradation characteristics of both PGS-based scaffolds showed 
a steady and linear decline. In the enzyme-free PBS solution the PGS/PLLA-D and 
PGS/PLLA-DMC specimens obtained similar degradation rates of 11% and 16% in 31 days, 
while in the enzymatic PBS solution the specimens exhibited statistically significant enhanced 
degradation rates of 55% and 54% in the same time period, respectively. As seen in  
Figure 4.10 (B1-2, C1-2) and 4.11 (B1-2, C1-2), the PGS/PLLA-D and PGS/PLLA-DMC 
specimens showed no major changes in the scaffold microstructure, compared to untreated 
samples. The pore-wall surface morphology demonstrated signs of surface degradation, 
characterised by rough features, craters and pits. The enzymatically tested PGS/PLLA-D and 
PGS/PLLA-DMC specimens showed a higher degree of degradation effects, indicating the 
catalysed hydrolysis of the ester bonds due to the lipase enzyme [345]. PGS primarily 
degrades by surface degradation [260], as supported by the comparison of the in vitro 
degradation behaviour of pristine PLLA and PGS film tests (Figure 4.S3-4, Appendix B). The 
large surface area of the PGS/PLLA scaffolds, the hydrophilic characteristics, as well as the 
low crosslink density of PGS contributed to the high degradation rates, similar to the results 
reported in previous PGS degradation studies [259,356]. With this respect, the cured PGS 
films and PGS/PLLA scaffolds of Chapter 3 exhibited slower degradation kinetics under the 
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same test conditions, indicating that the degradation rate of PGS-based scaffold constructs is 
tuneable and depends on the crosslink density and available surface area. 
 
Figure 4.10: SEM micrographs of (A1-2) PLLA-D, (B1-2) PGS/PLLA-D and (C1-2) 
PGS/PLLA-DMC scaffold after 31 days at 37 ˚C in enzyme-free PBS solution (note that 
visual differences are minor). 
 
 
Figure 4.11: SEM micrographs of (A1-2) PLLA-D, (B1-2) PGS/PLLA-D and (C1-2) 
PGS/PLLA-DMC scaffold after 31 days at 37 ˚C in enzyme-containing PBS solution (note 
that visual differences are minor). 
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4.3.5 Cell penetration and tissue growth 
 
Figure 4.12: Histological analysis via optical microscopy of ADSC-seeded (A1-2) PLLA-D 
and (B1-2) PGS/PLLA-D scaffold samples after 21 days culture in DMEM, stained with 
haematoxylin and eosin. 
 
 
Figure 4.13: Histological analysis via SEM of ADSC-seeded (A1-2) PLLA-D and (B1-2) 
PGS/PLLA-D scaffold samples after 21 days culture in DMEM. SEM micrographs of  
(A1, B1) the cross-sectional surface and (A2, B2) the top surface of the cell-seeded scaffolds. 
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Figure 4.14: Evaluation of the extracellular matrix deposition of ADSCs in PLLA-D and 
PGS/PLLA-D scaffolds by Sirius red staining after 21 days culture in DMEM. Visualised 
Sirius red staining of (A1) cell free PLLA-D control samples and (A2) ADSC-seeded  
PLLA-D samples, as well as (B1) cell free PGS/PLLA-D control samples and (B2)  
ADSC-seeded PGS/PLLA-D samples. (C) Total collagen amounts determined from Sirius red 
staining shown as mean ± SD (n = 3; * = p < 0.05). 
 
Figure 4.12 and 4.13 shows the histological analysis of ADSC-seeded PLLA-D and 
PGS/PLLA-D scaffold samples after 21 days culture in DMEM, demonstrating qualitatively 
the distribution of ADSCs in both scaffolds after the test period. Cells were successfully 
attached to both types of scaffold and were not removed after washes or medium changes. All 
the scaffolds had a dense layer of cells and ECM at the cell-seeding surface, as seen in  
Figure 4.12 (A1-2, B1-2). The inspection of the cross-sectional surfaces of the scaffolds 
showed deeper cell penetration and ECM growth within the PGS/PLLA-D scaffold than the 
PLLA-D scaffold. This was verified by SEM analysis which demonstrated the formation of 
abundant fibrous tissue in the deep layers of PGS/PLLA-D scaffold, in comparison to 
negligible tissue growth into the 3D structure of the PLLA-D scaffold, as seen in  
Figure 4.13 (A1-2). The improved cell penetration and tissue growth within the PGS/PLLA-D 
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scaffold can be attributed to their hydrophilicity and larger pore sizes, overall enhancing the 
absorption and diffusion of cell culture medium and allowing cells to attach onto and 
penetrate into the scaffold as well as to proliferate. As depicted in a previous study [266], the 
addition of partially crosslinked pre-PGS (with a high quantity of free hydroxyl groups) can 
significantly improve cell attachment, spreading and proliferation in hydrophobic PCL 
scaffolds, improving the cytocompatibility characteristics. In addition, the use of 1,4-dioxane 
for the scaffold fabrication in this study showed no negative toxicological effects. While no 
cell tests were performed with PGS/PLLA-DMC scaffolds, it is assumed that these scaffolds 
will achieve similar results as the tested PGS/PLLA-D specimens. 
Figure 4.14 (A1-2, B1-2) shows collagen accumulation in the control and ADSC-seeded 
PLLA-D and PGS/PLLA scaffold samples visualised by Sirius red staining. The control and 
ADSC-seeded PLLA-D scaffold samples (Figure 4.14 (A1-2)) had small differences in the 
sample size and shape, while the ADSC-seeded PGS/PLLA-D scaffold samples  
(Figure 4.14 (B1-2)) exhibited a much more distinctive difference from their control samples, 
with the former showing markedly enhanced maintenance of their original scaffold shape. 
These initially suggest that new ECM has been formed within the cell-seeded PGS/PLLA-D 
scaffolds which improved the structural integrity of the scaffold during the  
in vitro cell culture. The histological comparison of the cell-free and the ADCS-seeded 
PGS/PLLA-D scaffold samples showed a high density of structural integrated cells and ECM 
in the latter (Figure 4.S5-6, Appendix B). Previous studies have shown that a cell-produced 
ECM network can help retain or even exceed the initial mechanical properties of PGS-based 
scaffold constructs which compensates for the degradation related gradual decrease in the 
mechanical properties, thus, improving structural integrity [271,274]. As presented in  
Figure 4.14 (C), the collagen produced during the test period was significantly (p < 0.05) 
higher for both ADSC-seeded scaffold types compared to their respective controls without 
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cells. Further, the comparison between both ADSC-seeded scaffold types showed that ADSCs 
produced significantly (p < 0.05) more collagen per sample in PGS/PLLA-D than in PLLA-D 
specimens. Overall, the in vitro cell test results provide strong evidence that the PGS/PLLA-D 
scaffolds are suitable for the culture of ADSCs. 
The results presented here demonstrate that large 3D and flexible PGS/PLLA scaffolds, 
with similar bulk mechanical properties to those of native adipose tissue and porous structures 
suitable for cell penetration and growth, can be prepared by the freeze-drying fabrication 
strategy from Chapter 3 [356]. With respect to the bulk mechanical properties, both 
PGS/PLLA scaffolds exhibited comparable stiffness to high stress and low stress adapted 
adipose tissue from heel pad and breast [127]. The stiffness of the PLLA-D scaffold was 
significantly higher, confirming that the polymer is too rigid to mimic the mechanical 
properties of native adipose tissue. The PGS/PLLA scaffolds also showed excellent shape 
recovery after release of the compressive load, in contrast to the collapse and plastic 
deformation of the PLLA scaffold during testing. Due to the consistence of the obtained 
mechanical properties with the native anatomical site, implantation of the PGS/PLLA 
scaffolds may reduce the inflammatory response of native surrounding tissue and improve the 
patient comfort compared to rigid scaffold implants [6]. 
The in vitro degradation study of these soft and flexible PGS/PLLA scaffolds showed fast 
degradation kinetics, which could be too fast for scaffolds to support the growth of target 
tissue or organs. Further characterisation in vivo is needed to demonstrate if these scaffolds 
would be useful for clinical ATE applications. Previous in vivo degradation studies of pure 
PGS showed complete degradation in 60 days, whereas PLLA degraded fully in vivo within  
4 years [16,237,352]. If the present PGS/PLLA scaffolds degrade too fast in vivo, the 
chemical structure of PGS in the scaffolds may be modified by changing the crosslink 
mechanism and introducing more stable urethane groups [312,326]. Future work may also 
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include the investigation of the in vitro and in vivo tissue growth behaviour of cell-seeded 
scaffolds by varying the cell number and cell seeding method (such as constant perfusion of 
cells using a bioreactor) as well as studying cell behaviour on the scaffolds under mechanical 
stimulation (e.g., tensile strains or hydrostatic pressure) [12,82]. To ensure future successful 
clinical applications, it would be advantageous to seed freshly isolated SVF, without in vitro 
selection or expansion processes. SVF can develop into a diversity of cell types, and previous 
studies indicated that adipose tissue can be regenerated by seeding freshly isolated and 
uncultured SVF on fibrin hydrogels [360], porous 3D collagen matrix and gelatin  
sponge scaffolds [136]. 
Vascularisation is a critical aspect in tissue engineering and a key factor governing the 
survival of adipose tissue in engineered scaffolds [291,361] in particular in large-volume 
scaffolds. The highly interconnected open-pore structure with large pore sizes and hydrophilic 
characteristics of the PGS/PLLA scaffolds is expected to be advantageous in tissue 
vascularisation. However, vasculogenesis (i.e. the de novo formation of micro-vascular 
networks) and angiogenesis (i.e. the formation of micro-vascular networks based on existing 
adjacent vascular trees) in these scaffolds needs to be critically examined in vivo to further 
establish the potential of the scaffolds in the clinical reconstruction of large-volume adipose 
tissues. Of relevance to this, the application of SVF and growth factors to autologous fat 
transplants [362], as well as in fibrin hydrogels [360], has been found to promote 
neovascularisation, demonstrating high potential for SVF to mediate vasculogenesis and 
adipogenesis for ATE. 
4.4 Conclusions 
Large and flexible 3D porous PGS/PLLA scaffolds were fabricated with either 1,4-dioxane or 
DMC as the solvent, by a freeze-drying and a subsequent curing process. The PGS/PLLA 
scaffolds with a weight ratio of 1.25:0.5 were characterised with highly interconnected open-
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pore structures, as well as high porosities and pore sizes in the range of 91-92% and  
109-141 μm, respectively. The microstructure characteristics of the scaffolds varied with the 
solvent in use. The PGS/PLLA scaffold produced with 1,4-dioxane was characterised with 
favourable, relatively uniform and large pores, while scaffolds produced with DMC presented 
a more vertically aligned pore structure with thick pore walls and struts. Both PGS/PLLA 
scaffold types showed a tensile Young’s modulus, ultimate tensile strength and elongation at 
ultimate tensile strength in the range of 0.030-0.032 MPa, 0.007 MPa and 23-25%, 
respectively. Compressive tests presented elastomeric behaviour of both PGS/PLLA scaffolds 
with full shape recovery capability after 75% axial strain. The bulk mechanical properties of 
these scaffolds matched the stiffness of native low and high stress adapted adipose  
tissue, attributed to the high volume ratio of 73% PGS in scaffolds which possessed a  
low crosslink density, a low Young’s modulus, a low tensile strength and a high  
elongation at break. 
In vitro degradation tests of both PGS/PLLA scaffolds obtained similar weight losses in  
31 days of 11-16% and 54-55% in enzyme-free and enzyme-containing PBS solution, 
respectively. In vitro cell test results provided clear evidence that PGS/PLLA scaffolds are 
suitable for the culture of ADSCs, characterised with deep cell penetration and ECM growth, 
which improved the scaffold structure integrity during the test period. In contrast, the pure 
PLLA scaffolds prepared with the same fabrication procedure exhibited microstructures with 
smaller average pore sizes, hydrophobic characteristics, extremely rigid and less flexible bulk 
material properties, as well as less favourable scaffold cell penetration and tissue  
in-growth characteristics. 
The results demonstrated that the freeze-dried PGS/PLLA blend scaffolds with similar 
mechanical properties and desirable porous structures with respect to native adipose tissue as 
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well as hydrophilic characteristics have great potential to be further developed in tissue 
scaffolds for ATE.  
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Chapter 5. Structure and properties of stretchable and 
biodegradable poly(glycerol sebacate urethane) scaffolds 
5.1 Introduction 
The large and highly porous developed PGS/PLLA blend scaffolds as described in Chapter 4 
featured similar mechanical bulk properties to those of native adipose tissue, as well as 
desirable porous structures and hydrophilic characteristics, which showed great potential to be 
developed further in tissue scaffolds for ATE. The PGS/PLLA blend scaffolds, however, were 
characterised with fast degradation kinetics, which could potentially be too fast for scaffolds 
to support the growth of certain target tissue or organs, if highly elastomeric and porous  
PGS-based scaffolds are required. The harsh PGS curing conditions, which include long 
curing times, high curing temperatures and a mandatory vacuum environment, further limit 
the potential application of the fabrication strategy described in the previous two chapters. 
The main objective of this chapter is the development of large flexible 3D porous 
poly(glycerol sebacate urethane) (PGSU) scaffolds for ATE applications. PGSU was recently 
designed by Pereira et al. [312] to overcome the limitations of pristine PGS, such as its fast 
degradation kinetics and its relative narrow tuneable mechanical range [312]. PGSU is a 
biocompatible and highly tuneable elastomer, synthesised by reacting pre-PGS with 
isocyanate-based crosslinkers, such as HDI, as seen in Figure 5.1. It can be synthesised 
rapidly under mild conditions through a solvent-based or solvent-free method, therefore 
avoiding the time-consuming and harsh curing conditions of pristine PGS [312,326]. The 
mechanical and biodegradation properties of PGSU can be easily tailored by varying the 
synthesis method and the molar ratio of crosslinker [312]. PGSU featured broad mechanical 
properties with Young’s moduli, strengths and strains at break in the range of 0.71-19.7 MPa, 
1.00-12.10 MPa and 78-516%, respectively [312]. The biodegradation of PGSU is dominated 
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by surface erosion and presented in vivo degradation rates of over 280 days [312]. PGSU 
specimens presented no significant signs of inflammatory responses in vivo and the presence 
of sol content had no effect on its biocompatibility profile [312]. Previous studies on PGSU 
were mainly focused on their physical and chemical structures, mechanical properties and 
biocompatibility, while studies on large 3D PGSU scaffolds were limited [312,326]. 
 
Figure 5.1: (A) Reaction and chemical structure of PGSU. (B) PGSU synthesis under (i) 
solvent-based and (ii) solvent-free conditions. Adapted from Pereira et al. [312] with 
permission from John Wiley and Sons, copyright 2012. 
 
Flexible and large 3D porous PGSU scaffolds with three different low molar ratios of HDI 
were fabricated via a freeze-drying process. 1,4-dioxane was used as the solvent for the 
fabrication of PGSU scaffold. The morphology of the PGSU scaffolds was analysed by SEM. 
The hydrophilic characteristics and water absorption of the scaffolds were investigated and 
evaluated. The mechanical properties were measured in dry and hydrated state during  
quasi-static and cyclic tensile and compression tests, along with rheometry measurements.  
In vitro degradation studies up to 112 days were performed in enzyme-free and  
enzyme-containing PBS solutions. The chemical structure and physical characteristics of  
pre-PGS and PGSU films were also evaluated. 
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5.2 Experimental section 
5.2.1 Materials 
The materials for this chapter are those used in Chapters 3 and 4, with the following 
additions: HDI, Tin(II) 2-ethylhexanoate (Tin(II)), dimethylformamide (DMF), acetone, 
chloroform, were purchased from Sigma-Aldrich. 
5.2.2 Preparation of pre-PGS 
Pre-PGS was synthesised as described in Chapter 3. 
5.2.3 Preparation of PGSU films and Scaffolds 
Table 5.1: Material compositions of the PGSU solutions for freeze-drying. 
Sample code 
Molar ratio of glycerol 
to HDI / mol mol-1 
Weight ratio of pre-
PGS to HDI / g g-1 
Solvent 
Solvent quantity  
/ mL 
PGSU-1:0.4 1:0.4 1.42 : 0.33 1,4-dioxane 50 
PGSU-1:0.5 1:0.5 1.36 : 0.39 1,4-dioxane 50 
PGSU-1:0.6 1:0.6 1.30 : 0.45 1,4-dioxane 50 
 
PGSU specimens with three different low molar ratios of glycerol to HDI (glycerol:HDI = 
1:0.4; 1:0.5, 1:0.6) were synthesised on the basis of a previously reported solvent-based 
method [312]. These low molar ratios of glycerol to HDI were chosen to guarantee soft and 
flexible properties [312]. The nomenclature of the synthesised specimens is presented as 
PGSU-X, where “X” represents the molar ratio of glycerol to HDI: PGSU-1:0.4, PGSU-1:0.5 
and PGSU-1:0.6. Briefly, pre-PGS was dissolved in 1,4-dioxane under the presence of the 
catalyst Tin(II) (0.05% w/v) and heated to 55 °C under constant stirring in a sealed flask. HDI 
was then added drop wise to the solution, nitrogen purged into the reaction flask, sealed and 
held at 55 °C for 5 h. For the preparation of PGSU films, the solution was cast onto a Teflon 
dish and left for 2 days in a fume cardboard at room temperature, and then kept for  
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2 days in a vacuum oven at 37 °C to evaporate any residual solvent and allow for  
further crosslinking [312,326]. 
For the preparation of PGSU scaffolds, the solutions were cast into a non-sticky Teflon-
coated metal baking tray (six cylindrical cavities with a diameter of 60 mm purchased from a 
local store) and placed in a Labconco FreeZone Triad freeze-dryer for lyophilisation. With 
this respect, the PGSU scaffolds were prepared with a fixed total material concentration, as 
listed in Table 5.1, and fabricated via a modified freeze-drying procedure, based on the 
previous methods in Chapter 3 and 4. Hence, the solutions were cooled to -30 °C during the 
freezing stage and held for 5 h, allowing the complete freezing of the solutions. In the primary 
drying stage the frozen solutions were heated to -5 °C (heating rate of 1 °C min-1) and 
sublimated for 24 h under vacuum. For the secondary drying stage the temperature was raised 
to room temperature (heating rate of 1 °C min-1) and held for further 5 h. The as-prepared 
specimens were left for 2 days in a fume cupboard at room temperature, and then kept for  
2 days in a vacuum oven at 37 °C to evaporate any residual solvent and to cure it further 
[312,326]. All PGSU films and scaffolds underwent a cleaning procedure prior to tests (24 h 
saturation in ethanol at 21 °C; vacuum oven drying at 37 °C for 24 h) and were stored in a 
standard 50% relative humidity at 21 °C until further use. 
5.2.4 Characterisation and testing of pre-PGS and PGSU films 
The number average molecular weight, ?̅?𝑛, the weight average molecular weight, ?̅?𝑤, and 
the PDI of the pre-PGS were obtained by GPC as described in Chapter 3. FTIR 
characterisation on pre-PGS and PGSU films was the same as per Chapter 3. 
The densities, 𝜌𝑃𝐺𝑆𝑈, of PGSU films were measured by using a AccuPycII 1340 helium 
pycnometer. Samples were dried in a vacuum oven for 24 h at 37 °C, prior to  
density measurements. 
 122 
The solubility of PGSU film specimens were evaluated by 24 h solvent saturation in 
dimethylformamide, 1,4-dioxane, acetone, dimethyl carbonate, toluene, chloroform and 
ethanol at 21 °C. The sol content of non-cleaned PGSU film specimens (n = 5) was measured 
by determining the weight difference before and after 24 h ethanol saturation at 21 °C. The 
swelling properties of the dried PGSU specimens (n = 9) were analysed in PBS solution (24 h 
saturation at 37 °C) and ethanol (24 h saturation at 21 °C), in which the weight swelling ratio 
was determined by dividing the weight gained during the fluid saturation by the weight of the 
initial sample. 
Quasi-static tensile tests of dry and hydrated PGSU films (hydrated PGSU films had been 
immersed in PBS solution for 24 h at 37 °C and were immediately removed from the solution 
for the tests) were performed on a Hounsfield H100KS testing machine. Punched-out PGSU 
film specimens (n = 5; “dog bone” shaped; width: 2.6 mm, gauge length: 20 mm, thickness: 
0.4 ± 0.05 mm) were tested at a strain rate of 50 mm min-1 using a 10 N load cell till fracture 
(ASTM D412). All the tests were performed at room temperature. 
The crosslink density, 𝑛𝑚𝑒𝑐ℎ, of the PGSU films was evaluated as described in Chapter 3. 
5.2.5 Characterisation and testing of PGSU scaffolds 
The microstructures of as-prepared and cleaned PGSU scaffolds was examined by SEM on a 
Camscan S2, as described in Chapter 3. The average pore sizes (n = 450) of all scaffolds were 
evaluated by using ImageJ software. Only fully defined pores were considered for 
geometrical measurements. 
The procedures for measuring the scaffold densities, 𝜌𝑓, the relative density, 𝜌𝑟, and the 
porosity, 𝑃𝑓, of all PGSU scaffolds (n = 8) were the same as per Chapter 3. 
Quasi-static and cyclic tensile and compression tests of dry and hydrated PGSU scaffolds 
(hydrated PGSU scaffolds had been immersed in PBS solution for 24 h at 37 °C and were 
immediately removed from the solution for the tests) were performed on a Hounsfield 
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H100KS testing machine with a 10 N load cell. Scaffold tensile test samples for quasi-static 
(n = 10; width: 5.14 ± 0.70 mm (y-axis), gauge length: 15 mm (x-axis), thickness:  
3.04 ± 0.71 mm (z-axis)) and cyclic (n = 3; width: 5.60 ± 0.78 mm (y-axis), gauge length:  
15 mm (x-axis), thickness: 3.66 ± 0.82 mm (z-axis)) tests were prepared as described in 
Chapter 3. Tensile tests (ASTM D412) were performed at a tensile strain rate of 50 mm min-1 
till fracture, while the cyclic tensile tests were stretched to 20% strain during 20 cycles, at the 
same tensile strain rate. Cylindrical scaffold samples for quasi-static (n = 10; diameter:  
10 mm, thickness: 4.13 ± 0.94 mm (y-axis)) and cyclic (n = 3; diameter: 10 mm, thickness: 
5.99 ± 0.35 mm (y-axis)) compression tests were punched-out from the centre cross section of 
the scaffolds. Compression tests (ASTM C365-05) were performed at a strain rate of  
5 mm min-1 up to a strain of 75%, while cyclic compression tests were compressed to 50% 
strain during 20 cycles, at the same strain rate. The hysteresis, or dissipated energy, 𝑒𝑑, was 
determined by evaluating the area between the loading and unloading curves during  
cyclic tensile or compression tests, and a hysteresis loss ratio, ℎ𝑟, was defined  
by Equation 5.1 [363], 
 ℎ𝑟 =
𝑒0 − 𝑒𝑟
𝑒0
=
𝑒𝑑
𝑒0
 (5.1) 
where 𝑒0 and 𝑒𝑟 are the input and retraction strain-energy densities of the loading and 
unloading curves, respectively. All the tests were performed at room temperature. 
Rheological measurements on hydrated (after 24 h saturation in PBS solution at 37 °C) 
PGSU scaffold specimens were executed on an Anton Paar Physica MCR 301 rheometer. 
Dynamic frequency sweep measurements were performed at 25 °C, over a frequency range of 
0.1 to 10 Hz under a fixed strain of 0.1% (in the linear viscoelastic region; pre-determined by 
dynamic strain sweep tests), by using a stainless-steel-plate geometry (diameter: 12 mm) and 
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a fixed gap of 1 mm between the two parallel plates. Punched-out cylindrical samples 
(diameter: 12 mm, thickness: 1 mm) from the centre cross section of the scaffolds were used. 
The water absorption behaviour within PGSU scaffolds (n = 9) was evaluated by 
calculating the weight difference between initial dry and soaked specimens, after 24 h 
saturation in PBS solution at 37 °C. The specimens were carefully wiped with filter paper to 
remove excess water on their surface, prior to weight measurements. 
5.2.6 In vitro degradation tests 
In vitro degradation tests in enzyme-free and enzyme-containing PBS solution were 
performed on punched-out PGSU scaffolds (n = 3; diameter: 6 mm; thickness:  
2.58 ± 0.12 mm) for up to 112 days at 37 °C, as described in Chapter 3. SEM analysis was 
performed after 34 days in vitro degradation on a Camscan S2 at 5 kV on gold coated PGSU 
scaffold specimens. 
5.2.7 Statistics 
All measurements were reported as mean ± SD with a confidence level of 95%. Statistical 
analysis was performed as described in Chapter 3. 
5.3 Results and Discussion 
5.3.1 Characterisation of pre-PGS and PGSU Films 
The pre-PGS utilised for the solvent-based PGSU synthesis was characterised by GPC with a 
?̅?𝑛, ?̅?𝑤 and PDI of 1549 g mol
-1, 10522 g mol-1 and 6.8, respectively. As seen in Figure 5.2 
(A-B), the FTIR spectrum of pre-PGS shows the stretching vibration of -OH at 3443 cm-1,  
C-H2 at 2926 cm
-1 and 2854 cm-1, C=O and C-O at 1732 cm-1 and 1160 cm-1, respectively 
[17,252,339]. In comparison, the PGSUs were characterised with the stretching vibration of  
-OH and -NH at 3362 cm-1, C-H2 at 2926 cm
-1 and 2854 cm-1, C=O and C-O at 1720 cm-1, the 
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bending vibration of amide I, II and III at 1646 cm-1, 1532 cm-1 and 1238 cm-1, and stretching 
vibration of C=O and C-O at 1160 cm-1, respectively [312,326]. The amide groups are 
attributed to the formation of urethane, the reaction product of HDI and hydroxyl groups 
[312,326]. The crosslinking of pre-PGS and HDI resulted in peak shifts to lower 
wavenumbers (e.g. 3362 cm-1 and 1720 cm-1), also indicating the establishment of urethane 
linkages and an increase in hydrogen bonding strength [312,326]. In addition, the PGSU 
elastomers with higher molar ratios of glycerol to HDI presented stronger amide-based 
absorption peaks, demonstrating a higher degree of urethane groups. The results confirm the 
successful formation of urethane linkages between pre-PGS and HDI to form PGSU, as 
previously reported [312,326]. The characteristic isocyanate group band at 2270 cm-1 was 
absent in all the PGSUs, implying the complete reaction of the isocyanate groups [312,326]. 
 
Figure 5.2: FTIR spectra of pre-PGS and PGSU derivatives in the range of 4000-650 cm-1. 
The spectra were shifted vertically for clarity. 
 
All of the PGSUs were insoluble in various organic solvents (ethanol, acetone,  
1,4-dioxane, DMF, DMC, toluene, chloroform), confirming the formation of a covalently 
crosslinked network. They are, however, swellable in these solvents. For instance,  
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PGSU-1:0.4, PGSU-1:0.5 and PGSU-1:0.6 specimens presented relatively high mass swelling 
ratios in ethanol (after 24 h saturation at 21 °C) of 88.2 ± 5.6%, 67.9 ± 1.3% and 55.9 ± 5.7%, 
while these specimens presented only low mass swelling ratios in aqueous PBS solution (24 h 
saturation at 37 °C) of 4.9 ± 0.9%, 4.0 ± 0.8% and 2.7 ± 0.9%, respectively. The PGSU 
elastomers with higher molar ratios of glycerol to HDI showed in general lower degrees of 
mass swelling ratios, which can be linked to a presumably higher crosslink density, while the 
overall low mass swelling ratios in PBS solution can be attributed to the primarily 
hydrophobic nature of the elastomer [312]. In respect to the residual analysis of non-cleaned 
PGSU-1:0.4, PGSU-1:0.5 and PGSU-1:0.6 specimens (after 24 h ethanol extraction), mass 
losses of 15.9 ± 2.0%, 5.4 ± 0.9% and 2.0 ± 1.0% were measured, indicating the existence of 
unreacted monomers, oligomers, and pre-polymers [326]. The PGSU specimens had a similar 
𝜌𝑃𝐺𝑆𝑈 of 1.164 ± 0.004 Mg m
-3 to the value previously reported (1.15 Mg m-3) [326]. 
 
Figure 5.3: Representative quasi-static tensile stress-strain curves of dry and hydrated  
PGSU films. 
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Table 5.2: Quasi-static tensile properties of dry and hydrated PGSU films. 
 Sample code 
Young’s modulus, 
𝐸𝑠 / MPa 
Ultimate tensile strength,  
𝜎𝑠𝑚𝑎𝑥  / MPa 
Elongation at break,  
𝜀𝑠𝑏 / % 
C
le
an
ed
 /
 
 d
ry
 
PGSU-1:0.4 0.84 ± 0.03 0.93 ± 0.07 198.6 ± 1.0 
PGSU-1:0.5 2.11 ± 0.11 1.55 ± 0.07 125.2 ± 17.6 
PGSU-1:0.6 3.98 ± 0.62 2.24 ± 0.45 91.6 ± 3.8 
C
le
an
ed
 /
 
h
y
d
ra
te
d
a  
PGSU-1:0.4 0.84 ± 0.01 0.91 ± 0.04 186.4 ± 4.5 
PGSU-1:0.5 2.11 ± 0.03 1.44 ± 0.10 98.0 ± 4.1 
PGSU-1:0.6 3.51 ± 0.01 2.07 ± 0.12 90.8 ± 5.5 
a 24 h saturation in PBS at 37 °C. 
 
As shown in Figure 5.3, all the PGSUs were characterised with soft and highly flexible 
properties, which can be mainly ascribed to the urethane crosslinks [312,364,365]. The tensile 
Young’s modulus, 𝐸𝑠, the ultimate tensile strength, 𝜎𝑠𝑚𝑎𝑥, and the strain at break, 𝜀𝑠𝑏, were 
obtained for dry and hydrated PGSUs, as listed in Table 5.2. The tensile testing results of the 
cleaned and dry PGSUs demonstrated significant difference in terms of 𝐸𝑠, 𝜎𝑠𝑚𝑎𝑥 and 𝜀𝑠𝑏. 
The mechanical properties of the cleaned and hydrated PGSUs presented also difference 
among themselves, with only one exception (the 𝜀𝑠𝑏 results of the hydrated PGSU-1:0.5 and 
PGSU-1:0.6 specimens exhibited no statistical difference). So, in general the alteration of the 
HDI crosslinker ratio changed the PGSUs mechanical characteristics significantly. The 
PGSU-1:0.4 specimens presented the softest and most flexible properties with an 𝐸𝑠, 𝜎𝑠𝑚𝑎𝑥 
and 𝜀𝑠𝑏 in the range of 0.84 MPa, 0.91-0.93 MPa and 186-199%, while the PGSU-1:0.5 and 
PGSU-1:0.6 specimens exhibited stiffer mechanical characteristics with an 𝐸𝑠, 𝜎𝑠𝑚𝑎𝑥 and 𝜀𝑠𝑏 
in the range of 2.11-3.98 MPa, 1.44-2.24 MPa and 98-125%, respectively, both in dry and 
hydrated states. The direct comparison of dry and hydrated PGSU counterparts demonstrated 
similar results, due to their hydrophobicity as previously stated. Still, the hydrated PGSU 
specimens presented the tendency of decreased 𝜎𝑠𝑚𝑎𝑥 and 𝜀𝑠𝑏 results compared to their dry 
equivalents. It is assumed that the absorbed water molecules may interfere with the hydrogen 
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bonding of urethane N-H groups and urethane or ester C=O carbonyl groups, which also 
contributes to the mechanical performance of PUs [364–366]. In comparison to the cured PGS 
film (26 h at 120 °C) of Chapter 4, the PGSU films have in average a ~4-18 times higher 𝐸𝑠 
and a ~2-3 times lower 𝜀𝑠𝑏 (see Section 4.3.1), due to the strong urethane linkages which 
affects the materials final physicochemical properties significantly. 
All the PGSUs presented statistically significant difference in 𝑛𝑚𝑒𝑐ℎ, which were 
calculated for dry PGSU-1:0.4, PGSU-1:0.5 and PGSU-1:0.6 as 113.4 ± 6.9 mol m-3, 285.6 ±  
14.9 mol m-3 and 539.1 ± 84.4 mol m-3, respectively. The 𝑛𝑚𝑒𝑐ℎ results correlate to the prior 
discussed FTIR and swelling results. With this respect, previous studies demonstrated that 
minor differences in the molar ratio of HDI had substantial effects on the physicochemical 
properties of PGSU [312]. 
 
5.3.2 Microstructures of PGSU scaffolds 
 
Figure 5.4: As-prepared scaffolds of (A1) PGSU-1:0.4, (A2) PGSU-1:0.5 and  
(A3) PGSU-1:0.6, directly after freeze-drying. Punched-out scaffold specimens of (B1, C1) 
PGSU-1:0.4, (B2, C2) PGSU-1:0.5 and (B3, C3) PGSU-1:0.6, in as-prepared and  
cleaned state. 
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PGSU scaffolds with three different molar ratios of HDI to glycerol and a fixed material 
concentration of 1.75 g per 50 ml were fabricated by freeze-drying. All as-prepared PGSU 
scaffolds were characterised by a white colour and dimensions of approximately 6 cm in 
diameter and over 1 cm in thickness, as demonstrated in Figure 5.4 (A1-3). These results 
demonstrate that the immediate freeze-drying of the PGSU pre-polymer/solvent 
polymerisation medium can lead to stable three-dimensional PGSU scaffold constructs. The 
surfaces of the PGSU samples revealed minor adhesive properties, due to the low crosslink 
density and/or due to the presence of unreacted oligomers or pre-polymer, indicating the 
necessity of additional cleaning procedures. As seen in Figure 5.4 (B1-3, C1-3), the execution 
of cleaning procedures (24 h saturation in ethanol at 21 °C) on all the as-prepared PGSU 
scaffolds affected their physical shape and presented the tendency of specimen shrinkage, 
with the strongest effect on the PGSU-1:0.4 specimens. Thus, the scaffold microstructures of 
dry as-prepared and cleaned PGSU scaffolds were examined by SEM, analysing the impact of 
the cleaning procedure on the pore sizes and structures of the scaffolds. 
 
Figure 5.5: SEM micrographs of as-prepared (A1-2) PGSU-1:0.4, (B1-2) PGSU-1:0.5 and 
(C1-2) PGSU-1:0.6 scaffold microstructures. 
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All the as-prepared PGSU scaffolds showed randomly distributed and highly 
interconnected open-pore structures, illustrating relatively good distribution of the solid 
PGSU throughout the scaffold, as presented in Figure 5.5 (A1-2, B1-2, C1-2). The pores of 
the scaffold were characterised with non-uniform shapes, which are commonly found in 
freeze-dried PGS-based scaffolds with 1,4-dioxane as the solvent [356,367]. The as-prepared 
PGSU-1:0.4, PGSU-1:0.5 and PGSU-1:0.6 scaffolds featured broad pore size distributions 
(Figure 5.S1, Appendix C), in which the PGSU-1:0.4, PGSU-1:0.5 and PGSU-1:0.6 scaffolds 
presented similar pore sizes of 93 ± 4 µm, 102 ± 3 µm and 112 ± 4 µm, respectively. The 
variation of the HDI crosslinker ratio changes the average pore size of the PGSU scaffolds  
(at a fixed material concentration of the freeze-drying solution). Higher molar ratios of the 
HDI crosslinker lead to an increase in crosslink density, which improved the structural 
stability of the scaffold, due to more stable pore struts and walls in the microstructure. 
 
Figure 5.6: SEM micrographs of cleaned (A1-2) PGSU-1:0.4, (B1-2) PGSU-1:0.5 and (C1-2) 
PGSU-1:0.6 scaffold microstructures. 
 
As shown in Figure 5.6 (A1-2, B1-2, C1-2), all the cleaned PGSU scaffolds maintained a 
highly interconnected open-cell structure, but presented drops in pore size. The cleaned 
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PGSU-1:0.4, PGSU-1:0.5 and PGSU-1:0.6 scaffolds featured a narrow pore size distribution 
and average pore sizes of 55 ± 1 µm, 74 ± 2 µm and 72 ± 4 µm, demonstrating a statistically 
significant pore size drop of 41.2%, 27.4% and 35.9%, compared to the as-prepared counter 
parts, respectively. The pore size drop resulted in more compact microstructures, in particular 
for the cleaned PGSU-1:0.4 scaffold specimens, as seen in Figure 5.6 (A1-2). The open-pore 
structure of the cleaned PGSU-1:0.4 scaffold specimens were characterised with less defined 
pore shapes and struts, while the cleaned PGSU-1:0.5 and PGSU-1:0.6 scaffolds featured 
larger and better preserved pore shapes. The overall drop in pore sizes can be linked to the 
cleaning procedure, owing to the self-loaded deformation of the ethanol swollen PGSU 
matrix, as well as due to the sol content removal. Thus, the self-supporting microstructures of 
the PGSU scaffolds collapsed due to the high mass swelling ratio in ethanol. The PGSU-1:0.5 
and PGSU-1:0.6 specimens featured a higher crosslink density and were less swellable, 
contributing to greater scaffold structure stability. Previous studies also showed that cleaning 
or sterilisation treatments affected the physical properties of polymer scaffolds, resulting in 
changed pore sizes and scaffold dimensions [368–370]. In addition, the cleaned PGSU 
scaffolds featured smaller pore sizes than the PGS/PLLA scaffolds of Chapter 4, indicating 
room for improvements. 
5.3.3 Physical and mechanical properties of PGSU scaffolds 
Table 5.3: Densities and porosities of PGSU scaffolds. 
Sample code 
Scaffold density, 
ρf / Mg m-3 
Relative density, 
ρr / ρf / ρs 
Porosity,  
Pf / % 
PGSU-1:0.4 0.265 ± 0.042 0.227 ± 0.036 77.27 ± 3.60 
PGSU-1:0.5 0.170 ± 0.014 0.147 ± 0.012 85.34 ± 1.23 
PGSU-1:0.6 0.141 ± 0.009 0.121 ± 0.007 87.87 ± 1.28 
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The cleaned PGSU-1:0.5 and PGSU-1:0.6 scaffolds were characterised with relatively high 
porosities in the range of 85-88%, while the PGSU-1:0.4 scaffolds featured a lower porosity 
of 77%, as listed in Table 5.3. Overall, the porosities of the PGSU scaffolds align with the 
pore sizes discussed previously and presented relativly similar values to those of the 
PGS/PLLA scaffolds of Chapter 3 and 4. 
The water absorption abilities of the PGSU scaffolds were evaluated by immersing 
specimens for 24 h in PBS solution at 37 °C. The PGSU-1:0.5 and PGSU-1:0.6 scaffolds 
presented significant differences in the water swelling degree at equilibrium, compared to the 
PGSU-1:0.4 specimens. The PGSU-1:0.5 and PGSU-1:0.6 scaffolds obtained similar high 
water absorption ratios of 970 ± 127% and 1052 ± 72%, while the PGSU-1:0.4 specimens 
presented a lower value of 385 ± 25%. The results imply that the water absorption ability is 
dependent on the scaffold porosity. 
Table 5.4: Quasi-static tensile and compression properties of dry and hydrated PGSU 
scaffolds. 
  Tensile  Compression 
 Sample code 
Young’s 
modulus,  
Et / MPa 
Ultimate tensile 
strength, 
σtmax / MPa 
Elongation 
at σtmax, 
 εtσmax / % 
 
Young’s  
modulus,  
Ec / MPa 
Comp.a stress 
at εc75%,  
σc75% / MPa 
C
le
an
ed
 /
 
 d
ry
 
PGSU-1:0.4 0.040 ± 0.003 0.018 ± 0.004 48.9 ± 4.2  0.020 ± 0.007 0.075 ± 0.019 
PGSU-1:0.5 0.038 ± 0.013 0.016 ± 0.004 54.9 ± 3.1  0.006 ± 0.001 0.039 ± 0.007 
PGSU-1:0.6 0.030 ± 0.001 0.022 ± 0.001 81.6 ± 9.0  0.005 ± 0.001 0.032 ± 0.004 
C
le
an
ed
 /
 
h
y
d
ra
te
d
b
 PGSU-1:0.4 0.029 ± 0.014 0.016 ± 0.004 51.6 ± 4.7  0.008 ± 0.001 0.043 ± 0.010 
PGSU-1:0.5 0.032 ± 0.006 0.012 ± 0.003 50.0 ± 1.3  0.004 ± 0.001 0.029 ± 0.005 
PGSU-1:0.6 0.029 ± 0.003 0.019 ± 0.003 56.8 ± 1.7  0.003 ± 0.001 0.013 ± 0.001 
a Compressive; b 24 h saturation in PBS at 37 °C. 
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Figure 5.7: Representative quasi-static tensile stress-strain curves of (A) dry and (B) hydrated 
PGSU scaffolds. 
 
  
Figure 5.8: Representative quasi-static compressive stress-strain curves of (A) dry and (B) 
hydrated PGSU scaffolds. Compressive tests were terminated at a strain rate of 75%. 
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Figure 5.9: Compressive behaviour of (A) dry and (B) hydrated PGSU scaffolds, illustrating 
the shape restorability after released compression load. 
 
The mechanical properties of cleaned PGSU scaffolds were determined under dry and 
hydrated state by quasi-static and cyclic tensile and compression tests. Representative tensile 
stress-strain curves of the scaffolds are presented in Figure 5.7 (A, B). The tensile Young’s 
modulus, 𝐸𝑡, the ultimate tensile strength, 𝜎𝑡𝑚𝑎𝑥, and the elongation at ultimate tensile 
strength, 𝜀𝑡𝜎𝑚𝑎𝑥, were obtained, as listed in Table 5.4. The results showed that the PGSU 
scaffolds, are highly flexible in dry and hydrated conditions; no yielding was observed in the 
testing curves before failure occurred. At cleaned and dry state, all the PGSU scaffolds 
presented similar 𝐸𝑡 and 𝜎𝑡𝑚𝑎𝑥 results in the ranges of 0.030-0.040 MPa and 0.016-0.022 
MPa, respectively, while the PGSU-1:0.6 scaffold exhibited with significant difference a high 
𝜀𝑡𝜎𝑚𝑎𝑥 of 82% compared to the other two scaffolds. The physical characteristics of the 
PGSU-1:0.6 scaffold such as a large pore size and high porosity [371], as well as the 
relatively high ductility of the solid PGSU promoted the overall good 𝜀𝑡𝜎𝑚𝑎𝑥 properties. At 
cleaned and hydrated state, all the PGSU scaffolds obtained also similar 𝐸𝑡 and 𝜎𝑡𝑚𝑎𝑥 results. 
The hydrated PGSU-1:0.6 scaffold exhibited a low 𝐸𝑡 of 0.029 MPa and the highest 𝜀𝑡𝜎𝑚𝑎𝑥 of 
57%, representing a significant difference to the PGSU-1:0.5 scaffold. The comparison of the 
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tensile properties between dry and hydrated counterparts demonstrated no difference between 
the PGSU-1:0.4 and PGSU-1:0.5 scaffolds, however, the hydrated PGSU-1:0.6 scaffold 
exhibited decreased 𝜎𝑡𝑚𝑎𝑥 and 𝜀𝑡𝜎𝑚𝑎𝑥 results of 13.6% and 30%, respectively. The results 
indicate that the mechanical properties of the PGSU scaffolds can be affected under hydrated 
conditions, due to the water molecules absorbed into the polymer matrix which affected the 
hydrogen-bonding interactions between urethane and ester linkages within the network  
[364–366]. Compared to the PGS/PLLA-D and PGS/PLLA-DMC scaffolds of Chapter 4, 
these PGSU scaffolds presented under dry and hydrated state similarly low 𝐸𝑡 results, but 
have in average a ~2-3 times higher 𝜎𝑡𝑚𝑎𝑥 and a ~2-3 times higher 𝜀𝑡𝜎𝑚𝑎𝑥 (see Section 4.3.3). 
Figure 5.8 (A, B) shows representative compressive stress-strain curves of dry and 
hydrated PGSU scaffolds. The compressive Young’s modulus, 𝐸𝑐, and the compressive stress 
at 75% strain, 𝜎𝑐75%, were measured, as listed in Table 5.4. All the PGSU scaffolds withstood 
the high compression and presented full shape recovery after the release of load, both in dry 
and hydrated state, as demonstrated in Figure 5.9 (A, B). In addition, all the PGSU scaffolds 
were characterised with only a linear elastic and a densification regime, with no presence of a 
collapse plateau, indicating no structure collapse or fracture [358]. At cleaned and dry state, 
the PGSU-1:0.6 and PGSU-1:0.5 scaffolds showed similar 𝐸𝑐 and 𝜎𝑐75% results in the range 
of 0.003-0.004 MPa and 0.013-0.029 MPa, while the PGSU-1:0.4 scaffold featured 
significantly higher 𝐸𝑐 and 𝜎𝑐75% values of 0.020 MPa and 0.075 MPa, respectively. In this 
respect, the relatively dense microstructure of the PGSU-1:0.4 scaffold, characterised with 
small pore sizes and low porosity, resulted in stiffer scaffold constructs. At cleaned and 
hydrated state the PGSU scaffolds presented similar results as under dry conditions, in which 
the hydrated PGSU-1:0.6 scaffold obtained the lowest 𝐸𝑐 and 𝜎𝑐75% of 0.003 MPa and  
0.013 MPa, respectively. The comparison of the compressive properties between dry and 
hydrated counterparts demonstrated no difference in 𝐸𝑐, however, the hydrated PGSU-1:0.4 
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and PGSU-1:0.6 scaffolds exhibited a decrease in 𝜎𝑐75% of 43% and 59%, respectively. The 
results indicated the tendency that the 𝐸𝑐 and 𝜎𝑐75% values of the PGSU scaffolds were 
inversely related to their porosities and pore sizes. In comparison to the PGS/PLLA-D and 
PGS/PLLA-DMC scaffolds of Chapter 4, the PGSU scaffolds presented under dry and 
hydrated state similar low 𝐸𝑐 results (see Section 4.3.3). 
Cyclic tensile and compressive stress-strain curves of dry and hydrated PGSU scaffolds 
presented relatively minimal hysteresis loop during loading, as seen in Figure 5.10 (A, B) and 
Figure 5.11 (A, B). Under cyclic tensile testing, the dry PGSU-1:0.4, PGSU-1:0.5 and  
PGSU-1:0.6 scaffolds were characterised with a ℎ𝑟 of 0.17, 0.12 and 0.07, while hydrated 
PGSU-1:0.4, PGSU-1:0.5 and PGSU-1:0.6 scaffolds were characterised with a negligiblely 
low ℎ𝑟 of 0.07, 0.08 and 0.04 after 20 cycles of tensile loading to 20% strain, respectively. 
With respect to cyclic compressive testing, the dry PGSU-1:0.4, PGSU-1:0.5 and PGSU-1:0.6 
scaffolds were characterised with a ℎ𝑟 of 0.29, 0.36 and 0.17, while the hydrated PGSU-1:0.4, 
PGSU-1:0.5 and PGSU-1:0.6 scaffolds were characterised with a decreased ℎ𝑟 of 0.20, 0.14 
and 0.19 after 20 cycles of compressive loading to 50% strain, respectively. It is assumed that 
the expelling of water during the performed cyclic compressive tests resulted into higher ℎ𝑟 
results [372]. Nevertheless, all PGSU scaffolds were fully recoverable after cessation of the 
cyclic tensile and compression loadings under dry and hydrated state. The PGSU-1:0.6 
scaffold presented overall best resilience characteristics, due to the low ℎ𝑟 values under dry 
and hydrated state. With this respect, the low hysteresis properties can be attributed to the 
higher crosslink density of the generally light crosslinked PGSU scaffolds, which improved 
the load transfer efficiency of the polymer networks. 
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Figure 5.10: Representative cyclic tensile tress-strain curves of (A) dry and (B) hydrated 
PGSU scaffolds. 
 
  
Figure 5.11: Representative cyclic compressive stress-strain curves of (A) dry and (B) 
hydrated PGSU scaffolds. 
 
Rheological measurements were performed on hydrated PGSU scaffolds to assess their 
potential performance in dynamic and wet conditions similar to physiological environments. 
The storage modulus, 𝐺′, and loss modulus, 𝐺′′, as a function of the oscillatory frequency are 
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shown in Figure 5.12 (A, B). Briefly, the 𝐺′ values of the PGSU scaffolds dominated the 
whole range of frequency and were one to two orders of magnitude higher than corresponding 
𝐺′′ values, suggesting that the bulk response of the hydrated PGSU scaffolds to an applied 
deformation is mainly elastic, while the 𝐺′ and 𝐺′′ values increased slightly with increasing 
frequency. The PGSU-1:0.4 scaffolds presented overall the highest 𝐺′ and 𝐺′′ values, due to 
the highest scaffold density, lowest porosity and lowest water absorption ability, in 
comparison to the PGSU-1:0.5 and PGSU-1:0.6 scaffolds which presented similar results. 
 
Figure 5.12: Frequency sweep data for hydrated PGSU scaffolds. The (A) storage modulus 
and (B) loss modulus were measured as a function of frequency under oscillatory shear at a 
strain of 0.1%, in the frequency range of 0.1-10 Hz at 25 °C. 
 
Overall, the PGSU scaffolds reported here show excellent mechanical characteristics under 
quasi-static and cyclic tensile and compressive loads with structurally stable and stretchable 
properties, suitable to engineer scaffolds for a range of soft tissues, such as human cardiac 
muscles (Young’s modulus: 0.01-0.30 MPa) [258] or high stress adapted adipose tissue 
(Young’s modulus: 0.02-0.18 MPa) [76]. As illustrated in Figure 5.13, at the same relative 
density, the PGSU scaffolds show a much lower compressive modulus than other porous 
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scaffolds based on traditional synthetic polyesters, such as PLLA, PDLLA, PLGA and PCL.  
Scaffolds based on these common types of synthetic polyesters are more prone to plastic 
deformations under external loads, feature stiffer bulk properties and lack of ﬂexibility and 
strechability. Hence, the elastomeric PGSU scaffolds mimic the bulk mechanical properties of 
soft tissues more closely. The high flexibility and stretchability of the scaffold constructs 
indicate that the PGSUs have high potential in soft tissue engineering applications for 
dynamic environments. 
 
Figure 5.13: Compressive modulus of porous scaffolds as a function of relative density. 
Comparison of literature values of different polymer scaffolds based on traditional polyesters 
for tissue engineering [373–391] (Table 5.S1, Appendix C), in addition to the results from 
Chapter 4 (PLLA-D, PGS/PLLA-D and PGS/PLLA-DMC scaffolds) and 5 (PGSU-1:0.4, 
PGSU-1:0.5 and PGSU-1:0.6 scaffolds). 
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5.3.4 In vitro degradation 
 
Figure 5.14: Percentage of mass loss of PGSU scaffolds, incubated with and without the 
presence of lipase enzyme in PBS for up to 112 days in a shaker incubator at 37 °C  
at 100 rpm. 
 
The in vitro degradation performance of all PGSU scaffolds were analysed in enzyme-free 
and lipase enzyme-containing PBS solution for up to 112 days, as shown in Figure 5.14. In 
the enzyme-free PBS solution the PGSU-1:0.4, PGSU-1:0.5 and PGSU-1:0.6 scaffold 
specimens obtained degradation degrees of 16%, 12% and 10% in 112 days, while in the 
enzymatic PBS solution the PGSU specimens exhibited higher degradation degrees of 62%, 
54% and 30% in the same time period, respectively. The PGSU scaffolds were characterised 
with relatively linear degradation kinetics and presented a gradual and visible loss in volume 
(Figure 5.S2-4, Appendix C), suggesting that the degradation mechanism is based on the 
surface erosion like PGS [312]. However, the microstructure (e.g. pore sizes, porosities) of 
the PGSU scaffolds had no direct effect on the degradation kinetics, implying that the 
degradation kinetics are more dependent on the number of urethane groups (increased 
urethane content hindered the accessibility to ester bonds, resulting in slower degradation 
 141 
rates) [312]. The enzymatically tested PGSU specimens displayed quicker degradation, 
indicating the catalysed hydrolysis of the ester bonds of the PGS segments due to the lipase 
enzyme [345]. SEM examination (after 34 days in vitro degradation) presented smooth strut 
surface morphologies for the PGSU scaffolds in enzyme-free PBS solution, while in  
enzyme-containing PBS solution the specimens showed stronger signs of surface degradation, 
characterised by rough features, as seen in Figure 5.15 and 5.16. The PGSU-1:0.6 scaffold 
specimens presented the slowest degradation, due to their higher degree of crosslinking and 
urethane groups, indicating that the degradation rate of PGSU can be tuned and depend on the 
molar ratio of glycerol to HDI, which is in alignment with previous studies [312,326]. 
 
Figure 5.15: SEM micrographs of (A1-2) PGSU-1:0.4, (B1-2) PGSU-1:0.5 and (C1-2) 
PGSU-1:0.6 scaffold specimens after 34 days in vitro incubation at 37 ˚C in enzyme-free  
PBS solution (note that visual differences are minor). 
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Figure 5.16: SEM micrographs of (A1-2) PGSU-1:0.4, (B1-2) PGSU-1:0.5 and (C1-2) 
PGSU-1:0.6 scaffold specimens after 34 days in vitro incubation at 37 ˚C in  
enzyme-containing PBS solution (note that visual differences are minor). 
 
The in vitro degradation tests of the PGSU scaffolds illustrate high potential for designing 
tissue engineered constructs with long-term stability and tuneable degradation kinetics. 
Previous in vitro degradation studies with large and porous PGS/PLLA scaffolds from 
Chapter 4, containing 73 vol% PGS and characterised with porosities and pore sizes in the 
range of 91-92% and 109-141 μm, presented mass losses of 11-16% and 54-55% without and 
with the presence of lipase enzyme in 31 days, respectively. In addition, in vivo studies of 
channelled PGS scaffolds with porosities and pore sizes in the range ~95% and ~100 μm 
presented mass losses of up to 80% during the implantation period of 35 days [287]. In 
comparison, under the same in vitro degradation test conditions and period the PGSU 
scaffolds presented mass losses of 2-6% and 5-10% in the enzyme-free and enzyme-
containing PBS solution, respectively, demonstrating significantly reduced degradation rates 
due to the urethane groups in the chemical structure [312]. Previously performed in vivo 
studies with PGSU film specimens also demonstrated long-term shape maintenance and slow 
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degradations rates, in which sample fragmentation was first discovered after  
280 days implantation [312]. 
The freeze-dried PGSU scaffolds in this work presented slow degradation kinetics, 
microstructures with high porosities and interconnected large pores, relative good hydrophilic 
characteristics, as well as soft and highly stretchable mechanical properties, demonstrating 
great potential for soft tissue engineering applications. Compared to other fabrication 
strategies, the freeze-drying fabrication method is less complex and enables the production of 
large and porous 3D scaffold constructs with interconnected pores in a wide range of 
dimensions and directions, capable to fit specific cell types and tissue engineering 
applications [258,343,356,367,392]. With this respect, PGSU presented in previous studies 
good in vitro cytocompatibility with human mesenchymal stem cells, in which the cell 
proliferation and metabolic performance were equivalent compared to standard tissue culture 
polystyrene [312]. PGSU also presented similar in vivo inflammatory responses compared to 
PLGA material, which were characterised by mixed lymphohistiocytic infiltrates, however, 
no adverse reactions or complications were noted during the implantation period [312]. Due 
to the tunability of PGSU, scaffolds with a broad range of mechanical properties are 
producible to match those of the native host soft tissues. Soft tissues, e.g. fat, cardiac muscle 
and blood vessels, are physiologically exposed to large deformations, and exist in a 
mechanically dynamic environment where the loads can vary spatially and temporally 
[82,393,394]. For instance, in the sitting posture, physiological loads induced peak tensile, 
compressive and shear strains of ~30%, ~45% and ~40% on the anatomical site related fat 
tissues, as well as tensile, compressive and shear strains of  ~75%, ~75% and 91% on the 
anatomical site related muscle tissues, respectively [70,71]. Traditional synthetic 
biodegradable polyesters, such as PLA, PGA and their copolymers, although commonly used 
in tissue engineering, are not stretchable, subjected to plastic deformation, prone to failure 
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under cyclic deformations, and ultimately causing a mismatch in compliance [258,365,395]. 
Thus, the mechanical properties of engineered scaffold constructs are critical for successful 
surgical implantation [82,365,396]. Ideal engineered soft tissue scaffold should not only be 
structurally stable to withstand in vivo mechanical stresses and deformations, but also feature 
certain flexibility and stretchability which can provide mechanical stimulation, while 
providing support to the ingrowing tissue [365,394]. Future work should examine the in vitro 
and in vivo tissue growth behaviour of cell-seeded scaffolds, as well as analysing the cell 
behaviour under mechanical stimulation. 
5.4 Conclusions 
Flexible and large 3D porous PGSU scaffolds with different molar ratios of HDI were 
produced via a freeze-drying process. Results proved that the solvent-based PGSU synthesis 
with a subsequent freeze-drying process can create stable and highly interconnected  
open-pore scaffold constructs with no structure collapse. PGSU scaffolds were characterised 
with non-uniform shapes and smooth pore-wall surfaces, and featured high porosities and 
pore sizes in the range of 77-88% and 55-74 µm, respectively. The PGSU scaffolds exhibited 
relatively good hydrophilic characteristics, as well as high water absorption abilities. 
Hydrated PGSU scaffolds obtained a Young’s modulus, ultimate tensile strength and 
elongation at break in the range of 0.029-0.032 MPa, 0.012-0.019 MPa and 52-57%, 
respectively, and showed no fracture and full recoverability after 75% strain compression. In 
addition, hydrated PGSU scaffolds presented overall minor hysteresis loss ratio at high strain 
after performed cycle tensile and compression tests. Rheometer measurements indicated 
furthermore a primarily elastic bulk response at low strain. PGSU scaffolds were 
characterised with linear degradation kinetics and obtained in vitro degradation rates of 10-
16% and 30-62% in 112 days in enzyme-free and enzyme-containing PBS solution, 
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respectively. Overall, the freeze-dried PGSU scaffolds have great potential to be further 
developed for ATE, as well as for other soft tissue engineering applications.  
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Chapter 6. Stretchable, biodegradable and biocompatible 
poly(glycerol sebacate)-based polyurethane hydrogels with 
thermoresponsive properties 
6.1 Introduction 
The large and highly porous PGSU scaffolds developed in Chapter 5 featured improved 
physicochemical properties over the PGS/PLLA scaffolds of Chapter 3 and 4, while also 
offering similar mechanical bulk properties to those of native adipose tissue, illustrating great 
potential to be developed further for ATE applications and other soft tissue substitutes. The 
PGSU scaffolds with a high ratio of HDI, however, exhibited slow degradation rates and 
decreased hydrophilic characteristics. Ideally, the engineered scaffolds should degrade at the 
same rate as cells proliferate and secret their own ECM into the scaffold constructs [2]. Also, 
despite the highly interesting properties, PGS and PGSU material presented limited water 
absorption and diffusion capabilities [16,310,312], which is in need of improvement to 
guarantee the effective transport of oxygen and nutrients within the deeper compartments of 
large-volume engineered tissue scaffolds, especially in the absence of a functional  
vascular system [397,398]. 
The main purpose of this chapter is the development of PGS-based hydrogels with 
enhanced and tailorable hydrophilic properties, as well as mechanical and degradation 
characteristics. Novel polyester-based polyurethane (PEU) hydrogels were synthesised from 
pre-PGS and PEGs of different molecular weights, both containing hydroxyl groups, with 
aliphatic HDI. Hydrogels have attractive characteristics, owing to their high water content and 
3D network structure, which closely mimic the natural extracellular matrices of soft tissues 
[214]. It was hypothesised that the synthesis of the PEU using  
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(I) biodegradable pre-PGS as the main macromolecular crosslinker, (II) hydrophilic PEG as 
the main polyol component, and (III) hydrophobic HDI as the diisocyanate component, could 
theoretically create a chemically crosslinked hydrogel with the combined advantages of PGS, 
PEG and PU. The chemical and physical characteristics of the PEU hydrogels should 
potentially be tailorable by varying the molecular weight of PEG. 
Stretchable, biodegradable and biocompatible PEU hydrogels, based on pre-PGS and PEGs 
of different molecular weights were synthesised by a solvent-based two-step method. HDI 
was selected due to its extensive use in synthesizing biocompatible PUs [312,399]. The 
structure and properties of these materials were investigated, and their potential applications 
for tissue engineering evaluated. The structures of the PEUs were characterised by 
spectroscopic and calorimetric measurements. The mechanical properties were analysed via 
quasi-static and cyclic tensile and compression tests, and the hydration kinetics studied.  
In vitro degradation tests were carried out in media with and without lipase, and the cell 
proliferation response was examined in vitro with human ADSCs and dermal fibroblasts 
(FIBs). The potential of fabricating the PEU material into different forms such as 
microspheres and large 3D porous scaffolds was also investigated and demonstrated.  
In addition, the synthesised PEU hydrogels also presented negative thermoresponsive 
properties, thus, the swelling behaviour under various medium temperatures were analysed, 
and drug delivery and temperature-induced actuation tests were performed. 
6.2 Experimental section 
6.2.1 Materials 
The materials for this chapter are those used in Chapters 3, 4 and 5, with the addition of: PEG 
(with the number average molecular weight, ?̅?𝑛, of 400 g mol
-1 (PEG-400), 950-1050 g mol-1 
(PEG-1000) and 1305-1595 g mol-1 (PEG-1450)), hexane, mineral oil, Span 80, n-heptane, 
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lidocaine, formaldehyde, phalloidin-fluorescein isothiocyanate (phalloidin-FITC) and 
resazurin were purchased from Sigma-Aldrich. Glutamine and amphotericin B were 
purchased from Gibco. Difco-trypsin plus was obtained from Difco Laboratories. 
6.2.2 Preparation of pre-PGS 
Pre-PGS was synthesised as described in Chapter 3. 
6.2.3 Solvent-based Synthesis of PEUs 
PEUs were synthesised by using a solvent-based two-step approach with a fixed molar ratio 
(glycerol : isocyanate (NCO)-terminated PEG = 1 : 0.3). Briefly, the first step involved the 
reaction of PEG (1 mmol; PEG-400, PEG-1000 or PEG-1450) and HDI (2 mmol) in  
1,4-dioxane (20 mL) with Tin (II) (0.05% w/v) as the catalyst for 1 h at 85 °C. In the second 
step the NCO-terminated PEG/1,4-dioxane solution was cooled down to 55 °C, to which a 
pre-PGS solution (3.4 mmol pre-PGS in 20 mL 1,4-dioxane with 0.05% w/v Tin (II)) was 
added and reacted for 5 h. At each step the reaction flasks were purged with nitrogen and 
sealed. The reacted solution was poured onto a non-sticky mould and the solvent was allowed 
to evaporate for 2 days at room temperature and another 2 days in a vacuum oven at 40 °C, 
which also allowed for further crosslinking. All the specimens were subjected to a cleaning 
procedure (24 h ethanol saturation and drying in a vacuum oven at 37 °C) prior to tests, to 
remove unreacted pre-polymer and monomers. The nomenclature of the synthesised  
NCO-terminated PEG is presented as Pre-X, where “X” represents ?̅?𝑛 of the utilised PEG: 
Pre-400, Pre-1000 and Pre-1450. In addition, the nomenclature of the synthesised PEU 
hydrogels is presented as PEU-X, where “X” represents ?̅?𝑛 of the utilised PEG: PEU-400, 
PEU-1000 and PEU-1450. 
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6.2.4 Characterisation of pre-PGS 
The ?̅?𝑛, the weight average molecular weight, ?̅?𝑤, and the PDI of pre-PGS were measured 
by GPC as described in Chapter 4. FTIR characterisation on pre-PGS were performed as 
described in Chapter 3. 
6.2.5 Characterisation and testing of PEUs 
Proton nuclear magnetic resonance spectroscopy (1H NMR) was performed on a Bruker 
Avance III HD 500, and samples were recorded at 25 °C at 500 MHz, using deuterated 
chloroform (CDCl3) as the solvent. PEUs were soaked overnight in CDCl3 and the acquired 
1H NMR data were analysed using ACDLABS/1D NMR software. FTIR characterisation on 
PEU films were performed as described in Chapter 3. Raman spectroscopy was executed on a 
Renishaw inVia Raman spectroscope using a 514.5 nm wavelength laser. Spectra were 
recorded between 500-3500 cm-1 with a laser power of 2 mW and a spectra resolution  
of 0.5 cm-1. 
Differential Scanning Calorimetry (DSC) was carried out on a Perkin Elmer Diamond 
DSC, and temperature scans from -60 °C to 120 °C at 10 °C min-1 under a nitrogen flow rate 
of 20 ml min-1 were performed during two consecutive heating cycles. The heat capacity 
change in the second heating cycle was used for analysis. 
The solubility of PEU film specimens was evaluated by immersing the specimens in a 
solvent, 1,4-dioxane, dimethylformamide, DMC, toluene, chloroform, acetone or ethanol, for 
24 h at room temperature. The sol contents of non-cleaned PEU film specimens (n = 5)  
were calculated by determining the weight difference after 24 h ethanol saturation at  
room temperature. 
Quasi-static tensile and compression tests were performed on dry and hydrated PEU film 
specimens (hydrated PEU specimens had been immersed in PBS solution for 24 h at 37 °C 
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and were immediately removed from the solution for the tests), while cyclic tensile and 
compression tests were conducted on hydrated PEUs. Briefly, quasi-static tensile tests 
(ASTM D412) were carried-out on a Hounsfield H100KS testing machine with a 10 N load 
cell, at a tensile strain rate of 50 mm min-1 till fracture with punched-out “dog bone” shaped 
specimens (n = 8; width: 2.6 mm, gauge length: 20 mm, thickness: 0.42-1.29 mm). Cyclic 
tensile tests (n = 3; width: 2.6 mm, gauge length: 20 mm, thickness: 0.82-1.65 mm) were 
performed under the same testing set-up at a tensile strain rate of 50 mm min-1 and stretched 
to 50% strain during 20 cycles. Quasi-static compression tests were executed on punched-out 
cylindrical specimens (n = 7; diameter: 6 mm; thickness: 1.10-3.72 mm) with a 1 kN load cell 
up to a strain of 75% and a strain rate of 1 mm min-1. Cyclic compression tests (n = 3; 
diameter: 6 mm; thickness: 1.09-3.57 mm) were performed under the same testing set-up at a 
strain rate of 1 mm min-1 and compressed to 50% strain during 20 cycles. All the tests were 
performed at room temperature. 
The effective crosslink density, 𝑛𝑒𝑓𝑓, of the PEU hydrogels was calculated  
from compressive testing results (based on 24 h saturation in PBS at 37 °C)  
by Equation 6.1 [400,401], 
 
𝜎𝑐 = 𝑛𝑒𝑓𝑓𝑅𝑇𝜙2
1/3
𝜙0
2/3(𝛼 − 𝛼−2) (6.1) 
where 𝜎𝑐 is the applied force per unit area of swollen hydrogel during compression, 𝜙2 is the 
polymer volume ratio in the swollen state, 𝜙0 is the polymer volume ratio in the gel in the 
relaxed state, and 𝛼 is the deformation ratio (𝛼 = 𝐿/𝐿0 ≥ 0.95) under compression. The 𝜙2 
and the 𝜙0 were calculated by Equation 6.2 and 6.3 [400,401], 
 𝜙0 =
𝜐𝑑𝑟𝑦
𝜐𝑟𝑒𝑙𝑎𝑥𝑒𝑑
 (6.2) 
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𝜙2 =
𝜐𝑑𝑟𝑦
𝜐𝑠𝑤𝑜𝑙𝑙𝑒𝑛
 (6.3) 
where 𝜐𝑑𝑟𝑦, 𝜐𝑟𝑒𝑙𝑎𝑥𝑒𝑑 and 𝜐𝑠𝑤𝑜𝑙𝑙𝑒𝑛 are the PEU polymer volume fractions in dry, relaxed and 
swollen state, respectively. The polymer volume fractions of relaxed, swollen and dried PEU 
polymers (n = 5) were calculated by Equation 6.4 [400,401], 
 𝜐𝑥  =
𝑊𝑎𝑖𝑟 − 𝑊ℎ𝑒𝑝𝑡𝑎𝑛𝑒
𝜌ℎ𝑒𝑝𝑡𝑎𝑛𝑒
 (6.4) 
where the subscript 𝑥 refers to the dry, or relaxed or swollen state, respectively. 𝑊𝑎𝑖𝑟 is the 
weight of the corresponding PEU polymer in air at dry, relaxed (after the crosslinking 
process) or swollen (after 24 h saturation in PBS solution at 37 °C) state, 𝑊ℎ𝑒𝑝𝑡𝑎𝑛𝑒 is the 
weight of the corresponding PEU polymer in n-heptane at dry, relaxed or swollen state, and 
𝜌ℎ𝑒𝑝𝑡𝑎𝑛𝑒 is the density of n-heptane (0.7 g ml
-1). 
Hydration kinetics and swelling behaviour of dried PEU film specimens (n = 5) were 
analysed at various medium temperatures for up to 48 h. Dry specimens of initial known 
weight were immersed in PBS solution at constant 5 °C, 21 °C or 37 °C. At specific time 
intervals, swollen specimens were taken out of the medium, with excessive surface water 
removed and their swollen weight determined, and the tests was continued until the specimens 
reached the stage of equilibrium. The weight swelling ratio was determined by the difference 
between the weights of the swollen sample and the initial dry sample divided by the weight of 
the initial sample. The reversible swelling/deswelling behaviour of dried PEU film specimens 
(n = 5) was analysed in PBS solution at alternating temperatures of 5 °C and 50 °C, at an 
interval of 40 min for up to 4 h. 
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6.2.6 In vitro degradation tests 
In vitro degradation tests in enzyme-free and enzyme-containing PBS solution were 
performed on PEU films (n = 3; thickness: 0.57 ± 0.10 mm; width: 2.5 ± 0.03 mm; length:  
4.8 ± 0.02 mm) for up to 31 days, as described in Chapter 3. SEM analysis was performed 
after 31 days in vitro degradation on a Camscan S2 at 5 kV on gold coated  
PEU film specimens. 
6.2.7 Drug encapsulation and release tests of PEUs 
For the drug encapsulation, dry punched-out PEU film specimens (n = 5; diameter: 6 mm; 
thickness: 0.74 ± 0.18 mm) were soaked in a lidocaine solution (0.01 g mL-1 PBS, 10 mL) for 
48 h at 5 °C. The swollen specimens were removed and dried in a vacuum oven for 24 h at  
37 °C. The lidocaine-loaded samples were then immersed in PBS (10 mL) in a shaker 
incubator (100 rpm) at 37 °C. At several time intervals, 1 mL was removed and replaced by 
the same volume of fresh PBS. The cumulative drug release rate was calculated by evaluating 
the characteristic absorbance peak of lidocaine at 263 nm against a calibration curve of 
lidocaine-containing PBS solutions at known concentrations, determined via a Perkin Elmer 
Lambda 900 UV-Visible light spectrometer. 
6.2.8 In vitro cell culture experiments 
Skin and associated fat were obtained with informed consent from patients undergoing 
elective surgery for breast reductions or abdominoplasties, from tissue not required for their 
treatment donated for research. All donated tissues were handled on an anonymous basis, 
under a Human Tissue Authority research tissue bank license: 08/H1308/39. Human 
subcutaneous fat from discarded skin was selected as the ADSC source. Mechanical and 
enzymatic (collagenase type A) digestion was followed by several washes, and the SVF was 
cultured in DMEM (supplemented with 10% FCS, 100 IU ml-1 penicillin-streptomycin, 100 
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µg ml-1 glutamine and 0.625 µg ml-1 amphotericin B). The human ADSCs were subcultured 
to passage 4 for use in the experiments. Human skin biopsies were treated enzymatically 
(Difco-trypsin plus) to separate the dermis. FIBs were obtained after collagenase treatment 
(collagenase type A) from finely minced dermis and cultured in supplemented DMEM. The 
human skin FIBs were subcultured to passage 9, as described previously [402]. 
Experiments were performed in triplicate. Briefly, PEU specimens (diameter: 15 mm) were 
placed in a 12-well plate and sterilised with 0.1% peracetic acid in PBS overnight. Then, 
specimens were washed 3 times with PBS (1 h each) and dried overnight in a sterile laminar 
flow culture hood under UV light. The sterilised and dried specimens were soaked in DMEM 
overnight in an incubator (37 ºC, 5% CO2), and fixed with a metal ring (internal diameter:  
10 mm) for cell seeding. After cell trypsinisation with Trypsin-EDTA, ADSCs (5 x 104 cells 
per sample) or FIBs (5 x 104 cells per sample) were seeded onto the PEU specimens with 
DMEM (cell-free specimens were included as controls in DMEM). After 2 h incubation  
(37 ºC, 5% CO2), rings and DMEM were removed and a metabolic activity assay was 
performed (1 ml of resazurin (5 µg mL-1 in PBS) was added to each well and incubated for  
60 min). The absorbance at 570 nm was measured in a colorimetric plate reader (Bio-TEK). 
Resazurin was then removed and samples returned to culture conditions with 2 mL of 
DMEM. This metabolic assay was repeated on days 3, 6 and 9 and images of the well plates 
were taken after each incubation. After the final incubation, all samples were washed in PBS 
and fixed with 3.7% formaldehyde in PBS for 15 min. After 3 PBS washes, the samples were 
incubated in 2 mL phalloidin-FITC (diluted 1:500 in PBS) for 30 min. After 3 further PBS 
washes, images (512x512 pixels) were obtained using a Zeiss LSM 510Meta inverted 
confocal microscope and WN-Achroplan 40x 0.75 NA objective, with a 12.8 µs pixel dwell 
time. FITC was excited using a 488 nm laser and emission detected between 500 and 550 nm. 
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6.2.9 Water temperature activated force generation measurements 
 
Scheme 6.1: Schematic illustration of the water-temperature activated force  
generation measurements. 
 
Water temperature activated force generation was evaluated on PBS saturated (at 21 °C for  
48 h) and stretched (constant strain = 40 %) PEU-1450 strip samples (n = 2; thickness:  
~1.45 mm; width: 8 mm; gauge length: 20 mm), as illustrated in Scheme 6.1. During the 
testing period water temperature was alternated between 21 °C and 37 °C, or 5 °C and 37 °C, 
with an interval of 10 min for up to 70 min. This was accomplished by exchanging the same 
volume of water (of the desired temperature) rapidly. The force was measured with a 10 N 
load cell on a Hounsfield H100KS mechanical testing machine. 
6.2.10 Water temperature responsive cantilever tests 
 
Scheme 6.2: Schematic illustration of the cantilever stripe test setup. 
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A two-layer cantilever was constructed from a pre-hydrated PEU-1450 (24 h PBS saturation 
at 21 °C; thickness: ~2.1 mm; width: 5 mm; gauge length: 50 mm) and a flexible 
poly(tetrafluoroethylene) (PTFE) film strip, as illustrated in Scheme 6.2. The two strips were 
connected to each other at both ends only using an adhesive. The PTFE side was further fixed 
with adhesive to the centre of a screw tip, allowing both strip ends to move freely. The test 
was performed according to the following steps. The cantilever was first placed in cold PBS 
(5 °C) for 15 min (low medium temperature = PEU hydrogel swelling). The test started by 
adding hot PBS (95 °C), until the medium exchange resulted in a stable high temperature of 
~90 °C (high medium temperature = PEU hydrogel deswelling). After 3 min cold PBS (5 °C) 
was added until a low temperature of ~5 °C was reached. The test was completed  
within 6 min. 
6.2.11 Proof-of-concept preparation of PEU microspheres 
PEU microspheres were prepared by an oil-in-oil solvent evaporation method [403]. Briefly, 
the PEU/solvent mixture (40 mL of the final reacted solution, as described in Section 6.2.3) 
was dispersed in pre-heated mineral oil (100 mL at 55 °C) in the presence of Span 80 
surfactant (2 mL) and stirred with an overhead stirrer at 400 rpm for 5 h, allowing further 
crosslinking and solvent evaporation. The microspheres were collected by filtration and 
washed five times with hexane to remove the mineral oil. Cleaned microspheres were kept in 
ethanol and stored at 5 °C in a fridge until further use. SEM analysis was performed on a 
Camscan S2 at 5 kV on dry and gold coated PEU microspheres. The sizes of the dry 
microspheres were evaluated by using ImageJ software (n = 170). Only fully defined 
microspheres were considered for geometrical measurements. 
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6.2.12 Proof-of-concept preparation of PEU scaffolds 
PEU-1450 scaffolds were prepared via a freeze-drying procedure, based on the previous 
method in Chapter 5. Briefly, the PEU/solvent mixture (40 mL of the final reacted solution, as 
described in Section 6.2.3) was cast into a non-sticky Teflon-coated metal baking tray 
(cylindrical cavities; diameter: 60 mm; purchased from a local store) and placed in a 
Labconco FreeZone Triad freeze-dryer for lyophilisation. The solutions were cooled during 
the freezing stage to -30 °C and held at the temperature for 5 h, allowing the solutions to 
freeze completely. During the primary drying stage the solutions were heated to -5 °C 
(heating rate of 1 °C min-1) and sublimated for 10 h under vacuum. In the secondary drying 
stage, the temperature was raised to 20 °C (heating rate of 5 °C min-1) and kept for 5 h. SEM 
analysis was performed on a Camscan S2 at 5 kV on dry and gold coated PEU scaffolds. The 
pore sizes of the dry scaffold microstructures were calculated by using ImageJ software  
(n = 315). Only fully defined pores were considered for geometrical measurements. 
6.2.13 Statistics 
All measurements were reported as mean ± SD with a confidence level of 95%. Statistical 
analysis was performed as described in Chapter 3. Two-way analysis of variance (ANOVA) 
was performed in addition to determine the differences in metabolic activity (see  
Section 6.2.8) of the in vitro cultured ADSCs and FIBs in respect to test time and material. 
6.3 Results and discussion 
6.3.1 Synthesis and characterisation of PEUs 
Chemically crosslinked PEU hydrogels were synthesised using a solvent-based two-step 
approach with a fixed molar ratio (glycerol : NCO-terminated PEG = 1 : 0.3), according to the 
synthetic rout illustrated in Scheme 6.3 and 6.4. The first step involved the synthesis of  
NCO-terminated PEGs, by reacting PEG (?̅?𝑛 = 400, 1000 or 1450) with HDI in 1,4-dioxane. 
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In the second step, pre-synthesised pre-PGS was dissolved in 1,4-dioxane and added to the 
NCO-terminated PEG solution to produce PEU through the crosslinking reaction between the 
hydroxyl groups of the pre-PGS units and the –NCO groups from the functionalised PEG. 
The pre-PGS in use had a ?̅?𝑛, ?̅?𝑤 and PDI of 1549 g mol
-1, 10522 g mol-1 and 6.8 
respectively, as determined by GPC. 
 
Scheme 6.3: Schematic representation of the synthetic rout of PEUs. 
 
 
Scheme 6.4: Schematic representation of the formation of the PEU network. 
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Figure 6.1: Normalised 1H NMR spectra of PEU-400, PEU-1000 and PEU-1450. The figures 
on the right show the methylene proton related peak of PEG, “k”, increases with its increasing 
molecular mass. 
 
The molecular structure of the PEUs synthesised using three different molecular weights of 
PEG was confirmed by 1H NMR spectroscopy, characterised with distinctive peaks of pre-
PGS and PEGs, as well as urethane related peaks due to the reaction between pre-PGS and the 
NCO-terminated PEGs, as shown in Figure 6.1 and 6.2. Characteristic peaks of pre-PGS 
related methylene protons were assigned at 1.29, 1.61 and 2.32 ppm (position “c”, “d” and 
“e”) for sebacic acid, while peaks from 4.05-4.35 ppm and 4.92-5.24 ppm (position “b” and 
“a”) were linked to the methylene protons of glycerol [253,302]. The methylene proton 
related peaks of PEG were assigned at 3.63 ppm (position “k”) and 4.05-4.35 ppm (position 
“j”, which overlaps position “b”) [302]. The intensity of peak “k” increased with enhanced 
molecular weight of PEG, confirming the presence of a higher mass of PEG segments within 
the PEU. The peaks at 1.48 ppm, 1.61 ppm, 3.12 ppm and 5.34 ppm (position “i”, “h”, “g” 
and “f”) were assigned to urethane and HDI related methylene protons, highlighting urethane 
bonds. Compared to the glycerol related peaks in the 1H NMR spectra of pre-PGS, the 1H 
NMR data of PEUs presented increased integral signals at 4.92-5.24 ppm (position “a”), 
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indicating that the urethane-bond formation between the NCO-terminated PEGs and the  
free hydroxyl groups of pre-PGS occurred preferentially with the hydroxyl groups  
of glycerol [253]. 
 
Figure 6.2: 1H NMR spectra of PEG-1450, PEG-1000, PEG-400 and pre-PGS. 
 
The analysis of FTIR spectra of PEUs, pre-PGS and PEGs supported the 1H NMR results, 
as presented in Figure 6.3 and 6.4 (A, B). The spectra of PEUs showed the stretching 
vibrations of N-H at 3360 cm-1, C=O at 1723 cm-1, amide III at 1241 cm-1, C-O at 1093 cm-1, 
C-O-C at 948 cm-1, and amide IV at 842 cm-1, as well as the bending vibrations of amide II at 
1532 cm-1, confirming the formation of urethane linkages [16,404,405]. In contrast, FTIR 
spectra of NCO-terminated PEGs were characterised with the stretching vibration of HDI 
related –NCO end groups at 2270 cm-1, the stretching and bending vibrations of  
urethane-bond linked C=O and amide II at 1723 cm-1 and 1537 cm-1, and the stretching 
vibration of PEG associated C-O-C at 950 cm-1, showing the unreacted residual –NCO groups 
at the chain ends and the urethane-bond formation between HDI and PEG [404,405]. The 
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absence of –NCO band at 2270 cm-1 in all the three spectra of the PEUs indicates the 
complete reaction of the –NCO end groups from the PEG with the hydroxyls of pre-PGS. 
 
Figure 6.3: FTIR spectra of PEU-400, PEU-1000 and PEU-1450. The spectra were shifted 
vertically for clarity. 
 
  
Figure 6.4: (A) FTIR spectra of pre-PGS, PEG-400, PEG-1000 and PEG-1450. (B) FTIR 
spectra of 1,4-dioxane, Pre-400, Pre-1000 and Pre-1450. The spectra were shifted vertically 
for clarity. 
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Raman spectra analysis of PEUs also affirmed the above 1H NMR and FTIR results, as 
shown in Figure 6.5 (A, B). The spectra of PEUs showed the stretching vibrations of CH2 in 
the range of 2700-3000 cm-1, C=O at ~1731 cm-1, the bending vibrations of CH2 and  
CH2-CH2 in the range of 1200-1500 cm
-1, the stretching vibration of C-O at ~1140 cm-1 and 
the rocking vibration of CH2 at 843 cm
-1 [406–408]. Comparing the spectra of the PEUs with 
pre-PGS and PEGs showed a decrease of the pre-PGS related stretching vibration of C-O at 
1102 cm-1, as well as the disappearance of the PEG linked twisting vibration peaks of C-O-H 
at ~533 cm-1 and ~581 cm-1, which are associated to the hydrogen bond reduction due to the 
formation of urethane bonds [406–408]. No peaks for unreacted -NCO urethane groups were 
detected in the spectra of PEUs, confirming the establishment of urethane linkage. 
  
Figure 6.5: (A) Raman spectra of PEU-400, PEU-1000 and PEU-1450. (B) Raman spectra of 
pre-PGS, PEG-400, PEG-1000 and PEG-1450. The spectra were shifted vertically for clarity. 
 
The thermal properties of the PEUs and their main individual components were analysed 
by DSC, as shown in Figure 6.6 (A, B). PEUs presented glass transition temperatures, 𝑇𝑔, 
below 0 °C, which decreased with the incorporation of longer PEG chains due to higher chain 
mobility (PEU-400: 𝑇𝑔 = -27.7 °C; PEU-1000: 𝑇𝑔 = -40.3 °C; PEU-1450: 𝑇𝑔 = -45.2 °C). No 
 162 
crystallisation temperature, 𝑇𝑐, or melting temperature, 𝑇𝑚, was detected for PEU-400 and 
PEU-1000 specimens within the test range, owing to the lower-molecular-weight PEG 
segments, which yield restricted chain mobility and no crystallisation in the PEU network 
[409]. However, 𝑇𝑐 and 𝑇𝑚 were observed in PEU-1450 specimens (𝑇𝑐 = -12.9 °C; 
 𝑇𝑚 = 29.1 °C), owing to the presence of the semi-crystalline PEG-1450 in the network [404]. 
Pre-PGS presented three 𝑇𝑚 peaks at -7.6 °C, 14.4 °C and 33.4 °C, which is typical for  
pre-PGS in its partially crosslinked state and related to its large PDI values, which depends on 
its synthesis procedure [16,252,410]. PEG-400 exhibits a low 𝑇𝑚 of 2.1 °C, while PEG-1000 
and PEG-1450 presented higher 𝑇𝑚 values of 39.9 °C and 50.8 °C, respectively. The 𝑇𝑚 
observed for the PEU-1450 specimen was lower than that from neat PEG-1450, indicating 
that the chemically crosslinked network and the reduced chain mobility affected the 
crystallisation of the PEG-1450 segments [411]. Overall, the results reveal that the molecular 
weight of PEG affects the thermal transition of the PEU. 
  
Figure 6.6: (A) DSC curves of PEU-400, PEU-1000 and PEU-1450. (B) DSC curves of pre-
PGS, PEG-400, PEG-1000 and PEG-1450. The curves were shifted vertically for clarity. 
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All the PEUs were insoluble in various organic solvents (1,4-dioxane, dimethylformamide, 
diemethyl carbonate, toluene, chloroform, acetone and ethanol) and only showed strong 
swelling after immersion for 24 h, confirming the formation of a covalently crosslinked 
network. Residual analysis of PEU-400, PEU-1000 and PEU-1450 specimens gave weight 
losses of 23.6 ± 2.4%, 24.7 ± 0.5% and 24.5 ± 7.7% respectively, after 24 h ethanol 
extraction, indicating the existence of non-crosslinked components. 
6.3.2 Mechanical properties of PEUs 
Table 6.1: Tensile and compression properties of dry and hydrated PEUs. 
  Tensile  Compression 
 
Sample 
code 
Young’s 
 modulus, 
𝐸𝑠 / MPa 
UTSa, 
𝜎𝑠𝑚𝑎𝑥  / 
MPa 
Elongation 
at break, 
𝜀𝑠𝑏 / % 
Energy at 
break, 𝑈𝑠𝑏 
/ MJ m-3 
 
Young’s 
modulus, 𝐸𝑐 
/ MPa 
Comp.b stress 
at 𝜀𝑐75%, 
𝜎𝑐75% / MPa 
D
ry
 
PEU-400 0.72 ± 0.01 0.70 ± 0.02 438 ± 7 1.63 ± 0.07  1.86 ± 0.81 12.68 ± 1.01 
PEU-1000 0.71 ± 0.14 0.49 ± 0.04 400 ± 67 1.03 ± 0.17  0.80 ± 0.07 9.36 ± 2.55 
PEU-1450 13.11 ± 2.22 1.59 ± 0.25 505 ± 77 6.78 ± 0.93  17.91 ± 0.77 16.36 ± 2.86 
H
y
d
ra
te
d
c  PEU-400 0.20 ± 0.11 0.47 ± 0.11 426 ± 44 1.09 ± 0.10  1.44 ± 0.22 10.39 ± 1.37 
PEU-1000 0.03 ± 0.01 0.05 ± 0.01 497 ± 153 0.19 ± 0.03  0.44 ± 0.17 4.60 ± 0.86 
PEU-1450 0.02 ± 0.01 0.07 ± 0.01 623 ± 193 0.23 ± 0.04  0.10 ± 0.02 0.67 ± 0.07 
a Ultimate tensile strength; b Compressive; c 24 h saturation in PBS at 37 °C. 
 
The mechanical properties of PEUs were determined under dry and hydrated states by  
quasi-static tensile and unconfined compression tests, while cyclic tensile and compressive 
testing were also performed for hydrated PEU hydrogels. Tensile and compression properties 
of dry and hydrated PEUs are listed in Table 6.1. The quasi-static mechanical properties of 
dry PEU-400 and PEU-1000 were similar under tensile load, while dry PEU-1450 shows 
significantly higher mechanical properties, with a tensile Young’s modulus, 𝐸𝑠, ultimate 
tensile strength, 𝜎𝑠𝑚𝑎𝑥, strain at break, 𝜀𝑠𝑏, of 13.11 MPa, 1.59 MPa and 505%, respectively, 
as presented in in Figure 6.7 (A). Correspondingly, dry PEU-400 and PEU-1000 were 
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comparatively flexible, whereas the PEU-1450 specimens were more rigid. Moreover, dry 
PEUs demonstrated significant differences in the compressive Young’s modulus, 𝐸𝑐, and in 
the compressive stress at 75% strain, 𝜎𝑐75%, with the dry PEU-1450 specimens again showing 
the highest stiffness, as seen in Figure 6.7 (B). This can be accounted for by the presence of 
the semi-crystalline PEG-1450 with the highest molecular weight in the PEU network, as 
previously confirmed by DSC results. 
   
Figure 6.7 Representative quasi-static (A) tensile and (B) compression stress-strain (test 
terminated at a compressive strain of 75%) curves of dry PEUs. 
 
 
Figure 6.8: (A, B) Mechanical knotting and stretching reliability of PEU-1450  
hydrogel specimens. 
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Figure 6.9: Representative quasi-static (A) tensile and (B) compression stress-strain (test 
terminated at a compressive strain of 75%) curve of PEU hydrogels. 
 
 
Figure 6.10: Images of the compressive behaviour of PEU hydrogels after 75% strain 
compression, presenting no damage and fully recovery after load is released. 
 
With respect to the mechanical properties of hydrated PEU hydrogels, complex 
deformations such as knotting and stretching could be performed on all the PEU hydrogels 
without fracture, demonstrating excellent flexibility and stretchability, as shown in Figure 6.8 
(A, B). One of the main issues with most hydrogels is their mechanical weakness [412,413]. 
Ideally, hydrogels for soft tissue engineering should be structurally stable and flexible to 
 166 
withstand mechanical forces and deformations in demanding in vivo environments [412,413]. 
Tensile test results of PEU hydrogels indicated that an increase in PEG molecular weight 
from 400 to either 1000 or 1450 led to a decrease with statistical significance (p < 0.05) in 𝐸𝑠 
and 𝜎𝑠𝑚𝑎𝑥, as well as a significant increase in the energy at break, 𝑈𝑠𝑏, of the PEU hydrogel. 
PEU-1450 hydrogels presented the lowest 𝐸𝑠 of 0.02 MPa, a 𝜎𝑠𝑚𝑎𝑥 of 0.07 MPa, and the 
highest 𝜀𝑠𝑏 of 623%, as demonstrated in Figure 6.9 (A). Furthermore, all the PEU hydrogels 
could be compressed to a high strain (75%) without fracture and recover their original shape 
upon the release of the load, as seen in Figure 6.9 (B) and 6.10. The PEU hydrogels presented 
significant differences in 𝐸𝑐 and 𝜎𝑐75%. The PEU-1450 hydrogel demonstrated the softest 
characteristics overall. The values of 𝑛𝑒𝑓𝑓 were calculated as 322, 64 and 11 mol m
-3 for 
PEU-400, PEU-1000 and PEU-1450 hydrogels, respectively. The decrease of the tensile 
strength and Young’s modulus, as well as the increase of elongation at break in the PEUs with 
higher molecular weights is a consequence of the increase in the chain length between the 
neighbouring crosslinks, lowering the 𝑛𝑒𝑓𝑓 in the hydrogels and improving their flexibility, 
which correlates with the swelling properties of the hydrogels (see Section 6.3.3) [214]. 
  
Figure 6.11: Representative cyclic (A) tensile and (B) compression stress-strain curves of 
PEU hydrogels. 
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Cyclic stress-strain curves of PEUs were characterised with a hysteresis loop during tensile 
and compression tests, as presented in Figure 6.11 (A, B). Under cyclic tensile testing, a 
minimal hysteresis loss ratio, ℎ𝑟, was observed for all the PEU hydrogels. The PEU-400, 
PEU-1000 and PEU-1450 hydrogels were characterised with ℎ𝑟 values of 0.06, 0.11 and 0.15 
after 20 cycles of tensile loading to 50% strain, respectively. In respect to cyclic compression 
testing, PEU-1450 specimens showed a ℎ𝑟 of 0.31, while the PEU-400 and PEU-1000 
specimens presented higher degrees of ℎ𝑟 of 0.74 and 0.55 after 20 cycles of compression 
loading to 50% strain, respectively. The expelling of water from the hydrogel observed during 
the loading cycles presumably contributed to the higher hysteresis loss under compression. 
Overall, the PEU hydrogels reported here show excellent performance under quasi-static 
and cyclic tensile and compressive loads. They are structurally stable, highly stretchable and 
suitable to engineer scaffolds for a range of soft tissues, such as human cardiac muscles 
(Young’s modulus: 0.01-0.30 MPa) [258] or high stress adapted adipose tissue (Young’s 
modulus: 0.02-0.18 MPa) [76] due to their similar mechanical properties. The incorporation 
of PEG segments with different molecular weights into the PEU hydrogel altered mechanical 
properties. The PEG segment with a higher molecular weight improved the flexibility and 
stretchability of the PEU hydrogel, while reducing their strength and modulus, mainly due to 
its lower crosslink density and higher water uptake (see Section 6.3.3). In comparison to the 
mechanical properties of PGS (see Section 3.3.1 and 4.3.1) and PGSU (see Section 5.3.1) 
from Chapters 3-5, the PEU hydrogels presented softer and more flexible properties, along 
with an enhanced toughness. 
6.3.3 Swelling properties of PEUs 
The hydration behaviour of the PEUs was evaluated in PBS at 5, 21 and 37 °C, as illustrated 
in Figure 6.12 (A, B, C, D) and 6.13. The weight swelling ratio of the PEUs increased rapidly 
within the first 12 h, and gradually reached a plateau after 24 h. At 5 °C, PEU-400, PEU-1000 
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and PEU-1450 presented the highest ratios of swelling at equilibrium of 31%, 207% and 
499%, respectively, among the three test temperatures. PEU-400, PEU-1000 and PEU-1450 
reached swelling ratios at equilibrium of 20%, 154% and 426% at 21 °C, and of 12%, 113% 
and 235% at 37 °C, respectively. The difference in the swelling ratio of the PEU hydrogels 
between low and high test temperatures is statistically significant (p < 0.05). The PEUs 
presented negative thermo-sensitivity, and the equilibrium ratio of swelling depended on the 
medium temperature as well as the hydrophilic/hydrophobic segment composition of the 
PEUs. The swelling capacities of the PEUs increased with higher molecular weight PEGs, 
due to the increased chain length between the crosslinks as discussed previously and the 
increased hydrophilicity of the PEGs [404]. Analysis of the dynamic swelling/deswelling 
behaviour of the PEU hydrogels demonstrated repeatable and reversible response to 
alternating medium temperatures, as shown in Figure 6.14. At lower medium temperatures the 
hydrogen bonding between hydrophilic PEU polymer segments and the water molecules are 
dominating, while at higher medium temperatures the hydrophobic interactions between the 
PEU polymer segments are enhanced (due to the increased intrinsic affinity of the polymer 
chains), causing the secretion of hydrated water molecules from the PEU network [414,415]. 
The PEUs presented relatively high swelling rates, while the deswelling rates were slightly 
lower, which can be in part associated with the alternation of the matrix permeability during 
the change of the medium temperature [416]. The swelling/deswelling rates depend on the 
specific surface area of the specimen, the composition of the hydrogel and the environmental 
conditions. These results also indicated that the PEUs with higher molecular weight PEGs 
would respond with greater swelling/deswelling rates upon minor changes of temperature, 
thus making these PEU hydrogels more attractive for potential thermosensitive actuation 
applications, such as cantilever and smart valves [417]. Also, in comparison to the water 
absorption capability to PGS (2.1-10.0%) [16,237] and PGSU (2.7-4.9%) from Chapters 3-5, 
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the PEU hydrogels presented superior water uptake properties and presumably enhanced 
diffusion characteristics, which should allow to engineer large-volume constructs  
with improved transport performance of oxygen and nutrients within the deeper  
compartments [397,398]. 
  
  
Figure 6.12: (A) Equilibrium ratio of swelling of PEU specimens in PBS solution as a 
function of the temperature. Hydration kinetics of PEU samples at (B) 5 °C, (C) 21 °C and 
(D) 37 °C for 2 days. 
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Figure 6.13: Pictures of PEU specimens in dry state and after 24 h hydration at 5 °C, 21 °C 
and 37 °C. 
 
 
Figure 6.14: Dynamic swelling/deswelling behaviour of PEU specimens in PBS solution at 
alternating temperatures of 5 °C and 50 °C, at an interval of 40 min. 
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6.3.4 In vitro degradation 
 
Figure 6.15: Percentage of weight loss of PEU specimens, incubated in enzyme-free or 
enzyme-containing PBS solutions in a shaker incubator for up to 31 days at 37 °C. 
 
The biodegradability of thermoresponsive hydrogels is an important factor for potential 
biomedical applications [404,418]. In vitro degradation studies were performed in PBS with 
or without lipase for up to 31 days at 37 °C in a shaker bioincubator, as illustrated in  
Figure 6.15 and 6.16 (A1-3, B1-3, C1-3). The results illustrate that the rate of degradation of 
the PEUs can be tuned, depending on the molecular weight of the PEG segments. The higher 
molecular weight PEGs showed faster degradation over the 31 days studied and this was only 
slightly enhanced in the presence of the enzyme, which catalysed the hydrolysis process of 
the ester bonds of the PGS segments [356,367]. The PEUs showed bulk degradation, 
attributable to their high water content, in which an increase in the PEG molecular weight, as 
well as the presence of lipase led overall to a greater weight loss. PEU-400 underwent similar 
weight losses of 10.1% and 10.7% in 31 days in the enzyme-free and lipase-containing PBS 
solution, respectively. PEU-1000 and PEU-1450 underwent weight losses of 8.4% and 16.3% 
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in 31 days in the enzyme-free PBS solution, which increased to 12.9% and 20.7%, 
respectively, with statistical significance, in the lipase-containing solution. 
 
Figure 6.16: SEM micrographs of vacuum-dried (A1-3) PEU-400, (B1-3) PEU-1000 and 
(C1-3) PEU-1450 film surfaces: (A1, B1, C1) untreated, (A2, B2, C2) in enzyme-free PBS 
solution and (A3, B3, C3) in enzyme-containing PBS solution after 31 days at 37 ˚C (note that 
visual differences are minor). 
 
Together with the matched mechanical properties discussed above, biodegradability 
enables the potential application of the PEUs in soft tissue engineering [412–414,418]. The 
use of thermosensitive poly(N-isopropylacrylamide) (PNIPAM)-based hydrogels and its 
copolymers in biomedical applications are restricted, due to PNIPAM’s non-biodegradability 
and toxicity in its monomeric form [412,413,419]. In comparison to pristine PGS from 
Chapters 3 and 4, and to recently developed PGS-co-PEG block copolymers [302,310], the 
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PEU hydrogels presented slower degradation kinetics owing to the urethane linkages in the 
covalently crosslinked network. For instance, pristine PGS exhibited under the same tests 
conditions degradation rates of 10-18% and 29-45% after 31 days in enzyme-free and 
enzyme-containing PBS solution, respectively, while the PGS-co-PEG block copolymers 
presented weight losses of ~15-80% after 21 days under enzyme-free in vitro conditions 
[310]. PGSU scaffolds from Chapter 5 presented slower degradation rates of 3-6% and 5-9% 
in 35 days under enzyme-free and enzyme-containing in vitro conditions, respectively, due to 
the PGSUs higher degree of urethane linkages and low water absorption capability of PGSUs. 
Also, according to prior studies [302,420], the use of higher molecular weight PEGs in in vivo 
applications is preferred within the test range (< 40,000 or 60,000 g mol-1) which showed that 
chronic high oral doses of low molecular weight PEGs (≤ 400 g mol-1) led to adverse renal 
effects in human and animal experiments. 
6.3.5 In vitro cell viability and proliferation 
  
Figure 6.17: Metabolic activity assay results of (A) ADSCs and (B) FIBs cultured on  
PEU-400, PEU-1000 and PEU-1450 after subtracting the data for cell-free PEU controls. The 
data are represented as mean ± SD (n = 3; ∗ = p < 0.05, two-sample t-test). 
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Metabolic activity assay with resazurin was used to evaluate the in vitro cell viability and 
proliferation of ADSCs and FIBs on PEU hydrogels for up to 9 days, while confocal 
fluorescence microscopy was performed for cell morphology analysis, as presented in  
Figure 6.17 (A, B) and 6.18 (A, B). The PEU hydrogels showed no evidence of toxicity to 
either ADSCs or FIBs. Two-way ANOVA found significant difference between the metabolic 
activities of ADSCs (p < 0.0001) and FIBs (p < 0.05) with respect to the test time, while no 
difference in metabolic activities was found between the different PEU hydrogels. Two-
sample t-test (p < 0.05) found PEU-1000 and PEU-1450 hydrogels presented a significant 
increase in metabolic activity for both cell types from day 0 to day 6 or 9, while both cell 
types showed statistically insignificant metabolic activities on the PEU-400 hydrogels. 
Maximum metabolic activity was achieved for both seeded cell types at day 6 without 
significant differences between day 6 and 9. ADSCs exhibited the highest metabolic activity 
on PEU-1000 hydrogels at day 6 (73% increase compared to day 0 cell-seeded specimens), 
while FIBs demonstrated the highest metabolic activity on PEU-1450 hydrogels at day 6 
(51% increase compared to day 0 cell-seeded specimens). The colorimetric measurements 
were visually confirmed by the colour change of the blue resazurin dye, with a clear change to 
a purple colour (resorufin) for both cell types on all PEU hydrogels from day 0 to day 9 
(Figure 6.S1, Appendix D). The reduction of blue resazurin to purple resorufin was only seen 
when living cells were present (cell-free control specimens always remained blue). In 
contrast, the cell-seeded area on PEU-400 and PEU-1000 hydrogels turned in a distinct pink 
colour, confirming the presence of cells on the surfaces and indicating similar metabolic 
activities between days 6 and 9. In contrast, the surfaces of the cell-seeded PEU-1450 
hydrogels had less visible colour alterations for both cell types after cell seeding, as  
discussed below. 
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Figure 6.18 Confocal fluorescence micrographs of (A1-3) PEU-400, (B1-3) PEU-1000 and 
(C1-3) PEU-1450 specimens following 9 days in vitro cultivation: (A1, B1, C1) Cell-free 
PEU control samples, (A2, B2, C2) ADSCs seeded PEU samples and (A3, B3, C3) FIBs 
seeded PEU samples. 
 
The confocal microscopic analysis showed elongated morphologies of the ADSCs attached 
to the surface of PEU-400 and PEU-1000 hydrogels and verified highly confluent cell 
populations, as seen in Figure 6.18 (A2, B2). FIBs also exhibited elongated morphologies on 
the PEU-400 and PEU-1000 hydrogel surfaces, however, the PEU-400 hydrogels facilitated a 
higher degree of confluence compared to the PEU-1000 hydrogels, as shown in  
Figure 6.18 (A3, B3). The surfaces of the PEU-1450 hydrogels showed relatively few ADSCs 
and FIBs in line with the colorimetric measurements, as seen in Figure 6.18 (C2, C3). This 
may be the result of cell detachment from the PEU hydrogels. It is likely that the temperature 
changes of approximately ±16 °C during the culture period (triggered by moving the samples 
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from the incubator to the sterile laminar flow hood for medium changes and resazurin 
incubations) would have resulted in volume alterations of the thermosensitive PEU 
specimens, causing the detachment of cells from the hydrogels [421–424]. In these 
experiments any detached cells would then be able to proliferate on the surrounding well plate 
surfaces. The swelling/deswelling rates in response to temperature changes were in the order 
of PEU-1450 > PEU-1000 > PEU-400, and correspondingly the degree of cell detachment 
was highest in PEU-1450. 
Overall, the above results showed that the ADSCs and FIBs proliferated on the PEU 
hydrogels, indicating that the PEU hydrogels had no toxic effects on the cells within this test 
period of 9 days. These results are consistent with previous studies on thermoresponsive and 
shape-changing hydrogels where a deliberate change in temperature is then used to release 
cell sheets for subsequent use [421–424]. 
6.3.6 Drug loading and release 
 
Figure 6.19: Cumulative drug release from PEUs versus swelling time at 37 °C in PBS 
solution in a shaker incubator. 
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These thermoresponsive PEU hydrogels can also be used for drug delivery applications [416]. 
The release of the model drug, lidocaine, from PEU hydrogels was assessed using UV-Vis 
spectroscopy. Dry PEU specimens were soaked in a lidocaine solution at 5 °C, to enhance the 
swelling ratio and thus the amount of drug loaded into the hydrogels. The swollen and 
lidocaine-loaded specimens were dried and then immersed in PBS at 37 °C under shaking 
conditions. The release profile of PEUs showed a rapid release within the first 4 h, followed 
by a reduced and sustained drug release in the proceeding time, as presented in Figure 6.19. 
PEU-400, PEU-1000 and PEU-1450 hydrogels obtained maximum drug release of 15.8% 
(0.37 mg ml-1), 29.4% (0.70 mg ml-1) and 61.2% (1.62 mg ml-1) after 168 h, respectively. The 
initial rapid release was presumably caused by a higher drug concentration on the outer layer 
of the samples [425] and their shrinkage because of the higher test temperature than the drug-
loading temperature. The subsequent decelerated drug release can be associated with the less 
permeable hydrogel matrix [416] and reduced releasable drug content over time. These results 
demonstrated the prospective use of the PEUs in temperature-controlled or sustained drug 
delivery. With a modulated volume phase transition temperature (Figure 6.S2,  
Appendix D), the PEU hydrogels could also potentially feature a temperature dependent  
on-off drug release [414,418]. 
6.3.7 Water-temperature activated force generation and motions 
Thermoresponsive hydrogels can also be used for actuation and power generation [414,426]. 
PEU-1450 hydrogels at 40% strain generated temperature-induced contractile forces and 
stresses, as seen in Figure 6.20 (A, B). The cyclic change of water temperature from 21 °C to 
37 °C and from 5 °C to 37 °C generated contractile forces of 16 ± 1 mN and 44 ± 1 mN, and 
stresses of 1.4 ± 0.03 kPa and 3.8 ± 0.06 kPa, respectively. Generation of the contractile 
forces occurred instantly upon temperature alteration and was reversible. Their values are 
affected by the specimen dimensions (e.g. the specific surface area), water temperature 
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difference, environmental conditions and swelling/deswelling capability of the PEU hydrogel. 
Higher contractile forces are achievable by altering these parameters, which could then be 
used to generate ultralow power by attaching a piezoelectric element to drive a micro- or 
nano-device [426]. The excellent stimuli-responsiveness of the PEU-1450 hydrogel also 
allowed for the design of water temperature-activated cantilevers, transducing the 
temperature-stimulus into reversible bending, as presented in Figure 6.21 (Movie 6.S1, 
Appendix D). These characteristics will enable the PEU hydrogels to be used in actuators 
(e.g. cantilever: transduce temperature changes into a bending motion), sensors (e.g. 
capacitive plate sensor: transduce temperature changes into a changing distance between the 
plates of a capacitor), soft robotics (e.g. shape-shifting: transduce temperature changes into a 
changing shape) and fluid control devices (e.g. microfluid flow regulator: transduce 
temperature changes into an opening or closing valve) [414]. 
  
Figure 6.20: (A) Water temperature activated force generation of submerged and stretched 
PEU-1450 strip samples by cyclic alteration of water temperature from 𝑇1 = 21 °C to 𝑇2 =  
37 °C, or from (B) 𝑇1 = 5 °C to 𝑇2 = 37 °C (sharp peaks = replacement of an equal volume of 
water with the pre-determined temperature to achieve the target temperature 𝑇1 or 𝑇2). 
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Figure 6.21: Water temperature responsive cantilever composed of a PEU-1450 and a PTFE 
film strip, transducing the water temperature dependent swelling/deswelling response into 
reversible bending motions. 
 
 
Figure 6.22: (A, B) SEM images of dry PEU-1000 microspheres, fabricated in a proof of 
concept study. Images of PEU-1000 microspheres immersed in PBS solution, demonstrating 
the microspheres swelling/deswelling behaviour after 24 h at (C) 5 °C and (D) 37 °C. 
 
 180 
The results presented here demonstrate the successful synthesis of thermoresponsive, 
stretchable, biodegradable and biocompatible PEU hydrogels with tuneable physicochemical 
properties for a variety of possible applications. The chemically crosslinked PEU hydrogels 
have structurally stable and highly stretchable characteristics, which may prove useful in 
mechanically dynamic environments for soft tissues [412,413]. Conventional 
thermoresponsive PNIPAM-based hydrogels are comparably less ductile, characterised with 
low elongation at break values of ~50% [417,427–429], restraining their scope of potential 
applications in soft tissue engineering. Furthermore, the PEU hydrogels exhibited softer 
and/or more flexible properties in comparison to hydrated PGS-co-PEG block copolymers 
[310], which presented a Young’s modulus, tensile strength and elongation at break in the 
range of 0.013-1.55 MPa, 0.012-0.30 MPa and ~25-200%, respectively [310]. 
 
Figure 6.23: (A, B) SEM images of the microstructure dry PEU-1450 scaffold, fabricated in a 
proof of concept study. (C) Image of a PEU-1450 scaffold specimen. 
 
The biodegradability and biocompatibility are critical aspects for developing 
thermosensitive PU-based hydrogels for biomedical applications. Further critical examination 
in vivo is needed to assess the potential for PEU hydrogels in soft tissue engineering and/or 
drug delivery applications, along with their prospective use in the development of 
bioresorbable actuators [417]. Further work can also include fabrication of the PEU hydrogels 
into different structures to address the needs of different applications. In a proof-of-concept 
study, the fabrication of the PEU into microspheres with a size range of 289 ± 42 µm was 
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achievable by using an oil-in-oil solvent evaporation technique [403], which also presented 
negative thermo-sensitivity, as seen in Figure 6.22 (A, B, C, D). Injectable microspheres are 
interesting for localised drug delivery and targeted soft tissue engineering applications [430]. 
The proof-of-concept production of large 3D scaffold constructs via freeze-drying was also 
realisable [356,367], producing highly porous and interconnected microstructures with pore 
sizes of 31 ± 5 µm, demonstrating great potential for further optimisation of the pore size and 
porosity for soft tissue engineering applications, as demonstrated in Figure 6.23 (A, B, C). 
6.4 Conclusions 
Stretchable, thermoresponsive, biodegradable and biocompatible PEU hydrogels with varying 
molecular weight of PEG were synthesised by a facile solvent-based two-step method. The 
chemical and physical characteristics of the covalently crosslinked PEU hydrogels are 
tuneable by changing the molecular weight of the PEG segments. PEU hydrogels were 
processed into films, with structurally stable and highly stretchable mechanical properties in 
dry and hydrated states. The PEU hydrogels were characterised with a tensile Young’s 
modulus, ultimate tensile strength and elongation at break in the range of 0.02-0.20 MPa, 
0.05-0.47 MPa and 426-623%, respectively. Compression tests showed no fracture and good 
recoverability after 75% axial strain. The PEU hydrogels demonstrated minimal hysteresis 
loss ratio during cyclic tensile tests, while cyclic compression tests showed higher hysteresis 
loss ratios. The PEU hydrogels were characterised with negative thermo-sensitivity, and the 
equilibrium ratio of swelling depended on the medium temperature and PEU composition. 
The PEU hydrogels demonstrate repetitive and reversible responses to changes in medium 
temperature from 5 oC to 37 oC with the swelling ratio at equilibrium varying from 499% to 
12%. In vitro degradation tests of PEU hydrogels obtained weight losses of 9-16% or 11-21% 
in 31 days in PBS or lipase solution, respectively. In vitro cell test results provided clear 
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evidence that all the PEU hydrogels are biocompatible and suitable for the culture of  
ADSCs and FIBs. 
The PEU hydrogels showed a rapid drug release within the first hour in PBS, followed by a 
sustained drug release rate in the proceeding time and reaching a maximum drug release in the 
range of 16-61% after 168 h. Water temperature activated force generation of submerged and 
stretched PEU strip samples generated contractile forces of 16 ± 1 mN and 44 ± 1 mN and 
stresses of 1.4 ± 0.03 kPa and 3.8 ± 0.06 kPa by cyclic water temperature changes, which 
occurred instantly upon temperature alteration and was reversible. The proof-of-concept 
fabrication of structures such as PEU microspheres and large 3D scaffolds illustrates 
versatility of the polymers. The high flexibility, stretchability, thermoresponsivity, 
biodegradability and biocompatibility show the potential of the PEU hydrogels to be applied 
in a variety of applications such as soft tissue engineering, temperature-controlled or 
sustained drug delivery as well as thermal actuation.  
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Chapter 7. Overall conclusions and future work 
7.1 Overall conclusions 
This thesis has focused on the design and development of synthetic PGS-based materials and 
biomimetic tissue scaffolds with similar bulk mechanical properties to those of native adipose 
tissue, suitable for potential application in ATE. Key findings have been discussed in each 
individual chapter and the research yielded several major conclusions. 
Firstly, in comparison to other PGS scaffold fabrication strategies, the freeze-drying 
fabrication strategy utilised in this work, accompanied by the blending of pre-PGS with a 
minor structure-supporting biopolymer and a subsequent curing process, presented to be a 
more feasible and less complex method in fabricating large 3D and porous PGS-based 
scaffolds, whilst offering opportunities for further optimisations and modifiability for a wide 
variety of soft tissue engineering applications. 
Secondly, large and porous PGS/PLLA scaffolds with similar mechanical properties to 
native low and high stress adapted adipose tissue were fabricated via the freeze-drying 
fabrication strategy, confirming that the fabrication method allows one to design scaffold 
constructs with specifically required properties. The engineered scaffolds were characterised 
with highly porous microstructures, as well as good cell penetration and tissue in-growth 
characteristics, demonstrating great potential for applications in ATE. 
Thirdly, the application of isocyanate-based crosslinkers allowed the synthesis of  
PGS-based PU with significantly improved processability, enhanced flexibility and slower 
degradation kinetics. The fabrication of large and porous PGSU scaffolds was successful via 
the freeze-drying fabrication strategy, without the necessity of an additional minor structure-
supporting biopolymer and a second curing stage. The PGSU scaffolds were characterised 
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with soft, flexible and more stretchable mechanical properties, as well as long-term stability 
and tuneable degradation kinetics. 
Fourthly, the application of NCO-terminated PEGs with varying molecular weight PEGs 
allowed to synthesise PGS-based PU hydrogels with enhanced hydrophilicity, high flexibility, 
stretchability, good biodegradability and biocompatibility. The functionalities of the PEU 
hydrogels were evaluated for potential applications in ATE and other soft tissue engineering 
fields. The PEU hydrogels featured also negative thermoresponsive properties, demonstrating 
highly interesting properties for potential drug delivery, thermal actuation and ultralow power 
generation applications. 
Overall, this thesis is the first step in investigating the prospective use of PGS-based 
materials in ATE. Several PGS related limitations in terms of scaffold fabrication, 
processability and physicochemical properties were overcome. The developed freeze-drying-
fabrication strategy, along with the designed PGS/PLLA blends, PGSUs and PEUs, presented 
great potential to be developed further for ATE, as well as for other soft tissue  
engineering applications. 
7.2 Future work 
The future applications of the PGS/PLLA and PGSU scaffolds, along with the 
thermoresponsive PEU hydrogels are numerous, with potential uses in both biomedical and 
engineering applications. The materials and scaffolds need to be critically examined in vivo to 
further establish their potential utilisation in the field of tissue engineering. Furthermore, the 
usage of large porous scaffolds requires the application of novel vascularisation strategies. 
Insufficient vascularisation is still one of the major key problems in tissue engineering, which 
should be addressed in future work. 
Future research work may also focus on the development of injectable PGS-based 
materials, which would be beneficial for ATE and other soft tissue engineering applications, 
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due to the prevention of complex surgeries. With this respect, it is assumed that the fabricated 
porous scaffolds (or films) can be further processed to create sheet-like and injectable 
particles via cryogenic grinding (working temperature of liquid nitrogen: -196 °C). For 
instance, the glass transition temperature, 𝑇𝑔, of crosslinked PGS, PGSU and PEU materials 
are in the range of -10 °C to -45 °C, respectively, and are therefore capable of being ground at 
low temperatures. This fabrication strategy could provide an opportunity to produce sheet-like 
and injectable particles for cell delivery strategies aimed for tissue engineering applications, 
but also as filler materials for designing novel polymer composites. 
The freeze-drying fabrication strategy of PGS/biopolymer scaffolds could also be 
developed further, by using different solvents (e.g. dimethyl sulfoxide) or biopolymers (e.g. 
PDLA, polydioxanone) combinations, as well as by altering the freeze-drying and/or curing 
parameters. The biocompatibility, the biodegradability or the mechanical characteristics of 
these scaffolds could be modified by incorporating nanoparticles (e.g. graphene, graphene 
oxide, sepiolite), microfibers (e.g. PVA, chitosan) or microspheres (e.g. PVA, chitosan) into 
the polymer matrix, which may also enhance the structure stability of the scaffold constructs 
during the curing stage. The realisation of complex 3D shapes with pre-
PGS/biopolymer/solvent mixtures is presumably possible via SFF by using a dispensing 
system connected to a cryogenic plotting plate (the usage of a support material to assist 
overhangs may be required) [431,432], which could be further processed through the freeze-
drying and curing processing steps. Also, it is assumed that the production process of the 
PGS/biopolymer scaffolds could be accelerated by using a microwave-assisted curing stage 
[254,320], thus improving the manufacturing throughput of the freeze-drying fabrication 
strategy significantly. 
Similarly, further developments can be performed on the PGSU scaffolds. The 
biocompatibility, the biodegradability and the mechanical properties of the scaffolds could be 
 186 
modified by incorporating nanoparticles, microfibers or microspheres into the  
polymer matrix. 
With respect to the chemically crosslinked PEU hydrogels, further investigation is required 
in respect to the scaffold and microsphere fabrication process. The modification of the PEU 
synthesis procedure, such as the alteration of the glycerol to NCO-terminated PEG ratio, as 
well as the molecular weight of the PEG segments, could modify the physicochemical 
properties of the PEU hydrogels further. The biocompatibility, the biodegradation and the 
mechanical properties of PEU hydrogels could be also modified by incorporating 
nanoparticles, microfibers or microspheres into the polymer matrix. In addition, further 
analysis is required in terms of the PEUs potential applications in drug delivery, thermal 
actuation and ultralow power generation.  
 187 
Bibliography 
[1] A.R. Golas, K.A. Hernandez, J.A. Spector, "Tissue engineering for plastic surgeons: A 
primer", Aesthetic Plast. Surg., 2014, 38, 207–221. 
[2] F.J. O’Brien, "Biomaterials & scaffolds for tissue engineering", Mater. Today., 2011, 
14, 88–95. 
[3] A. Persidis, "Tissue engineering", Nat. Biotechnol., 1999, 17, 508–5010. 
[4] S. Bhat, A. Kumar, "Biomaterials and bioengineering tomorrow’s healthcare", 
Biomatter, 2013, 3, e24717. 
[5] J.H. Choi, J.M. Gimble, K. Lee, K.G. Marra, J.P. Rubin, J.J. Yoo, G. Vunjak-
Novakovic, D.L. Kaplan, "Adipose tissue engineering for soft tissue regeneration", 
Tissue Eng. B, 2010, 16, 413–426. 
[6] C.W. Patrick, "Tissue engineering strategies for adipose tissue repair", Anat. Rec., 
2001, 263, 361–366. 
[7] L. Flynn, K.A. Woodhouse, "Adipose tissue engineering with cells in engineered 
matrices", Organogenesis, 2008, 4, 228–235. 
[8] P. Bauer-Kreisel, A. Goepferich, T. Blunk, "Cell-delivery therapeutics for adipose 
tissue regeneration", Adv. Drug Deliv. Rev., 2010, 62, 798–813. 
[9] Y.C. Chiu, M.H. Cheng, S. Uriel, E.M. Brey, "Materials for engineering vascularized 
adipose tissue", J. Tissue Viability., 2011, 20, 37–48. 
[10] A.R. Webb, J. Yang, G.A. Ameer, "Biodegradable polyester elastomers in tissue 
engineering.", Expert Opin. Biol. Ther., 2004, 4, 801–812. 
[11] A.B. Brochu, S.L. Craig, W.M. Reichert, "Self-healing biomaterials", J. Biomed. 
Mater. Res. A, 2011, 96, 492–506. 
[12] N. Shoham, A. Gefen, "Mechanotransduction in adipocytes", J. Biomech., 2012,  
45, 1–8. 
[13] Y. Ye, Y. Yuan, F. Lu, J. Gao, "Possible role of mechanical force in regulating 
regeneration of the vascularized fat flap inside a tissue engineering chamber", Med. 
Hypotheses, 2015, 85, 807-809. 
[14] Y. Li, G.A. Thouas, Q.Z. Chen, "Biodegradable soft elastomers: synthesis/properties of 
materials and fabrication of scaffolds", RSC Adv., 2012, 2, 8229–8242. 
[15] R. Shi, D. Chen, Q. Liu, Y. Wu, X. Xu, L. Zhang, W. Tian, "Recent advances in 
synthetic bioelastomers", Int. J. Mol. Sci., 2009, 10, 4223–4256. 
[16] Y. Wang, G.A. Ameer, B.J. Sheppard, R. Langer, "A tough biodegradable elastomer", 
Nat. Biotechnol., 2002, 20, 602–606. 
[17] R. Rai, M. Tallawi, A. Grigore, A.R. Boccaccini, "Synthesis, properties and biomedical 
applications of poly(glycerol sebacate) (PGS): A review", Prog. Polym. Sci., 2012,  
37, 1051–1078. 
[18] R. Langer, J.P. Vacanti, "Tissue engineering", Science, 1993, 260, 920–926. 
[19] B. Gridelli, G. Panarello, S. Gruttadauria, A. Marcos, P. Grossi, "Infections after 
living-donor liver transplantation", Surg. Infect., 2006, 7, 105–108. 
[20] J. Weitz, M. Koch, A. Mehrabi, P. Schemmer, M. Zeier, J. Beimler, M. Büchler, J. 
Schmidt, "Living-donor kidney transplantation: Risks of the donor-benefits of the 
 188 
recipient", Clin. Transplant., 2006, 20, 13–16. 
[21] M.D. Fox, "The price is wrong: The moral cost of living donor inducements", Am. J. 
Transplant., 2006, 6, 2529–2530. 
[22] R.S. Gaston, G.M. Danovitch, R.A. Epstein, J.P. Kahn, A.J. Matas, M.A. Schnitzler, 
"Limiting financial disincentives in live organ donation: A rational solution to the 
kidney shortage", Am. J. Transplant., 2006, 6, 2548–2555. 
[23] D.L. Kaserman, "On the feasibility of resolving the organ shortage", Inquiry., 2006,  
43, 160–166. 
[24] M. Quante, S. Wiedebusch, "Overcoming the shortage of transplantable organs: Ethical 
and psychological aspects", Swiss Med. Wkly., 2006, 136, 523–528. 
[25] R. Langer, "Tissue engineering: A new field and its challenges", Pharm. Res., 1997,  
14, 840–841. 
[26] S. Liao, C.K. Chan, S. Ramakrishna, "Stem cells and biomimetic materials strategies 
for tissue engineering", Mater. Sci. Eng. C, 2008, 28, 1189–1202. 
[27] B.S. Kim, D.J. Mooney, "Development of biocompatible synthetic extracellular 
matrices for tissue engineering", Trends Biotechnol., 1998, 16, 224–230. 
[28] T.C. Flanagan, A. Pandit, P. Taylor, S. Jockenhövel, "Living artificial heart valve 
alternatives: A review", Eur. Cells Mater., 2003, 6, 28–45. 
[29] B. Demirbag, P.Y. Huri, G.T. Kose, A. Buyuksungur, V. Hasirci, "Advanced cell 
therapies with and without scaffolds", Biotechnol. J., 2011, 6, 1437–1453. 
[30] E.L. Scheller, P.H. Krebsbach, D.H. Kohn, "Tissue engineering: State of the art in oral 
rehabilitation", J. Oral Rehabil., 2009, 36, 368–389. 
[31] J.W. Nichol, A. Khademhosseini, "Modular tissue engineering: Engineering biological 
tissues from the bottom up", Soft Matters., 2010, 5, 1312–1319. 
[32] T. Lu, Y. Li, T. Chen, "Techniques for fabrication and construction of three-
dimensional scaffolds for tissue engineering", Int. J. Nanomedicine., 2013, 8, 337–350. 
[33] D.M. Dean, A.P. Napolitano, J. Youssef, J.R. Morgan, "Rods, tori, and honeycombs: 
The directed self-assembly of microtissues with prescribed microscale geometries", 
FASEB J., 2007, 21, 4005–4012. 
[34] J. Yeh, Y. Ling, J.M. Karp, J. Gantz, A. Chandawarkar, G. Eng, J. Blumling III, R. 
Langer, A. Khademhosseini, "Micromolding of shape-controlled, harvestable cell-
laden hydrogels", Biomaterials, 2006, 27, 5391–5398. 
[35] N. L’Heureux, S. Pâquet, R. Labbé, L. Germain, F.A. Auger, "A completely biological 
tissue-engineered human blood vessel", FASEB J., 1998, 12, 47–56. 
[36] V. Mironov, T. Boland, T. Trusk, G. Forgacs, R.R. Markwald, "Organ printing: 
Computer-aided jet-based 3D tissue engineering", Trends Biotechnol., 2003,  
21, 157–161. 
[37] Y. Du, E. Lo, S. Ali, A. Khademhosseini, "Directed assembly of cell-laden microgels 
for fabrication of 3D tissue constructs", Proc. Natl. Acad. Sci. U. S. A., 2008,  
105, 9522–9527. 
[38] A.P. McGuigan, M.V. Sefton, "Design and fabrication of sub-mm-sized modules 
containing encapsulated cells for modular tissue engineering", Tissue Eng., 2007,  
13, 1069–1078. 
[39] B. Dhandayuthapani, Y. Yoshida, T. Maekawa, D.S. Kumar, "Polymeric scaffolds in 
 189 
tissue engineering application: A review", Int. J. Polym. Sci., 2011, 290602. 
[40] W. Liu, Y. Cao, "Application of scaffold materials in tissue reconstruction in 
immunocompetent mammals: Our experience and future requirements", Biomaterials, 
2007, 28, 5078–5086. 
[41] J.D. Kretlow, L. Klouda, A.G. Mikos, "Injectable matrices and scaffolds for drug 
delivery in tissue engineering", Adv. Drug Deliv. Rev., 2007, 59, 263–273. 
[42] American Society of Plastic Surgeons, "2014 American Society of Plastic Surgeons 
Statistics", http://www.plasticsurgery.org/Documents/news-resources/statistics/2014-
statistics/reconstructive-procedure-trends-2014.pdf (accessed: 15 April 2015). 
[43] L. Flynn, G.D. Prestwich, J.L. Semple, K.A. Woodhouse, "Adipose tissue engineering 
with naturally derived scaffolds and adipose-derived stem cells", Biomaterials, 2007, 
28, 3834–3842. 
[44] S.R. Coleman, "Long-term survival of fat transplants: Controlled demonstrations", 
Aesthetic Plast. Surg., 1995, 19, 421–425. 
[45] S.R. Coleman, "Facial recontouring with lipostructure", Clin. Plast. Surg., 1997,  
24, 347–367. 
[46] J. Smahel, "Adipose tissue engineering in plastic surgery", Ann. Plast. Surg., 1986,  
16, 444–452. 
[47] A. Nguyen, K.A. Pasyk, T.N. Bouvier, C.A. Hassett, L.C. Argenta, "Comparative study 
of survival of autologous adipose tissue taken and transplanted by different 
techniques", Plast. Reconstr. Surg., 1990, 85, 378–386. 
[48] S.R. Coleman, A.P. Saboeiro, "Fat grafting to the breast revisited: Safty and efficacy", 
Plast. Reconstr. Surg., 2007, 119, 775–785. 
[49] M.C. Missana, I. Laurent, L. Barreau, C. Balleyguier, "Autologous fat transfer in 
reconstructive breast surgery: Indications, technique and results", Eur. J. Surg. Oncol., 
2007, 33, 685–90. 
[50] C.T. Gomillion, K.J.L. Burg, "Stem cells and adipose tissue engineering", 
Biomaterials, 2006, 27, 6052–6063. 
[51] A.L. Albright, J.S. Stern, "Adipose tissue", Encycl. Sport. Med. Sci., 1998, 
http://www.sportsci.org/encyc/adipose/adipose.html (accessed: 23 Janurary 2015). 
[52] S.R. Farmer, "Molecular determinants of brown adipocyte formation and function", 
Genes Dev., 2008, 22, 1269–1275. 
[53] H.N. Langstein, G.L. Robb, "Reconstructive approaches in a soft tissue sarcoma", 
Semin. Surg. Oncol., 1999, 17, 52–65. 
[54] D.T. Lindsay, Functional human anatomy, St. Louis: Mosby, 1996, 1–976. 
[55] H. Tilg, A.R. Moschen, "Adipocytokines: Mediators linking adipose tissue, 
inflammation and immunity", Nat. Rev. Immunol., 2006, 6, 772–783. 
[56] G. Rajashekhar, D.O. Traktuev, W.C. Roell, B.H. Johnstone, S. Merfeld-Clauss, B. 
Van Natta, E.D. Rosen, K.L. March, M. Clauss, "IFATS collection: Adipose stromal 
cell differentiation is reduced by endothelial cell contact and paracrine communication: 
Role of canonical Wnt signaling", Stem Cells., 2008, 26, 2674–2681. 
[57] K. Yoshimura, K. Sato, N. Aoi, M. Kurita, T. Hirohi, K. Harii, "Cell-assisted 
lipotransfer for cosmetic breast augmentation: Supportive use of adipose-derived 
stem/stromal cells", Aesthetic Plast. Surg., 2008, 32, 48–55. 
 190 
[58] S. Cinti, "The adipose organ", Prostaglandins Leukot. Essent. Fat. Acids., 2005,  
73, 9–15. 
[59] S. Gesta, Y.H. Tseng, C.R. Kahn, "Developmental Origin of Fat: Tracking Obesity to 
Its Source", Cell., 2007, 131, 242–256. 
[60] A. Rigamonti, K. Brennand, F. Lau, C.A. Cowan, "Rapid cellular turnover in adipose 
tissue", PLoS One., 2011, 6, e17637. 
[61] W.T. Branch, R.W. Alexander, R.C. Schlant, J. Hurst, Cardiology in Primary Care, 
New York: McGraw-Hill Medical Publishing Division, 2000, 1–940. 
[62] K. Comley, N.A. Fleck, "The toughness of adipose tissue: Measurements and physical 
basis", J. Biomech., 2010, 43, 1823–1826. 
[63] C.G. Brook, J.K. Lloyd, O.H. Wolf, "Relation between age of onset of obesity and size 
and number of adipose cells.", Br. Med. J., 1972, 2, 25–27. 
[64] P. Trayhurn, C. Bing, I.S. Wood, "Adipose tissue and adipokines - energy regulation 
from the human perspective", J. Nutr., 2006, 136, 1935S–1939S. 
[65] K. Comley, N.A. Fleck, "A micromechanical model for the Young’s modulus of 
adipose tissue", Int. J. Solids Struct., 2010, 47, 2982–2990. 
[66] L. Flynn, J.L. Semple, K.A. Woodhouse, "Decellularized placental matrices for adipose 
tissue engineering", J. Biomed. Mater. Res. A., 2006, 79, 359–369. 
[67] G. Sommer, M. Eder, L. Kovacs, H. Pathak, L. Bonitz, C. Mueller, P. Regitnig, G.A. 
Holzapfer, "Multiaxial mechanical properties and constitutive modeling of human 
adipose tissue: A basis for preoperative simulations in plastic and reconstructive 
surgery", Acta Biomater., 2013, 9, 9036–9048. 
[68] S. Cinti, "Transdifferentiation properties of adipocytes in the adipose organ", AJP 
Endocrinol. Metab., 2009, 297, E977–E986. 
[69] W.J.F.M. Jurgens, M.J. Oedayrajsingh-Varma, M.N. Helder, B. ZandiehDoulabi, T.E. 
Schouten, D.J. Kuik, M.J.P.F. Ritt, F.J. Van Milligen, "Effect of tissue-harvesting site 
on yield of stem cells derived from adipose tissue: Implications for cell-based 
therapies", Cell Tissue Res., 2008, 332, 415–426. 
[70] E. Linder-Ganz, N. Shabshin, Y. Itzchak, A. Gefen, "Assessment of mechanical 
conditions in sub-dermal tissues during sitting: A combined experimental-MRI and 
finite element approach", J. Biomech., 2007, 40, 1443–1454. 
[71] E. Linder-Ganz, N. Shabshin, Y. Itzchak, Z. Yizhar, I. Siev-Ner, A. Gefen, "Strains and 
stresses in sub-dermal tissues of the buttocks are greater in paraplegics than in healthy 
during sitting", J. Biomech., 2008, 41, 567–580. 
[72] H Zhao, N.A. Fleck, IUTAM Symposium on Mechanical Properties of Cellular 
Materials, Cachan: Springer Science & Business Media, 2008, 1-240. 
[73] N. Alkhouli, J. Mansfield, E. Green, J. Bell, B. Knight, N. Liversedge, J.C. Tham, R. 
Welbourn, A.C. Shore, K. Kos, C.P. Winlove, "The mechanical properties of human 
adipose tissues and their relationships to the structure and composition of the 
extracellular matrix.", Am. J. Physiol. Endocrinol. Metab., 2013, 305, E1427–1435. 
[74] K. Chen, J.D. Weiland, "Mechanical properties of orbital fat and its encapsulating 
connective tissue", J. Biomech. Eng., 2011, 133, 064505. 
[75] J.E. Miller-Young, N.A. Duncan, G. Baroud, "Material properties of the human 
calcaneal fat pad in compression experiment and theory", J. Biomech., 2002,  
 191 
35, 1523–1531. 
[76] A. Gefen, E. Haberman, "Viscoelastic properties of ovine adipose tissue covering the 
gluteus muscles", J. Biomech. Eng., 2007, 129, 924–930. 
[77] A. Samani, D. Plewes, "A method to measure the hyperelastic parameters of ex vivo 
breast tissue samples", Phys. Med. Biol., 2004, 49, 4395–4405. 
[78] A. Samani, J. Zubovits, D. Plewes, "Elastic moduli of normal and pathological human 
breast tissues: An inversion-technique-based investigation of 169 samples", Phys. Med. 
Biol., 2007, 52, 1565–1576. 
[79] R. Sinkus, M. Tanterb, T. Xydeasc, S. Cathelineb, J. Bercoffb, M. Fink, "Viscoelastic 
shear properties of in vivo breast lesions measured by MR elastography", Magn. Reson. 
Imaging., 2005, 23, 159–165. 
[80] J.B. Weaver, M. Doyley, Y. Cheung, F. Kennedy, E.L. Madsen, E.E.W. Van Houten, 
K. Paulsen, "Imaging the shear modulus of the heel fat pads", Clin. Biomech., 2005,  
20, 312–319. 
[81] K. Comley, N. Fleck, "The mechanical response of porcine adipose tissue", J. Biomech. 
Eng., 2009, 1–30. 
[82] N. Shoham, A.L. Sasson, F.H. Lin, D. Benayahu, R. Haj-Ali, A. Gefen, "The 
mechanics of hyaluronic acid/adipic acid dihydrazide hydrogel: Towards developing a 
vessel for delivery of preadipocytes to native tissues", J. Mech. Behav. Biomed. Mater., 
2013, 28, 320–331. 
[83] D.E. Jaalouk, J. Lammerding, "Mechanotransduction gone awry", Nat. Rev. Mol. Cell 
Biol., 2009, 10, 63–73. 
[84] P.N. Patel, C.K. Smith, C.W. Patrick, "Rheological and recovery properties of 
poly(ethylene glycol) diacrylate hydrogels and human adipose tissue", J. Biomed. 
Mater. Res. A., 2005, 73, 313–319. 
[85] E.E.W. Van Houten, M.M. Doyley, F.E. Kennedy, J.B. Weaver, K.D. Paulsen, "Initial 
in vivo experience with steady-state subzone-based MR elastography of the human 
breast", J. Magn. Reson. Imaging., 2003, 17, 72–85. 
[86] A. Gefen, M. Megido-Ravid, Y. Itzchak, "In vivo biomechanical behavior of the 
human heel pad during the stance phase of gait", J. Biomech., 2001, 34, 1661–1665. 
[87] M. Geerligs, G.W.M. Peters, P.A.J. Ackermans, C.W.J. Oomens, F.P.T. Baaijens, 
"Linear viscoelastic behavior of subcutaneous adipose tissue", Biorheology, 2008,  
45, 677–688. 
[88] I. Schoemaker, P.P.W. Hoefnagel, T.J. Mastenbroek, C.F. Kolff, S. Schutte, F.C.T. 
Van Der Helm, S.J. Picken, A.F.C. Gerritsen, P.A. Wielopolski, H. Spekreijse, H.J. 
Simonsz, "Elasticity, viscosity, and deformation of orbital fat", Investig. Ophthalmol. 
Vis. Sci., 2006, 47, 4819–4826. 
[89] C.W. Patrick, "Adipose tissue engineering : The future of breast and soft tissue 
reconstruction following tumor resection", Semin. Surg. Oncol., 2000, 19, 302–311. 
[90] L.P. Bucky, I. Percec, "The Science of Autologous Fat Grafting : Views on Current and 
Future Approaches", Aesthetic Surg. J., 2008, 28, 313–321. 
[91] C.W. Patrick, P.B. Chauvin, J. Hobley, G.P. Reece, "Preadipocyte seeded PLGA 
scaffolds for adipose tissue engineering", Tissue Eng., 1999, 5, 139–151. 
[92] C.W. Patrick, "Engineering Adipose Tissue for Regenerative and Reparative 
 192 
Therapies", Semin. Plast. Surg., 2005, 19, 207–215. 
[93] D.A. De Ugarte, K. Morizono, A. Elbarbary, Z. Alfonso, P.A. Zuk, M. Zhu, J.L. 
Dragoo, P. Ashjian, B. Thomas, P. Benhaim, I. Chen, J. Fraser, M.H. Hedrick, 
"Comparison of Multi-Lineage Cells from Human Adipose Tissue and Bone Marrow", 
Cells Tissues Organs., 2003, 174, 101–109. 
[94] F.P. Barry, J.M. Murphy, "Mesenchymal stem cells: clinical applications and biological 
characterization", Int. J. Biochem. Cell Biol., 2004, 36, 568–584. 
[95] J. Ringe, C. Kaps, G.R. Burmester, M. Sittinger, "Stem cells for regenerative medicine: 
advances in the engineering of tissues and organs", Naturwissenschaften, 2002,  
89, 338–351. 
[96] D.A. De Ugarte, P.H. Ashjian, A. Elbarbary, M.H. Hedrick, "Future of fat as raw 
material for tissue regeneration", Ann. Plast. Surg., 2003, 50, 215–219. 
[97] S.S. Tholpady, R. Llull, R.C. Ogle, J.P. Rubin, J.W. Futrell, A.J. Katz, "Adipose tissue: 
stem cells and beyond", Clin. Plast. Surg., 2006, 33, 55–62. 
[98] T.M. Liu, M. Martina, D.W. Hutmacher, J.H.P. Hui, E.H. Lee, B. Lim, "Identification 
of common pathways mediating differentiation of bone marrow- and adipose tissue-
derived human mesenchymal stem cells into three mesenchymal lineages.", Stem 
Cells., 2007, 25, 750–760. 
[99] F. Giorgino, L. Laviola, J.W. Eriksson, "Regional differences of insulin action in 
adipose tissue: insights from in vivo and in vitro studies", Acta Physiol. Scand., 2005, 
183, 13–30. 
[100] K.J. Burg, T. Boland, "Minimally invasive tissue engineering composites and cell 
printing", IEEE Eng. Med. Bilogy Mag., 2003, 22, 84–91. 
[101] C.T. Gomillion, A.N. Cavin, S.E. Ellis, K.J.L. Burg, “Evaluation of tissue engineered 
injectable devices for breast tissue engineering”, in: Transactions of the 30th annual 
meeting of the Society for Biomaterials, Memphis, Texas. 2005. 
[102] K. Hemmrich, K. Van de Sijpe, N.P. Rhodes, J.A. Hunt, C. Di Bartolo, N. Pallua, P. 
Blondeel, D. von Heimburg, "Autologous in vivo adipose tissue engineering in 
hyaluronan-based gels - A pilot study", J. Surg. Res., 2008, 144, 82–88. 
[103] K.J.L. Burg, C.E. Austin, C.R. Culberson, K.G. Greene, C.R. Halberstadt, W.D. Holder 
Jr., E. Al., “A novel approach to tissue engineering: injectable composites”, in: 
Transactions of the 2000 world biomaterials congress, Kona, Hawaii, 2000. 
[104] Y.S. Choi, S.N. Park, H. Suh, "Adipose tissue engineering using mesenchymal stem 
cells attached to injectable PLGA spheres", Biomaterials, 2005, 26, 5855–5863. 
[105] Y.S. Choi, S.M. Cha, Y.Y. Lee, S.W. Kwon, C.J. Park, M. Kim, "Adipogenic 
differentiation of adipose tissue derived adult stem cells in nude mouse", Biochem. 
Biophys. Res. Commun., 2006, 345, 631–637. 
[106] J.P. Rubin, J.M. Bennett, J.S. Doctor, B.M. Tebbets, K.G. Marra, "Collagenous 
microbeads as a scaffold for tissue engineering with adipose-derived stem cells", Plast. 
Reconstr. Surg., 2007, 120, 414–424. 
[107] S. Natesan, D.G. Baer, T.J. Walters, M. Babu, R.J. Christy, "Adipose-derived stem cell 
delivery into collagen gels using chitosan microspheres", Tissue Eng. A, 2010,  
16, 1369–1384. 
[108] M.L. Moya, M.H. Cheng, J.J. Huang, M.E. Francis-Sedlak, S.W. Kao, E.C. Opara, 
 193 
E.M. Brey, "The effect of FGF-1 loaded alginate microbeads on neovascularization and 
adipogenesis in a vascular pedicle model of adipose tissue engineering", Biomaterials, 
2010, 31, 2816–2826. 
[109] Y. Kimura, M. Ozeki, T. Inamoto, Y. Tabata, "Time course of de novo adipogenesis in 
matrigel by gelatin microspheres incorporating basic fibroblast growth factor", Tissue 
Eng., 2002, 8, 603–613. 
[110] T. Masuda, M. Furue, T. Matsuda, "Novel strategy for soft tissue augmentation based 
on transplantation of fragmented omentum and preadipocytes", Tissue Eng., 2004,  
10, 1672–1683. 
[111] N. Kawaguchi, K. Toriyama, E. Nicodemou-Lena, K. Inou, S. Torii, Y. Kitagawa, "De 
novo adipogenesis in mice at the site of injection of basement membrane and basic 
fibroblast growth factor", Proc. Natl. Acad. Sci. U. S. A., 1998, 95, 1062–1066. 
[112] Y. Tabata, M. Miyao, T. Inamoto, T. Ishii, Y. Hirano, Y. Yamaoki, Y. Ikada, "De novo 
formation of adipose tissue by controlled release of basic fibroblast growth factor", 
Tissue Eng., 2000, 6, 279–89. 
[113] K. Toriyama, N. Kawaguchi, J. Kitoh, R. Tajima, K. Inou, Y. Kitagawa, S. Torii, 
"Endogenous adipocyte precursor cells for regenerative soft-tissue engineering", Tissue 
Eng., 2002, 8, 157–165. 
[114] T. Masuda, M. Furue, T. Matsuda, "Photocured, styrenated gelatin-based microspheres 
for de novo adipogenesis through corelease of basic fibroblast growth factor, insulin, 
and insulin-like growth factor I", Tissue Eng., 2004, 10, 523–535. 
[115] E. Yuksel, A.B. Weinfeld, R. Cleek, J.M. Waugh, J. Jensen, S. Boutros, S.M. Shenaq, 
M. Spira, "De novo adipose tissue generation through long-term, local delivery of 
insulin and insulin-like growth factor-1 by PLGA/PEG microshperes in an in vivo rat 
model: a novel concept and capability", Plast. Reconstr. Surg., 2000, 105, 1721–1729. 
[116] A.V. Vashi, K.M. Abberton, G.P. Thomas, W.A. Morrison, A.J. O’Connor, J.J. 
Cooper-White, E.W. Thompson, "Adipose tissue engineering based on the controlled 
release of fibroblast growth factor-2 in a collagen matrix", Tissue Eng., 2006,  
12, 3035–3043. 
[117] R.L. Walton, E.K. Beahm, L. Wu, "De novo adipose formation in a vascularized 
engineered construct", Microsurgery, 2004, 24, 378–384. 
[118] J.H. Dolderer, K.M. Abberton, E.W. Thompson, J.L. Slavin, G.W. Stevens, A.J. 
Penington, W.A. Morrison, "Spontaneous large volume adipose tissue generation from 
a vascularized pedicled fat flap inside a chamber space", Tissue Eng., 2007,  
13, 673–681. 
[119] K.J. Cronin, A. Messina, K.R. Knight, J.J. Cooper-White, G.W. Stevens, A.J. 
Penington, W.A. Morrison, "New murine model of spontaneous autologous tissue 
engineering, combining an arteriovenous pedicle with matrix materials", Plast. 
Reconstr. Surg., 2004, 113, 260–269. 
[120] P.S. Wiggenhauser, D.F. Müller, F.P. Melchels, J.T. Egaña, K. Storck, H. Mayer, P. 
Leuthner, D. Skodacek, U. Hopfner, H.G. Machens, R. Staudenmaier, J.T. Schantz, 
"Engineering of vascularized adipose constructs", Cell Tissue Res., 2012,  
347, 747–757. 
[121] B. Weiser, L. Prantl, T.E.O. Schubert, J. Zellner, C. Fischbach-Teschl, T. Spruss, A.K. 
 194 
Seitz, J. Tessmar, A. Goepferich, T. Blunk, "In vivo development and long-term 
survival of engineered adipose tissue depend on in vitro precultivation strategy", Tissue 
Eng. A, 2008, 14, 275–284. 
[122] D.A. Young, K.L. Christman, "Injectable biomaterials for adipose tissue engineering", 
Biomed. Mater., 2012, 7, 024104. 
[123] A.K.L. Chen, S. Reuveny, S.K.W. Oh, "Application of human mesenchymal and 
pluripotent stem cell microcarrier cultures in cellular therapy: Achievements and future 
direction.", Biotechnol. Adv., 2013, 31, 1032–46. 
[124] G.E. Wnek, G.L. Bowlin, Encyclopedia of Biomaterials and Biomedical Engineering, 4 
Volume Set, Second Edition, New York: CRC Press, 2008, 1–3552. 
[125] E. Lavik, R. Langer, "Tissue engineering: current state and perspectives", Appl. 
Microbiol. Biotechnol., 2004, 65, 1–8. 
[126] A.V. Vashi, E. Keramidaris, K.M. Abberton, W.A. Morrison, J.L. Wilson, A.J. 
O’Connor, J.J. Cooper-White, E.W. Thompson, "Adipose differentiation of bone 
marrow-derived mesenchymal stem cells using Pluronic F-127 hydrogel in vitro", 
Biomaterials, 2008, 29, 573–579. 
[127] J.R. Mauney, T. Nguyen, K. Gillen, C. Kirker-Head, J.M. Gimble, D.L. Kaplan, 
"Engineering adipose-like tissue in vitro and in vivo utilizing human bone marrow and 
adipose-derived mesenchymal stem cells with silk fibroin 3D scaffolds", Biomaterials, 
2007, 28, 5280–5290. 
[128] Y. Hiraoka, H. Yamashiro, K. Yasuda, Y. Kimura, T. Inamoto, Y. Tabata, "In situ 
regeneration of adipose tissue in rat fat pad by combining a collagen scaffold with 
gelatin microspheres containing basic fibroblast growth factor", Tissue Eng., 2006,  
12, 1475–1487. 
[129] Y. Kimura, M. Ozeki, T. Inamoto, Y. Tabata, "Adipose tissue engineering based on 
human preadipocytes combined with gelatin microspheres containing basic fibroblast 
growth factor", Biomaterials, 2003, 24, 2513–2521. 
[130] K.C. O’Connor, H. Song, N. Rosenzweig, D.A. Jansen, "Extracellular matrix substrata 
alter adipocyte yield and lipogenesis in primary cultures of stromal-vascular cells from 
human adipose", Biotechnol. Lett., 2003, 25, 1967–1972. 
[131] S. Neuss, R. Stainforth, J. Salber, P. Schenck, M. Bovi, R. Knüchel,  a. Perez-Bouza, 
"Long-term survival and bipotent terminal differentiation of human mesenchymal stem 
cells (hMSC) in combination with a commercially available three-dimensional collagen 
scaffold", Cell Transplant., 2008, 17, 977–986. 
[132] E. Gentleman, E.A. Nauman, G.A. Livesay, K.C. Dee, "Collagen composite 
biomaterials resist contraction while allowing development of adipocytic soft tissue in 
vitro", Tissue Eng., 2006, 12, 1639–49. 
[133] W. Tsuji, T. Inamoto, H. Yamashiro, T. Ueno, H. Kato, Y. Kimura, Y. Tabata, M. Toi, 
"Adipogenesis induced by human adipose tissue-derived stem cells", Tissue Eng. A, 
2009, 15, 83–93. 
[134] X. Wu, L. Black, G. Santacana-Laffitte, C.W. Patrick, "Preparation and assessment of 
glutaraldehyde-crosslinked collagen-chitosan hydrogels for adipose tissue 
engineering", J. Biomed. Mater. Res. A, 2007, 81, 59–65. 
[135] D. Von Heimburg, S. Zachariah, H. Kühling, I. Heschel, H. Schoof, B. Hafemann, N. 
 195 
Pallua, "Human preadipocytes seeded on freeze-dried collagen scaffolds investigated in 
vitro and in vivo", Biomaterials, 2001, 22, 429–438. 
[136] S.D. Lin, S.H. Huang, Y.N. Lin, S.H. Wu, H.W. Chang, T.M. Lin, C.Y. Chai, C.S. Lai, 
"Engineering adipose tissue from uncultured human adipose stromal vascular fraction 
on collagen matrix and gelatin sponge scaffolds", Tissue Eng. A, 2011, 17, 1489–1498. 
[137] Y. Itoi, M. Takatori, H. Hyakusoku, H. Mizuno, "Comparison of readily available 
scaffolds for adipose tissue engineering using adipose-derived stem cells", J. Plast. 
Reconstr. Asthetic Surg. JPRAS., 2010, 63, 858–864. 
[138] L.E. Flynn, G.D. Prestwich, J.L. Semple, K.A. Woodhouse, "Proliferation and 
differentiation of adipose-derived stem cells on naturally derived scaffolds", 
Biomaterials, 2008, 29, 1862–1871. 
[139] L. Flynn, G.D. Prestwich, J.L. Semple, K.A. Woodhouse, "Adipose tissue engineering 
in vivo with adipose-derived stem cells on naturally derived scaffolds", J. Biomed. 
Mater. Res. A, 2009, 89, 929–941. 
[140] A. Borzacchiello, L. Mayol, P.A. Ramires, A. Pastorello, C.D. Bartolo, L. Ambrosio, 
E. Milella, "Structural and rheological characterization of hyaluronic acid-based 
scaffolds for adipose tissue engineering", Biomaterials, 2007, 28, 4399–4408. 
[141] M. Halbleib, T. Skurk, C. De Luca, D. Von Heimburg, H. Hauner, "Tissue engineering 
of white adipose tissue using hyaluronic acid-based scaffolds. I: In vitro differentiation 
of human adipocyte precursor cells on scaffolds", Biomaterials, 2003, 24, 3125–3132. 
[142] K. Hemmrich, D. Von Heimburg, R. Rendchen, C. Di Bartolo, E. Milella, N. Pallua, 
"Implantation of preadipocyte-loaded hyaluronic acid-based scaffolds into nude mice 
to evaluate potential for soft tissue engineering", Biomaterials, 2005, 26, 7025–7037. 
[143] N.P. Rhodes, "Inflammatory signals in the development of tissue-engineered soft 
tissue", Biomaterials, 2007, 28, 5131–5136. 
[144] F.B. Stillaert, C. Di Bartolo, J.A. Hunt, N.P. Rhodes, E. Tognana, S. Monstrey, P.N. 
Blondeel, "Human clinical experience with adipose precursor cells seeded on 
hyaluronic acid-based spongy scaffolds", Biomaterials, 2008, 29, 3953–3959. 
[145] D. von Heimburg, S. Zachariah, A. Low, N. Pallua, "Influence of differerent 
biodegradable carriers on the in vivo behavior of adipose precursors cells", Plast. 
Reconstr. Surg., 2001, 108, 411–420. 
[146] S. Uriel, J.J. Huang, M.L. Moya, M.E. Francis, R. Wang, S.Y. Chang, M.H. Cheng, 
E.M. Brey, "The role of adipose protein derived hydrogels in adipogenesis", 
Biomaterials, 2008, 29, 3712–3719. 
[147] K. Hemmrich, G.P.L. Thomas, K.M. Abberton, E.W. Thompson, J.A. Rophael, A.J. 
Penington, W.A. Morrison, "Monocyte chemoattractant protein-1 and nitric oxide 
promote adipogenesis in a model that mimics obesity", Obesity, 2007, 15, 2951–2957. 
[148] J.H. Piasecki, K.A. Gutowski, G.P. Lahvis, K.I. Moreno, "An Experimental Model for 
Improving Fat Graft Viability and Purity", Plast. Reconstr. Surg., 2007,  
119, 1571–1583. 
[149] J.A. Rophael, R.O. Craft, J.A. Palmer, A.J. Hussey, G.P.L. Thomas, W.A. Morrison, 
A.J. Penington, G.M. Mitchell, "Angiogenic growth factor synergism in a murine tissue 
engineering model of angiogenesis and adipogenesis", Am. J. Pathol., 2007,  
171, 2048–2057. 
 196 
[150] M.H. Cheng, S. Uriel, M.L. Moya, M. Francis-Sedlak, R. Wang, J.J. Huang, S.Y. 
Chang, E.M. Brey, "Dermis-derived hydrogels support adipogenesis in vivo.", J. 
Biomed. Mater. Res. A, 2010, 92, 852–858. 
[151] N. Kawaguchi, K. Toriyama, E. Nicodemou-Lena, K. Inou, S. Torii, Y. Kitagawa, 
"Reconstituted basement membrane potentiates in vivo adipogenesis of 3T3-F442A 
cells.", Cytotechnology, 1999, 31, 215–220. 
[152] K.J. Cronin, A. Messina, E.W. Thompson, W.A. Morrison, G.W. Stevens, K.R. Knight, 
"The role of biological extracellular matrix scaffolds in vascularized three-dimensional 
tissue growth in vivo", J. Biomed. Mater. Res. B, 2007, 82, 122–128. 
[153] J.J. Marler, A. Guha, J. Rowley, R. Koka, D. Mooney, J. Upton, J.P. Vacanti, "Soft-
tissue augmentation with injectable alginate and syngeneic fibroblasts", Plast. 
Reconstr. Surg., 2000, 105, 2049–2058. 
[154] W.S. Kim, D.J. Mooney, P.R. Arany, K. Lee, N. Huebsch, J. Kim, "Adipose tissue 
engineering using injectable, oxidized alginate hydrogels", Tissue Eng. A, 2012,  
18, 737–743. 
[155] R. Yao, R. Zhang, F. Lin, J. Luan, "Biomimetic injectable HUVEC-
adipocytes/collagen/alginate microsphere co-cultures for adipose tissue engineering", 
Biotechnol. Bioeng., 2013, 110, 1430–1443. 
[156] D. Jaikumar, K.M. Sajesh, S. Soumya, T.R. Nimal, K.P. Chennazhi, S.V. Nair, R. 
Jayakumar, "Injectable alginate-O-carboxymethyl chitosan/nano fibrin composite 
hydrogels for adipose tissue engineering", Int. J. Biol. Macromol., 2015, 74, 318–326. 
[157] S.W. Cho, K.W. Song, J.W. Rhie, M.H. Park, C.Y. Choi, B.-S. Kim, "Engineered 
adipose tissue formation enhanced by basic fibroblast growth factor and a mechanically 
stable environment", Cell Transplant., 2007, 16, 421–434. 
[158] S.W. Cho, S.S. Kim, J. Won Rhie, H. Mi Cho, C. Yong Choi, B.S. Kim, "Engineering 
of volume-stable adipose tissues", Biomaterials, 2005, 26, 3577–3585. 
[159] J. Borges, M.C. Mueller, N.T. Padron, F. Tegtmeier, E.M. Lang, G.B. Stark, 
"Engineered adipose tissue supplied by functional microvessels", Tissue Eng., 2003,  
9, 1263–1270. 
[160] S.W. Cho, I. Kim, S.H. Kim, J.W. Rhie, C.Y. Choi, B.S. Kim, "Enhancement of 
adipose tissue formation by implantation of adipogenic-differentiated preadipocytes", 
Biochem. Biophys. Res. Commun., 2006, 345, 588–594. 
[161] N. Torio-Padron, N. Baerlecken, A. Momeni, G.B. Stark, J. Borges, "Engineering of 
adipose tissue by injection of human preadipocytes in fibrin", Aesthetic Plast. Surg., 
2007, 31, 285–293. 
[162] S.D. Lin, K.-H. Wang, A.P. Kao, "Engineered adipose tissue of predefined shape and 
dimensions from human adipose-derived mesenchymal stem cells", Tissue Eng. A, 
2008, 14, 571–581. 
[163] L. Hong, I. Peptan, P. Clark, J.J. Mao, "Ex vivo adipose tissue engineering by human 
marrow stromal cell seeded gelatin sponge", Ann. Biomed. Eng., 2005, 33, 511–517. 
[164] J.H. Choi, E. Bellas, G. Vunjak-Novakovic, D.L. Kaplan, "Adipogenic Differentiation 
of Human Adipose-Derived Stem Cells on 3D Silk Scaffolds", Methods Mol. Biol., 
2011, 702, 319–330. 
[165] E. Bellas, K.G. Marra, D.L. Kaplan, "Sustainable three-dimensional tissue model of 
 197 
human adipose tissue", Tissue Eng. C, 2013, 19, 745–754. 
[166] J.H. Kang, J.M. Gimble, D.L. Kaplan, "In vitro 3D model for human vascularized 
adipose tissue", Tissue Eng. A, 2009, 15, 2227–2236. 
[167] M. Vermette, V. Trottier, V. Ménard, L. Saint-Pierre, A. Roy, J. Fradette, "Production 
of a new tissue-engineered adipose substitute from human adipose-derived stromal 
cells", Biomaterials, 2007, 28, 2850–2860. 
[168] M. Vallée, J.F. Côté, J. Fradette, "Adipose-tissue engineering: Taking advantage of the 
properties of human adipose-derived stem/stromal cells", Pathol. Biol., 2009,  
57, 309–317. 
[169] M.E. Nimni, D. Cheung, B. Strates, M. Kodama, K. Sheikh, "Chemically modified 
collagen: a natural biomaterial for tissue replacement", J. Biomed. Mater. Res., 1987, 
21, 741–771. 
[170] B.S. Kim, C.E. Baez, A. Atala, "Biomaterials for tissue engineering", World J. Urol., 
2000, 18, 2–9. 
[171] R. Parenteau-Bareil, R. Gauvin, F. Berthod, "Collagen-based biomaterials for tissue 
engineering applications", Materials, 2010, 3, 1863–1887. 
[172] V. Vindigni, R. Cortivo, L. Iacobellis, G. Abatangelo, B. Zavan, "Hyaluronan benzyl 
ester as a scaffold for tissue engineering", Int. J. Mol. Sci., 2009, 10, 2972–2985. 
[173] J.A. Burdick, G.D. Prestwich, "Hyaluronic acid hydrogels for biomedical applications", 
Adv. Healthc. Mater., 2011, 23, H41–H56. 
[174] M.N. Collins, C. Birkinshaw, "Hyaluronic acid based scaffolds for tissue engineering-a 
review", Carbohydr. Polym., 2013, 92, 1262–1279. 
[175] S.K. Seidlits, Z.Z. Khaing, R.R. Petersen, J.D. Nickels, J.E. Vanscoy, J.B. Shear, C.E. 
Schmidt, "The effects of hyaluronic acid hydrogels with tunable mechanical properties 
on neural progenitor cell differentiation", Biomaterials, 2010, 31, 3930–3940. 
[176] J.M. Cloyd, N.R. Malhotra, L. Weng, W. Chen, R.L. Mauck, D.M. Elliott, "Material 
properties in unconfined compression of human nucleus pulposus, injectable 
hyaluronic acid-based hydrogels and tissue engineering scaffolds", Eur. Spine J., 2007,  
16, 1892–1898. 
[177] A. Casadei, R. Epis, L. Ferroni, I. Tocco, C. Gardin, E. Bressan, S. Sivolella, V. 
Vindigni, P. Pinton, G. Mucci, B. Zavan, "Adipose tissue regeneration: A state of the 
art", J. Biomed. Biotechnol., 2012, 2012, 462543. 
[178] H.K. Kleinman, G.R. Martin, "Matrigel: basement membrane matrix with biological 
activity", Semin. Cancer Biol., 2005, 15, 378–386. 
[179] J. Alcaraz, R. Xu, H. Mori, C.M. Nelson, R. Mroue, V.A. Spencer, D. Brownfield, 
D.C. Radisky, C. Bustamante, M.J. Bissell, "Laminin and biomimetic extracellular 
elasticity enhance functional differentiation in mammary epithelia", EMBO J., 2008,  
27, 2829–2838. 
[180] J. Reed, W.J. Walczak, O.N. Petzold, J.K. Gimzewski, "In situ mechanical 
interferometry of MatrigelTM films", Langmuir, 2009, 25, 36–39. 
[181] S.S. Soofi, J.A. Last, S.J. Liliensiek, P.F. Nealey, C.J. Murphy, "The elastic modulus of 
Matrigel as determined by atomic force microscopy", J. Struct. Biol., 2009,  
167, 216–219. 
[182] J.A. Wood, S.J. Liliensiek, P. Russell, P.F. Nealey, C.J. Murphy, "Biophysical cueing 
 198 
and vascular endothelial cell behavior", Materials, 2010, 3, 1620–1639. 
[183] J.H. Piasecki, K.A. Gutowski, K.M. Moreno, G.L. Lahvis, "Purified viable fat 
suspended in matrigel improves volume longevity", Asthetic Surg. J., 2008, 28, 24–32. 
[184] K. Hemmrich, D. von Heimburg, "Biomaterials for adipose tissue engineering", Expert 
Rev. Med. Devices., 2006, 3, 635–645. 
[185] R.M. Shanti, S. Janjanin, W.-J. Li, L.J. Nesti, M.B. Mueller, M.B. Tzeng, R.S. Tuan, 
"In vitro adipose tissue engineering using an electrospun nanofibrous scaffold", Ann. 
Plast. Surg., 2008, 61, 566–571. 
[186] A. Chaubey, K.J. Ross, R.M. Leadbetter, K.J. Burg, "Surface patterning: tool to 
modulate stem cell differentiation in an adipose system", J. Biomed. Mater. Res. B, 
2008, 84, 70–78. 
[187] C. Fischbach, T. Spruß, B. Weiser, M. Neubauer, C. Becker, M. Hacker, A. Göpferich, 
T. Blunk, "Generation of mature fat pads in vitro and in vivo utilizing 3-D long-term 
culture of 3T3-L1 preadipocytes", Exp. Cell Res., 2004, 300, 54–64. 
[188] S.W. Kang, S.W. Seo, C.Y. Choi, B.S. Kim, "Porous poly(lactic-co-glycolic acid) 
microsphere as cell culture substrate and cell transplantation vehicle for adipose tissue 
engineering", Tissue Eng. C, 2008, 14, 25–34. 
[189] M. Neubauer, M. Hacker, P. Bauer-Kreisel, B. Weiser, C. Fischbach, M.B. Schulz, A. 
Goepferich, T. Blunk, "Adipose tissue engineering based on mesenchymal stem cells 
and basic fibroblast growth factor in vitro", Tissue Eng., 2005, 11, 1840–1851. 
[190] C.W. Patrick, B. Zheng, C. Johnston, G.P. Reece, "Long-term implantation of 
preadipocyte-seeded PLGA scaffolds", Tissue Eng., 2002, 8, 283–293. 
[191] S.M. Morgan, B.J. Ainsworth, J.M. Kanczler, J.C. Babister, J.B. Chaudhuri, R.O.C. 
Oreffo, "Formation of a human-derived fat tissue layer in PDLLGA hollow fibre 
scaffolds for adipocyte tissue engineering", Biomaterials, 2009, 30, 1910–1917. 
[192] Y.S. Choi, S.N. Park, H. Suh, "The effect of PLGA sphere diameter on rabbit 
mesenchymal stem cells in adipose tissue engineering", J. Mater. Sci. Mater. Med., 
2008, 19, 2165–2171. 
[193] H.J. Chung, T.G. Park, "Injectable cellular aggregates prepared from biodegradable 
porous microspheres for adipose tissue engineering", Tissue Eng. A, 2009,  
15, 1391–400. 
[194] K.G. Marra, A.J. Defail, J.A. Clavijo-Alvarez, S.F. Badylak, A. Taieb, B. Schipper, J. 
Bennett, J.P. Rubin, "FGF-2 enhances vascularization for adipose tissue engineering", 
Plast. Reconstr. Surg., 2008, 121, 1153–1164. 
[195] X. Kang, Y. Xie, H.M. Powell, L. James Lee, M.A. Belury, J.J. Lannutti, D.A. Kniss, 
"Adipogenesis of murine embryonic stem cells in a three-dimensional culture system 
using electrospun polymer scaffolds", Biomaterials, 2007, 28, 450–458. 
[196] A. Alhadlaq, M. Tang, J.J. Mao, "Engineered adipose tissue from human mesenchymal 
stem cells maintains predefined shape and dimension: Implications in soft tissue 
augmentation and reconstruction.", Tissue Eng., 2005, 11, 556–566. 
[197] E.N. Lamme, D. Druecke, J. Pieper, P.S. May, P. Kaim, F. Jacobsen, H.-U. Steinau, L. 
Steinstraesser, "Long-term evaluation of porous PEGT/PBT implants for soft tissue 
augmentation", J. Biomater. Appl., 2008, 22, 309–335. 
[198] F.P. Brandl, A.K. Seitz, J.K.V. Teßmar, T. Blunk, A.M. Göpferich, "Enzymatically 
 199 
degradable poly(ethylene glycol) based hydrogels for adipose tissue engineering", 
Biomaterials, 2010, 31, 3957–3966. 
[199] M.S. Stosich, J.J. Mao, "Adipose tissue engineering from human adult stem cells: 
Clinical implications in plastic and reconstructive surgery", Plast. Reconstr. Surg., 
2007, 119, 71–85. 
[200] A.T. Hillel, S. Varghese, J. Petsche, M.J. Shamblott, J.H. Elisseeff, "Embryonic germ 
cells are capable of adipogenic differentiation in vitro and in vivo", Tissue Eng. A, 
2009, 15, 479–486. 
[201] P.N. Patel, A.S. Gobin, J.L. West, C.W.J. Patrick, "Poly(ethylene glycol) hydrogel 
system supports preadipocyte viability, adhesion, and proliferation", Tissue Eng., 2005, 
11, 1498–1505. 
[202] D.H. Stacey, S.E. Hanson, G. Lahvis, K.A. Gutowski, K.S. Masters, "In vitro 
adipogenic differentiation of preadipocytes varies with differentiation stimulus, culture 
dimensionality, and scaffold composition", Tissue Eng. A, 2009, 15, 3389–3399. 
[203] A. Gugerell, J. Kober, T. Laube, T. Walter, S. Nürnberger, E. Grönniger, S. Brönneke, 
R. Wyrwa, M. Schnabelrauch, M. Keck, "Electrospun poly(ester-urethane)- and 
poly(ester-urethane-urea) fleeces as promising tissue engineering scaffolds for adipose-
derived stem cells", PLoS One., 2014, 9, e90676. 
[204] X. Kang, Y. Xie, D.A. Kniss, "Adipose tissue model using three-dimensional 
cultivation of preadipocytes seeded onto fibrous polymer scaffolds", Tissue Eng., 2005,  
11, 458–468. 
[205] J.A. Clavijo-Alvarez, J.P. Rubin, J. Bennett, V.T. Nguyen, J. Dudas, C. Underwood, 
K.G. Marra, "A novel perfluoroelastomer seeded with adipose-derived stem cells for 
soft-tissue repair", Plast. Reconstr. Surg., 2006, 118, 1132–1142. 
[206] J.G. Kral, D.L. Crandall, "Development of a human adipocyte synthetic polymer 
scaffold", Plast. Reconstr. Surg., 1999, 104, 1732–1738. 
[207] M.I. Sabir, X. Xu, L. Li, "A review on biodegradable polymeric materials for bone 
tissue engineering applications", J. Mater. Sci., 2009, 44, 5713–5724. 
[208] I. Vroman, L. Tighzert, "Biodegradable Polymers", Materials (Basel)., 2009,  
2, 307–344. 
[209] ASM International, Materials and Coatings for Medical Devices: Cardiovascular, Ohio: 
ASM International, 2009, 1–444. 
[210] A.J.R. Lasprilla, G.A.R. Martinez, B.H. Lunelli, A.L. Jardini, R.M. Filho, "Poly-lactic 
acid synthesis for application in biomedical devices - A review", Biotechnol. Adv., 
2012, 30, 321–328. 
[211] M.A. Woodruff, D.W. Hutmacher, "The return of a forgotten polymer - 
Polycaprolactone in the 21st century", Prog. Polym. Sci., 2010, 35, 1217–1256. 
[212] C. Bastioli, Handbook of Biodegradable Polymers, Shropshire: Rapra Technology 
Limted, 2005, 1–552. 
[213] S. Eshraghi, S. Das, "Mechanical and microstructural properties of polycaprolactone 
scaffolds with 1-D, 2-D, and 3-D orthogonally oriented porous architectures produced 
by selective laser sintering", Acta Biomater., 2010, 6, 2467–2476. 
[214] J. Zhu, R.E. Marchant, "Design properties of hydrogel tissue-engineering scaffolds", 
Expert Rev. Med. Devices., 2011, 8, 607–626. 
 200 
[215] J.P. Mazzoccoli, D.L. Feke, H. Baskaran, P.N. Pintauro, "Mechanical and cell viability 
properties of crosslinked low- and high-molecular weight poly(ethylene glycol) 
diacrylate blends", J. Biomed. Mater. Res. A, 2010, 93, 558–566. 
[216] J. Malda, T.B. Woodfield, F. van der Vloodt, C. Wilson, D.E. Martens, J. Tramper, 
C.A. van Blitterswijk, J. Riesle, "The effect of PEGT/PBT scaffold architecture on the 
composition of tissue engineered cartilage", Biomaterials, 2005, 26, 63–72. 
[217] A. El-Ghalbzouri, E.N. Lamme, C. van Blitterswijk, J. Koopman, M. Ponec, "The use 
of PEGT/PBT as a dermal scaffold for skin tissue engineerin", Biomaterials, 2004,  
25, 2978–2996. 
[218] J. Malda, T.B. Woodfield, F. van der Vloodt, F.K. Kooy, D.E. Martens, J. Tramper, 
C.A. van Blitterswijk, J. Riesle, "The effect of PEGT/PBT scaffold architecture on 
oxygen gradients in tissue engineered cartilaginous constructs", Biomaterials, 2004,  
25, 5773–5780. 
[219] S.A. Guelcher, "Biodegradable polyurethanes: synthesis and applications in 
regenerative medicine", Tissue Eng. B, 2008, 14, 3–17. 
[220] H. Janik, M. Marzec, "A review: Fabrication of porous polyurethane scaffolds", Mater. 
Sci. Eng. C., 2015, 48, 586–591. 
[221] B. Ellis, R. Smith, Polymers: A property database, Second edition, Boca Raton: CRC 
Press - Taylor & Francis Group, 2009, 1–1052. 
[222] J.E. Mark, Polymer Data Handbook, Oxford: Oxford Press, 1999, 1–1018. 
[223] C.A. Harper, Handbook of Plastics, Elastomers, and Composites, Second Edition, New 
York: MacGraw-Hill, 1992, 1–768. 
[224] K. Modjarrad, S. Ebnesajjad, Handbook of Polymer Applications in Medicine and 
Medical Devices, Oxford: Elsevier, 2014, 1–278. 
[225] C. Legnani, A. Ventura, C. Terzaghi, E. Borgo, W. Albisetti, "Anterior cruciate 
ligament reconstruction with synthetic grafts. A review of literature", Int. Orthop., 
2010, 34, 465–471. 
[226] B. Veleirinho, D.S. Coelho, P.F. Dias, M. Maraschin, R. Pinto, E. Cargnin-Ferreira, A. 
Peixoto, J.A. Souza, R.M. Ribeiro-do-Valle, J.A. Lopes-da-Silva, "Foreign body 
reaction associated with PET and PET/chitosan electrospun nanofibrous abdominal 
meshes", PLoS One., 2014, 9, e95293. 
[227] Y. Bilsel, I. Abci, "The search for ideal hernia repair; mesh materials and types", Int. J. 
Surg., 2012, 10, 317–321. 
[228] S. Ravi, E.L. Chaikof, "Biomaterials for vascular tissue engineering", Regen. Med., 
2010, 5, 107–120. 
[229] Y. Kinoshita, H. Maeda, "Recent developments of functional scaffolds for 
craniomaxillofacial bone tissue engineering applications", Sci. World J., 2013,  
2013, 863157. 
[230] A.U. Daniels, "Silicone breast implant materials", Swiss Med. Wkly., 2012,  
142, w13614. 
[231] T.J. Gampper, H. Khoury, W. Gottlieb, R.F. Morgan, "Silicone gel implants in breast 
augmentation and reconstruction", Ann. Plast. Surg., 2007, 59, 581–590. 
[232] K. Gerszten, P.C. Gerszten, "Silicone Breast Implants: An Oncologic Perspective", 
Oncology, 1998, 12, 1439–1443. 
 201 
[233] C.A. Sundback, J.Y. Shyu, Y. Wang, W.C. Faquin, R.S. Langer, J.P. Vacanti, T.A. 
Hadlock, "Biocompatibility analysis of poly(glycerol sebacate) as a nerve guide 
material", Biomaterials, 2005, 26, 5454–5464. 
[234] H. Park, B.L. Larson, M.D. Guillemette, S.R. Jain, C. Hua, G.C. Engelmayr, L.E. 
Freed, "The significance of pore microarchitecture in a multi-layered elastomeric 
scaffold for contractile cardiac muscle constructs", Biomaterials, 2011, 32, 1856–1864. 
[235] R. Maidhof, A. Marsano, E.J. Lee, G. Vunjak-Novakovic, "Perfusion seeding of 
channeled elastomeric scaffolds with myocytes and endothelial cells for cardiac tissue 
engineering", Biotechnol. Prog., 2010, 26, 565–572. 
[236] M. Radisic, H. Park, T.P. Martens, J.E. Salazar-Lazaro, W. Geng, Y. Wang, R. Langer, 
L.E. Freed, G. Vunjak-Novakovic, "Pre-treatment of synthetic elastomeric scaffolds by 
cardiac fibroblasts improves engineered heart tissue", J. Biomed. Mater. Res. A, 2008, 
86, 713–724. 
[237] Q.Z. Chen, A. Bismarck, U. Hansen, S. Junaid, M.Q. Tran, S.E. Harding, N.N. Ali, 
A.R. Boccaccini, "Characterisation of a soft elastomer poly(glycerol sebacate) designed 
to match the mechanical properties of myocardial tissue", Biomaterials, 2008,  
29, 47–57. 
[238] W.L. Neeley, S. Redenti, H. Klassen, S. Tao, T. Desai, M.J. Young, R. Langer, "A 
microfabricated scaffold for retinal progenitor cell grafting", Biomaterials, 2008,  
29, 418–426. 
[239] S. Redenti, W.L. Neeley, S. Rompani, S. Saigal, J. Yang, H. Klassen, R. Langer, M.J. 
Young, "Engineering retinal progenitor cell and scrollable poly(glycerol-sebacate) 
composites for expansion and subretinal transplantation", Biomaterials, 2009,  
30, 3405–3414. 
[240] D. Motlagh, J. Yang, K.Y. Lui, A.R. Webb, G.A. Ameer, "Hemocompatibility 
evaluation of poly(glycerol-sebacate) in vitro for vascular tissue engineering", 
Biomaterials, 2006, 27, 4315–4324. 
[241] J. Gao, A.E. Ensley, R.M. Nerem, Y. Wang, "Poly(glycerol sebacate) supports the 
proliferation and phenotypic protein expression of primary baboon vascular cells", J. 
Biomed. Mater. Res. A, 2007, 83, 1070–1075. 
[242] J.M. Kemppainen, S.J. Hollister, "Tailoring the mechanical properties of 3D-designed 
poly(glycerol sebacate) scaffolds for cartilage applications", J. Biomed. Mater. Res. A, 
2010, 94, 9–18. 
[243] X. Zhao, Y. Wu, Y. Du, X. Chen, B. Lei, Y. Xue, P.X. Ma, "A highly bioactive and 
biodegradable poly(glycerol sebacate)–silica glass hybrid elastomer with tailored 
mechanical properties for bone tissue regeneration", J. Mater. Chem. B, 2015,  
3, 3222–3233. 
[244] Z.J. Sun, C. Chen, M.Z. Sun, C.H. Ai, X.L. Lu, Y.F. Zheng, B.F. Yang, D.L. Dong, 
"The application of poly (glycerol-sebacate) as biodegradable drug carrier", 
Biomaterials, 2009, 30, 5209–5214. 
[245] Q.Z. Chen, S. Liang, G.A. Thouas, "Synthesis and characterisation of poly(glycerol 
sebacate)-co-lactic acid as surgical sealants", Soft Matter., 2011, 7, 6484. 
[246] A. Mahdavi, L. Ferreira, C. Sundback, J.W. Nichol, E.P. Chan, D.J.D. Carter, C.J. 
Bettinger, S. Patanavanich, L. Chignozha, E. Ben-Joseph, A. Galakatos, H. Pryor, I. 
 202 
Pomerantseva, P.T. Masiakos, W. Faquin, A. Zumbuehl, S. Hong, J. Borenstein, J. 
Vacanti, R. Langer, J.M. Karp, “A biodegradable and biocompatible gecko-inspired 
tissue adhesive", Proc. Natl. Acad. Sci. U. S. A., 2008, 105, 2307–2312. 
[247] M.F. Yanik, "Towards gecko-feet-inspired bandages", Trends Biotechnol., 2009,  
27, 1–2. 
[248] D. Lin, K. Yang, W. Tang, Y. Liu, Y. Yuan, C. Liu, "A poly(glycerol sebacate)-coated 
mesoporous bioactive glass scaffold with adjustable mechanical strength, degradation 
rate, controlled-release and cell behavior for bone tissue engineering", Colloids 
Surfaces B, 2015, 131, 1–11. 
[249] M.J. Kim, M.Y. Hwang, J. Kim, D.J. Chung, "Biodegradable and Elastomeric Poly ( 
glycerol sebacate ) as a Coating Material for Nitinol Bare Stent", Biomed Res. Int., 
2014, 2014, 956952. 
[250] H. Shi, Q. Gan, X. Liu, Y. Ma, J. Hu, Y. Yuan, C. Liu, "Poly(glycerol sebacate)-
modified polylactic acid scaffolds with improved hydrophilicity, mechanical strength 
and bioactivity for bone tissue regeneration", RSC Adv., 2015, 5, 79703–79714. 
[251] I. Pomerantseva, N. Krebs, A. Hart, C.M. Neville, A.Y. Huang, C.A. Sundback, 
"Degradation behavior of poly(glycerol sebacate)", J. Biomed. Mater. Res. A, 2009,  
91, 1038–1047. 
[252] I.H. Jaafar, M.M. Ammar, S.S. Jedlicka, R.A. Pearson, J.P. Coulter, "Spectroscopic 
evaluation, thermal, and thermomechanical characterization of poly(glycerol-sebacate) 
with variations in curing temperatures and durations", J. Mater. Sci., 2010,  
45, 2525–2529. 
[253] C.L.E. Nijst, J.P. Bruggeman, J.M. Karp, L. Ferreira, A. Zumbuehl, C.J. Bettinger, R. 
Langer, "Synthesis and characterization of photocurable elastomers from 
poly(glycerol-co-sebacate)", Biomacromolecules, 2007, 8, 3067–3073. 
[254] H.M. Aydin, K. Salimi, Z.M.O. Rzayevc, E. Pişkin, "Microwave-assisted rapid 
synthesis of poly(glycerol-sebacate) elastomers", Biomater. Sci., 2013, 1, 503–509. 
[255] G.C. Engelmayr, M. Cheng, C.J. Bettinger, J.T. Borenstein, R. Langer, L.E. Freed, 
"Accordion-like honeycombs for tissue engineering of cardiac anisotropy", Nat. 
Mater., 2008, 7, 1003–1010. 
[256] S.L. Liang, W.D. Cook, G.A. Thouas, Q.Z. Chen, "The mechanical characteristics and 
in vitro biocompatibility of poly(glycerol sebacate)-Bioglass elastomeric composites", 
Biomaterials, 2010, 31, 8516–8529. 
[257] Q.Z. Chen, S.L. Liang, J. Wang, G.P. Simon, "Manipulation of mechanical compliance 
of elastomeric PGS by incorporation of halloysite nanotubes for soft tissue engineering 
applications", J. Mech. Behav. Biomed. Mater., 2011, 4, 1805–1818. 
[258] Q.Z. Chen, S.E. Harding, N.N. Ali, A.R. Lyon, A.R. Boccaccini, "Biomaterials in 
cardiac tissue engineering : Ten years of research survey", Mater. Sci. Eng. R., 2008, 
59, 1–37. 
[259] S.L. Liang, X.Y. Yang, X.Y. Fang, W.D. Cook, G.A. Thouas, Q.Z. Chen, "In Vitro 
enzymatic degradation of poly(glycerol sebacate)-based materials", Biomaterials, 2011, 
32, 8486–8496. 
[260] Y. Wang, Y.M. Kim, R. Langer, "In vivo degradation characteristics of poly(glycerol 
sebacate)", J. Biomed. Mater. Res. A, 2003, 66, 192–197. 
 203 
[261] Q.Z. Chen, L. Jin, W.D. Cook, D. Mohn, E.L. Lagerqvist, D.A. Elliott, J.M. Haynes, 
N. Boyd, W.J. Stark, C.W. Pouton, E.G. Stanleye, A.G. Elefanty, "Elastomeric 
nanocomposites as cell delivery vehicles and cardiac support devices", Soft Matter., 
2010, 6, 4715–4726. 
[262] Q.Z. Chen, H. Ishii, G.A. Thouas, A.R. Lyon, J.S. Wright, J.J. Blaker, W. 
Chrzanowski, A.R. Boccaccini, N.N. Ali, J.C. Knowles, S.E. Harding, "An elastomeric 
patch derived from poly(glycerol sebacate) for delivery of embryonic stem cells to the 
heart", Biomaterials, 2010, 31, 3885–3893. 
[263] P.M. Crapo, J. Gao, Y. Wang, "Seamless tubular poly(glycerol sebacate) scaffolds: 
High-yield fabrication and potential applications", J. Biomed. Mater. Res. A, 2008,  
86, 354–363. 
[264] P.M. Crapo, Y. Wang, "Physiologic compliance in engineered small-diameter arterial 
constructs based on an elastomeric substrate", Biomaterials, 2010, 31, 1626–1635. 
[265] C.J. Bettinger, E.J. Weinberg, K.M. Kulig, J.P. Vacanti, Y. Wang, J.T. Borenstein, R. 
Langer, "Three-dimensional microfluidic tissue-engineering scaffolds using a flexible 
biodegradable polymer", Adv. Mater., 2006, 18, 165–169. 
[266] S. Sant, C.M. Hwang, S.H. Lee, A. Khademhosseini, "Hybrid PGS-PCL microfibrous 
scaffolds with improved mechanical and biological properties", J. Tissue Eng. Regen. 
Med., 2011, 5, 283–291. 
[267] C.J. Bettinger, B. Orrick, A. Misra, R. Langer, J.T. Borenstein, "Microfabrication of 
poly (glycerol-sebacate) for contact guidance applications", Biomaterials, 2006,  
27, 2558–2565. 
[268] F. Yi, D.A. La Van, "Poly(glycerol sebacate) nanofiber scaffolds by core/shell 
electrospinning", Macromol. Biosci., 2008, 8, 803–806. 
[269] C. Fidkowski, M.R. Kaazempur-Mofrad, J. Borenstein, J.P. Vacanti, R. Langer, Y. 
Wang, "Endothelialized microvasculature based on a biodegradable elastomer", Tissue 
Eng., 2005, 11, 302–309. 
[270] N. Masoumi, N. Annabi, A. Assmann, B.L. Larson, J. Hjortnaes, N. Alemdar, M. 
Kharaziha, K.B. Manning, J.E. Mayer, A. Khademhosseini, "Tri-layered elastomeric 
scaffolds for engineering heart valve leaflets", Biomaterials, 2014, 35, 7774–7785. 
[271] N. Masoumi, K.L. Johnson, M.C. Howell, G.C. Engelmayr, "Valvular interstitial cell 
seeded poly(glycerol sebacate) scaffolds: Toward a biomimetic in vitro model for heart 
valve tissue engineering", Acta Biomater., 2013, 9, 5974–5988. 
[272] A. Jean, G.C. Engelmayr, "Finite element analysis of an accordion-like honeycomb 
scaffold for cardiac tissue engineering", J. Biomech., 2010, 43, 3035–3043. 
[273] N. Masoumi, A. Jean, J.T. Zugates, K.L. Johnson, G.C. Engelmayr, "Laser 
microfabricated poly(glycerol sebacate) scaffolds for heart valve tissue engineering", J. 
Biomed. Mater. Res. A, 2013, 101, 104–114. 
[274] S. Sant, D. Iyer, A.K. Gaharwar, A. Patel, A. Khademhosseini, "Effect of 
biodegradation and de novo matrix synthesis on the mechanical properties of valvular 
interstitial cell-seeded polyglycerol sebacate-polycaprolactone scaffolds", Acta 
Biomater., 2013, 9, 5963–5973. 
[275] S. Salehi, M. Fathi, S.H. Javanmard, T. Bahners, J.S. Gutmann, S. Ergün, K.P. Steuhl, 
T.A. Fuchsluger, "Generation of PGS/PCL blend nanofibrous scaffolds mimicking 
 204 
corneal stroma structure", Macromol. Mater. Eng., 2014, 299, 455–469. 
[276] M. Kharaziha, M. Nikkhah, S.R. Shin, N. Annabi, N. Masoumi, A.K. Gaharwar, G. 
Camci-Unal, A. Khademhosseini, "PGS:Gelatin nanofibrous scaffolds with tunable 
mechanical and structural properties for engineering cardiac tissues", Biomaterials, 
2013, 34, 6355–6366. 
[277] E.M. Jeffries, R.A. Allen, J. Gao, M. Pesce, Y. Wang, "Highly elastic and suturable 
electrospun poly(glycerol sebacate) fibrous scaffolds", Acta Biomater., 2015,  
18, 30–39. 
[278] B. Xu, B. Rollo, L.A. Stamp, D. Zhang, X. Fang, D.F. Newgreen, Q.Z. Chen, "Non-
linear elasticity of core/shell spun PGS/PLLA fibres and their effect on cell 
proliferation", Biomaterials, 2013, 34, 6306–6317. 
[279] H. Kenar, G.T. Kose, V. Hasirci, "Design of a 3D aligned myocardial tissue construct 
from biodegradable polyesters", J. Mater. Sci. Mater. Med., 2010, 21, 989–997. 
[280] M. Tallawi, D.C. Zebrowski, R. Rai, J.A. Roether, D.W. Schubert, M. El Fray, F.B. 
Engel, K.E. Aifantis, A.R. Boccaccini, "Poly(Glycerol Sebacate)/poly(butylene 
succinate-butylene dilinoleate) fibrous scaffolds for cardiac tissue engineering", Tissue 
Eng. C, 2015, 21, 585–596. 
[281] R. Rai, M. Tallawi, C. Frati, A. Falco, A. Gervasi, F. Quaini, J.A. Roether, T. 
Hochburger, D.W. Schubert, L. Seik, N. Barbani, L. Lazzeri, E. Rosellini, A.R. 
Boccaccini, "Bioactive electrospun fibers of poly(glycerol sebacate) and  
poly(ε-caprolactone) for cardiac patch application", Adv. Healthc. Mater., 2015,  
4, 2012–2025. 
[282] R. Ravichandran, J.R. Venugopal, S. Sundarrajan, S. Mukherjee, R. Sridhar, S. 
Ramakrishna, "Minimally invasive injectable short nanofibers of poly(glycerol 
sebacate) for cardiac tissue engineering", Nanotechnology, 2012, 23, 385102. 
[283] R. Ravichandran, J.R. Venugopal, S. Sundarrajan, S. Mukherjee, S. Ramakrishna, 
"Poly(glycerol sebacate)/gelatin core/shell fibrous structure for regeneration of 
myocardial infarction", Tissue Eng. A, 2011, 17, 1363–1373. 
[284] R. Ravichandran, J.R. Venugopal, S. Sundarrajan, S. Mukherjee, S. Ramakrishna, 
"Cardiogenic differentiation of mesenchymal stem cells on elastomeric poly (glycerol 
sebacate)/collagen core/shell fibers", World J. Cardiol., 2013, 5, 28–41. 
[285] R. Ravichandran, J.R. Venugopal, S. Sundarrajan, S. Mukherjee, R. Sridhar, S. 
Ramakrishna, "Expression of cardiac proteins in neonatal cardiomyocytes on 
PGS/fibrinogen core/shell substrate for Cardiac tissue engineering", Int. J. Cardiol., 
2013, 167, 1461–1468. 
[286] B. Xu, Y. Li, C. Zhu, W.D. Cook, J. Forsythe, Q.Z. Chen, "Fabrication, mechanical 
properties and cytocompatibility of elastomeric nanofibrous mats of poly(glycerol 
sebacate)", Eur. Polym. J., 2015, 64, 79–92. 
[287] M. Radisic, A. Marsano, R. Maidhof, Y. Wang, G. Vunjak-Novakovic, "Cardiac tissue 
engineering using perfusion bioreactor systems", Nat. Protoc., 2008, 3, 719–738. 
[288] J. Gao, P.M. Crapo, Y. Wang, "Macroporous elastomeric scaffolds with extensive 
micropores for soft tissue engineering", Tissue Eng., 2006, 12, 917–925. 
[289] R. Rai, M. Tallawi, N. Barbani, C. Frati, D. Madeddu, S. Cavalli, G. Graiani, F. 
Quaini, J.A. Roether, D.W. Schubert, E. Rosellini, A.R. Boccaccini, "Biomimetic 
 205 
poly(glycerol sebacate) (PGS) membranes for cardiac patch application", Mater. Sci. 
Eng. C, 2013, 33, 3677–3687. 
[290] J. Folkman, M. Hochberg, "Self-regulation of growth in three dimesnions", J. Exp. 
Med., 1973, 138, 745–753. 
[291] C.K. Colton, "Implantable biohybrid artificial organs", Cell Transplant., 1995,  
4, 415–436. 
[292] H. Ye, C. Owh, X.J. Loh, "A thixotropic polyglycerol sebacate-based supramolecular 
hydrogel showing UCST behavior", RSC Adv., 2015, 5, 48720–48728. 
[293] T. Dvir, B.P. Timko, D.S. Kohane, R. Langer, "Nanotechnological strategies for 
engineering complex tissues", Nat. Nanotechnol., 2011, 6, 13–22. 
[294] J.J. Stankus, J. Guanc, K. Fujimoto, W.R. Wagner, "Microintegrating smooth muscle 
cells into a biodegradable, elastomeric fiber matrix", Biomaterials, 2006, 27, 735–744. 
[295] C. Vaquette, J. Cooper-White, "The use of an electrostatic lens to enhance the 
efficiency of the electrospinning process", Cell Tissue Res., 2012, 347, 815–826. 
[296] R. Kessick, J. Fenn, G. Tepper, "The use of AC potentials in electrospraying and 
electrospinning processes", Polymer, 2004, 45, 2981–2984. 
[297] S. Thandavamoorthy, N. Gopinath, S.S. Ramkumar, "Self-assembled honeycomb 
polyurethane nanofibers", J. Appl. Polym. Sci., 2006, 101, 3121–3124. 
[298] J.L. Ifkovits, J.J. Devlin, G. Eng, T.P. Martens, G. Vunjak-Novakovic, J.A. Burdick, 
"Biodegradable fibrous scaffolds with tunable properties formed from photo-cross-
linkable poly(glycerol sebacate)", ACS Appl. Mater. Interfaces., 2009, 1, 1878–1886. 
[299] J.L. Ifkovits, K. Wu, R.L. Mauck, J.A. Burdick, "The influence of fibrous elastomer 
structure and porosity on matrix organization", PLoS One., 2010, 5, e15717. 
[300] W.L. Murphy, R.G. Dennis, J.L. Kileny, D.J. Mooney, "Salt fusion: An approach to 
improve pore interconnectivity within tissue engineering scaffolds", Tissue Eng., 2002, 
8, 43–52. 
[301] S. Gerecht, S.A. Townsend, H. Pressler, H. Zhu, C.L.E. Nijst, J.P. Bruggeman, J.W. 
Nichol, R. Langer, "A porous photocurable elastomer for cell encapsulation and 
culture", Biomaterials, 2007, 28, 4826–4835. 
[302] Y. Wu, L. Wang, B. Guo, P. X Ma, "Injectable biodegradable hydrogels and microgels 
based on methacrylated poly(ethylene glycol)-co-poly(glycerol sebacate) multi-block 
copolymers: synthesis, characterization, and cell encapsulation", J. Mater. Chem. B, 
2014, 2, 3674-3685. 
[303] C. Zhu, S.R. Kustra, C.J. Bettinger, "Photocrosslinkable biodegradable elastomers 
based on cinnamate- functionalized polyesters", Acta Biomater., 2013, 9, 7362–7370. 
[304] Z.J. Sun, L. Wu, W. Huang, C. Chen, Y. Chen, X.L. Lu, X.L. Zhang, B.F. Yang, D.L. 
Dong, "Glycolic acid modulates the mechanical property and degradation of 
poly(glycerol, sebacate, glycolic acid)", J. Biomed. Mater. Res. A, 2010, 92, 332–339. 
[305] Z.J. Sun, L. Wu, W. Huang, X.L. Zhang, X.L. Lu, Y.F. Zheng, B.F. Yang, D.L. Dong, 
"The influence of lactic on the properties of poly(glycerol-sebacate-lactic acid)", 
Mater. Sci. Eng. C, 2009, 29, 178–182. 
[306] Z.J. Sun, L. Wu, X.L. Lu, Z.X. Meng, Y.F. Zheng, D.L. Dong, "The characterization of 
mechanical and surface properties of poly(glycerol-sebacate-lactic acid) during 
degradation in phosphate buffered saline", Appl. Surf. Sci., 2008, 255, 350–352. 
 206 
[307] Y. Wu, R. Shi, D. Chen, L. Zhang, W. Tian, "Nanosilica filled poly(glycerol-sebacate-
citrate) elastomers with improved mechanical properties, adjustable degradability, and 
better biocompatibility", J. Appl. Polym. Sci., 2012, 123, 1612–1620. 
[308] Q. Liu, T. Tan, J. Weng, L. Zhang, "Study on the control of the compositions and 
properties of a biodegradable polyester elastomer", Biomed. Mater., 2009, 4, 025015. 
[309] Q. Liu, J. Wu, T. Tan, L. Zhang, D. Chen, W. Tian, "Preparation, properties and 
cytotoxicity evaluation of a biodegradable polyester elastomer composite", Polym. 
Degrad. Stab., 2009, 94, 1427–1435. 
[310] A. Patel, A.K. Gaharwar, G. Iviglia, H. Zhang, S. Mukundan, S.M. Mihaila, D. 
Demarchi, A. Khademhosseini, "Highly elastomeric poly(glycerol sebacate)-co-
poly(ethylene glycol) amphiphilic block copolymers", Biomaterials, 2013,  
34, 3970–3983. 
[311] S. Cheng, L. Yang, F. Gong, "Novel branched poly(L-lactide) with poly(glycerol-co-
sebacate) core", Polym. Bull., 2010, 65, 643–655. 
[312] M.J.N. Pereira, B. Ouyang, C.A. Sundback, N. Lang, I. Friehs, S. Mureli, I. 
Pomerantseva, J. McFadden, M.C. Mochel, O. Mwizerwa, P. Del Nido, D. Sarkar, P.T. 
Masiakos, R. Langer, L.S. Ferreira, J.M. Karp, "A highly tunable biocompatible and 
multifunctional biodegradable elastomer", Adv. Mater., 2013, 25, 1209–1215. 
[313] S. Liang, W.D. Cook, Q.Z. Chen, "Physical characterization of poly(glycerol 
sebacate)/Bioglass composites", Polym. Int., 2012, 61, 17–22. 
[314] T.N. Rosenbalm, M. Teruel, C.S. Day, G.L. Donati, M. Morykwas, L. Argenta, N. 
Kuthirummal, N. Levi-Polyachenko, "Structural and mechanical characterization of 
bioresorbable, elastomeric nanocomposites from poly(glycerol 
sebacate)/nanohydroxyapatite for tissue transport applications", J. Biomed. Mater. Res. 
B., 2015, DOI: 10.1002/jbm.b.33467. 
[315] L. Zhou, H. He, C. Jiang, S. He, "Preparation and characterization of poly(glycerol 
sebacate)/cellulose nanocrystals elastomeric composites", J. Appl. Polym. Sci., 2015, 
132, DOI: 10.1002/app.42196.  
[316] A.K. Gaharwar, A. Patel, A. Dolatshahi-Pirouz, "Biomaterials Science poly(glycerol 
sebacate) chemically crosslinked with carbon nanotubes", Biomater. Sci., 2014,  
3, 46–58. 
[317] P. Kerativitayanan, A.K. Gaharwar, "Elastomeric and mechanically stiff 
nanocomposites from poly(glycerol sebacate) and bioactive nanosilicates", Acta 
Biomater., 2015, 26, 34–44. 
[318] S. Bodakhe, S. Verma, K. Garkhal, S.K. Samal, S.S. Sharma, N. Kumar, "Injectable 
photocrosslinkable nanocomposite based on poly(glycerol sebacate) fumarate and 
hydroxyapatite: development, biocompatibility and bone regeneration in a rat calvarial 
bone defect model", Nanomedicine, 2013, 8, 1777–1795. 
[319] H.M. Aydin, K. Salimi, M. Yilmaz, M. Turk, Z.M. Rzayev, E. Pişkin, "Synthesis and 
characterization of poly(glycerol-co-sebacate-co-ε-caprolactone) elastomers", J. Tissue 
Eng. Regen. Med., 2013, DOI: 10.1002/term.1759. 
[320] X. Li, A.T.L. Hong, N. Naskar, H.J. Chung, "Criteria for quick and consistent synthesis 
of poly(glycerol sebacate) for tailored mechanical properties", Biomacromolecules, 
2015, 16, 1525–1533. 
 207 
[321] E.L. Petsonk, M.L. Wang, D.M. Lewis, P.D. Siegel, B.J. Husberg, "Asthma-like 
symptoms in wood product plant workers exposed to methylene diphenyl 
diisocyanate", Chest., 2000, 118, 1183–1193. 
[322] L. Yu, K. Dean, L. Lin, "Polymer blends and composites from renewable resources", 
Prog. Polym. Sci., 2006, 31, 576–602. 
[323] M. Tallawi, R. Rai, M. R-Gleixner, O. Roerick, M. Weyand, J. a. Roether, D.W. 
Schubert, A. Kozlowska, M.E. Fray, B. Merle, M. Göken, K. Aifantis, A.R. 
Boccaccini, "Poly(glycerol sebacate)\poly(butylene succinate-dilinoleate) blends as 
candidate materials for cardiac tissue engineering", Macromol. Symp., 2013,  
334, 57–67. 
[324] J.A. Roether, R. Rai, R. Wolf, M. Tallawi, A.R. Boccaccini, "Biodegradable 
poly(glycerol sebacate)/poly(3-hydroxybutyrate)-TiO 2 nanocomposites: fabrication 
and characterisation", Mater. Sci. Technol., 2014, 30, 574–581. 
[325] T.H. Qazi, R. Rai, D. Dippold, J.E. Roether, D.W. Schubert, E. Rosellini, N. Barbani, 
A.R. Boccaccini, "Development and characterization of novel electrically conductive 
PANI-PGS composites for cardiac tissue engineering applications", Acta Biomater., 
2014, 10, 2434–2445. 
[326] T. Wu, M. Frydrych, K.O. Kelly, B. Chen, "Poly(glycerol sebacate urethane) − 
Cellulose nanocomposites with water-active shape-memory effects", 
Biomacromolecules, 2014, 15, 2663–2671. 
[327] G.W. Oetien, P. Haseley, Freeze-Drying, Weinheim: Wiley-VCH GmbH & Co. KGaA, 
2004, 1–407. 
[328] F. Franks, "Freeze-drying of bioproducts: putting principles into practice", Eur. J. 
Pharm. Biopharm., 1998, 45, 221–229. 
[329] E. Landi, F. Valentini, A. Tampieri, "Porous hydroxyapatite/gelatine scaﬀolds with ice-
designed channel-like porosity for biomedical applications", Acta Biomater., 2008,  
4, 1620–1626. 
[330] I. Aranaz, M.C. Gutiérrez, M.L. Ferrer, F. del Monte, "Preparation of chitosan 
nanocomposites with a macroporous structure by unidirectional freezing and 
subsequent freeze-drying", Mar. Drugs., 2014, 12, 5619–5642. 
[331] Labconco Corporation, "User’s Manual - FreeZone® TriadTM Freeze Dry System",  
2007, 1–59. 
[332] M.J. Pikal, S. Shah, M.L. Roy, R. Putman, "The secondary drying stage of freeze-
drying kinetics as a function of temperature and chamber pressure", Int. J. Pharm., 
1990, 60, 203–217. 
[333] L. Rey, J.C. May, Freeze Drying/Lyopilization of Pharmaceutical and Biological 
Products, Third Edition, London: CRC Press, 2010, 1–584. 
[334] Q. Hou, D.W. Grijpma, J. Feijen, "Preparation of interconnected highly porous 
polymeric structures by a replication and freeze-drying process", J. Biomed. Mater. 
Res. B, 2003, 67, 732–740. 
[335] F.J. O’Brien, B.A. Harley, I.V. Yannas, L. Gibson, "Influence of freezing rate on pore 
structure in freeze-dried collagen-GAG scaffolds", Biomaterials, 2004, 25, 1077–1086. 
[336] L.H. Sperling, Introduction to Physical Polymer Science, Fourth Edition, Hoboken: 
Wiley, 2005, 1–845. 
 208 
[337] C. Wan, B. Chen, "Reinforcement and interphase of polymer/graphene oxide 
nanocomposites", J. Mater. Chem., 2012, 22, 3637–3646. 
[338] J.S. Chawla, M.M. Amiji, "Biodegradable poly(ε-caprolactone) nanoparticles for 
tumor-targeted delivery of tamoxifen", Int. J. Pharm., 2002, 249, 127–138. 
[339] W. Cai, L. Liu, "Shape-memory effect of poly (glycerol-sebacate) elastomer", Mater. 
Lett., 2008, 62, 2175–2177. 
[340] V. Maquet, A.R. Boccaccini, L. Pravata, I. Notingher, R. Jérôme, "Porous poly(alpha-
hydroxyacid)/Bioglass composite scaffolds for bone tissue engineering. I: Preparation 
and in vitro characterisation.", Biomaterials, 2004, 25, 4185–4194. 
[341] S.P. Khan, G.G. Auner, G.M. Newaz, "Influence of nanoscale surface roughness on 
neural cell attachment on silicon", Nanomed. Nanotechnol., 2005, 1, 125–129. 
[342] J.Y. Lim, A.D. Dreiss, Z. Zhou, J.C. Hansen, C.A. Siedlecki, R.W. Hengstebeck, J. 
Cheng, N. Winograd, H.J. Donahue, "The regulation of integrin-mediated osteoblast 
focal adhesion and focal adhesion kinase expression by nanoscale topography", 
Biomaterials, 2007, 28, 1787–1797. 
[343] J.E. Nichols, J.A. Niles, J. Cortiella, "Production and utilization of acellular lung 
scaffolds in tissue engineering", J. Cell. Biochem., 2012, 113, 2185–2192. 
[344] X. Gu, F. Ding, Y. Yang, J. Liu, "Construction of tissue engineered nerve grafts and 
their application in peripheral nerve regeneration", Prog. Neurobiol., 2011,  
93, 204–230. 
[345] J. Tang, Z. Zhang, Z. Song, L. Chen, X. Hou, K. Yao, "Synthesis and characterization 
of elastic aliphatic polyesters from sebacic acid, glycol and glycerol", Eur. Polym. J., 
2006, 42, 3360–3366. 
[346] L. Lu, S.J. Peter, M.D. Lyman, H.L. Lai, S.M. Leite, J.A. Tamada, J.P. Vacanti, R. 
Langer, A.G. Mikos, "In vitro degradation of porous poly(L-lactic acid) foams", 
Biomaterials, 2000, 21, 1595–1605. 
[347] H. Tsuji, A. Mizuno, Y. Ikada, "Properties and morphology of poly(L-lactide). III. 
Effects of initial crystallinity on long-term in vitro hydrolysis of high molecular weight 
poly(L-lactide) film in phosphate-buffered solution", J. Appl. Polym. Sci., 2000,  
77, 1452–1464. 
[348] H. Tsuji, T. Ishizaka, "Blends of aliphatic polyesters. VI. Lipase-catalyzed hydrolysis 
and visualized phase structure of biodegradable blends from poly(ε-caprolactone) and 
poly(L-lactide)", Int. J. Biol. Macromol., 2001, 29, 83–89. 
[349] M. Frydrych, C. Wan, R. Stengler, K.U. O’Kelly, B. Chen, "Structure and mechanical 
properties of gelatin/sepiolite nanocomposite foams", J. Mater. Chem., 2011,  
21, 9103–9111. 
[350] Y. Gong, Q. Zhou, C. Gao, J. Shen, "In vitro and in vivo degradability and 
cytocompatibility of poly(L-lactic acid) scaffold fabricated by a gelatin particle 
leaching method", Acta Biomater., 2007, 3, 531–540. 
[351] Y. Cao, T.I. Croll, A.J. Oconnor, G.W. Stevens, J.J. Cooper-White, "Systematic 
selection of solvents for the fabrication of 3D combined macro- and microporous 
polymeric scaffolds for soft tissue engineering.", J. Biomater. Sci. Polym. Ed., 2006,  
17, 369–402. 
[352] M. J. Radford, J. Noakes, J. Read, D.G. Wood, "The natural history of a bioabsorbable 
 209 
interference screw used for anterior cruciate ligament reconstruction with a 4-strand 
hamstring technique", Arthrosc. J. Arthrosc. Relat. Surg., 2005, 21, 707–710. 
[353] V.J. Chen, P.X. Ma, "Nano-fibrous poly(L-lactic acid) scaffolds with interconnected 
spherical macropores", Biomaterials, 2004, 25, 2065–2073. 
[354] J. Zhang, L. Wu, D. Jing, J. Ding, "A comparative study of porous scaffolds with cubic 
and spherical macropores", Polymer, 2005, 46, 4979–4985. 
[355] S. Román, A. Mangera, N.I. Osman, A.J. Bullock, C.R. Chapple, S. MacNeil, 
"Developing a tissue engineered repair material for treatment of stress urinary 
incontinence and pelvic organ prolapse-which cell source?", Neurourol. Urodyn., 2014, 
33, 531–537. 
[356] M. Frydrych, B. Chen, "Large three-dimensional poly(glycerol sebacate)-based 
scaffolds – a freeze-drying preparation approach", J. Mater. Chem. B, 2013,  
1, 6650–6661. 
[357] A. Montesi, M. Pasquali, F.C. MacKintosh, "Collapse of a semiflexible polymer in 
poor solvent", Phys. Rev. E Stat. Nonlin. Soft Mattern Phys., 2004, 69, 021916. 
[358] L.J. Gibson, "Biomechanics of cellular solids", J. Biomech., 2005, 38, 377–399. 
[359] S.H. Oh, J.H. Lee, "Hydrophilization of synthetic biodegradable polymer scaffolds for 
improved cell/tissue compatibility", Biomed. Mater., 2013, 8, 014101. 
[360] K. Wittmann, S. Dietl, N. Ludwig, O. Berberich, C. Hoefner, K. Storck, T. Blunk, P. 
Bauer-Kreisel, "Engineering vascularized adipose tissue using the stromal-vascular 
fraction and fibrin hydrogels", Tissue Eng. A, 2015, 21, 1343–1353. 
[361] R.P. Lanza, R. Langer, J. Vacanti, Principles of Tissue Engineering, San Diego: 
Academic Press, 2000, 1-995. 
[362] L. Li, S. Pan, B. Ni, Y. Lin, "Improvement in autologous human fat transplant survival 
with SVF plus VEGF-PLA nano-sustained release microspheres", Cell Biol. Int., 2014, 
38, 962–970. 
[363] A.J. Kinloch, R.J. Young, Fracture Behaviour of Polymers, London and New York: 
Applied Science Publisher, 1983, 1–496. 
[364] H. Cheng, P.S. Hill, D.J. Siegwart, N. Vacanti, A.K.R. Lytton-Jean, S.W. Cho, A. Ye, 
R. Langer, D.G. Anderson, "A Novel Family of Biodegradable Poly(ester amide) 
Elastomers", Adv. Mater., 2011, 23, H95–H100. 
[365] Q. Liu, L. Jiang, R. Shi, L. Zhang, "Synthesis, preparation, in vitro degradation, and 
application of novel degradable bioelastomers - A review", Prog. Polym. Sci., 2012,  
37, 715–765. 
[366] F.S. Yen, J.L. Hong, "Hydrogen-bond interactions between ester and urethane linkages 
in small model compounds and polyurethanes", Macromolecules, 1997,  
30, 7927–7938. 
[367] M. Frydrych, S. Román, S. MacNeil, B. Chen, "Biomimetic poly(glycerol 
sebacate)/poly(L-lactic acid) blend scaffolds for adipose tissue engineering", Acta 
Biomater., 2015, 18, 40–49. 
[368] H. Shearer, M.J. Ellis, S.P. Perera, J.B. Chaudhuri, "Effects of common sterilization 
methods on the structure and properties of poly(D,L lactic-co-glycolic acid) scaffolds", 
Tissue Eng., 2006, 12, 2717–2727. 
[369] Z. Pan, J. Ding, "Poly(lactide-co-glycolide) porous scaffolds for tissue engineering and 
 210 
regenerative medicine", Interface Focus., 2012, 2, 366–377. 
[370] T. Siritientong, T. Srichana, P. Aramwit, "The Effect of Sterilization Methods on the 
Physical Properties of Silk Sericin Scaffolds", AAPS PharmSciTech., 2011,  
12, 771–781. 
[371] S.B.G. Blanquer, S.P. Haimi, A.A. Poot, D.W. Grijpma, "Effect of pore characteristics 
on mechanical properties and annulus fibrosus cell seeding and proliferation in 
designed PTMC tissue engineering scaffolds", Macromol. Symp., 2013, 334, 75–81. 
[372] M. Frydrych, S. Román, N.H. Green, S. MacNeil, B. Chen, "Thermoresponsive, 
stretchable, biodegradable and biocompatible poly(glycerol sebacate)-based 
polyurethane hydrogels", Polym. Chem., 2015, 6, 7974–7987. 
[373] L. Budyanto, Y.Q. Goh, C.P. Ooi, "Fabrication of porous poly(L-lactide) (PLLA) 
scaffolds for tissue engineering using liquid-liquid phase separation and freeze 
extraction", J. Mater. Sci. Mater. Med., 2009, 20, 105–111. 
[374] R. Zhang, P.X. Ma, "Poly(α-hydroxyl acids)/hydroxyapatite porous composites for 
bone-tissue engineering", J. Biomed. Mater. Res., 1999, 44, 446–455. 
[375] C. Tu, Q. Cai, J. Yang, Y. Wan, J. Bei, S. Wang, "The fabrication and characterization 
of poly(lactic acid) scaffolds for tissue engineering by improved solid–liquid phase 
separation", Polym. Adv. Technol., 2003, 14, 565–573. 
[376] E. Nejati, V. Firouzdor, M.B. Eslaminejad, F. Bagheri, "Needle-like nano 
hydroxyapatite/poly(L-lactide acid) composite scaffold for bone tissue engineering 
application", Mater. Sci. Eng. C, 2009, 29, 942–949. 
[377] G. Wei, P.X. Ma, "Structure and properties of nano-hydroxyapatite/polymer composite 
scaffolds for bone tissue engineering", Biomaterials, 2004, 25, 4749–4757. 
[378] P.X. Ma, J.W. Choi, "Biodegradable polymer scaffolds with well-defined 
interconnected spherical pore network", Tissue Eng., 2001, 7, 23–33. 
[379] D. Jing, L. Wu, J. Ding, "Solvent-assisted room-temperature compression molding 
approach to fabricate porous scaffolds for tissue engineering", Macromol. Biosci., 
2006, 6, 747–757. 
[380] J.J. Blaker, V. Maquet, R. Jérôme, A.R. Boccaccini, S.N. Nazhat, "Mechanical 
properties of highly porous PDLLA/Bioglass® composite foams as scaffolds for bone 
tissue engineering", Acta Biomater., 2005, 1, 643–652. 
[381] L. Wu, H. Zhang, J. Zhang, J. Ding, "Fabrication of three-dimensional porous scaffolds 
of complicated shape for tissue engineering. I. Compression molding based on flexible-
rigid combined mold", Tissue Eng., 2005, 11, 1105–1114. 
[382] L.D. Harris, B.S. Kim, D.J. Mooney, "Open pore biodegradable matrices formed with 
gas foaming", J. Biomed. Mater. Res., 1998, 42, 396–402. 
[383] J. Zhang, H. Zhang, L. Wu, J. Ding, "Fabrication of three dimensional polymeric 
scaffolds with spherical pores", J. Mater. Sci., 2006, 41, 1725–1731. 
[384] L. Wu, J. Zhang, D. Jing, J. Ding, "“Wet-state” mechanical properties of three-
dimensional polyester porous scaffolds", J. Biomed. Mater. Res., 2006, 76, 264–271. 
[385] H.M. Wong, P.K. Chu, F.K.L. Leung, K.M.C. Cheung, K.D.K. Luk, K.W.K. Yeung, 
"Engineered polycaprolactone–magnesium hybrid biodegradable porous scaffold for 
bone tissue engineering", Prog. Nat. Sci. Mater. Int., 2014, 24, 561–567. 
[386] M.J. Chern, L.Y. Yang, Y.K. Shen, J.H. Hung, "3D scaffold with PCL combined 
 211 
biomedical ceramic materials for bone tissue regeneration", Int. J. Precis. Eng. Manuf., 
2013, 14, 2201–2207. 
[387] F. Naghizadeh, N. Sultana, M.R.A. Kadir, T.M.T.M. Shihabudin, R. Hussain, T. 
Kamarul, "The fabrication and characterization of PCL/rice husk derived bioactive 
glass-ceramic composite scaffolds", J. Nanomater., 2014, 2014, 253185. 
[388] F. Wu, C. Liu, B. O’Neill, J. Wei, Y. Ngothai, "Fabrication and properties of porous 
scaffold of magnesium phosphate/polycaprolactone biocomposite for bone tissue 
engineering", Appl. Surf. Sci., 2012, 258, 7589–7595. 
[389] M. Diba, M. Kharaziha, M.H. Fathi, M. Gholipourmalekabadi, A. Samadikuchaksaraei, 
"Preparation and characterization of polycaprolactone/forsterite nanocomposite porous 
scaffolds designed for bone tissue regeneration", Compos. Sci. Technol., 2012,  
72, 716–723. 
[390] J.J. Kim, R.K. Singh, S.J. Seo, T.H. Kim, J.H. Kim, E.J. Lee, H.W. Kim, "Magnetic 
scaffolds of polycaprolactone with functionalized magnetite nanoparticles: 
physicochemical, mechanical, and biological properties effective for bone 
regeneration", RSC Adv., 2014, 4, 17325–17336. 
[391] P. Fabbri, V. Cannillo, A. Sola, A. Dorigato, F. Chiellini, "Highly porous 
polycaprolactone-45S5 Bioglass® scaffolds for bone tissue engineering", Compos. Sci. 
Technol., 2010, 70, 1869–1878. 
[392] H. Zhang, A.I. Cooper, "Aligned porous structures by directional freezing", Adv. 
Mater., 2007, 19, 1529–1533. 
[393] Z. Tong, X. Jia, "Biomaterials-based strategies for the engineering of mechanically 
active soft tissues", MRS Commun., 2012, 2, 31–39. 
[394] S. Mitragotri, J. Lahann, "Physical approaches to biomaterial design", Nat. Mater., 
2009, 8, 15–23. 
[395] C.J. Bettinger, "Synthesis and microfabrication of biomaterials for soft-tissue 
engineering", Pure Appl. Chem., 2009, 81, 2183–2201. 
[396] J. Yang, D. Motlagh, A.R. Webb, G.A. Ameer, "Novel biphasic elastomeric scaffold 
for small-diameter blood vessel tissue engineering", Tissue Eng., 2005, 11, 1876–1886. 
[397] N. Annabi, J.W. Nichol, X. Zhong, C. Ji, S. Koshy, F. Khademhosseini, A. Dehghani, 
"Controlling the porosity and microarchitecture of hydrogels for tissue engineering", 
Tissue Eng. B, 2010, 16, 371–383. 
[398] A. Khademhosseinia, R. Langer, "Microengineered hydrogels for tissue engineering", 
Biomaterials, 2007, 28, 5087–5092. 
[399] J. Tuominen, J. Kylma, A. Kapanen, O. Venelampi, M. Itävaara, J. Seppälä, 
"Biodegradation of lactic acid based polymers under controlled composting conditions 
and evaluation of the ecotoxicological impact", Biomacromolecules, 2002, 3, 445–455. 
[400] K. Park, W.S.W. Shalby, H. Park, Biodegradable Hydrogels for Drug Delivery, 
Lancaster: CRC Press, 1993, 1–262. 
[401] J. Ruiz, A. Mantecón, V. Cádiz, "Synthesis and properties of hydrogels from poly(vinyl 
alcohol) and ethylenediaminetetraacetic dianhydride", Polymer, 2001, 42, 6347–6354. 
[402] D.R. Ralston, C. Layton, A.J. Dalley, S.G. Boyce, E. Freedlander, S. MacNeil, 
"Keratinocytes contract human dermal extracellular matrix and reduce soluble 
fibronectin production by fibroblasts in a skin composite model", Br. J. Plast. Surg., 
 212 
1997, 50, 408–415. 
[403] M. Li, O. Rouaud, D. Poncelet, "Microencapsulation by solvent evaporation: State of 
the art for process engineering approaches", Int. J. Pharm., 2008, 363, 26–39. 
[404] R. París, Á. Marcos-Fernández, I. Quijada-Garrido, "Synthesis and characterization of 
poly(ethylene glycol)-based thermo-responsive polyurethane hydrogels for controlled 
drug release", Polym. Adv. Technol., 2013, 24, 1062–1067. 
[405] M.W. Urban, C.L. Allison, "Interfacial studies of crosslinked urethanes: Part IV. 
Substrate effect on film formation in polyester waterborne polyurethanes", J. Coatings 
Technol., 1999, 71, 73–78. 
[406] R. Maliger, P.J. Halley, J.J. Cooper-White, "Poly(glycerol-sebacate) bioelastomers-
kinetics of step-growth reactions using Fourier Transform (FT)-Raman spectroscopy", 
J. Appl. Polym. Sci., 2013, 127, 3980–3986. 
[407] D. Yamini, G. Devanand Venkatasubbu, J. Kumar, V. Ramakrishnan, "Raman 
scattering studies on PEG functionalized hydroxyapatite nanoparticles", Spectrochim. 
Acta A Mol. Biomol. Spectrosc., 2014, 117, 299–303. 
[408] Y. Jin, M. Sun, D. Mu, X. Ren, Q. Wang, L. Wen, "Investigation of PEG adsorption on 
copper in Cu 2+ -free solution by SERS and AFM", Electrochim. Acta., 2012,  
78, 459–465. 
[409] S.Y. Moon, Y.D. Park, C.J. Kim, C.H. Won, Y.S. Lee, "Effect of chain extenders on 
polyurethanes containing both poly(butylene succinate) and poly(ethylene glycol) as 
soft segments", Bull. Korean Chem. Soc., 2003, 24, 1361–1364. 
[410] Z. You, H. Cao, J. Gao, P.H. Shin, B.W. Day, Y. Wang, "A functionalizable polyester 
with free hydroxyl groups and tunable physiochemical and biological properties", 
Biomaterials, 2010, 31, 3129–3138. 
[411] Y. Li, Q. Ma, C. Huang, G. Liu, "Crystallization of poly(ethylene glycol) in 
poly(methyl methacrylate) networks", Mater. Sci. Medzg., 2013, 19, 147–151. 
[412] H.L. Lim, Y. Hwang, M. Kar, S. Varghese, "Smart hydrogels as functional biomimetic 
systems", Biomater. Sci., 2014, 2, 603–618. 
[413] A.B. Imran, T. Seki, Y. Takeoka, "Recent advances in hydrogels in terms of fast 
stimuli responsiveness and superior mechanical performance", Polym. J., 2010,  
42, 839–851. 
[414] K. Deligkaris, T.S. Tadele, W. Olthuis, A. van den Berg, "Hydrogel-based devices for 
biomedical applications", Sensor. Actuat. B Chem., 2010, 147, 765–774. 
[415] A.K. Bajpai, S.K. Shukla, S. Bhanu, S. Kankane, "Responsive polymers in controlled 
drug delivery", Prog. Polym. Sci., 2008, 33, 1088–1118. 
[416] Y. Qiu, K. Park, "Environment-sensitive hydrogels for drug delivery", Adv. Drug 
Deliv. Rev., 2012, 64, 49–60. 
[417] L. Ionov, "Hydrogel-based actuators: Possibilities and limitations", Mater. Today., 
2014, 17, 494–503. 
[418] L. Klouda, A.G. Mikos, "Thermoresponsive hydrogels in biomedical applications", 
Eur. J. Pharm. Biopharm., 2008, 68, 34–45. 
[419] H.G. Schild, "Poly(N-isopropylacrylamide): Experiment, theory and application", 
Prog. Polym. Sci., 1992, 17, 163–249. 
[420] K. Knop, R. Hoogenboom, D. Fischer, U.S. Schubert, "Poly(ethylene glycol) in drug 
 213 
delivery: Pros and cons as well as potential alternatives", Angew. Chem. Int. Ed., 2010, 
49, 6288–6308. 
[421] S.J. Kim, I. Jun, D.W. Kim, Y.B. Lee, Y.J. Lee, J.H. Lee, K.D. Park, H. Park, H. Shin, 
"Rapid transfer of endothelial cell sheet using a thermosensitive hydrogel and its effect 
on therapeutic angiogenesis", Biomacromolecules, 2013, 14, 4309–4319. 
[422] I. Jun, Y.B. Lee, Y.S. Choi, A.J. Engler, H. Park, H. Shin, "Transfer stamping of 
human mesenchymal stem cell patches using thermally expandable hydrogels with 
tunable cell-adhesive properties", Biomaterials, 2015, 54, 44–54. 
[423] O.O. Akintewe, S.J. DuPont, K.K. Elineni, M.C. Cross, R.G. Toomey, N.D. Gallant, 
"Shape-changing hydrogel surfaces trigger rapid release of patterned tissue modules", 
Acta Biomater., 2015, 11, 96–103. 
[424] A. Kikuchi, T. Okano, "Nanostructured designs of biomedical materials: Applications 
of cell sheet engineering to functional regenerative tissues and organs", J. Control. 
Release., 2005, 101, 69–84. 
[425] X. Huang, C.S. Brazel, "On the importance and mechanisms of burst release in matrix-
controlled drug delivery systems", J. Control. Release., 2001, 73, 121–136. 
[426] M. Ma, L. Guo, D.G. Anderson, R. Langer, "Bio-inspired polymer composite actuator 
and generator driven by water gradients", Science, 2012, 339, 9–12. 
[427] Y. Tan, K. Xu, P. Wang, W. Li, S. Sun, L.S. Dong, "High mechanical strength and 
rapid response rate of poly(N-isopropyl acrylamide) hydrogel crosslinked by starch-
based nanospheres", Soft Matter., 2010, 6, 1467-1471. 
[428] Z. Li, J. Shen, H. Ma, X. Lu, M. Shi, N. Li, M. Ye, "Preparation and characterization of 
pH- and temperature-responsive nanocomposite double network hydrogels", Mater. 
Sci. Eng. C, 2013, 33, 1951–1957. 
[429] K. Haraguchi, T. Takehisa, S. Fan, "Effects of clay content on the properties of 
nanocomposite hydrogels composed of poly(N-isopropylacrylamide) and clay", 
Macromolecules, 2002, 35, 10162–10171. 
[430] N.K. Varde, D.W. Pack, "Microspheres for controlled release drug delivery", Expert 
Opin. Biol. Ther., 2004, 4, 35–51. 
[431] Y.B. Kim, G.H. Kim, "Rapid-prototyped collagen scaffolds reinforced with PCL/β-
TCP nanofibres to obtain high cell seeding efficiency and enhanced mechanical 
properties for bone tissue regeneration", J. Mater. Chem., 2012, 22, 16880–16889. 
[432] S.H. Ahn, Y.B. Kim, H.J. Lee, G.H. Kim, "A new hybrid scaffold constructed of solid 
freeform-fabricated PCL struts and collagen struts for bone tissue regeneration: 
fabrication, mechanical properties, and cellular activity", J. Mater. Chem. Chem., 2012, 
22, 15901–15909. 
 
  
 214 
Appendix A - Supplementary information for Chapter 3 
 
Figure 3.S1: (A, B) SEM micrographs of the cured PGS (24 h at 150 °C) film surface, after 
24 h ethanol extraction. 
 
 
Figure 3.S2: (A) Top and (B) side view (cross section) of non-cured freeze-dried PLLA 
scaffold, produced with 2 g PLLA and 40 mL 1,4-dioxane. 
 
 
Figure 3.S3: (A) Top and (B) side view of cured PGS/PLLA blend scaffold with a weight 
ratios of 2.5:1. 
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Figure 3.S4: (A) Top and (B) side view of cured PGS/PLLA blend scaffold with a weight 
ratios of 3:1. 
 
 
Figure 3.S5: (A) Top and (B) side view of cured PGS/PLLA blend scaffold with a weight 
ratios of 3.5:1. 
 
 
Figure 3.S6: (A) Top and (B) side view of cured PGS/PLLA blend scaffold with a weight 
ratios of 4:1. 
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Figure 3.S7: Pictures of cured PGS film (24 h for 150 °C) samples, (A1, B1) before and (A2, 
B2) after 31 days in vitro biodegradation tests in (A1-2) enzyme-free and in (B1-2)  
enzyme-containing PBS solution. 
 
 
Figure 3.S8: Pictures of PLLA scaffold samples, (A1, B1) before and (A2, B2) after 31 days 
in vitro biodegradation tests in (A1-2) enzyme-free and in (B1-2) enzyme-containing  
PBS solution. 
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Figure 3.S9: Pictures of PGS/PLLA scaffold samples with a weight ratio of 2.5:1, (A1, B1) 
before and (A2, B2) after 31 days in vitro biodegradation tests in (A1-2) enzyme-free and in 
(B1-2) enzyme-containing PBS solution. 
 
 
Figure 3.S10: Pictures of PGS/PLLA scaffold samples with a weight ratio of 3:1, (A1, B1) 
before and (A2, B2) after 31 days in vitro biodegradation tests in (A1-2) enzyme-free and in 
(B1-2) enzyme-containing PBS solution. 
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Appendix B - Supplementary information for Chapter 4 
 
Figure 4.S1: Histograms of the pore size distribution of PLLA-D (narrow distribution:  
50 µm - 100 µm), PGS/PLLA-D (wide distribution: 75 µm - 175 µm) and PGS/PLLA-DMC 
(wide distribution: 50 µm - 175 µm) scaffold samples (n = 350). 
 
 
Figure 4.S2: Compressive stress-strain curve for PLLA-D scaffold. 𝐸𝑐 is the Young’s 
modulus, 𝜎𝑐 and 𝜀𝑐 are the collapse stress and strain. ∆𝜎 ∆𝜀⁄  is the linear regression of the 
collapse plateau regime. The compressive stress-strain curve is characterised with a distinct 
linear elastic, collapse plateau and densification regime. 
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Figure 4.S3: Percentage of weight loss of PLLA and PGS (cured at 120 °C for 36 h) films, 
incubated in PBS for up to 31 days in a shaker incubator at 37 °C and 100 rpm (n = 3; 
Diameter: 6 mm and thickness: 0.44 ± 0.12 mm). The PLLA specimens maintained in the 
enzyme-free and lipase enzyme-containing PBS solution a constant weight and obtained in 
both cases a negligible weight loss of less than 3% in 31 days. During the test period PGS 
presented in the enzymatic-free PBS solution a weight loss of 18%, while in the lipase 
enzyme-containing PBS solution PGS obtained an increased weight loss of 45%. 
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Figure 4.S4: SEM micrographs of the (A1-3) PLLA and (B1-3) PGS film surface: (A1, B1) 
untreated (36 h at 120 ˚C), after 31 days at 37 ˚C in (A2, B2) enzyme-free PBS solution and 
(A3, B3) in lipase enzyme-containing PBS solution. 
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Figure 4.S5: (A, B, C) Histological section of a PGS/PLLA-D scaffold control sample 
(without cells), stained with haematoxylin and eosin after 21 days in DMEM. The results 
present a relatively porous scaffold microstructure with large pore sizes. 
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Figure 4.S6: (A, B, C) Histological section of an ADSC-seeded PGS/PLLA-D scaffold 
sample, stained with haematoxylin and eosin after cultured for 21 days in DMEM. The results 
present a high density of structural integrated cells and ECM within the cell-seeded scaffold 
surface, overall improving the structure integrity of the scaffold. 
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Appendix C - Supplementary information for Chapter 5 
  
Figure 5.S1: Histograms of the pore size distribution of (A) “as-prepared” and (B) cleaned 
and dry PGSU scaffold samples (n = 450). 
 
 
Figure 5.S2: Pictures of PGSU-1:0.4 scaffold samples, (A1, B1) before and (A2, B2) after 
112 days in vitro biodegradation tests in (A1-2) enzyme-free and in (B1-2)  
enzyme-containing PBS solution. 
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Figure 5.S3: Pictures of PGSU-1:0.5 scaffold samples, (A1, B1) before and (A2, B2) after 
112 days in vitro biodegradation tests in (A1-2) enzyme-free and in (B1-2)  
enzyme-containing PBS solution. 
 
 
Figure 5.S4: Pictures of PGSU-1:0.6 scaffold samples, (A1, B1) before and (A2, B2) after 
112 days in vitro biodegradation tests in (A1-2) enzyme-free and in (B1-2)  
enzyme-containing PBS solution.  
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Table 5.S1. Selected physical properties of polymer scaffolds reported in the literature. 
Polymer Fabrication 
Method 
Porosity, 
Pf  / % 
Relative density, 
ρr / (1-Pf) 
Compressive modulus, 
Ec / MPa 
Reference 
PLLA TIPSb 82.4 0.176 4.40 [373] 
PLLA TIPSb 81.3 0.187 7.50 [373] 
PLLA TIPSb 92.7 0.073 6.00 [374] 
PLLA SC/PLc 93.5 0.065 3.60 [375] 
PLLA SC/PLc 95.5 0.045 3.10 [375] 
PLLA SC/PLc 96.4 0.036 2.30 [375] 
PLLA SC/PLc 98.5 0.015 2.10 [375] 
PLLA TIPSb 87.0 0.130 1.79 [376] 
PLLA TIPSb 93.0 0.070 4.30 [377] 
PLLA SC/PLc 94.5 0.055 0.30 [378] 
PLLA SC/PLc 96.8 0.032 0.02 [378] 
PLLA SC/PLc 95.2 0.048 0.05 [378] 
PLLA SC/PLc 95.8 0.042 0.05 [378] 
PLLA SC/PLc 96.1 0.039 0.08 [378] 
PDLLA RM/PL 90.0 0.100 5.20 [379] 
PDLLA RM/PL 92.6 0.074 1.70 [379] 
PDLLA TIPSb 94.0 0.06 0.89 [380] 
PDLLA SC/PLc 93.0 0.070 2.40 [381] 
PLGA SC/PL 90.0 0.100 0.16 [382] 
PLGA GF/PL 90.0 0.100 0.29 [382] 
PLGA SC/PLc 97.0 0.030 0.25 [383] 
PLGA SC/PLc 93.0 0.070 2.00 [383] 
PLGA SC/PLc 92.0 0.080 3.00 [383] 
PLGA SC/PLc 91.5 0.085 3.50 [383] 
PLGA SC/PLc 87.0 0.130 7.50 [383] 
PLGA SC/PLc 80.0 0.200 12.00 [383] 
PLGA RM/PL 88.0 0.120 14.80 [384] 
PLGA RM/PL 88.0 0.120 7.50 [384] 
PLGA RM/PL 88.0 0.120 7.00 [384] 
PLGA RM/PL 88.0 0.120 5.50 [384] 
PLGA RM/PL 88.0 0.120 4.50 [384] 
PCL SC/PLc 74.0 0.260 0.40 [385] 
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PCL SC/PLc 88.1 0.119 0.22 [386] 
PCL TIPSb 80.0 0.200 0.38 [387] 
PCL SC/PLc 76.0 0.240 4.32 [388] 
PCL SC/PLc 93.0 0.070 3.10 [389] 
PCL SC/PLc 65.0 0.350 1.20 [390] 
PCL TIPSb 89.0 0.110 0.08 [391] 
PCL TIPSb 88.0 0.120 0.19 [391] 
a Freeze-drying; b Thermally induced phase separation; c Solvent casting / particulate leaching; 
RM/PL = Room temperature compression moulding / particular leaching; GF/PL = Gas 
foamed / particular leaching. 
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Appendix D - Supplementary information for Chapter 6 
 
Figure 6.S1: Images of performed metabolic activity assay tests (at days 0, 3, 6 and 9), 
illustrating the resazurin color change for FIBs and ADSCs cultured PEUs in comparison to 
cell-free PEU control specimens. Briefly, the assay is based on the mechanism that blue 
resazurin can only be reduced to pink resorufin by proliferating cells. Thus, the production of 
pink resorufin correlates confidently with cell viability and proliferation.  
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Figure 6.S2: Estimation of the volume phase transition temperature (VPTT) of (A) PEU-400, 
(B) PEU-1000 and (C) PEU-1450 films by the cloud point method and defined in a 
temperature range at the onset of cloudiness by optical conformation. Briefly, the absorbance 
coefficient (absorbance/sample thickness) at 600 nm was measured as a function of the PBS 
solution temperature (monitored at 5, 21, 37, 55, 71 and 86 °C) with a UV-Vis spectrometer 
(Perkin Elmer Lambda 900. Pre-hydrated samples (n = 5; 24 h saturation in PBS solution at 
21 °C) were submerged for 2 h in the temperature monitored PBS solution, and the 
absorbance of the individual swollen specimens and the sample thickness were measured. No 
sharp VPTT transitions were observed in the figure; PEU-400, PEU-1000 and PEU-1450 
specimens presented a VPTT within the range of 37-55 °C, 55-71 °C and 71-86 °C, 
respectively. The VPTT can be defined as the critical temperature below which the hydrogel 
swells (hydrophilic characteristics) and above which the hydrogel contracts (hydrophobic 
characteristics). The results imply that the VPTT is adjustable and that the incorporation of 
higher molecular weight PEG increased the VPTT, due to its enhanced hydrophilicity. (D) 
Swollen PEUs were transparent at low medium temperatures but changed to opaque at higher 
temperatures, which is associated with temperature-dependent phase separation of the 
hydrogels from the aqueous solution. 
 
Movie 6.S1: Water temperature responsive cantilever tests (see Section 6.2.10 and  
Scheme 6.2). The supplemental movie is in MP4 format included on the enclosed CD-ROM. 
